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Preface to the Second Edition
The first edition of Orthogeriatrics [1] stressed that the key feature of older patients 
with fragility fractures is that they often have the dual problem of fragility (of the 
bone) and frailty (of their entire physiology). Therefore, the appropriate mode of 
management in the acute phase is orthogeriatric co-management, bringing to bear 
the relevant skillsets for dealing with these two problems simultaneously. We 
asserted that this is true in all parts of the planet but that card-carrying geriatricians 
are not essential—geriatric competencies can be acquired by other physicians in 
countries where the discipline of geriatric medicine is not well established—and we 
tried to show what these competencies are. This second edition takes that attempt 
further, in the context of two significant developments that have occurred over the 
last 3 years.
The first was the publication of A global call to action to improve the care of 
people with fragility fractures [2]. The writing of this paper was led by the Fragility 
Fracture Network (FFN), with input from five other international organisations 
(EFORT, EuGMS, ICON, IGFS and IOF). It was then endorsed, prior to publica-
tion, by a further 75 organisations from the relevant disciplines, some global, some 
regional and some national from the larger countries of Brazil, China, India, Japan 
and the United States of America. Since publication, a steady stream of other 
national professional associations has been adding their endorsement.
However, this uniquely broad base of support is not the only special feature of 
this statement. It not only covers (i) the multidisciplinary management of the acute 
post-fracture period but also encompasses (ii) the rehabilitation phase, starting 
immediately post-op but continuing for the rest of the patient’s life and (iii) the vital 
business of secondary prevention—stopping the next fracture by addressing both 
osteoporosis and falls risk. We have come to refer to these as the three ‘Clinical 
Pillars’ of the Call to Action (CtA). To these, a fourth pillar was added—the politi-
cal pillar of creating national multidisciplinary alliances between the relevant main-
stream professional associations, which can push for the policy change and 
multi-professional education needed to give impetus to the first three. The CtA has 
brought home the fact that these four elements are all essential to tackle the problem 
of fragility fractures going forward. Their linkage has effectively enlarged the mean-
ing of ‘the orthogeriatric approach’ to encompass all the four pillars.
The second significant development was the development of the Regionalisation 
Policy of the FFN. This is specifically aimed at stimulating the creation of National 
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FFNs (nFFNs), who have the mission to promote the implementation of the four 
pillars of the CtA in their country. It was devised to address the fact that the ageing 
trajectory, and hence the predictions of fragility fracture incidence, are worst in the 
emerging economies of Asia Pacific, Latin America and the Middle East, where the 
FFN was least well established and from where health professionals could least 
afford to come to meetings in Europe, where the FFN was strong and the concept of 
orthogeriatrics better established. However, the fact that healthcare policy can only 
be changed at a national level means that the rationale for nFFNs is just as valid in 
the mature economies of Europe, North America and elsewhere.
This strategy has been accelerated by organising the so-called Regional Expert 
Meetings, starting in the Asia Pacific region and continued in Latin America and 
Europe. By March 2020, there were 14 nFFNs, 8 of them in Asia Pacific.
At a meeting held in Oxford, following the 2019 Global Congress, the authors of 
the chapters in this book got together with other fragility fracture activists to con-
sider how the second edition needed to be modified to properly take into account 
these developments. The conclusions reached, including the grouping of chapters in 
accordance with the pillars of the Call to Action, are described in Chap. 1, which 
functions as a guide to the book as a whole.
This edition is open access and planned to be translated into several languages; 
we hope that this will increase the impact of the book in stimulating positive change 
on the ground, to the benefit of patients.
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This chapter is a component of Part 1: Background.
An explanation of the grouping of chapters in this book is given in this chapter.
The Multidisciplinary Approach 
to Fragility Fractures Around the World: 
An Overview
David Marsh, Paul Mitchell, Paolo Falaschi, 
Lauren Beaupre, Jay Magaziner, Hannah Seymour, 
and Matthew Costa
1.1  Introduction
The opening chapter of the first edition of this book [1] told the story of the early 
evolution of orthogeriatric co-management in the UK and the beginnings of its 
spread around the world. It covered evidence accumulated up to 2016. That history 
will not be repeated here. Instead, this chapter aims to provide a guide to the book 
as a whole, which—as well as reviewing the more recent evidence—will consider 
the basic competencies that an effective orthogeriatric approach should deliver and 
propose how they might be supplied in health economies with fewer resources, in 
particular fewer geriatricians.
We are considering the orthogeriatric approach in its wider sense, covering the 
entire post-fracture pathway, including rehabilitation and secondary prevention, as 
well as multidisciplinary co-management of the acute fracture episode.
Already in 2015, a significant number of published studies showed better out-
comes and improved cost-effectiveness with orthogeriatric co-management [2]. As 
Fig. 1.1 shows, the accumulation of further evidence since then has accelerated and 
there have now been almost 3500 publications in the decade beginning 2010, albeit 
not all uniformly positive in their assessment of the approach.
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One important publication in 2017 was the UN report on World Population 
Prospects [3]. Among other things, this gives—for each country—the Old-Age 
Dependency Ratio: The number of people aged 65 years or older per 100 persons 
of working age (15–64). As Fig. 1.2 shows (giving Thailand as a somewhat extreme 
example), nothing illustrates more dramatically the suddenness of the demographic 
change the world will experience.
The curves are a little less steep in the developed healthcare economies because 
the ageing of the population has already been progressing in those territories for 
longer. In Africa, the ratio does not rise so high in the current century but otherwise, 
in most regions, levels of 40–60 are expected by 2100. Thus—at this moment in 
history—humankind is en route to a new demographic era.
The challenge of the ageing population, in terms of predicted population inci-
dence of fragility fractures, is described in Chap. 2. However, the Old-Age 
Dependency Ratio adds a further dimension, stressing the societal consequences of 
ageing. The implications include:
• Society will need older people to be independent for much longer in the future. 
Prevention of fragility fractures and restoration of function after those fractures 
that do occur can make a significant contribution to that independence
• Mere survival after fracture is not going to be enough; we have to provide much 
more effective rehabilitation, so that ‘dependency’ is reduced/postponed: quality 
of life being more important to patients than longevity per se
• The change, and thus the pressure on health and social care services, is going to 
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Fig. 1.1 Cumulative numbers of citations for keyword ‘orthogeriatrics’ in Google Scholar
D. Marsh et al.
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1.2  General Developments Since 2016
The explosion of data generation indicates that clinical leaders all over the world are 
recognising the challenge and rising to it. However, it was also accompanied by 
other positive developments.
1.2.1  The Global Call to Action
At the conclusion of the 6th Global Congress of the Fragility Fracture Network 
(FFN) in Rome in 2016, five other organisations1 joined with FFN in laying out their 
vision for the following decade of work in fragility fractures. This led to the col-
laborative writing of a Global Call to Action, which was published in 2018 
1 The European Federation of National Associations of Orthopaedics and Traumatology (EFORT), 
European Union Geriatric Medicine Society (EuGMS), International Collaboration of Orthopaedic 
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Fig. 1.2 The previous and projected Old-Age Dependency Ratio for Thailand (see text). (Data 
from [3], with permission)
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[4]—after it had been endorsed by 81 relevant professional associations, either 
international or from the countries with the largest populations (Brazil, China, India, 
Japan and USA). The recommendations in this paper can be summarised as four 
‘pillars’:
 1. Multidisciplinary care of the acute fracture episode along orthogeriatric lines
 2. Excellent rehabilitation to recover function, independence and quality of life, 
starting immediately but continued long term
 3. Reliable secondary prevention after every fragility fracture, addressing falls risk 
as well as bone health
 4. Formation of multidisciplinary national alliances to promote policy change that 
enables the above three
Following publication, invitations to relevant national professional associations 
to endorse the Call to Action have been made; the total extent of global endorsement 
can be followed on the FFN website (www.fragilityfracturenetwork.org).
This succinct description of the entire sequence that should be triggered by a 
fragility fracture, plus the fourth—enabling—pillar, has effectively expanded the 
meaning of ‘the orthogeriatric approach’ to encompass the total response, not just 
the first phase. This integrated concept is well described by Pioli et al. [5], arguing 
that all elements are required in order to optimise patients’ recovery from their 
fracture.
1.2.2  The Formation of National FFNs
The fourth pillar, multidisciplinary national alliances, took some time to achieve 
in the UK and other pioneer countries. Now, clinical leaders in countries wishing 
to take this path can speed up the process considerably by creating National FFNs. 
The National FFN is not the multidisciplinary national alliance per se—it is the 
catalyst to achieve it; the alliance has to be between the mainstream national pro-
fessional associations, which the National FFN must never try to replace. The 
Memorandum of Understanding between the British Orthopaedic and Geriatrics 
organisations—described in the first edition [1]—is an early example of this 
approach.
The creation of National FFNs is considered the most effective method for ensur-
ing that the Call to Action is actually implemented, rather than gathering dust on a 
shelf. The FFN is, therefore, promoting their formation, through a series of Regional 
Expert Meetings, where leaders from neighbouring countries can share experience, 
strategies for clinical and policy implementation, and encouragement. This approach 
constitutes the FFN’s Regionalisation Strategy and its current status can also be 
found on the FFN website (www.fragilityfracturenetwork.org). A Guide to 
Formation of National FFNs is available at https://www.fragilityfracturenetwork.
org/regionalisation/.
D. Marsh et al.
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1.2.3  Initiation of New Hip Fracture Registries
A number of countries have adopted the approach pioneered in Sweden and then the 
UK, where a consensus agreement on quality standards for hip fracture care was 
accompanied by the creation of a patient-level audit tool for measurement of com-
pliance with those standards. There is increasing evidence (reviewed in Chap. 19) 
that good quality audit data linked to quality indicators reduces mortality and 
improves the quality of life.
However, ensuring the completeness and quality of the data requires dedication 
and appropriate resources. Ideally, this involves the employment of clinically- 
trained coordinators who can advise data-entry personnel in busy fracture units. 
Such advisors are also ideally placed to promote the philosophy behind the qual-
ity standards and the logic of orthogeriatric co-management as the best way to 
deliver them. In the absence of clinical advisors, a critical analysis of the quality 
of data that is accumulated is needed, along with an assessment of the potential 
harm done by relying on data that is subsequently demonstrated to be unreliable. 
Certainly, the idea that the installation of a registry/audit system is some kind of 
magic wand—that will automatically raise the quality of care—needs to be 
resisted.
1.2.4  Implications of These General Developments 
for the Design of This Second Edition
At a meeting held in Oxford, following the 2019 Global Congress, the authors of the 
chapters in this book got together with other fragility fracture activists to consider 
how the second edition needed to be modified to properly take into account these 
developments. The main conclusions were:
• The chapters should be grouped according to the three clinical pillars of the Call 
to Action described earlier, with comprehensive cross-referencing between chap-
ters to avoid too much repetition. The fourth pillar will be covered in other pub-
lications from the FFN
• There should be a background section covering epidemiology, osteoporosis, 
frailty and sarcopenia
• There should be a cross-cutting section for the role of nurses, audit and nutrition, 
which are relevant in all three phases
• For each of the pillars, there should be:
 – up-to-date evaluation of the current evidence for the best practice where 
resources are available
 – an analysis of what is really fundamental and critical to achieve in each pillar, 
that can be put in place even where resources are scarce
 – advice on how to progress from a minimalist implementation to a more exten-
sive one, as experience accumulates and resources become available
1 The Multidisciplinary Approach to Fragility Fractures Around the World…
8
• Although the book necessarily has to emphasise the principles within each pillar, 
allowing readers to shape the implementation in their healthcare system, where 
possible a sequence of essential practical steps towards implementation should 
be recommended
1.3  Background: Chaps. 2–4
1.3.1  Epidemiology of Fractures and Social Costs: Chap. 2
In addition to the re-shaping of society in terms of the Old-Age Dependency Ratio 
described earlier, the ageing population also has a direct effect on the population 
incidence of fragility fractures. This is particularly true of hip fractures, for which 
increasing age is a powerful risk fracture, independent of bone mineral density, and 
which tend to occur at later ages. Even in countries where the age-specific incidence 
of hip fractures is static or falling, the ageing population completely overwhelms 
that, so that population incidence is climbing everywhere. Chapter 2 explores that 
issue across the world and describes the very heavy costs of the condition, for 
patients, their carers and the health services.
The remaining two background issues are the underlying drivers of fragility frac-
tures that stem from ageing: osteoporosis, which causes bone fragility (Chap. 3) and 
frailty, linked to sarcopenia (Chap. 4).
1.3.2  Osteoporosis in Older Patients: Chap. 3
Chapter 3 describes the basic biology of bone and how and why it deteriorates in 
osteoporosis. However, this does not lead to symptoms per se, until there is a frac-
ture. The risk factors for fracture are manifold, in addition to the loss of bone min-
eral density, but there is a consistent increase in fracture risk as the T-score 
diminishes. Age plays a powerful role—independently of BMD, as do a history of 
previous fracture and a family history of fracture. The various modalities for esti-
mating bone quality and fracture risk are discussed in this chapter (but also in Chap. 
14). Similarly, the principles of treatment aimed at reducing fracture risk are cov-
ered in Chap. 3, but also in more detail in Chap. 15.
1.3.3  Frailty and Sarcopenia: Chap. 4
Frailty is a syndrome that affects the whole of an older person’s physiology. As 
described below (Sect. 1.4), the existence of frailty in many patients presenting with 
fragility fractures is the prime reason for the need of orthogeriatric co-management, 
since the discipline of geriatric medicine specialises in it. This chapter, written by 
two leading European experts, defines its nature, its epidemiology and aetiology 
and its implications for clinical care. The prominent role of sarcopenia in frailty 
(analogous to that of osteoporosis in fragility) is explained.
D. Marsh et al.
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The practical implications of frailty and sarcopenia for falls, fractures and recov-
ery after fractures are explored, including the planning of rehabilitation and dis-
charge from the hospital.
There are close links epidemiologically, biologically and clinically between 
frailty, sarcopenia, poor bone health and the geriatric syndrome of falls. Older peo-
ple who have had a fall and/or a fracture should be assessed for frailty and sarcope-
nia to better develop a care plan. This calls for an integrated clinical approach to the 
prevention and treatment of fragility fractures.
1.4  Pillar I: Co-Management in the Acute Episode—
Chaps. 5–11
The basic point about patients presenting with fragility fractures, especially older 
patients with hip fractures, is that most of them are suffering from two separate 
issues. The first is the fragility of their bone, due to osteoporosis or osteopenia, 
which has allowed the fracture to occur with minimal trauma. The second is frailty—
of their whole body, which as Chap. 4 explains, weakens their capacity to respond 
to stress and is associated with comorbidities. It is unfortunate that several lan-
guages use the same word to describe these two entities, since they are totally dif-
ferent; the first being a biomechanical issue, the second physiological.
Orthopaedic surgeons are trained to deal with the fragility; geriatricians are 
trained to address frailty (other medical disciplines can also learn to do so). The 
older patients with fragility fractures, therefore, need the application of both skill-
sets if they are to emerge from the experience with good health and function. That 
is the basic argument for orthogeriatric co-management. It is expanded by the need 
to include other disciplines in a multidisciplinary team, particularly anaesthetists, 
nurses and physiotherapists.
The operative and non-operative treatment of incident fractures is clearly an 
enormous subject by itself, and one that is more appropriately dealt with in other 
publications. In this book, we have chosen two examples that illustrate important 
principles. The first is hip fracture, which we have chosen because (i) it is the index 
fracture for fragility fractures generally in much of the epidemiological and health 
economic literature, (ii) it accounts for the majority of in-patient costs of fragility 
fractures generally and (iii) it was historically, and remains, the prime setting for 
orthogeriatric co-management. The second is a proximal humeral fracture, which 
illustrates the paucity of solid evidence, in many fracture types, that operative fixa-
tion, with the maximal restoration of skeletal anatomy, leads to a better clini-
cal result.
1.4.1  Establishing an Orthogeriatric Service: Chap. 5
Chapter 5 tackles the challenge of putting such a multidisciplinary service into prac-
tice, using a well-attested change-management methodology. It is as much a politi-
cal as a medical challenge since it inescapably involves sharing between disciplines 
1 The Multidisciplinary Approach to Fragility Fractures Around the World…
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the care of patients traditionally under the sole care of one discipline—orthopaedic 
surgery. Diplomacy is required. This chapter describes an approach, based on 
eight steps:
 1. Process mapping the hip fracture pathway
 2. Identify a core multidisciplinary team and form a steering group
 3. Analyse and review the patient pathway
 4. Evaluate the resources required to drive change within the organisation
 5. Develop the business case for the orthogeriatric service
 6. Implementing and sustaining the service
 7. Collect evidence of service improvement—Audit
 8. Embrace the support of regional, national and international organisations
The sequence of chapters after that follows the patient journey in the acute epi-
sode: pre-hospital—pre-operative—anaesthetic—surgery—post-operative.
1.4.2  Pre-hospital Care and the Emergency Department:  
Chap. 6
Chapter 6 covers the period between the patient’s injurious fall and their admis-
sion to the hospital. It is consistent with the well-developed methodology that is 
applied to high energy trauma victims and other emergencies, with prioritised 
primary and secondary surveys. There is an emphasis on rapid transfer, but with 
due regard to minimising pain through gentle immobilisation of the limb and 
gentle driving of the ambulance. History-taking at the scene and on the journey is 
a valuable contribution to the holistic picture of the patient and their circum-
stances that will guide future management and discharge. Pain relief is paramount 
but must not be gained at the expense of opiate overdosing. Paramedic-administered 
pre-hospital fascia iliaca compartment blockade can be seen on the horizon but, 
for the most part, that is currently something to be done once the Emergency 
Department has been reached.
The situation in developed countries, with short journeys in modern vehicles 
with highly-trained crews, is radically different from that in many low-resource 
settings in developing countries. There, it may be a difficult and prolonged jour-
ney to get the patient to the hospital, but the principles and goals of safety, pain-
relief and adequate fluid management are universal. So the challenge is to 
implement effective protocols that deliver those goals as completely as possible in 
each setting. In some areas, every effort is made to minimise the time spent in 
A&E as this is a busy and often chaotic area where an immobile patient with 
frailty may come to harm with delirium and pressure damage. However, appropri-
ate triage with recognition and management of acute inter-current conditions must 
not be missed. In contrast, in some countries, A&E physicians may take the lead 
in pre-operative optimisation.
D. Marsh et al.
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1.4.3  Perioperative Orthogeriatric Care: Chaps. 7 and 11
The substantial meat of orthogeriatric wisdom and experience is to be found in 
Chaps. 7 and 11, covering respectively pre- and post-operative medical manage-
ment. These chapters have been written by authors working in developed coun-
tries where there has been a drive to identify and proactively manage patients 
with frailty with the development of the specialty of geriatric medicine. 
Orthogeriatrics has evolved as a sub-specialty, with orthogeriatricians working 
closely with orthopaedic surgeons and anaesthetists, in addition to the multidis-
ciplinary team.
These chapters are written aiming to describe gold standard management. It is 
important to acknowledge that many countries, and particularly those with the most 
significant challenges, where an epidemic of patients with hip fracture is predicted, 
may not have geriatric medicine as a defined specialty, and solutions to orthogeriat-
ric care need to be imaginatively devised. This requires that the role of the orthoge-
riatrician be analysed and understood so that every country can find a way to ensure 
that patients with hip fracture and other fragility fractures, particularly in those with 
significant frailty, are managed appropriately.
Orthogeriatricians have often led the development of local pathways and proto-
cols to standardise and improve care and to ensure communication between all spe-
cialists involved. This leadership role may be taken on by any member of the team 
but requires a real understanding of frailty and all the roles in the multidisci-
plinary team.
However, we must face up to the fact that there is no way that sufficient numbers 
of card-carrying geriatricians can be generated in time to deal with the epidemic of 
hip fractures that is on its way. Orthogeriatric competencies, based on recognition 
and understanding of frailty, must be inculcated in other species of health workers. 
There needs to be a wide army of ‘Frailty Practitioners’ who may, in different set-
tings, be derived from other types of physicians or other professions such as nurs-
ing/pharmacy/physiotherapy/occupational therapy, albeit led and taught by 
geriatricians wherever possible. This is going to require a substantial shift in culture 
in many countries, where the empowerment of nurses and other healthcare profes-
sionals is an anathema. But the alternative, when the epidemiological predictions 
become reality, is chaos and misery.
Some key areas of orthogeriatric competency that are transferable from the dis-
cipline of geriatric medicine are:
• Skills in pre-operative assessment and optimisation of comorbidities: There is 
now a reasonable evidence base, as covered in Chaps. 7 and 11, that can be 
protocol- driven and delivered by those with basic training (junior doctors, 
advanced nurse practitioners) liaising with anaesthetists
• Recognition of severe frailty with limited reversibility: About a quarter of 
patients presenting with hip fracture are in their last year of life. Patients with 
significant frailty and limited physiological reserve benefit most from an early 
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operation and early mobilisation, aiming to reduce their high risk of complica-
tions. Setting realistic expectations—and appreciating when an operation is 
purely about managing pain rather than restoring mobility/independence—
is crucial
• Continuity of care: The orthogeriatrician often oversees the patient’s journey 
from admission through to discharge. This advocate role, requiring excellent 
communication with the patient, their family and all members of the team, is 
increasingly being undertaken by specialist nurses or others
Sandwiched between Chaps. 7 and 11, as they are in clinical reality—are the 
anaesthetic episode and the surgical intervention.
1.4.4  Orthogeriatric Anaesthesia: Chap. 8
Chapter 8 covers a lot more than the techniques of anaesthesia per se. The role of 
the anaesthetist is considered alongside that of the orthogeriatrician; after all, both 
are primarily interested in the patient’s physiology. The goal is not just to bring the 
patient safely through the surgical procedure but also (i) to expedite readiness for 
surgery, (ii) to use the intraoperative, intensely-monitored phase to normalise the 
patient’s physiology as far as possible, to maximise their ability to mobilise early 
and rehabilitate and (iii) to assist in ensuring good control of pain in all phases of 
the in-patient episode.
A simple key step, which can be a liberation in many fracture units, is to include 
anaesthetic colleagues in the definition of the consensus protocols governing the 
multidisciplinary management of fragility fractures requiring admission for surgery. 
The prime purpose of this is to secure the agreement of anaesthetic colleagues to a 
set of standardised procedures covering readiness for surgery and, as far as possible, 
the anaesthetic and pain management techniques to be deployed. An example of an 
issue where standardised techniques, established in consultation with orthogeriatric 
colleagues, can improve safety and early mobilisation, is the agreement to use only 
low doses of the local anaesthetic in spinal anaesthesia, to minimise the induced 
hypotension.
Anaesthetic practice also varies enormously across the world with access to 
trained practitioners, drugs, equipment and electricity lacking in some areas. There 
is a huge amount of work to do but, again, Chap. 8 summarises the evidence from 
developed countries and makes recommendations towards gold standard practice.
1.4.5  Hip Fracture: The Choice of Surgery—Chap. 9
Chapter 9 focuses on how to achieve stable fixation in the different patterns of hip 
fracture. As described in the first edition of this book [1], the very first paper on 
orthogeriatric co-management of elderly hip fracture patients, presented to the 
British Orthopaedic Association in 1966 was from the original orthogeriatric unit of 
D. Marsh et al.
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Devas (a surgeon) and Irvine (a geriatrician) in Hastings, UK [6]. Already, from 
these first 100 cases, they asserted that a successful operation needs to make it pos-
sible for the patient to mobilise, fully weight-bearing, on the first post-operative day. 
The bed is a dangerous place for older patients! It is disappointing how many ortho-
paedic surgeons around the world, over 50 years later, still insist on prolonged bed 
rest for their hip fracture patients, as if maintaining the pristine beauty of the post-
operative X-ray is more important than the functional recovery of the patient.
1.4.6  Proximal Humeral Fractures: The Choice  
of Treatment—Chap. 10
Many surgeons find operating on proximal humeral fractures enjoyable and satisfy-
ing. However, the recent clinical evidence suggests that their enthusiasm is not 
matched by improved outcomes following operative treatment. Neither operative 
nor conservative management leads to a great recovery of shoulder mobility and 
function and the relief of pain—overwhelmingly the top priority for the patients—
seems to be at least as good after non-operative management. There might, however, 
be a place for evidence-based surgery in older patients with fracture-dislocations, 
articular surface fractures and fractures with no contact between the bony frag-
ments. Evidence from clinical trials is not of the highest quality so far, with very 
heterogeneous cohorts, but better-designed studies are in the pipeline; perhaps ‘big 
data’ from registries may give further insights.
1.5  Pillar II: Rehabilitation—Chaps. 12 and 13
As pointed out in Sect. 1.1 of this chapter, one of the implications of the rapidly- 
increasing Old-Age Dependency Ratio is that we need to provide much more effec-
tive rehabilitation after a fragility fracture, so that ‘dependency’ is reduced/
postponed. A complementary dimension is that, to the extent that post-fracture 
patients do become dependent, their care is going to devolve increasingly to family 
caregivers, since the volume of cases will overwhelm existing services in all 
countries.
1.5.1  Rehabilitation Following Hip Fracture: Chap. 12
As noted above, in Sect. 1.4.5, the most immediate goal after hip fracture surgery 
should be early—next-day—mobilisation. It will take time to convince surgeons in 
some countries that this is so. However, that is just the beginning; there needs to be 
a planned, individualised rehabilitation programme that starts in the hospital and 
carries on for an extended period—basically for the rest of the patient’s life—after 
discharge. Ideally, this should be delivered by a multidisciplinary team, integrating 
physical therapy with social support, nutrition advice and so on. It is important that 
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the team meets to review progress and gives the patient a sense of coordination—
and optimism. Chapter 12 is an exhaustive review of the current evidence about 
what rehabilitative measures are effective.
Recognising that large rehabilitation teams will not be available in many low- 
and middle-income countries, implementation strategies for those settings, includ-
ing input from families, are suggested.
The point is made that cognitively-impaired patients are among those who ben-
efit most from robust programmes and must not be excluded from rehabilitation 
efforts.
1.5.2  The Psychological Health of Patients and Their Caregivers: 
Chap. 13
The physical and emotional burden of looking after an elderly relative with some 
degree of disablement is considerable. As might intuitively be expected, there is 
now good evidence that the physical and psychological health of post-fracture 
patients and their caregivers are interdependent. Chapter 13 addresses the issue of 
how their status can be assessed and how the orthogeriatric team can help.
1.6  Pillar III: Secondary Prevention—Chaps. 14–16
As most readers of this book will know: (i) having a fragility fracture increases the 
risk of another one—‘fracture begets fracture’; (ii) half of all hip fractures have 
been preceded by a previous fragility fracture and (iii) the risk of recurrent fracture 
is greatest in the first year the ‘imminent refracture’. The obvious consequence of 
these facts is that the response to a patient presenting with any fragility fracture is 
not complete until there has been a determined attempt to prevent another one. This 
must address both osteoporosis and falls risk and it must happen as quickly as pos-
sible after the incident fragility fracture.
If this is done reliably, given that current treatments reduce fracture risk by 
around 50%, there is the potential to prevent 25% of subsequent hip fractures; as 
treatments improve, this should increase. The fact that it is not done reliably—with 
a ‘treatment gap’ in the order of 80%—means that the burning issue right now is the 
need for reconfiguration of fracture services to capture every fragility fracture and 
link them to the appropriate bone health and falls prevention services.
1.6.1  Fracture Liaison Services: Chap. 14
The basic model for achieving this is very clear and well-documented—it is the 
Fracture Liaison Service. Chapter 14 focuses on how such a service should assess 
the magnitude of the risk of another fracture and initiate action to reduce that risk. 
D. Marsh et al.
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It explains how such a service can be created, whatever the level of resources in 
any given location. Like orthogeriatric co-management generally, it is more a 
matter of changing attitudes than spending money. This chapter is written by lead-
ing drivers of the Capture the Fracture® campaign of the International Osteoporosis 
Foundation.
1.6.2  Current and Emerging Treatment of Osteoporosis: 
Chap. 15
Chapter 15 focuses on the pharmacological treatment of osteoporosis: the indica-
tions for it and the prospects for more powerful treatments than we have previously 
enjoyed. Gold standards of assessment in developed economies include measure-
ment of bone mineral density, in younger fracture patients, by DXA scan; this will 
not be available in many low-resource settings. The authors suggest that, in such 
settings, the fact that a fragility fracture has already occurred can be considered suf-
ficient grounds for initiating anti-resorptive treatment—even in younger patients. 
This is controversial, but all would agree that the possibility should be considered, 
and the decision be made on clinical judgement.
1.6.3  How Can We Prevent Falls?—Chap. 16
Whatever the degree of fragility conferred on the bones by osteoporosis, the vast 
majority of fragility fractures are nonetheless precipitated by falls (vertebral frac-
tures being the obvious exception). The evidence base for fracture prevention by 
falls risk reduction is meagre compared to that for osteoporosis treatment because 
there has so far not been the commercial imperative for the industry to fund large 
scale trials. This may change whenever a realistic anti-sarcopenia agent becomes 
available.
However, Chap. 16 summarises a gradually-accumulating body of evidence 
about how an individual’s risk of falling may be classified as low, intermediate or 
high and what treatment programmes are effective for each category. This body of 
evidence is related to that exhaustively described in Chap. 12—rehabilitation after 
hip fracture.
There is understandably great concern about falls that occur in care settings and 
it is recommended that all in-patients over the age of 65 be considered and treated 
as high risk. Patients with cognitive impairment may require special attention in 
addition to the high-risk programme; in advanced dementia, recurrent falls indicate 
the need for palliative care.
In post-fracture cases, falls clinics and programmes need to be linked to the 
Fracture Liaison Service and fall risk and bone health should always be considered 
together.
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1.7  Cross-Cutting Issues: Chaps. 17–19
The nursing role, nutrition and fracture audit systems are relevant in all three clini-
cal pillars.
1.7.1  Nursing in the Orthogeriatric Setting: Chap. 17
Attitudes to nurses, and what they may be capable of, vary widely across the 
globe. In some developed economies, they have been significantly empowered, 
based on models of advanced training, protocol-driven care and supervision by 
appropriate medical specialists. This includes, in many locations, the ability to 
order investigations and treatments within protocols. By contrast, there are many 
countries where such autonomy would be anathema. What is very clear, and needs 
to be asserted as frequently as possible, is that the volume of fragility fracture-
related work—already now but more so in the future—is such that it cannot real-
istically be delivered without enhanced nurse input. There is no prospect that 
there will be (i) enough geriatricians on the planet to deliver orthogeriatric sur-
veillance of all older fracture inpatients on a daily basis or (ii) enough endocri-
nologists for every fragility fracture patient to be assessed for secondary prevention 
by a doctor.
This chapter explores the key nursing roles and interventions relating to orthoge-
riatric nursing care. It considers how nursing care quality, focused on nurse-specific 
indicators, skill, education, leadership and resources, can positively impact patient 
outcomes in all phases of the care journey. The central nursing role in preventing 
and managing complications is specifically outlined.
1.7.2  Nutritional Care of the Older Patient with Fragility 
Fracture: Chap. 18
Nutrition is a subject that can be very complex in the elderly. Chapter 18 opts for the 
SIMPLE approach:
S Screen for nutrition risk
I Interdisciplinary assessment
M Make the diagnosis (es)
P Plan with the patient
L impLement interventions
E Evaluate ongoing care requirements
The essence of this approach is that, rather than requiring a highly-specialised 
nutritionist, a systematic assessment on the part of all the disciplines that are 
interacting with the patients can achieve what is needed for the nutritional care of 
the older patient with a fragility fracture, regardless of setting or healthcare 
provider.
D. Marsh et al.
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1.7.3  Fragility Fracture Audit: Chap. 19
Fragility fracture audit is key to understanding fragility fracture management, iden-
tifying areas for its improvement, and measuring the impact of clinical initiatives 
and service change. A hip fracture can be considered a marker for fragility fractures, 
and hip fracture audits indirectly show the strengths and weaknesses of fragility 
fracture care overall. Notably, where effective hip fracture care exists, this has a 
favourable impact on the care of other fragility fractures. Early established audits, 
clinically led, have used clinical standards and feedback on compliance with them 
to improve care and outcomes. Although data collection, analysis and feedback 
require investment, the cost per case amounts to only a very small fraction of the 
cost of care per case.
Because patients with fractures requiring surgical intervention, such as hip frac-
tures, are available for some time in the hospital, it is relatively easy to collect the 
data needed for a registry or audit database. Capturing the necessary data for sec-
ondary prevention is a lot harder, between the fleeting outpatient clinic visits and the 
variable passage from secondary to primary care settings. It is also complex to link 
databases in such a way that recurrent fractures are reliably captured and matched 
with data describing secondary prevention interventions. Nonetheless, this problem 
must be solved, if we are ever to have the evidence needed to persuade healthcare 
funders to commission reliable Fracture Liaison Services for the long term. This is 
likely to be one of the main developments in the following phase of fragility fracture 
service evolution.
1.8  Concluding Remarks
Demographic change over the following decades presents significant challenges in 
many areas of medicine. However, the strong association between age, skeletal fra-
gility and physiological frailty mean that fragility fractures will feature very promi-
nently in that development. Furthermore, the need to extend the period of 
independence in people’s longer lives drives us to realise that we need to (i) prevent 
as many fractures as possible—in which secondary prevention represents the 
lowest- hanging fruit and (ii) treat those that do occur in the most cost-effective way 
possible, with full regard to recovery of function.
Hopefully, the chapters of this book summarise the current (2020) state of these 
arts adequately. But equally hopefully, they will be out of date pretty soon, as prog-
ress is made.
While the book will remain as it is until a subsequent edition, the FFN will main-
tain, on its website www.fragilityfracturenetwork.org, two toolkits that will comple-
ment the book and be updated as experience grows. One is a Clinical Toolkit, which 
is concerned with the practical implementation of Pillars I–III, as described in most 
of the chapters of this book. The other is a Policy Toolkit, which expands Chap. 
1—particularly Sect. 1.2—in other words the fourth pillar of the healthcare policy 
change and the work of the National FFNs.
1 The Multidisciplinary Approach to Fragility Fractures Around the World…
18
References
 1. Marsh D (2017) The orthogeriatric approach—progress worldwide. In: Falaschi P, Marsh D 
(eds) Orthogeriatrics. Springer International, Cham
 2. Sabharwal S, Wilson H (2015) Orthogeriatrics in the management of frail older patients with a 
fragility fracture. Osteoporos Int 26:2387–2399
 3. Department of Economic and Social Affairs, Population Division (2017) World Population 
Prospects: The 2017 Revision. Volume II: Demographic Profiles. United Nations, New York.
 4. Dreinhöfer KE (2018) A global call to action to improve the care of people with fragility frac-
tures. Injury 49:1393–1397
 5. Pioli G et  al (2018) Orthogeriatric co-management—managing frailty as well as fragility. 
Injury 49:1398–1402
 6. Devas RE, Irvine MB (1967) The geriatric orthopaedic unit. J Bone Jt Surg 49:186–187
Open Access This book is licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/
by-nc-nd/4.0/), which permits any noncommercial use, sharing, distribution and reproduction in 
any medium or format, as long as you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons license and indicate if you modified the licensed 
material. You do not have permission under this license to share adapted material derived from this 
book or parts of it.
The images or other third party material in this book are included in the book’s Creative 
Commons license, unless indicated otherwise in a credit line to the material. If material is not 
included in the book’s Creative Commons license and your intended use is not permitted by statu-
tory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder.
D. Marsh et al.
19© The Author(s) 2021




National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy 
Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, 
Palermo, Italy 
H. Kolk 
Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, 
Palermo, Italy 
Department of Traumatology and Orthopaedics, University of Tartu, Tartu, Estonia
e-mail: helgi.kolk@kliinikum.ee 
S. Maggi (*) 
National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy
e-mail: stefania.maggi@in.cnr.it
This chapter is a component of Part 1: Background.
For an explanation of the grouping of chapters in this book, please see Chapter 1: ‘The 
Multidisciplinary Approach to Fragility Fractures Around the World—An Overview’.




Ageing is becoming the next public health challenge worldwide. According to 
WHO data, the proportion of the population more than 60 years will nearly double 
from 12% in 2015 to 22% in 2050. By 2050, this population age group is expected 
to increase from the current 900 million to 2 billion, 80% of these people living in 
low- and middle-income countries [1]. Understanding the trends of age-related dis-
eases has an important role in healthcare policy. Musculoskeletal disorders are 
among the most common problems affecting the elderly, with osteoporosis and 
osteoporotic fractures leading the field [2].
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Osteoporosis, defined by WHO as bone densitometry (DXA) T-scores less 
than −2.5 at the lumbar spine or femoral neck and microarchitectural deterioration 
of bone tissue, is recognised as a major public health issue through its association 
with fragility fractures, particularly of the hip, vertebrae, wrist and upper arm. 
Sarcopenia is generally understood as an age-dependent decline in muscle mass 
combined with low muscle strength and/or low physical performance. The combi-
nation of osteoporosis and sarcopenia is known as osteosarcopenia, which contrib-
utes to frailty, poor balance, falls and fragility fractures [3]. Fragility fractures have 
been defined as fractures that occur after minimal trauma (falling from a standing 
height or less) or without considerable trauma. Several factors contribute to the 
development of fragility fractures, two major groups are those affecting/decreasing 
bone mineral density (BMD) and increasing the rate of falls. To provide compre-
hensive care to older adults, particularly with attention to musculoskeletal health, 
clinicians must assess and manage different aspects, including osteosarcopenia 
and falls.
Please refer to Chaps. 3 and 15 for the management of osteoporosis in older 
patients and to Chap. 16 for the prevention of falls.
Fragility fractures may have a negative impact on the quality of life of older 
people and their families due to loss of independence and may also lead to dis-
ability and death. Significant geographic variation occurs in the age-specific inci-
dence in osteoporotic fractures worldwide (Fig. 2.1), with Western populations 
(Europe, North America and Oceania) reporting an increase in hip fracture inci-
dence during the second half of the twentieth century and a decline since 2000 [4, 
5]. However, even in these countries, the fall in age-specific incidence is far out-
weighed by the ageing demographic described earlier, so population incidence 
continues to rise [6]. Osteoporosis and sarcopenia are frequently underdiagnosed 
and thus undertreated, even persons with proven bone mineral density loss and 














































Fig. 2.1 Age-standardised hip fracture incidence rates (/100,000) for some representative 
countries
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subsequent fractures. On the other hand, there is much current debate on what is 
the target population that may potentially benefit from treatments acting on bone 
metabolism [6].
The total costs of osteoporosis are difficult to calculate as cost estimates are 
based on many assumptions, making a comparison between countries and different 
healthcare systems challenging. In addition to direct medical costs in acute care of 
osteoporotic fractures and medications, these costs also include work-absence of 
family caregivers and long-term care of elderly fracture patients. The economic 
impact of hip fractures, the most detrimental of osteoporotic fractures, has been 
widely investigated, however, few studies have utilised the same instruments. 
Recovery from a fragility fracture can be influenced by social factors but might 
itself influence social activity and family relationships [7].
The objective of this chapter is to review and describe the epidemiology of osteo-
porosis and fragility fractures, highlighting the costs to society and the individual.
2.2  Prevalence of Osteoporosis
The WHO Osteoporosis Working Group and other international osteoporosis organ-
isations have stated that the femoral neck is the only site that should be used in the 
estimation of osteoporosis prevalence at a population level. Osteoporosis is diag-
nosed using dual-energy X-ray absorptiometry (DXA), which measures bone min-
eral density (BMD) of the femoral neck. BMD is one of the most used tools for the 
management of osteoporosis, being used for diagnosis, fracture risk assessment, 
selection of patients for treatment and treatment monitoring [2]. According to the 
criterion set by a WHO Working Group, osteoporosis is diagnosed when the BMD at 
the femoral neck is 2.5 standard deviations or more below the average BMD of the 
young white female population. Accurate estimates of the prevalence of osteoporosis 
require country-specific data on the distribution of femoral neck BMD, for most 
studies, it is assumed that the mean femoral neck BMD is similar between countries 
at the age of 50 years and also the bone loss is similar [2]. Based on these estimates 
approximately 5.5 million osteoporotic men and more than 22 million osteoporotic 
women resided in the EU27 in 2010, that is, there were four times as many women 
with osteoporosis as there were men. Of all countries in the EU27, Germany was 
estimated to have the highest number of individuals with osteoporosis with approxi-
mately 1 million osteoporotic men and 4 million osteoporotic women. Overall the 
prevalence of osteoporosis was 6.6% and 22.1% in men and women aged 50 years or 
more and 5.5% in the general population of the EU. In males aged 50 years or more, 
the prevalence of osteoporosis varied from 5.7% in Slovakia to 6.9% in Greece, Italy 
and Sweden. The corresponding data for females were 19.3% in Bulgaria and 23.4% 
in Italy [2]. The prevalence of osteoporosis increased progressively with age, 
although the absolute number of individuals with osteoporosis increases less mark-
edly. When stratifying the population between ages 50 and 80 in 5-year age groups, 
the highest number of women with osteoporosis (approximately 3.9 million) was 
observed in the 75–79 year age group, for men the highest estimated number was in 
the age group of 60–64 years (approximately 0.8 million) [2].
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According to a review published in 2016, in East Asia (Hong Kong, Japan, 
Macau, Mongolia, North Korea, the People’s Republic of China, South Korea and 
Taiwan) osteoporosis is recognised as a growing problem because of the rapidly 
increasing number of older people [8]. China has the largest aged population in the 
world, as the population aged more than 60 years will reach 400 million (approxi-
mately 30% of the total population) by 2050. In Japan, the percentage of the popula-
tion aged more than 65  years rose from 10.3% in 1985 to 20.1% in 2005; this 
percentage is expected to double by 2050 [8]. Studies from the Chinese mainland, 
Hong Kong and Taiwan published between 1990 and 2017 have reported various 
prevalence rates of osteoporosis due to different reference values (US and Asian) 
and age groups; a clear tendency of increase in prevalence with age was recorded 
with osteoporosis affecting more than one-third of people aged 50 years and older. 
Variable osteoporosis prevalence was reported across Chinese cities before 2002: 
Jilin (15.5%) > Shanghai (14.2%) > Sichuan (11.3%) > Guangzhou (10.2%) > Beijing 
(5.2%). According to studies by Zhang et al., with a cut-off value of − 2.5 SD, osteo-
porosis prevalence increased from 6.37% in women aged 40–50 years to 76.74% in 
those aged 80–90 years [9]. A higher prevalence of osteoporosis was demonstrated 
in the female population and residents of northern China [9].
In Hong Kong, osteoporosis prevalence in women aged more than 50 years was 
16% at the total hip, while in men the figure was 6% in 2005. In earlier studies 
(published in 1999) the prevalence of osteoporosis in Hong Kong was significantly 
higher than in the mainland at the same time. The prevalence of osteoporosis in 
Taiwan was comparable to that in the Chinese mainland [9].
The data on the prevalence of osteoporosis among women in India come from 
studies conducted in small groups spread across the country. The estimates sug-
gested that out of the 230 million Indians expected to be over the age of 50 years in 
2015, 20%, that is, ~46 million were women with osteoporosis. Thus, osteoporosis 
is a major public health problem in Indian women [10].
The reported prevalence of osteoporosis among postmenopausal women in 
Brazil varies from 15% to 33%, depending on the study methodology and the use of 
bone densitometry data or self-reporting by participants. However, recent studies 
using DXA report similar prevalence data to other countries [11].
Prevalence estimates of osteoporosis or low bone mass at the femoral neck or 
lumbar spine (adjusted by age, sex, and race/ethnicity to the 2010 Census, defined 
by WHO criteria) for the non-institutionalised population age 50 years and older 
were applied to determine the total number of older US residents with osteoporosis 
and low bone mass [12]. There were over 99 million adults 50 years and older in the 
US in 2010. Based on an overall 10.3% prevalence of osteoporosis, the estimated 
number of older adults having osteoporosis was 10.2 million in 2010, women and 
non-Hispanic Whites having the largest counts. The prevalence of osteoporosis was 
higher in men 80+ (10.9%) compared to men 50–59 years of age (3.4%); however, 
due to the decrease in male population counts by age, the estimated number of men 
with osteoporosis was lower by age: 0.7 million in the 50–59 group and 0.4 million 
in the 80+ group [12].
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2.3  Factors Affecting Bone Mineral Density
Non-modifiable factors negatively affecting BMD and bone microstructure include 
older age, female sex, White race, personal and parental history of osteoporosis and 
fractures, and low body frame size. The known modifiable risk factors for osteopo-
rosis include low calcium intake, reduced exposure to sunlight, prolonged immobil-
ity, excessive alcohol intake, smoking, eating disorders, long time immobility, low 
body mass index (BMI) and low physical activity. Several medications (glucocorti-
coids, PPI, anticonvulsants, chemotherapy of breast and prostatic cancer) require 
special attention: if these cannot be avoided, the length of treatment courses should 
be modified and measures to prevent the progression of osteoporosis need to be 
taken. The same risk factors are generally included in the FRAX model for the 
assessment of fracture probability [2, 13].
2.4  Osteosarcopenia
Prevalence rates of sarcopenia vary greatly due to different definitions, tools of 
diagnosis, and patient populations. Prevalence rates utilising the European Working 
Group on Sarcopenia in Older People (EWGSOP) definition vary from 1 to 29% in 
elderly community-dwelling populations and from 14 to 33% in long-term care 
populations [14]. Advanced age consistently appears to be a risk factor for sarcope-
nia. In most studies that reported gender, there was no significant association with 
sarcopenia prevalence. Nursing home residents, patients with hip fracture and these 
more than 80 years have higher rates of diagnosis [14].
Epidemiological measures of osteosarcopenia are fairly limited due to the recent 
origin of the term. A study of 680 elderly adults with a history of falls found an 
osteosarcopenia prevalence of 37%, with these patients having a higher frequency 
of comorbidities, impaired mobility and depression [15].
2.5  Falls
Age is one of the key risk factors for falls. Older people have the highest risk of 
death or serious injury arising from a fall and the risk increases with age. For exam-
ple, in the US, 20 to 30% of older people who fall suffer moderate to severe injuries 
such as bruises, hip fractures, or head trauma (WHO). An estimated 95% of hip 
fractures are due to falls [16]. However, data on the prevalence and incidence of 
falls among the elderly are heterogeneous as there is no international consensus for 
assessing the fall risk profile of older people even for people at high risk of falls. 
People aged 75 or older, those who have fallen during the previous 12 months or 
those who have fear of falling or significant gait, muscle strength, or balance prob-
lems constitute the group of highest fall risk. The fall risk profile is also dependent 
on the setting and some other factors, including cognitive impairment. Even though 
a decline in balance, gait and muscle function increase the risk of falling, the 
2 Epidemiology of Fragility Fractures and Social Impact
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relationship is not completely linear since those with most problems (i.e. bedridden) 
usually have a lower falls risk, similar to those without such problems, presumably 
due to low exposure to risk [2].
Knowledge of factors that predispose older persons to falls is important for tai-
loring appropriate preventive interventions. This is covered in more depth in 
Chap. 16.
2.6  Incidence of Fragility Fractures
Osteoporosis is clinically significant in the fractures that occur as a consequence of 
increased bone fragility. Although low BMD identifies individuals at increased risk 
of fracture, the majority of fragility fractures occur in individuals who have less 
marked reductions in bone mass or normal BMD, which means that other factors 
independent of BMD, such as the geometric and microarchitectural properties of the 
bone itself, and an individual’s clinical risk factors, contribute to fracture risk [13]. 
The definition of an osteoporotic fracture is not straightforward, opinions differ 
concerning the inclusion or exclusion of different sites of fracture (most common 
are the forearm, hip, spine, proximal humerus) of fracture and also possible caus-
ative mechanisms [2]. One approach is to consider all fractures from low energy 
trauma as being osteoporotic. Low energy trauma is defined as a fall from a standing 
height or less, or trauma that in a healthy individual would not result in fracture 
[16]. The rising incidence of fractures with age might be caused by the rising inci-
dence of falls and be multifactorial. The approach used in the report “Osteoporosis 
in the European Union” published by E. Hernlund and group in 2013 by and else-
where is to characterise fracture sites as osteoporotic when they are associated with 
low bone mass and their incidence rises with age after of 50 years of age [2].
As hip fracture patients are treated in hospitals, the reports of incidence of hip 
fracture are more commonly available than reports of other sites of fractures [2]. 
Identifying the number of individuals at high fracture risk has value for future health 
resource allocation. Information on the incidence of fragility fractures varies 
between EU countries, as well as worldwide (Fig. 2.1). According to the calcula-
tions of the International Osteoporosis Foundation [2], there was marked heteroge-
neity in hip fracture risk between EU 27 countries: in women, the lowest annual 
incidences were found in Romania and Poland with the highest rates observed in 
Denmark and Sweden. There was an approximately three-fold range in hip fracture 
incidence which is somewhat lower than the tenfold range worldwide, but still sub-
stantial. The reason for the variation in hip fracture rates between countries is not 
known. Socio-economic prosperity seems to be one of the influencing factors, with 
higher hip fracture rates in countries with higher GDP.
In developing populations, however, particularly in Asia, the rates of osteopo-
rotic fracture appear to be increasing [8, 13]. The lifetime risk for hip, vertebral and 
forearm (wrist) fractures has been estimated to be approximately 40%, similar to 
that for coronary heart disease.
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It has been estimated that in 2010 there were 21 million men and 137 million 
women aged 50 years or more at high fracture risk and that this number is expected 
to double by 2040, with the increase predominantly borne by Asia [13].
2.7  Hip Fracture
Hip fractures are an important cause of disability and death around the world, espe-
cially amongst older people. Studies have shown heterogeneity in annual age- 
standardised hip fracture rates globally (Fig. 2.1). The systematic review, published 
in 2012, used a literature survey covering a 50-year period and UN data on popula-
tion demography [4]. By this review, the highest annual age-standardised hip frac-
ture incidences (per 100,000 person-years) were observed in Scandinavia: Denmark 
(574), Norway (563) and Sweden (539), also in Austria (501). The lowest rates were 
detected in Tunisia (58) and Ecuador (73). North-Western Europe, Central Europe, 
the Russian Federation and Middle-East countries (Iran, Kuwait, Oman), Hong 
Kong, Singapore and Taiwan were high-risk countries for the hip fracture. Low-risk 
regions included Latin America (except for Argentina), Africa, and Saudi Arabia. 
There was around a tenfold range in hip fracture incidence worldwide, with the 
overall age-standardised incidence in men being half that of women [4, 13].
The highest incidence of hip fracture was observed mainly in countries furthest 
from the equator and in countries with extensive coverage of the skin due to reli-
gious or cultural practices, suggesting that vitamin D status might be an important 
factor underlying this distribution [4].
The aforenamed systematic review reported the age-standardised annual inci-
dence of hip fractures to be higher in Hong Kong, Japan, South Korea and Taiwan 
than in the United States and some European countries [4]. This is in contrast to a 
study two decades ago that showed the hip fracture incidence to be higher in the 
United States compared to Hong Kong [17]. For women, Taiwan was in the high- 
incidence category (incidence >300/100,000), ranking number 9 among 61 coun-
tries/regions. Hong Kong, Japan and South Korea were in the medium-incidence 
category (200–300/100,000), ranking 23, 32 and 34, respectively. China was in the 
low-incidence category (<200/100,000). For men, Japan, Korea and Taiwan were 
among the high-incidence countries (>150/100,000), while China and Hong Kong 
were in the moderate-incidence category (100–150/100,000) [4, 8].
The reasons for the large variation in age- and sex-adjusted hip fracture inci-
dence worldwide are not clear. Genetic differences, environmental factors and treat-
ment of osteoporosis might have a role. Interestingly, people living in the 
Mediterranean area have a lower incidence of fractures. This seems to be attribut-
able to several factors, particularly higher serum 25-hydroxy vitamin D (25OHD) 
levels and healthier lifestyle [18]. Recent research highlights the role for a 
Mediterranean diet since the dietary pattern is associated with lower inflammation 
levels, lower adiposity and decreased risk of falls, all these factors being important 
for the development of hip fracture [19].
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The total number of persons affected by hip fractures may be increasing over 
time in the following years, mainly due to the progressive ageing of the population. 
According to a conservative estimate, the annual number of hip fractures will 
increase from 1.66 million in 1990 to 6.26 million in 2050 [13]. Hip fracture rates 
appeared to have plateaued or decreased during the last one to two decades in many 
developed countries, following a rise in preceding years; however, in the developing 
world, age- and sex-specific rates are still rising in many areas [2, 8, 13]. In studies 
reporting a lower incidence of age- and sex-specific incidence hip fracture over 
time, possible explanations seem to be a higher adherence to anti-osteoporotic med-
ications as well as increased use of calcium and vitamin D supplementation, avoid-
ance of smoking and alcohol, and more efficacious strategies for the prevention of 
falls [20].
Technical reasons, such as inaccurate coding and recording of fractures and poor 
access to medical services in some regions might be part of the explanation of high 
variability in hip fracture incidence. According to the Eastern European & Central 
Asian Regional Audit: Epidemiology, Costs and Burden of Osteoporosis in 2010, in 
Georgia, 75% of patients with hip fracture are not hospitalised and, in Kazakhstan 
and Kyrgyzstan, 50% are not hospitalised due to poor access to surgical services 
and non-affordable medical care [13].
In summary, with a few exceptions, age-specific incidence rates of hip fracture 
significantly rose in Western populations until 1980 with subsequent stability or 
even a decrease. In Western countries, the trends seem to be more pronounced in 
women than in men [16]. However, confirmation is needed, by further longitudinal 
studies (particularly in non-white populations) to clarify in which direction we are 
moving. Moreover, the mean age of sustaining a hip fracture is increasing, meaning 
that this event is increasingly associated with disability and mortality, possibly 
because patients have more medical comorbidities.
2.8  Other Osteoporotic Fractures
From an epidemiological perspective, distal radius fractures are typical of the pae-
diatric population, up to 25% of fractures in children involve the distal end of the 
radius, in older people up to 18% of all fractures involve the wrist [21]. The most 
common distal forearm fracture is a Colles’ fracture. This fracture lies within 2.5 cm 
of the wrist joint margin and is associated with dorsal angulation and displacement 
of the distal fragment of the radius. It may be accompanied by a fracture of the ulna 
styloid process [2]. Forearm fractures account for a greater proportion in younger 
adults than the elderly. Conversely, hip fractures are rare at the age of 50 years but 
become the predominant osteoporosis fracture from the age of 75 years. In women, 
the median age for distal forearm fractures is around 65 years and for hip fracture, 
80 years [2].
Vertebral fractures are the most common single osteoporotic fractures world-
wide, these occur in 30–50% of people more than the age of 50 [22]. In contrast to 
hip fractures, many factors limit the availability of reliable information on their 
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epidemiology: two-thirds to three-fourths of vertebral fractures are clinically silent 
and less than 10% require hospital admission, which itself may vary due to geo-
graphic differences in access to healthcare.
For example, in a study involving about 1000 hospitalised persons of older age, 
chest radiographs were assessed for various reasons. Of importance, moderate 
(25–40% height loss) or severe (>40% height loss) vertebral fractures were scored 
in 14% women by trained radiologists in a reference centre, but only half were 
reported in the X-ray report by the local radiologists [23]. This is often due to the 
scarce knowledge among radiologists in recognising asymptomatic vertebral frac-
tures, the lack of any relevant signs or symptoms and/or the presence of other medi-
cal conditions for which a chest/abdomen X-ray was done that requires more 
attention (e.g. pneumonia or cancer) [23]. However, asymptomatic vertebral frac-
tures are of importance since they represent a potential risk factor for symptomatic 
fractures and they are associated with a higher rate of disability and mortality, par-
ticularly in those having secondary forms of osteoporosis, such as glucocorticoid- 
induced osteoporosis [23].
In Europe, studies in men and women aged more than 50 years report that the 
incidence of clinical vertebral fracture is higher in men than women under 55 years, 
but that the risk rises in women after the age of 60 years [24]. The age-specific 
incidence of radiographic vertebral fracture (symptomatic or not) is estimated to be 
2–2.5-fold higher in women than in men, being significantly higher in Scandinavia 
than in other European countries. It is reported that the incidence of vertebral frac-
tures is highest at T12 and L1, second highest at L2 and L3, and third highest at T7 
through T9 and at L4 [24]. However, the age-adjusted incidence may vary substan-
tially from country to country. Some of these differences may be due to different 
patterns of clinical presentation and differences in vertebral fracture ascertainment 
in the studies that were used for calculating the incidence, rather than true differ-
ences in fracture incidence across countries. For example, symptomatic vertebral 
fracture rates seem to be particularly high in the United States, but the population- 
based study on which of these estimates are calculated included vertebral fractures 
discovered incidentally on lateral spine imaging obtained for other clinical rea-
sons, not only for assessing vertebral fractures as was the case in European coun-
tries [25].
In terms of prevalence data, it is estimated that, in both men and women, preva-
lence linearly increases with age independently of country, with some data suggest-
ing that almost half of very old people (i.e. ageing >85 years) are affected by a 
vertebral fracture [24].
2.9  The Burden of Fragility Fractures
Measurement of the burden of diseases and injuries is a crucial input into health 
policy. The burden of osteoporosis in the 27 EU countries in 2010 was characterised 
by 22 million women and 5.5 million men to have osteoporosis; and 3.5 million new 
fragility fractures were sustained, comprising 610,000 hip fractures, 520,000 
2 Epidemiology of Fragility Fractures and Social Impact
28
vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures [2]. The 
greatest burden of hip fractures around the world is expected to occur in East Asia, 
especially China [8].
Information on the burden of osteoporosis in Latin American countries is lim-
ited. When analysing data in four Latin American countries [26] more than 840,000 
osteoporosis-related fractures were predicted to occur in 2018, amounting to a total 
annual cost of ∼1.17 billion USD. The total projected 5-year cost was ∼6.25 billion 
USD.  Annual costs were highest in Mexico (411 million USD), followed by 
Argentina (360 million USD), Brazil (310 million USD), and Colombia (94 million 
USD). The average burden per 1000 at risk was greatest in Argentina (32,583 USD), 
followed by Mexico (16,671 USD), Colombia (8240 USD), and Brazil (6130 USD). 
In the following 5 years, about four and half million fractures are anticipated to 
occur in these four countries.
To control and prevent these fractures, stakeholders must work together to 
close the care gap, particularly in secondary prevention. Indeed, all international 
scientific bodies agree upon the clinical recommendations to close the gap after a 
hip fracture, mainly: communicating with patients about their risks of future frac-
tures and how to prevent them, by offering osteoporosis medications, improving 
long-term treatment persistence and assessing the risk of falls in routine follow-up 
visits [26].
2.10  The Costs and Social Impact of Hip Fracture
Hip fractures constitute a significant public health problem worldwide, and is asso-
ciated with high rates of disability and mortality. Since hip fracture incidence 
increases linearly with advancing age and older people are expected to represent a 
growing proportion of the worldwide population in the near future, the costs of hip 
fracture will increase. Overall, hip fracture seems to be comparable to other disease 
groups, such as cardiovascular, in terms of hospitalisation and rehabilitation. 
However, other social costs, due to the onset of new comorbidities, sarcopenia, poor 
quality of life, disability and mortality are probably greater. Hip fracture and its 
surgical treatment predispose frail older persons to decompensation of chronic dis-
eases, as well as complications such as anaemia, pneumonia, delirium, UTI and 
thromboembolic events.
Patients who have a hip fracture are at considerable risk for premature death. 
There has been no change in mortality rates for hip fractures since the last three 
decades, despite advancements in surgical solutions and the fact that the majority 
of patients in the developed economies are now operated on [27]. A report of 
osteoporosis in the European Union estimated that mortality related to low-impact 
trauma hip fracture is greater than road traffic accidents and equivalent to breast 
cancer [2]. The increased mortality risk after the hip fracture may persist for sev-
eral years thereafter [28]. Patients experiencing hip fractures after low-impact 
trauma are at considerable risk for subsequent osteoporotic fractures and prema-
ture death [28].
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In contrast to other types of fragility fracture (e.g. vertebral), hip fractures usu-
ally need immediate intervention and consequent hospitalisation. The mean dura-
tion of hospitalisation is highly variable dependent on local healthcare systems and 
populations studied.
A recent systematic review [29] has found that costs during the first year after the 
hip fracture ($43,669) are greater than equivalent estimates for the acute coronary 
syndrome ($32,345) and ischaemic stroke ($34,772). A systematic review of the 
costs of fragility hip fractures and key drivers of the differences in hip fracture costs 
between 1990 and 2015 analysed data of 670,173 patients from 27 different coun-
tries (mostly North America and Western Europe) [29]. The estimate for total health 
and social care costs in the first year following hip fracture was $43,669 per patient. 
High variability was found between regions but also inside the country: in the 
United States, the costs of medical care in the 12 months ranged from $21,259 to 
$44,200. Inpatient care was with the highest cost, estimated at $13,331. The mean 
length of stay for the index hospitalisation was 8.6 days and varied significantly by 
region. Studies from North America reported the shortest mean length of stay, whilst 
studies from Asia had the longest length of stay. Inpatient cost was followed by the 
cost of rehabilitation care, estimated at $12,020. The high costs of rehabilitation 
might be biased as a limited number of studies in this category were available with 
a very high cost from one study [29].
Comorbidities prior to fracture were associated with significantly higher costs in 
80% of studies. Developing a complication after hip fracture was associated with 
significantly higher costs in 93% of studies assessing this variable. Gender, year of 
study, US studies and length of stay were significantly associated with costs. In 
studies outside the United States, the mean cost per patient was $3304 less per addi-
tional day of length of stay compared to the United States. On average, cases in 
females were found to be statistically significantly less expensive than in men, cost-
ing $134 less per patient. Studies published more recently were significantly associ-
ated with lower costs: authors suggested that this might represent changes in clinical 
practice and fewer complications, as well as methodological changes [29].
Saving hospital costs by reducing the length of stay could be an important factor 
to diminish the expenditure on hip fracture management. Data from the Swedish 
National Patient Register, published in 2015, indicate that shorter length of hospital 
stay was associated with an increased risk of death after discharge in older hip frac-
ture patients (mean age 82 years) with the length of stay 10 days less. In this study, 
the discharge placement was not available, but the authors suggest that the quality 
of rehabilitation in the early postoperative period might have influenced the out-
come as reductions in length of stay will probably result in more complications 
occurring after discharge. Furthermore, shorter length of stay reduces the time 
available for the comprehensive geriatric assessment (CGA) during hospital stay 
[30]. CGA has been shown to decrease the risks of complications and death after 
discharge in elderly hip fracture patients.
In contrast, a study in the United States by Nikkel et  al. demonstrated that 
decreased length of stay was associated with reduced rates of early mortality [31]. 
A total of 188,208 patients admitted to hospital for hip fracture in New York state 
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from 2000 to 2011, with 169,258 treated surgically and 18,950 treated non- 
surgically, were analysed. The average length of hospital stay was 8.1 days; during 
the study, the average length of stay decreased from 12.9 days in 2000 to 5.6 days 
in 2011. The 30-day mortality rate for surgically-treated hip fracture patients was 
4.5%. A shorter hospital stay (<5 days and <10 days) was associated with decreased 
30-day mortality. Factors associated with increased 30-day mortality were non- 
surgical treatment, male sex, being white, older age, longer time to surgery, blood 
transfusion, comorbid conditions, and discharge to hospice. The important factor in 
predicting early mortality is a longer time to surgery (more than 24/48 h after the 
fracture), which is also associated with a longer hospital stay, as has been described 
in earlier studies [32].
It has been estimated earlier that the expenditure needed for hip fracture exceeds 
that for breast and gynaecological cancers combined, but not those for cardiovascu-
lar disease in the United States [33]. The comparison of costs between hip fractures 
and cardiovascular diseases is intriguing. In Switzerland, osteoporotic hip fractures 
accounted for more hospital bed days than myocardial infarction and stroke and 
consequently led to higher costs [34], while in Italy the costs due to hip fractures 
were comparable to those of acute myocardial infarction.
As described in Chap. 12, rehabilitation is crucial for people after hip fracture 
[35]. However, the advanced age and the comorbidities affecting hip fracture 
patients often dictate that the completion of the rehabilitation programme takes 
place in long-term care (LTC) facility or a nursing home. The costs needed for a 
LTC seem to be almost double those required by a rehabilitation institute. However, 
the roles of these organisations for the rehabilitation of older patients are still 
debated. In a well-known study on this topic, hip fracture patients admitted to reha-
bilitation hospitals did not differ from patients admitted to nursing homes in their 
return to the community or disability rate [36]. Moreover, costs were significantly 
greater for rehabilitation hospital patients than for nursing home patients and the 
evidence about the value of these organisations in the elderly is still conflicting.
Poor recovery among older adults with hip fractures can occur despite successful 
surgical repair and rehabilitation, suggesting other factors might play a role in 
recovery, such as social factors [37]. In the review of the role of social factors in 
recovery after hip fracture, the majority of included studies have shown that both a 
higher level of social support and a better socioeconomic status has a positive effect 
on physical functional recovery post-hip fracture in individuals aged more than 
65 years. Socioeconomic status was associated with both physical functional recov-
ery and mortality from hip fractures. Income, employment, education skills and 
training are all socioeconomic factors that have been studied and found to influence 
recovery from hip fracture [7, 37].
Other consequences may be loss of muscle strength, increased postural sway and 
decline in walking speed that can lead to loss of functional muscle mass, sarcopenia 
and finally to disability. The impact on disability is striking: 1 year after fracturing 
a hip, 40% of patients are still unable to walk independently, 60% have difficulty 
with at least one essential activity of daily living, and 80% are restricted in instru-
mental activities of daily living, such as driving and grocery shopping [16].
N. Veronese et al.
31
A review published in 2016 included data from 32 cohort studies mostly from 
Western European and North American countries, but also included some studies 
from Australia, New Zealand, Japan and China [37]. The review provided clear 
evidence that people recovering from hip fractures experience ongoing limitations 
in mobility, basic activities of daily living (ADL), self-care, participation and qual-
ity of life. Between 40 and 60% of hip fracture survivors are likely to recover their 
pre-fracture level of mobility. Up to 70% of people may regain their pre-fracture 
level of independence for composite measures of basic ADL, but this proportion is 
likely to be lower for those with higher levels of dependence pre-fracture [37]. Only 
half or fewer people experiencing hip fracture may regain their pre-fracture level of 
independence in instrumental activities of daily living (IADLs). Most people who 
recover their ability to perform basic or instrumental ADLs do so within the first 
6 months after discharge, although the time to recovery for individual ADLs ranges 
from approximately 4 to 11 months [37]. Studies in many countries world-wide 
have indicated that hip fracture has a significant impact on the quality of life in the 
medium to long term. In Western nations, between 10 and 20% of hip fracture 
patients are institutionalised within 6–12 months post-fracture [37].
Hip fracture seems to be associated with the onset of other co-morbidities with a 
high cost for society. Recent research has highlighted that people experiencing a hip 
fracture have a greater incidence of depression [38] and consequently a higher use 
of anti-depressant medications [39]. Another field of interest is the possible rela-
tionship between hip fracture and the onset of cardiovascular diseases. Hip fracture, 
in fact, seems to increase the risk of coronary heart disease, particularly during the 
first year after the event [40]. Since cardiovascular diseases are among the most 
expensive medical conditions, the impact of hip fracture in contributing to a huge 
increase in medical and social costs is highly relevant.
2.11  The Costs and Social Impact of Other 
Osteoporotic Fractures
Other osteoporotic/fragility fractures (e.g. wrist, spine, shoulder) are more common 
than hip fractures, but some of them (such as vertebral) are often asymptomatic and 
the others require less hospital stay than hip fractures. Limited data exist regarding 
the social costs of the other osteoporotic fractures. In a study including six different 
cohorts, the authors report that the adjusted mean first-year costs associated with 
hip, vertebral, and non-vertebral fractures were $26,545, $14,977, and $9183 for the 
50–64 age cohort, and $15,196, $6701, and $6106 for patients ≥65 years, respec-
tively [41]. However, after considering the prevalence rate of all major osteoporotic 
fractures, the proportion of the total fracture costs accounted for by non-vertebral, 
hip, and vertebral fractures were 66%, 21% and 13% in younger and 36%, 52% and 
12% for in older people [41].
The importance of osteoporotic fractures, other than hip, from an economic point 
of view, was confirmed by a large study using administrative data and including 
almost all European countries. In this report, European countries report a marked 
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difference in the LOS between men and women, with differences ranging from 
0.32 days in Austria to 20.2 days in Spain [42]. The total cost of vertebral fractures 
in the European Union is enormous, being estimated at 377 million euros per year—
about 63% of hip fractures [42]. However, more economic data are needed for non- 
femoral fractures, including data regarding asymptomatic fractures; this will require 
cohort studies designed to achieve this aim.
2.12  Conclusions
Hip fracture is a common and debilitating condition, particularly in older persons. 
Although the age- and gender-specific incidence is decreasing in some countries, 
the global incidence of hip fracture is rising worldwide, due to population ageing. 
More attention should be paid to prevention, given its great impact on social costs 
and quality of life. Other osteoporotic fractures, in particular those affecting spine 
and wrist, play an important role from an epidemiological point of view, but more 
data on their economic impact are needed. Thus, further epidemiological studies are 
needed to better verify the trends in the incidence of osteoporotic fractures and the 
strategies of effective prevention.
References
 1. WHO. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Approached 
February 1, 2020
 2. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, 
Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epi-
demiology and economic burden. A report prepared in collaboration with the International 
Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry 
Associations (EFPIA). Arch Osteoporos 8:136
 3. Zanker J, Duque G (2019) Osteoporosis in older persons: old and new players. J Am Geriatr 
Soc 67(4):831–840
 4. Kanis JA, Oden A, McCloskey EV et al (2012) A systematic review of hip fracture incidence 
and probability of fracture worldwide. Osteoporos Int 23(9):2239–2256
 5. Liu J, Curtis EM, Cooper C, Harvey NC (2019) State of the art in osteoporosis risk assessment 
and treatment. J Endocrinol Investig 42(10):1149–1164
 6. Veronese N, Maggi S (2018) Epidemiology and social costs of hip fracture. Injury 
49(8):1458–1460
 7. Auais M, Al-Zoubi F, Matheson A, Brown K, Magaziner J, French SD (2019) Understanding 
the role of social factors in recovery after hip fractures: a structured scoping review. Health Soc 
Care Community 27(6):1375–1387
 8. Cheung EYN, Tan KCB, Cheung CL, Kung AWC (2016) Osteoporosis in East Asia: current 
issues in assessment and management. Osteoporos Sarcopenia 2:118–133
 9. Yu F, Xia W (2019) The epidemiology of osteoporosis, associated fragility fractures, and man-
agement gap in China. Arch Osteoporos 14(1):32
 10. Khadilkar AV, Mandlik RM (2015) Epidemiology and treatment of osteoporosis in women: an 
Indian perspective. Int J Women’s Health 7:841–850
 11. Francisco L, Délio Marques C, Costa-Paiva L, Pinto-Neto AM (2015) The epidemiology and 
management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging 
10:583–591
N. Veronese et al.
33
 12. Wright NC, Looker AC, Saag KG et al (2014) The recent prevalence of osteoporosis and low 
bone mass in the United States based on bone mineral density at the femoral neck or lumbar 
spine. J Bone Miner Res 29(11):2520–2526
 13. Curtis EM, Moon RJ, Harvey NC, Cooper C (2017) The impact of fragility fracture and 
approaches to osteoporosis risk assessment worldwide. Bone 104:29–38
 14. Cruz-Jentoft A, Landi F, Schneider FM et al (2014) Prevalence of and interventions for sarco-
penia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative 
(EWGSOP and IWGS). Age Ageing 43(6):748–759
 15. Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, Montero-Odasso M, 
Gunawardene P, Demontiero O, Duque G (2015) Phenotype of osteosarcopenia in older indi-
viduals with a history of falling. J Am Med Dir Assoc 16:290–295
 16. Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM et al (2011) Secular 
trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22(5):1277–1288
 17. Ho S, Bacon E, Harris T, Looker A, Maggi S (1993) Hip fracture rates in Hong Kong and the 
United States, 1988 through 1989. Am J Public Health 83:694–697
 18. Haring B, Crandall CJ, Wu C, LeBlanc ES, Shikany JM, Carbone L et al (2016) Dietary pat-
terns and fractures in postmenopausal women: results from the women’s health initiative. 
JAMA Intern Med 176(5):645–652
 19. Romero Pérez A, Rivas VA (2014) Adherence to Mediterranean diet and bone health. Nutr 
Hosp 29(5):989–996
 20. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip 
fractures in the United States. JAMA 302(14):1573–1579
 21. Nellans KW, Kowalski E, Chung KC (2012) The epidemiology of distal radius fractures. Hand 
Clin 28(2):113–125
 22. Ballane G, Cauley JA, Luckey MM, Fuleihan GE (2017) Worldwide prevalence and incidence 
of osteoporotic vertebral fractures. Osteoporosis Int 28:1531–1542
 23. Lems WF (2007) Clinical relevance of vertebral fractures. Ann Rheum Dis 66(1):2–4
 24. Ensrud KE, Schousboe JT (2011) Vertebral fractures. NEJM 364(17):1634–1642
 25. Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ III (2014) Trends in fracture inci-
dence: a population-based study over 20 years. J Bone Miner Res 29(3):581–589
 26. Aziziyeh R, Amin M, Habib M, Perlaza JG, McTavish RK, Lüdke A, Fernandes S, Sripada 
K, Cameron C (2019) A scorecard for osteoporosis in four Latin American countries: Brazil, 
Mexico, Colombia, and Argentina. Arch Osteoporos 14(1):69
 27. Johansen A, Golding D, Brent L, Close J, Gjertsen J-E, Holt G, Hommel A, Pedersen AB, 
Röck ND, Thorngren K-G (2017) Using national hip fracture registries and audit databases to 
develop an international perspective. Injury 48(10):2174–2179
 28. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following 
hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650
 29. Williamson S, Landeiro F, McConnell T et al (2017) Costs of fragility hip fractures globally: 
a systematic review and meta-regression analysis. Osteoporos Int 28:2791–2800
 30. Nordstrom P, Gustafson Y, Michaelsson K, Nordstrom A (2015) Length of hospital stay after 
hip fracture and short term risk of death after discharge: a total cohort study in Sweden. BMJ 
350:h696
 31. Nikkel LE, Kates SL, Schreck M, Maceroli M, Mahmood B, Elfar JC (2015) Length of hos-
pital stay after hip fracture and risk of early mortality after discharge in New York state: retro-
spective cohort study. BMJ 351:h6246
 32. Maggi S, Siviero P, Wetle T, Besdine RW, Saugo M, Crepaldi G (2010) A multicenter sur-
vey on profile of care for hip fracture: predictors of mortality and disability. Osteoporosis Int 
21(2):223–231
 33. Hoerger TJ, Downs KE, Lakshmanan MC, Lindrooth RC, Plouffe L, Wendling B et al (1999) 
Healthcare use among U.S. women aged 45 and older: total costs and costs for selected post-
menopausal health risks. J Womens Health Gend Based Med 8(8):1077–1089
 34. Lippuner K, von Overbeck J, Perrelet R, Bosshard H, Jaeger P (1997) Incidence and direct 
medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporosis Int 
7(5):414–425
2 Epidemiology of Fragility Fractures and Social Impact
34
 35. De Rui M, Veronese N, Manzato E, Sergi G (2013) Role of comprehensive geriatric assess-
ment in the management of osteoporotic hip fracture in the elderly: an overview. Disabil 
Rehabil 35(9):758–765
 36. Kramer AM, Steiner JF, Schlenker RE, Eilertsen TB, Hrincevich CA, Tropea DA et al (1997) 
Outcomes and costs after hip fracture and stroke. A comparison of rehabilitation settings. 
JAMA 277(5):396–404
 37. Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, Sherrington C (2016) 
Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group. A critical 
review of the long-term disability outcomes following hip fracture. BMC Geriatr 16(1):158
 38. Cristancho P, Lenze EJ, Avidan MS, Rawson KS (2016) Trajectories of depressive symptoms 
after hip fracture. Psychol Med 46(07):1413–1425
 39. Iaboni A, Seitz DP, Fischer HD, Diong CC, Rochon PA, Flint AJ (2015) Initiation of anti-
depressant medication after hip fracture in community-dwelling older adults. Am J Geriatr 
Psychiatry 23(10):1007–1015
 40. Veronese N, Stubbs B, Crepaldi G, Solmi M, Cooper C, Reginster J-Y et al (2017) Low bone 
mineral density and fractures are associated with incident cardiovascular disease: a systematic 
review and meta-analysis. Osteoporosis Int 28:180–181
 41. Shi N, Foley K, Lenhart G, Badamgarav E (2009) Direct healthcare costs of hip, vertebral, and 
non-hip, non-vertebral fractures. Bone 45(6):1084–1090
 42. Finnern HW, Sykes DP (2003) The hospital cost of vertebral fractures in the EU: estimates 
using national datasets. Osteoporosis Int 14(5):429–436
Open Access This book is licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/
by-nc-nd/4.0/), which permits any noncommercial use, sharing, distribution and reproduction in 
any medium or format, as long as you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons license and indicate if you modified the licensed 
material. You do not have permission under this license to share adapted material derived from this 
book or parts of it.
The images or other third party material in this book are included in the book’s Creative 
Commons license, unless indicated otherwise in a credit line to the material. If material is not 
included in the book’s Creative Commons license and your intended use is not permitted by statu-
tory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder.
N. Veronese et al.
35© The Author(s) 2021
P. Falaschi, D. Marsh (eds.), Orthogeriatrics, Practical Issues in Geriatrics, 
https://doi.org/10.1007/978-3-030-48126-1_3
3
P. Falaschi (*) 
Fragility Fracture Network, Zurich, Switzerland 
Sapienza University of Rome, Rome, Italy
e-mail: paolo.falaschi@fondazione.uniroma1.it 
A. Marques 
RN at Rheumatology Department, Centro Hospitalar e Universitário de Coimbra,  
Coimbra, Portugal 
School of Nursing, Coimbra, Portugal 
S. Giordano 
RSA Salus, Rome, Italy
This chapter is a component of Part 1: Background.
For an explanation of the grouping of chapters in this book, please see Chapter 1: ‘The 
Multidisciplinary Approach to Fragility Fractures Around the World—An Overview’.




Osteoporosis is a systemic bone disease characterised by a reduction and qualitative 
alterations of the bone mass leading to increased risk of fractures. There are two 
primary forms of osteoporosis (types I and II): postmenopausal osteoporosis and 
senile osteoporosis, which appears with advancing age. Secondary forms of osteo-
porosis are associated with a vast range of diseases and drugs [1].
According to the World Health Organisation, the diagnosis of osteoporosis rests 
on densitometry, as described below in Sect. 3.7.1, with a T-score diagnostic thresh-
old of < −2.5 [1, 2].
This disease is progressive and if not diagnosed and treated (primary prevention) 
causes progressive fragility of the bones through a complex pathogenetic mecha-
nism described in detail in Sect. 3.5. This acquired fragility of the skeleton increases 
the risk of fracture with low energy trauma or even spontaneously in the most severe 
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cases. When a fragility fracture occurs a DEXA may not be necessary and the anti-
osteoporotic treatment can be started to reduce the risk of further fractures (second-
ary prevention).
3.2  Epidemiology
Osteoporosis is a disease that impacts significantly on society. Its incidence increases 
with age; in fact, it affects most of the population which has entered the eighth 
decade of life [1]. Common sites of osteoporotic fractures are the spine, hip, distal 
forearm and proximal humerus. All told, osteoporotic fractures occur in 2.7 million 
in men and women in Europe with high direct costs [3]. A recent estimate (for 2010) 
calculated the direct cost at 29 billion in the five largest EU countries (France, 
Germany, Italy, Spain and the UK) [4] and 38.7 billion in the 27 EU countries of the 
time [5]. Hip fractures cause acute pain and loss of function, and nearly always lead 
to hospitalisation. Recovery is slow, and rehabilitation is often incomplete, with 
many patients permanently institutionalised in nursing homes. Vertebral fractures 
may cause acute pain and loss of function but may also occur without serious symp-
toms. Distal radial fractures also lead to acute pain and loss of function, but func-
tional recovery is usually good, at times excellent. It is widely recognised that 
osteoporosis and the fractures it causes are associated with increased mortality, with 
the exception of forearm fractures [6]. In the case of hip fractures, most deaths occur 
during the first 3–6  months following the event, of which 20–30% are causally 
related to the fracture itself [7]. For an extensive description of the epidemiological 
distribution of osteoporosis, fragility fractures and costs, see Chap. 2.
3.3  The Anatomy of Bone
Eighty percent of the adult human skeleton is composed of cortical bone, 20% of 
trabecular bone. Cortical bone is dense and solid and surrounds the space occupied 
by the marrow, whereas trabecular bone is composed of a honeycomb-like network 
of trabecular plates and rods interspersed throughout the bone-marrow compart-
ment. Both cortical and trabecular bone are composed of osteons. Cortical osteons 
are called Haversian systems. Haversian systems are cylindrical in shape, approxi-
mately 400 mm in length and 200 mm in width at their base and form a branching 
network within the cortical bone [8].
Bone tissue is composed of cells (Osteoclast, osteoblast and osteocytes) and 
matrix [8].
Osteoclasts are the only cells known to be capable of resorbing bone. Activated 
multinucleated osteoclasts are derived from mononuclear precursor cells of the 
monocyte-macrophage lineage [9].
Osteoblasts: Osteoprogenitor cells give rise to and maintain the osteoblasts that 
synthesise new bone matrix on bone-forming surfaces, the osteocytes within the 
bone matrix supporting the bone structure, and the protective lining cells that 
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cover the surface of the quiescent bone. Within the osteoblast lineage, subpopula-
tions of cells respond differently to various hormonal, mechanical or cytokine 
signals [8].
Osteocytes: Osteocytes represent terminally differentiated osteoblasts and func-
tion within syncytial networks to support bone structure and metabolism. Osteocytes 
lie in lacunae within mineralised bone and create extensive filopodial processes 
within the canaliculi in mineralised bone. Osteocytes express several matrix pro-
teins that support intercellular adhesion and regulate the exchange of mineral in the 
bone fluid within the lacunae and the canalicular network. Osteocytes are active 
during osteolysis and may function as phagocytic cells because they contain lyso-
somes [8].
The bone extracellular matrix is composed of between 85% and 90% of col-
lagenous proteins. Bone matrix is mostly composed of type I collagen, with trace 
amounts of types III and V and FACIT collagens at certain stages of bone forma-
tion. FACIT collagens are members of the family of Fibril-Associated Collagens 
with Interrupted Triple Helices, a group of nonfibrillar collagens that serve as 
molecular bridges important for the organisation and stability of extracellular 
matrices [10].
Bone is composed of 50–70% minerals, 20–40% organic matrix, 5–10% water, 
and <3% lipids. The mineral content of bone is mostly hydroxyapatite 
[Ca10(PO4)6(OH)2], with small amounts of carbonate, magnesium, and acid phos-
phate, with missing hydroxyl groups that are normally present. Matrix maturation is 
associated with the expression of alkaline phosphatase and several non-collagenous 
proteins, including osteocalcin, osteopontin, and bone sialoprotein. Bone mineral 
provides mechanical rigidity and load-bearing strength to bone, whereas the organic 
matrix provides elasticity and flexibility [8].
The term ‘bone quality’ is used in two senses in the literature: in one bone 
quality represents the sum of all the characteristics of bone that affect its ability 
to resist fracture (i.e. all aspects of bone size, shape and its material properties); 
in the other, bone quality refers to the influence of factors that affect fracture but 
are not accounted for by bone mass or quantity [11, 12]. Regardless of one’s 
preference regarding a general definition of bone quality, bone quality remains a 
skeletal trait and since it is important in determining fracture risk it must play a 
role in determining the mechanical properties of bone, and therefore cannot 
account for any non- skeletal factors that may also contribute to fracture inci-
dence such as the risk of falling or limitations of commonly used measurements 
of bone mass [13].
Following the hierarchic structure of the bone we can recognise the following 
determinants for bone quality: whole bone morphology (size and shape), spatial 
distribution of bone density, microarchitecture, porosity, cortical-shell thickness, 
lacunar number/morphology, number, size and distribution of the remodelling cav-
ity, mineral and collagen distribution/alignment, type, amount and distribution of 
microdamage structure and cross-linking of collagen, mineral type and crystal 
alignment and collagen–mineral interfaces [14].
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3.4  The Physiology of Bone
Modelling is the process by which bones change their overall shape in response to 
physiological influences or mechanical forces, leading to a gradual adjustment of 
the skeleton to the forces it encounters [15].
Bone remodelling is the process by which bone is renewed to maintain bone 
strength and mineral homeostasis. Remodelling involves continuous removal of dis-
crete packets of old bone, replacement of these packets with newly synthesised 
matrix, and subsequent mineralisation of the matrix to form new bone. The main 
functions of bone remodelling are preservation of the mechanical strength of bone 
by replacing the older, micro-damaged bone with newer, healthier bone and calcium 
and phosphate homeostasis [8].
The remodelling cycle comprises four sequential phases: activation, resorption, 
reversal, formation [16, 17]. Activation involves recruitment and activation of 
mononuclear monocyte-macrophage osteoclast precursors from the circulation, lift-
ing of the endosteum containing the lining cells off the bone surface, and fusion of 
multiple mononuclear cells to form multinucleated preosteoclasts. Preosteoclasts 
bind to the bone matrix via interactions between integrin receptors in their cell 
membranes and RGD (arginine, glycine, and asparagine)-containing peptides in 
matrix proteins, to form annular sealing zones around bone-resorbing compart-
ments beneath multinucleated osteoclasts [8].
Osteoclast-mediated bone resorption takes only approximately 2–4 weeks dur-
ing each remodelling cycle. Osteoclast formation, activation, and resorption are 
regulated by the ratio of receptor activator of NF-κB ligand (RANKL) to osteopro-
tegerin (OPG) IL-1 and IL-6, colony-stimulating factor (CSF), parathyroid hor-
mone, 1,25-dihydroxyvitamin D, and calcitonin [9, 18]. Resorbing osteoclasts 
secrete hydrogen ions via H+-ATPase proton pumps and chloride channels in their 
cell membranes into the resorbing compartment to lower the pH within the bone- 
resorbing compartment to as low as 4.5, which helps mobilise bone mineral. 
Resorbing osteoclasts secrete tartrate-resistant acid phosphatase, cathepsin K, 
matrix metalloproteinase 9, and gelatinase from cytoplasmic lysosomes to digest 
the organic matrix, resulting in the formation of saucer-shaped Howship’s lacunae 
on the surface of trabecular bone and Haversian canals in cortical bone. The resorp-
tion phase is completed by mononuclear cells after the multinucleated osteoclasts 
undergo apoptosis [19]. Upon completion of bone resorption, resorption cavities 
contain a variety of mononuclear cells, including monocytes, osteocytes released 
from bone matrix, and preosteoblasts recruited to begin the formation of new bone. 
The coupling signals linking the end of bone resorption to the beginning of bone 
formation are not totally clear [20]. It has also been proposed that the reversal 
phase may be mediated by the strain gradient in the lacunae. As osteoclasts resorb 
cortical bone in a cutting cone, the strain is reduced in front and increased behind, 
and in Howship’s lacunae, the strain is highest at the base and less in surrounding 
bone at the edges of the lacunae. The strain gradient may lead to sequential activa-
tion of osteoclasts and osteoblasts, with osteoclasts activated by reduced strain and 
osteoblasts by increased strain. It has also been proposed that the osteoclast itself 
may play a role during reversal [21]. Bone formation takes approximately 
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4–6 months to complete. Osteoblasts synthesise new collagenous organic matrix 
and regulate mineralisation of matrix by releasing small, membrane-bound matrix 
vesicles that concentrate calcium and phosphate and enzymatically destroy miner-
alisation inhibitors such as pyrophosphate or proteoglycans [22]. Osteoblasts sur-
rounded by and buried within matrix become osteocytes with an extensive 
canalicular network connecting them to bone surface lining cells, osteoblasts, and 
other osteocytes, maintained by gap junctions between the cytoplasmic processes 
extending from the osteocytes [23]. At the completion of bone formation, approxi-
mately 50–70% of the osteoblasts undergo apoptosis, with the balance becoming 
osteocytes or bone-lining cells.
A critical advance in our understanding of skeletal biology of the last few years 
was the discovery of the role of Wnt/β catenin signalling in bone [24, 25]. Wnt/β 
catenin signalling is activated by binding of Wnt proteins to receptor complexes 
composed of frizzled receptors and co-receptors of the low-density lipoprotein 
receptor-related protein (LRP) family, LRP5 and 6. This event stabilises β catenin, 
induces its translocation to the nucleus, and activates gene transcription. This so- 
called canonical Wnt signalling pathway controls the differentiation of mesenchy-
mal stem cells (MSC) restraining chondrogenic and adipogenic differentiation and 
favouring osteoblastic differentiation. Canonical Wnt signalling also promotes 
osteoblast maturation and survival of osteoblasts and osteocytes and inhibits osteo-
clast generation by increasing the expression in osteoblasts and osteocytes of osteo-
protegerin (OPG), the decoy receptor of the receptor activator of Nfκb ligand 
(RANKL). Thus, activation of this pathway is critical for bone acquisition and 
maintenance through the increased bone formation and decreased resorption. 
Osteocytes are key players in the regulation of the canonical Wnt signalling path-
way as producers and targets of Wnt ligands and as secretors of molecules that 
modulate Wnt actions [25, 26]. A potent antagonist of Wnt signalling secreted by 
osteocytes is sclerostin, a protein encoded by the SOST gene, primarily expressed 
by mature osteocytes but not by early osteocytes or osteoblasts [27]. Sclerostin 
binds to the Wnt co-receptors LRP5/6 antagonising downstream signalling [28]. 
Sclerostin also interacts with LRP4, another member of the LRP family of proteins, 
which acts as a chaperone and is required for the inhibitory action of sclerostin on 
Wnt/β catenin signalling [29]. Absence of sclerostin expression or secretion in 
humans causes inherited high bone mass conditions characterised by exaggerated 
bone formation, including sclerosteosis, van Buchem disease and craniodiaphyseal 
dysplasia [25].
Osteoprotegerin (OPG), the decoy receptor for RANKL and therefore the inhibi-
tor of bone resorption, is a Wnt/β catenin target gene [30]. Thus, genetic manipula-
tion of Wnt/β catenin signalling leads to marked changes in OPG expression with 
consequent effects on resorption. Specifically, inactivation of Wnt/β catenin in 
mature osteoblasts/osteocytes decreases OPG and increases osteoclast differentia-
tion and bone resorption [31–33]. Conversely, activation of Wnt/β catenin in osteo-
blasts increases OPG expression and reduces bone resorption [31, 32]. Because 
sclerostin antagonises the Wnt/β catenin signalling pathway, it is not unexpected 
that changes in SOST/sclerostin expression might also modulate resorption by regu-
lating OPG. In fact, neutralising anti-sclerostin antibodies increase bone formation 
3 Osteoporosis and Fragility in Elderly Patients
40
and decrease bone resorption markers in experimental animals and humans, sug-
gesting that the bone gain achieved results from the combination of enhanced bone 
formation and decreased bone resorption [34].
3.5  Pathogenesis
Peak bone mass is achieved between the ages of 16–25 in most people. After this 
age, bone mass decreases slowly but continuously [35].
There is epidemiologic evidence for substantial effects of nutrition and lifestyle 
on peak bone mass and fracture risk, not only during childhood and adolescence but 
even during gestation [36, 37].
Bone formation typically exceeds bone resorption on the periosteal surface, so 
bones normally increase in diameter with age. Bone resorption typically exceeds 
bone formation on the endosteal surface, so the marrow space normally expands as 
people age. Bone remodelling increases in perimenopausal and early postmeno-
pausal women and then slows down with further ageing but continues at a faster rate 
than in premenopausal women. Bone remodelling is thought to increase mildly in 
ageing men [8].
Normal rates of bone loss are different in men and women. In men, bone mass is 
lost at a rate of 0.3% per annum, while in women this rate is 0.5%. By way of con-
trast, bone loss after menopause, in particular during the first 5 years after its onset, 
can be as high as 5–6% per annum [35].
Besides the difference in age at onset, types I and II osteoporosis have somewhat 
different effects on the kinds of bone lost. Type I appears to affect mostly trabecular 
bone, while type II affects both cortical and trabecular bone [35]. The cellular mech-
anism of type II osteoporosis is multifactorial. Factors involved are progressive 
dietary calcium deficiency, progressive inactivity [35, 38], and as in type I osteopo-
rosis, decreases in oestrogen levels have been demonstrated in both elderly men and 
women to be an important cause of senile osteoporosis.
Normal cancellous bone is composed of both horizontal and vertical trabeculae. 
In the osteoporotic bone, there is a predisposition to loss of horizontal trabeculae. 
This leads to decreased interconnectivity of the internal scaffolding of the vertebral 
body. Without the support of crossing horizontal members, unsupported vertical 
beams of the bone easily succumb to minor loads [35].
3.6  Risk Factors for Fragility Fractures
Osteoporotic fractures are related to several risk factors (Table 3.1).
3.6.1  BMD
Several studies have demonstrated that the reduction of a single standard deviation 
in BMD corresponds to an increase in fracture risk of 1.5–3-fold [1]. However, 
fracture risk is not only related to BMD, consequently, T-score values alone are not 
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sufficient to define the probability of fracture and determine when a patient needs to 
be treated [39]. Moreover, the majority of fractures occur in patients presenting with 
osteopenia (T-scores of −2.5 to −1.0) [40].
An interesting situation is the diabetic patient since type 2 diabetes is usually 
associated with a 5–10% higher areal BMD than healthy subjects but despite that, 
they are at higher risk of fracture. It has been demonstrated that for a given T-score 
and age, the fracture risk was higher in type 2 diabetes patients than in those not 
presenting with type 2 diabetes [41].
3.6.2  Age
Age contributes, independently of BMD, to fracture risk; therefore, in the pres-
ence of the same BMD score, the risk of fracture will be higher for the elderly 
than for the young [39, 42]. Another major problem regarding the elderly is their 
reduced muscular functionality. This is an age-related condition, but it is often 
exaggerated by deficient nutrition and reduced mobility. Weakness is one of the 
five items that define frailty syndrome as proposed by Fried and colleagues [43]. 
Moreover, the ‘frail phenotype’ is associated with a very high risk of falls leading 
to fracture [44].
3.6.3  Previous Fractures
The presence of a previous fracture, regardless of its site, is an important risk factor 
for further fractures and is independent of BMD.  The most common prognostic 
fractures are those of the vertebrae, hip, humerus and wrist. Moreover, risk of fur-
ther fracture increases with the number of previous fractures: patients with three or 
more previous fractures have a ten times greater risk of fracture than patients who 
have never suffered from fractures [1].
Table 3.1 Summary of clini-
cal risk factors [1, 2]
Age
Female gender
Low body mass index
Previous fragility fracture, particularly of the hip, wrist and 
spine
Parental history of hip fracture
Glucocorticoid treatment (≥5 mg prednisolone daily or 
equivalent for 3 months or more)
Current smoking





Osteoporosis-related pathologies (see Table 3.2)
Organ transplant
For an extensive description of risk factors see Chap. 14
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Table 3.2 Pathologies relevant to fracture risk





– Diabetes mellitus type I and II
– Acromegaly
– GH deficiency
Haematological disorders – Myelo-lymphoproliferative diseases





Gastrointestinal disorders – Chronic liver disease
– Primary biliary cirrhosis
– Celiac disease











– Other forms of connectivitis
Renal disorders – Renal idiopathic hypercalciuria
– Renal tubular acidosis
– Chronic renal failure
Neurological disorders – Parkinson’s disease
– Multiple sclerosis
– Paraplegia
– Aftermath of stroke
– Muscular dystrophies
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3.6.4  Family History of Fracture
Family history influences fracture risk independently of BMD. In particular, paren-
tal hip fracture is significantly related to a higher risk of hip fractures in offspring 
and, to a lesser extent, of all other kinds of osteoporotic fractures [1].
3.6.5  Comorbidities
A broad range of pathologies is related to increased rates of fracture risk (Table 3.2).
In some cases, the increased fracture risk is caused by a reduction in BMD, 
but other mechanisms are often involved: chronic inflammation, alteration of 
bone quality, general impairment of health conditions, reduction of mobility, 
sarcopenia, with a higher risk of falls and other complications. Vitamin-D 
 deficiency, which often coexists with this pathology, is another negative 
factor [1].
3.6.6  Drugs
Several drugs increase the risks of fracture. The most important class of drugs is 
glucocorticoids that have a negative effect on bone, causing rapid bone-quality loss 
and BMD depletion. Among the more recent classes of drugs, hormone-blockade 
treatments (aromatase inhibitors for women operated for breast cancer and GnRH 
agonists for men with prostate cancer) also lead to a reduction of BMD but at a 
slower rate. Other drugs involved are SSRI, PPI, H2 inhibitors, anticonvulsants, 
loop diuretics, anticoagulants, excess of thyroid hormones and antiretroviral 
treatment.
3.6.7  Assessment of Fracture Risk
Although BMD acts as the cornerstone when diagnosing osteoporosis, as mentioned 
earlier, the use of BMD alone does not suffice to identify an intervention threshold. 
This is why a vast number of scores are drawn up to better identify fracture risks; 
the most widely used assessment tool is FRAX®. This is a web-based algorithm 
(www.shef.ac.uk/FRAX) which calculates the 10-year probability of a major frac-
ture (hip, clinical spine, humerus or wrist) and a 10-year hip-fracture probabil-
ity [45].
Despite the fact that international literature has demonstrated the validity of 
these instruments when evaluating the risk of fracture, the intervention thresholds 
for osteoporosis currently depend on regional treatment and reimbursement poli-
cies, which are increasingly based on cost-effectiveness evaluations [46–48].
For a more extensive discussion see Chap. 14.
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3.7  Diagnosis
There is no universally accepted population-screening policy in Europe for the rec-
ognition of patients with osteoporosis or those at high risk of fracture. In the absence 
of such a policy, patients are identified opportunistically using a case-finding strat-
egy based on previous fragility fractures or the presence of significant risk fac-
tors [2].
3.7.1  Instrumental Diagnosis
Bone Mineral Density (BMD) may be evaluated by means of several techniques 
generally described as bone densitometry. Densitometry permits accurate measure-
ment of bone mass, which is the best predictor of risks of osteoporotic fracture. The 
result is expressed as a T-score, which is the difference between the subject’s BMD 
value and the mean BMD value for healthy young adults (peak bone mass) of the 
same sex, expressed in standard deviations (SD). BMD can also be expressed by 
comparing the average value for subjects of the same age and sex (Z-score). The 
threshold required to diagnose the presence of osteoporosis, according to the WHO, 
is a T-score of < −2.5 SD.
3.7.1.1  Dual X-Ray Absorptiometry (DXA)
This is, at present, the technique preferred for bone-mass evaluation used to enable 
the diagnosis of osteoporosis, prediction of fracture risk and follow-up monitoring. 
The technique uses X-rays of two different energies, which allow the subtraction of 
soft tissue absorption and provide an estimate of the bone’s calcium content. When 
projected onto a surface, this gives a parameter called bone mineral density (BMD 
g/cm2), from which bone mineral content (BMC, g/cm3) may be inferred. In general, 
measurement at a particular site provides a more accurate estimate of fracture risk 
for that site. Since the most clinically relevant osteoporotic fractures occur in the 
spine and hip, the most frequently measured sites are the lumbar spine and proximal 
femur. However, there are a number of technical limitations to the application of 
DXA to diagnosis. For example, the presence of osteomalacia will underestimate 
the total bone matrix because of decreased bone mineralisation while, on the other 
hand, osteoarthrosis or osteoarthritis of the spine or hip will contribute to density 
but not to skeletal strength [2]. In the latter case, the specific site involved must be 
excluded from the analysis; at least two lumbar vertebrae must be evaluated so that 
the densitometry result may be considered reasonably accurate. For this reason, 
femoral densitometric evaluation is probably preferable after the age of 65. Recently 
some software has been developed to enable DXA to measure, not only BMD but 
also some of the geometrical parameters related to bone strength, such as HSA (hip 
structure analysis) and TBS (trabecular bone score).TBS has emerged as a novel 
grey-level texture measurement that uses experimental variograms of 2D projection 
images, quantifying variation in grey-level texture from one pixel to the adjacent 
pixels [49]. TBS is not a direct measurement of bone microarchitecture but is related 
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to 3D bone characteristics such as the trabecular number, the trabecular separation 
and the connectivity density [50, 51]. An elevated TBS appears to represent a strong, 
fracture-resistant microarchitecture, while a low TBS reflects a weak, fracture- 
prone microarchitecture. As such, there is evidence that TBS can differentiate 
between two three-dimensional (3D) microarchitectures that exhibit the same bone 
density and different trabecular characteristics. Lumbar TBS, like a BMD, is an age- 
dependent variable. Little change in TBS is observed between the ages of 30 and 
45 years. Thereafter, a progressive decrease is observed with advancing age, which 
is more marked in women than in men. Although this device has been approved by 
the FDA, its everyday use in clinical practice is still limited [52].
3.7.1.2  Quantitative Computerised Tomography (QCT)
This technique, because it is able to separate the trabecular BMD from the cortical 
BMD, permits total and local volumetric BMD (g/cm3) measurements at both ver-
tebral and femoral levels. However, this method exposes patients to high radiation 
dose levels (about 100 Sv). As a technique, DXA is usually preferred to QCT 
because of its accuracy, shorter scan times, more stable calibration, lower radiation 
dose and lower costs [2].
3.7.1.3  Quantitative Ultra-Sound (QUS)
This technique provides two parameters (speed and attenuation) which are indirect 
indicators of bone mass and structural integrity; it is used mainly to carry out mea-
surements in two sites, the phalanges and the calcaneus. It has been demonstrated 
that ultrasound parameters are capable of predicting the risk of osteoporotic frac-
tures (femoral and vertebral) no less accurately than lumbar or femoral DXA, both 
in postmenopausal women and in men, but this technique does not provide direct 
bone-density measurements. Discordant results between ultrasonographic and DXA 
evaluations are neither surprising nor infrequent and they do not necessarily indi-
cate an error, but rather, that the QUS parameters are independent predictors of 
fracture risk influenced by other characteristics of the bone tissue. It does mean, 
however, that QUS cannot be used for the diagnoses of osteoporosis based on WHO 
criteria. QUS can be useful when it is not possible to estimate a lumbar or femoral 
BMD with DXA and may be recommended for epidemiological investigations and 
first-level screening, considering its relatively low cost, easy transportability and 
absence of radiation [2].
3.7.2  X-Ray of the Dorsal and Lumbar Spine
The presence of a non-traumatic vertebral fracture indicates a condition of skeletal 
fragility, regardless of BMD, and is a strong indicator of the need to start treatment 
to reduce risks of further fractures. Since most vertebral fractures are mild and 
asymptomatic, the use of diagnostic imaging is the only way to diagnose them. 
Vertebral fractures are defined, applying Genant’s semi-quantitative method (SQ), 
more than a 20% reduction in one vertebral body height [2].
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3.7.3  Laboratory Tests
Laboratory tests are an indispensable step in the diagnosis of osteoporosis because 
they can distinguish between this condition and other metabolic diseases of the 
skeleton, which may present a clinical picture similar to that of osteoporosis. 
Moreover, they can identify possible causal factors, permitting the diagnosis of sec-
ondary osteoporosis and suggesting an aetiological treatment where one exists. 
First-level tests are blood count, protein electrophoresis, serum–calcium and phos-
phorus levels, total alkaline phosphatase, creatinine, the erythrocyte sedimentation 
rate and 24 h urinary calcium. Normal results for these tests exclude up to 90% of 
secondary forms of osteoporosis. Sometimes it is necessary to perform second-level 
tests too, such as ionised calcium, TSH, PTH, serum 25-OH-vitamin D, cortisol 
after a suppression test with 1 mg of dexamethasone, total testosterone in males, 
serum and/or urinary immunofixation for anti-transglutaminase antibodies and spe-
cific tests for associated diseases.
The specific markers of bone turnover, detectable in serum and/or urine, are 
divided into bone-formation (bone isoenzyme of alkaline phosphatase, osteocalcin, 
type I procollagen propeptide) and bone-resorption markers (pyridinoline, 
deoxypyridinoline, N or C telopeptides of collagen type I). In adult subjects, the 
increase in bone turnover markers indicates an accelerated bone loss or the exis-
tence of other primary or secondary skeletal disorders (osteomalacia, Paget’s dis-
ease, skeletal localisations of cancer). Markers are overall indices of skeletal 
remodelling and they may be useful when monitoring the efficacy of and adherence 
to therapy. However, these markers are characterised by broad biological variability 
so, at present, they cannot be used for routine clinical evaluations [2].
3.8  Management of Osteoporosis
3.8.1  Lifestyle Modification
Giving up smoking and abuse of alcohol and choosing an active lifestyle is funda-
mental as a starting point for the management of a patient with osteoporosis.
Immobility is one of the most important causes of bone loss and should be 
avoided wherever possible. Weight-bearing exercises are optimal for skeletal health 
and are, therefore, an important component of the management of patients with 
osteoporosis [53].
3.8.1.1  Prevention of Falls
Risk factors for falls include a history of fracture/falls, dizziness and orthostatic 
hypotension, visual impairment, gait deficits, urinary incontinence, chronic muscu-
loskeletal pain, depression, functional and cognitive impairment, low body mass 
index, female sex, erectile dysfunction (in male adults), and people aged over 80 
[54]. Some of these factors are modifiable and it is important to act on them [55]. 
A programme of exercises may prevent falls by improving confidence and 
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coordination and by preserving muscle strength but there is no consensus concern-
ing the most suitable programme for the ‘oldest old’ [55, 56].
For a more extensive discussion of this issue see Chap. 16.
3.9  The Importance of Vitamin D, Calcium 
and Protein Intake
3.9.1  Vitamin D
Vitamin D is involved in the intestinal absorption of calcium and phosphorus and is 
necessary for mineralisation of the bone and the maintenance of the muscle, while 
also having numerous beneficial effects on other organs. Most Vitamin D is synthe-
sised through the skin during exposure to the sun but this capacity is reduced in older 
people, moreover, they tend to expose their skin less than younger adults. Therefore, 
the majority of older people suffer from hypovitaminosis D [57]. The threshold values 
for vitamin D are presented below in Table 3.3. Several trials have demonstrated lower 
fracture risk in patients with a plasma concentration of 25-hydroxy-vitamin D (25-
OH-D) of at least 60  nmol/L [58]. It has been demonstrated that improvement in 
25-OH-D levels leads to a lower incidence of falls in older people; other trials have 
demonstrated that vitamin D supplementation is associated with a reduction in all-
cause mortality [59]. The Recommended Nutrient Intakes (RNI) are 800 IU of vita-
min D per day in men and women over 50 [2]. Intakes of at least 800 IU of vitamin D 
can be recommended in the general management of patients with osteoporosis, espe-
cially in patients receiving bone-protective therapy [60]. Considering that hypovita-
minosis D is an epidemic among the elderly, there is probably no strong necessity to 
measure circulating levels of 25-OH-D in patients with high fracture risk [57]. Vitamin 
D supplementation should start as soon as possible and should precede the administra-
tion of any drug used to treat osteoporosis [60]. Since the inactive form of vitamin D 
(cholecalciferol) is stored in fat tissue, it is sensible to saturate the stores with repeated 
small, loading doses and then to continue with maintenance doses.
3.9.2  Calcium
Calcium is an element necessary for the mineralisation of the bone. It is mainly 
contained in dairy products, which may have calcium and vitamin D added. The 
Recommended Nutrient Intakes (RNI) are a minimum of 1000 mg of calcium per 
Table 3.3 Threshold values of vitamin D [1]
Serum vitamin D level (nmol/L) Serum vitamin D level (ng/mL) Definition
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day for men and women aged more than 50 years [2]. It is fundamental to ensure 
correct calcium intake by means of a balanced diet, but when this is not possible, 
calcium supplements of 0.5–1.2 g a day are recommended, especially in patients 
receiving bone-protective therapy [4, 61]. Calcium and vitamin D supplements 
decrease secondary hyperparathyroidism thus reducing bone resorption. Although, 
in one meta-analysis, calcium supplementation seemed to increase the risk of 
myocardial infarction, although other studies contradict these results [62, 63].
For a more extensive discussion of this issue see Chap. 18.
3.9.3  Protein
Nutritional insufficiency—in particular protein-energy malnutrition—is frequent in 
the elderly. Adequate nutrition is very important for bone health [64]. The Insulin- 
like growth factor-I (IGF-I) mediates the effects of the growth hormone (GH) and 
has promoting effects on several body tissues, especially on skeletal muscle, carti-
lage and bone. Moreover, it plays a role in the regulation of phosphate reabsorption 
in the kidney and the active uptake of Ca2+ and phosphate from the intestine via 
renal synthesis of calcitriol. In view of impaired protein assimilation in older peo-
ple, for them, the RDA should be increased from 0.80 g/kg body weight per day to 
1.0 or 1.2 g/kg per day [56].
For a more extensive discussion on nutritional aspects see Chap. 18.
For the pharmacological treatment at issue see Chap. 15.
3.10  Therapeutic Adherence in Osteoporosis and the Role 
of Health Professionals
Compelling research confirms that the vast majority of patients with osteoporosis, 
worldwide, are not treated or even diagnosed, because the disease often fails to 
manifest itself before a fracture occurs [65]. Unfortunately, even after fractures take 
place only a minority of patients receive prescriptions for adequate preventive treat-
ment, either upon discharge from the hospital or over the following years. Research 
also demonstrates that although patients may have a good knowledge of what osteo-
porosis is, they generally have a low level of understanding of the role of medication 
in reducing fracture risk, various concerns about its side effects, poor understanding 
of the causes and risk factors of osteoporosis, and uncertainty about how it can be 
controlled [66].
An important epidemiological study by Rabenda and colleagues demonstrated 
that the medication possession ratio (MPR) at 12 months was higher among patients 
taking weekly, as compared to daily, doses of alendronate [67]. Adherence to thera-
peutic regimens is challenging, particularly for the elderly, who generally have a 
long list of drugs to take. They are often rather forgetful; it seems, however, that 
most instances of non-adherence are intentional, due to elderly patients carrying out 
an (erroneous) risk/benefit analysis on their behalf [68].
This situation obviously needs to be changed if we want to curtail the continuous 
expansion of the burden of osteoporotic fractures. New strategies and services, 
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involving an enlarged group of health professionals and reliable mechanisms to 
articulate, foster and monitor their actions are needed. Nurses are often appointed as 
the key to the success of these services, due to their role in coordinating and com-
municating with other health professionals.[66].
Health professionals should provide education based on patient-centred care and 
create a mechanism that allows involvement of patients and families in their care, 
with particular focus on caring, patient communication, sharing of control over 
decisions, and the integration into the decision-making process of guidance by 
nurses, physicians, and other providers. It is important to explain to patients who 
have experienced a fracture that this was due to ‘fragility’ caused by osteoporosis 
and show them how drug treatment can help. It is fundamental to understand their 
reasons and excuses for not adhering to their medication programme.
Many studies show that people who actively seek to learn about and manage their 
health are more likely to take preventive healthy behaviour measures, self-manage 
their health conditions, adhere to the treatments prescribed, have better care experi-
ences, and achieve better health outcomes.
Health care professionals should define a plan with the patient and family and 
provide education on dietary and lifestyle.
In general, periodic follow-up visits are beneficial: during which the patients 
should be asked to describe how they take their medicines while avoiding any notion 
of judgment [56].
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Frailty is generally understood as a progressive age-related decline in physiological 
systems that results in decreased reserves, which confers extreme vulnerability to 
stressors and increases the risk of a range of adverse health outcomes. There are 
however two distinct concepts that emerge from the clinical and research literature. 
The first is of a syndrome associated with underlying physiological and metabolic 
changes that are responsible for driving progressive physical and cognitive impair-
ments through to loss of functional capacity, often helped on the way by acute or 
chronic disease or injury. This can be encapsulated by the definition proposed some 
two decades ago and still valid [1]. As a result, the frail person is at increased risk 
of disability or death from minor external stresses.
The second concept underpins a pragmatic approach, which treats frailty as a 
collection of risk factors for future adverse events, whilst not necessarily bearing a 
direct pathophysiological relationship to these outcomes. As discussed later these 
positions are not incompatible. Either way, both epidemiologically and 
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conceptually, frailty overlaps with but is distinct from multimorbidity and disability 
[2]. In cross-sectional studies, some frail individuals are neither multimorbid nor 
disabled, but multimorbid individuals are more likely than others to be frail, and 
frail individuals are by definition more likely to develop a new disability. Frailty 
could therefore be looked upon as a risk factor for functional decline, in line with 
more traditional risk factors such as hypertension, hypercholesterolemia, obesity 
and smoking [3].
4.1.1  The Nature of Frailty
There are several diagnostic definitions and measures of frailty, validated in various 
populations in terms of predicting an increased incidence of adverse outcomes such 
as new disability, hospitalisation and death. The two best-established approaches 
are the phenotype model developed by Fried’s group in the United States [4] and the 
deficit accumulation model developed by Rockwood and Mitnitski in Canada [5]. 
Both have been validated subsequently in unrelated cohorts internationally.
The phenotype approach was generated empirically from a larger number of can-
didate features tested in a longitudinal dataset, and analysis resolved them into five 
components—unintentional weight loss, self-reported fatigue, low physical activity 
and impairment of grip strength and gait speed comparative to relevant population 
norms. Three or more abnormalities define frailty, with pre-frailty defined as the 
presence of one or two. The criteria for judging abnormality is illustrated in Fig. 4.1, 
but in practice, subsequent researchers have adapted criterion definitions to the data 
available.







Self-reported weight loss of more than 4·5 kg or recorded
weight loss of "5% per year
Self-reported exhaustion on US Center for Epidemiological
Studies depression scale73
(3–4 days per week or most of the time)
Energy expenditure <383 kcal/week (men) or <270 kcal/week 
(women)
Standardised cut-off times to walk 4·57 m, 
stratified by sex and height
Grip strength, stratified by sex and body-mass index
Fig. 4.1 The frailty phenotype
F. C. Martin and A. H. Ranhoff
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This phenotype model, therefore, does not explicitly include cognitive or psy-
chosocial features that are also well known to be predictive of adverse health out-
comes, but these domains may impact any of the five dimensions, for example, a 
low mood may be associated with self-assessed fatigue, and cognitive impairment 
is associated with slower gait. Nevertheless, there is substantial evidence that this 
predominantly physical frailty phenotype has predictive power for adverse health 
outcomes in several cohorts of older people.
The deficit accumulation approach is quite different. It operationalises frailty as 
the sum total of age-related factors that may be regarded as detrimental (“deficits”). 
These could be symptoms, sensory impairments, abnormal clinical findings or labo-
ratory test results, diseases, disabilities or lack of social support. Suitable parame-
ters are those that are increasingly prevalent with advancing age but do not saturate 
and are credibly associated with health. Thus, grey hair is not suitable! Generally, 
each is regarded as present or absent and thus accorded a score of 0 or 1, although 
some variables lend themselves to be divided in three or occasionally more grades, 
so become fractions of one. The total score, termed the frailty index (FI), is calcu-
lated from the sum of all the deficit scores divided by the number of items included. 
The theoretical range of the FI is therefore between 0 (no deficits apparent, good 
health) to 1 (deficits in every item), but in practice, a number of studies have now 
shown that survival is rare with scores above about 0.7. The deficit accumulation 
model is an approach rather than a fixed tool and is therefore highly flexible. A FI 
can be constructed from suitable variables in any comprehensive dataset about an 
individual as long as it covers a broad range of these health-related domains and 
includes upwards of 30 items. Despite these two approaches to diagnosing frailty 
being quite distinct, they perform fairly similarly in identifying frailty when applied 
to a common dataset [6, 7].
4.1.2  Epidemiology of Frailty
Whatever approach is used to define frailty, it becomes more prevalent with increas-
ing age. The prevalence in community versus institutional care settings is 12% 
(95% CI 10–15%) and 45% (95% CI 27–63%), respectively. When using broader 
definitions than the physical phenotype, the prevalence increases to 16% (95% CI 
7–29%) [8]. Frailty prevalence rises to 20–50% by age 85+ [9] and is more common 
in women, but several studies suggest that women are more resilient to frailty than 
men. Geographical differences in frailty prevalence may be related to health 
inequalities, as rates are significantly associated with national economic indicators. 
Differences within countries may also be associated with socioeconomic factors 
including social deprivation [10]. Frailty is a dynamic syndrome and may be 
 reversible—people move in and out of a frailty state [11]. However, there are few 
studies of frailty trajectories.
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4.1.3  How Does Frailty Develop?
Frailty may be best understood from the standpoint of ageing and evolution. A uni-
versal result of living is the gradual and progressive process of acquiring deleterious 
changes to body structure and function, affecting all individuals to variable degrees 
and not associated with a specific external cause. These ageing-related impairments 
result from the lifelong accumulation of unrepaired molecular and cellular damage, 
which take multiple forms and impact cell survival, protein synthesis and the effi-
ciency of damage detection and repair processes. The pathophysiological pathways 
that result from this damage are not fully elucidated, but candidates include cyto-
kines and other components of the inflammatory response [12, 13]. The defence and 
repair mechanisms are generally good enough in earlier life to enable normal 
growth, development and reproduction, but did not evolve to provide indefinite pro-
tection in older age. There was no evolutionary pressure to do so and since all meta-
bolic processes use energy (ultimately from food), it makes biological sense to 
develop enough but not surplus repair capacity. These age-related changes are 
accompanied by an increased chance of certain “degenerative” diseases, but these 
are not universal. Disability results from the critical impairment of specific attri-
butes, such as strength or balance, these impairments arising from ageing or disease 
or more usually both.
4.1.4  Assessment of Frailty in Clinical Practice
The scope and detail of assessment needed and the choice of assessment tool should 
be tailored to the population being assessed and the purpose of the assessment. For 
example, many of the functional tests such as walking speed and the Timed Up and 
Go test are not feasible in patients with acute hip fractures. Neither the phenotype 
model nor the FI is particularly feasible in routine clinical practice, so simpler tools 
are more commonly used such as the Clinical Frailty Scale [14] or the Edmonton 
Frail Scale [15]. The Clinical Frailty Scale uses descriptors covering the domains of 
mobility, energy, physical activity, and function to enable a standard clinical assess-
ment to characterise nine levels from very fit, healthy through very severely frail to 
terminally ill. (Fig. 4.2). This provides a feasible description based on routine clini-
cal assessment but does not conceptually distinguish frailty from multimorbidity or 
disability. Its mortality prediction is comparable to that of the more detailed FI and 
it is useful in settings where a quick impression can help indicate what clinical deci-
sions need to be considered.
The Edmonton scale requires a number of specific but fairly simple clinical mea-
sures to be performed, which would be additional to routine clinical practice. The 
domains included are cognition (the clock drawing test), general health status, func-
tional ability, social support, medication use, nutrition, mood, continence and a 
mobility function test—the Timed Up and Go. Scores range from 0 to 17, scores of 
8 or above usually being considered to be frail, but relevant cut-offs can be estab-
lished empirically depending upon the purpose. For example, the prediction of 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































likely higher rates of postoperative complications may be associated with lower 
scores. In contrast to some other tools, the Edmonton scale identifies potential tar-
gets for intervention across a number of clinically important domains.
In community or primary care settings, the issue may be to identify a target 
group for health-promoting interventions such as optimising nutrition and increas-
ing physical activity levels. Here a more simple screening approach may be needed. 
A recent systematic review assessing available tools suggested that PRISMA-7 may 
be the most accurate [16], a score of 3 or more suggesting the increased likelihood 
of incident disability [17] (Fig. 4.3).
4.1.5  Incorporating Frailty into Treatment Plans 
and Service Design
In general, there is not sufficient evidence for screening programmes for frailty [18]. 
Case finding in clinical settings could be carried out in two phases, using a short 
screening test and then confirming the diagnosis using a comprehensive geriatric 
assessment (CGA) if a geriatric service is available, or at least an assessment of nutri-
tion and muscle function. The need then is to provide intervention or package of inter-
ventions for those deemed to be pre-frail or frail to prevent, slow or reverse frailty 
[19]. Patients with fragility fractures could be assessed for frailty in the acute setting 
by using, for example, the Clinical Frailty Scale based on information from the patient 
and next-of-kin about the pre-fracture status. In a rehabilitation phase, the Edmonton 
scale or á full CGA would enable an individually tailored programme to be applied.
4.2  Sarcopenia
Sarcopenia was the term suggested by Rosenberg for the well-recognised loss of 
muscle with ageing [20]. It is a major component of frailty. The diagnosis, treat-
ment and prevention of sarcopenia is recommended to become part of routine 
Are you more than 85 years?
Male? 
In general, do you have any health problems that require you to limit your activities?
Do you need someone to help you on a regular basis?
In general, do you have any health problems that require you to stay at home? 
In case of need, can you count on someone close to you?
Do you regularly use a stick, walker or wheelchair to get about?
Total
Yes = 1 point
Yes = 1 point
Yes = 1 point
Yes = 1 point
Yes = 1 point
No= 1 point








Fig. 4.3 The PRISMA score
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clinical practice [21]. Skeletal muscle accounts for a third or more of total body 
mass. As well as movement, muscle plays a key role in temperature regulation and 
metabolism. Low muscle mass is associated with poor outcomes from acute ill-
ness, probably because of the reduced metabolic reserve, as muscle is a reservoir 
for proteins and energy that can be used for the synthesis of antibodies and 
gluconeogenesis.
4.2.1  The Nature of Sarcopenia
Sarcopenia is characterised by motor neurone loss, reduced muscle mass per motor 
unit, relatively more loss of fast-twitch fibres and reduced strength per unit of cross- 
sectional area. Muscle fibres are lost by drop-out of motor neurones. Reinnervation 
of fibres by sprouting from surviving neurones cause less even distribution of fibre 
types cross-sectionally and a relatively greater loss of type II fibres that are associ-
ated with the generation of power (the product of force generation and speed of 
muscle contraction) [22].
Muscle mass and strength are of course related but not linearly [23]. Function 
is more important than mass for physical performance and disability [24] Leg 
power accounts for 40% of the decline in functional status with ageing [25]. Men 
who maintain physical activity into their 80s show compensatory hypertrophy of 
muscle fibres to compensate for the decrease in fibre number. Loss of efficiency 
also results from an accumulation of fat within and between fibres and an increase 
in non- contractile connective tissue material. Muscle strength and function also 
depend on neuromuscular integrity and muscle performance as well as muscle 
characteristics. Indeed, the force produced by external electrical stimulation to 
large muscle groups such as quadriceps exceeds that which can be achieved by 
maximal voluntary contraction, emphasising the importance of non-muscle 
factors.
4.2.2  Epidemiology
A systematic review on the prevalence of sarcopenia by the European Working 
Group on Sarcopenia in Older People (EWGSOP) criteria reported a variable preva-
lence from 1 to 29% in persons living in the community, 14–33% in those living in 
long-term care institutions and 10% for those in acute hospital care [26]. A higher 
prevalence at 30% was reported from a Norwegian population of hospitalised older 
persons [27]. In most of these studies, the prevalence of sarcopenia increased with 
age, but the effect of sex varied. A study from Iceland found an increase in the 
prevalence of sarcopenia from 7 to 17% from age 75 to 80. In older (65+) hip frac-
ture patients sarcopenia is found in 17–74%, the highest prevalence in Chinese male 
patients. In a selected population of previously home-dwelling older hip fracture 




4.2.3  How Does Sarcopenia Develop?
Muscle fibre development occurs before birth but fibres enlarge during childhood 
reaching a peak in early adulthood. Mass and function then gradually decline into 
older age [29]. Peak mass is affected by intra-uterine, genetic and early life influ-
ences. The decline is affected by physical activity, nutrition and sex. It is more 
pronounced in women from menopause onwards. Adding to the inevitable moderate 
decline of some 15–25% by old age is the impact of acute illness or chronic condi-
tions, which have generally negative effects through the mechanisms of catabolic 
stress, reduced food intake and physical inactivity. The loss of muscle mass is 
thought to be multifactorial with potential factors illustrated in Fig. 4.4.
The factors implicated in sarcopenia overlap with those for frailty. A central fea-
ture of sarcopenia is a decrease in the rate of muscle protein synthesis. This leads to 
reduced protein levels including mitochondrial oxidative enzymes responsible for 
enabling work intensity. The age-related shift of the hormonal balance towards low 
testosterone, growth hormone and IGF-I contributes to the lower muscle protein 
synthesis rates, which also limits the structural recovery from muscle damage or 
apoptosis and possibly reduces the synthetic stimulus of exercise [30]. The role of 
cytokines such as interleukins IL-1β and IL-6 and TNF-α is less certain. They play 
Endocrine factors
Corticosteroids, growth hormone, 















Fig. 4.4 Aetiological factors and mechanisms of sarcopenia (Adapted from Cruz-Jentoft AJ, 
Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider 
SM, Topinková E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and 
diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 
2010 Jul;39(4):412–23)
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a role in the catabolic processes of acute illness and chronic inflammatory condi-
tions, but whether the small differences in circulating levels associated with frailty 
reported from some population studies are relevant to the age-related sarcopenia is 
not established.
4.2.4  Assessing Sarcopenia in Clinical Practice
There are several different diagnostic definitions resulting in the range of prevalence 
rates reported earlier from community-dwelling populations of older people. A con-
sensus definition and approach to screening and classification has been proposed by 
EWGSOP established by the European Geriatric Medicine Society, first in 2010, 
and with a revised version in 2018 [31]. This is shown in Fig. 4.5. Measuring gait 
speed of ambulant people is feasible in almost any community setting and is a useful 
global indicator of health, slower gait being associated with a greater likelihood of 




























Fig. 4.5 The EWGSOP algorithm for the diagnosis and grading of sarcopenia (Adapted from 
Cruz-Jentoft AJ, Bahat G, Bauer JM, et al. (2019) Sarcopenia: revised European consensus on defi-
nition and diagnosis: Age Ageing; 48(1):16–31). Further details on how to apply this algorithm can 
be found in this paper, with suggestions for feasible and reliable methods to assess muscle strength, 
quality and quantity, and physical performance
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chosen as it is a portable, simple, reliable and valid proxy measure of body strength, 
and has a good correlation with lower limb physical performance. Low grip strength 
of community-dwelling older people is associated with falls, increased incident dis-
ability and earlier mortality. It also predicts slower and less complete functional 
recovery from illness in men [33].
Measurement of muscle mass can be done with CT scan or, less accurately, with 
impedance techniques or anthropometry (measurements of upper mid-arm circum-
ference, estimation of upper mid-arm muscle cross-sectional area, measurement of 
mid-calf circumference) [31]. Ultrasound is a promising emerging technique but not 
yet in routine use. Assessment of sarcopenia with the above-mentioned methods 
may not be feasible in clinical populations such as after lower limb fractures, and 
measurement of muscle function is more important than measurement of muscle 
mass in clinical practice. An indication of pre-fracture severe sarcopenia can be 
obtained, using the Sarc-F tool, which is a brief questionnaire about muscle func-
tion (mobility and ability to carry a certain weight). The Sarc-F tool is available in 
many languages [34].
4.2.5  Incorporating Sarcopenia into Treatment Plans 
and Service Design
Sarcopenia has recently been recognized as a clinical diagnosis with a correspond-
ing code in the ICD system. For the diagnosis of sarcopenia, either the definitions 
from EWGSOP or the Foundation for the National Institutes of Health (FNIH) are 
recommended. But for rapid screening and special patient groups, such as hip frac-
ture patients, rapid screening with the SARC-F is recommended. All health person-
nel working with older patients should be aware of sarcopenia.
4.3  The Implications of Frailty and Sarcopenia on Falls, 
Fractures and the Recovery After Fractures
With the exception of the vertebra, most fractures in older people are related to falls. 
Poor bone health makes a fracture more likely, but from the population perspective, 
risk of falling is more predictive of fractures than bone mineral density [35], leading 
to the suggestion that the focus of primary fracture prevention must rest with iden-
tifying those at risk of falls rather than those with osteoporosis [36]. After a fragility 
fracture, however, it is imperative to consider falls prevention and bone health as 
described in detail in Chapters 14–16 of the IIIrd Pillar.
There are common risk factors and overlap in the biology of frailty, sarcopenia 
and osteoporosis. Frailty predicts lower bone mineral density, an increased likeli-
hood of falls, vertebral and hip fractures [37, 38]. Sarcopenia and osteoporosis often 
co-exist and shared risk factors have given rise to the notion of osteosarcopenioa 
[39]. The typical hip fracture sufferer is a frail woman more than 80 years, so pre-
vention requires a multicomponent approach embracing frailty.
F. C. Martin and A. H. Ranhoff
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For older people with osteoporosis, a consensus panel recommended a multi-
component exercise programme including resistance and balance training [40]. In 
general, physical exercise programmes are shown to be effective for reducing or 
postponing frailty with benefits more likely if conducted in groups. Physical exer-
cise with nutritional supplementation, supplementation alone, cognitive training 
and combined treatment do also show a favourable effect on frailty outcomes [41]. 
Recognition of frailty is also key in the management of those who have fractured. 
For example, frailty, as assessed with the FI, was associated with longer hospital 
length of stay and reduced chance of returning home within 30 days after hip frac-
ture [42].
4.4  Concluding Statement
There are close links epidemiologically, biologically and clinically between frailty, 
sarcopenia, poor bone health and the geriatric syndrome of falls. Older people who 
have had a fall and/or a fracture should be assessed for frailty and sarcopenia to bet-
ter develop a care plan. This calls for an integrated clinical approach to the preven-
tion and treatment of fragility fractures.
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Older people with fragility fractures do not present with the acute problem of the 
fracture only. Alongside their broken bone, many present concurrently with medi-
cal illnesses, frailty, multi-morbidity and disability. They are at risk of future falls 
and/or fractures, have a challenging peri-operative period, are at risk of medical 
complications and many do not return to their pre-fracture level of function. 
Orthogeriatric care is an adaption of the Comprehensive Geriatric Assessment 
(CGA) [1, 2], which is a multidimensional, interdisciplinary assessment and treat-
ment of an older person. This co-management model of care with CGA principles, 
bringing together the relevant multidisciplinary expertise in fragility fracture 
management, has been shown to be the most effective way to address the complex 
healthcare needs of these patients and deliver improved outcomes [1, 3, 4]. 
Orthogeriatric care is now established as the ideal model of care for hip fracture 
management and is recommended in several national guidelines (see Fragility 
Fracture Network website—select a region and then choose Fragility Fracture 
Care Guidelines option) [5].
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Different models of hip fracture orthogeriatric services have been described 
depending on how the different orthopaedic and geriatric medicine services inter-
act with each other [3, 6]. The most integrated model of co-management has dem-
onstrated the best outcome in time to surgery, hospital length of stay and survival 
[3, 4, 7]. This chapter focuses on the framework required to establish such an 
orthogeriatric service. The steps detailed here are not prescriptive but should pro-
vide the guidance required to either start the service or develop parts of the exist-
ing service.
5.2  Designing the Orthogeriatric Service
5.2.1  Step 1: Process Mapping the Hip Fracture Pathway
An orthogeriatric service needs to consider the entire journey of the patient with a 
hip fracture, from their presentation to the Emergency Department all the way 
through to their rehabilitation and recovery. Hence, an important initial step to 
understand the local hip fracture pathway and how the future orthogeriatric service 
can be delivered locally is by performing a mapping exercise. The mapping exercise 
has to be a detailed assessment of each phase of care during the patients’ hospital 
journey from what happens in the Emergency Department, pre-operatively, during 
the operation, after the operation and rehabilitation period. In each phase, the map-
ping exercise needs to specify what the treatment goals are (principles of care) and 
how these goals can be delivered (explicit care delivered) (Table 5.1).
Another benefit of mapping the hip fracture pathway is that it facilitates informa-
tion gathering to justify an orthogeriatric service locally. Orthogeriatric care is still 
not a routine practice in many parts of the world. Moving hip fracture care from the 
traditional model of an orthopaedic team overseeing care with reactive medical 
input, to a co-management model will require justification that such a service is 
required. This is especially important in places where musculoskeletal health is not 
part of a national agenda and receives little attention. Extracting information and 
translating clinical evidence generated from other units or countries may not suffice. 
Healthcare managers would also be more receptive to establishing a service with 
local data. Hence, this mapping exercise should also attempt to generate data to 
serve two important purposes:
Table 5.1 An example of a mapping exercise of an orthogeriatric service across the different 
phases of care and components of care delivered that need to be delivered




1.  Prompt fracture 
identification
2.  Pain relief
3.  Transfer to trauma/
orthopaedic wards
1.  Early clinical and radiological 
identification of a hip fracture
2.  Prompt assessment of pain and analgesia 
appropriate to pain severity
3.  Minimise delay in transferring patient to 
orthopaedic or trauma units




Phases of care Principles of care Care delivered
Pre-operative 
phase
1.  Multidisciplinary team 
involvement





3.  Risk stratification for 
adverse outcomes
1.  Early involvement of orthogeriatric care 
team to agree surgical, anaesthesia and 
medical plan
2.  Clear documentation and information 
sharing between specialties, e.g., using a 
joint admission clerking trauma booklet
3.  Adequate pain management before 
surgery and appropriate use of nerve 
blocks
4.  Optimisation of co-pathology and 
co-morbidities (e.g., fluid status, delirium, 
anaemia, glycaemic control, 
anticoagulation)
5.  Implementation of standardised guidelines 
in commonly encountered problems (e.g., 
anticoagulation reversal, blood 
transfusion, delirium management)
6.  Utilise validated hip fracture risk 
stratification tool (e.g., Nottingham Hip 
Fracture Score) and agree to appropriate 
ceilings of care
7.  Agreed pathways to a specialist 
investigation (e.g., magnetic resonance 
imaging for occult fracture, 
echocardiogram to assess cardiac 
function)
Operative phase 1.  Timely surgery
2.  Choice of anaesthesia 
and surgical technique 
as appropriate for the 
patient
1.  Minimise wait for an operation
2.  Adequate staff and theatre capacity
3.  Agreed prophylactic antibiotic treatment
4.  Surgical and anaesthetic plan in place 
delivered by adequately skilled clinicians
5.  Clear post-operative instructions, 
including weight-bearing status
6.  Identification of those that require more 
intense post-operative monitoring





2.  Minimising hospital 
complications
3.  Nutrition support
4.  Continence care
5.  Prevention of pressure 
sores
6.  Planning for post-
hospital care
1.  Routine review by orthogeriatric team 
members to identify complications early 
and facilitate recovery
2.  Early mobilisation and identification of 
barriers (e.g., pain, delirium, 
hypovolaemia, anaemia)
3.  Identification of those at risk of 
malnutrition and nutrition supporting 
strategies
4.  Bowel and continence care
5.  Regular review of pressure areas
6.  Identifying those that would require 
extended venous thromboprophylaxis
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 – Convincing people that there is a problem—gather data on local hip fracture 
epidemiology with an idea of absolute numbers presenting to the local hospital, 
and if available, how this has changed over time.
 – Convincing people that orthogeriatric co-management is the solution—demon-
strate the characteristics and outcomes of this patients that would require ortho-
geriatric co-management, that is, fragility fracture and frailty needs.
5.2.2  Step 2: Identify a Core Multidisciplinary Team and Form 
a Steering Group
Many healthcare professionals with different discipline backgrounds have impor-
tant contributions to make to high-quality care for older patients with hip fractures. 
Mapping the pathway allows identification of these key members of the inter- 
professional multidisciplinary team (MDT). These key members usually include:
 – Orthopaedic surgeon





 – Occupational therapist
This is not an exhaustive list as many successful services are supported by other 
health professionals such as social workers, clinical pharmacists, dieticians, fracture 
liaison services and radiology. The key to efficient multidisciplinary working has to 
be coordination and communication between the various team members. 
Responsibility is shared across the pathway depending on the patient’s clinical 
need. For instance, the operative procedure is the responsibility of the surgeon and 
managing medical barriers to early mobilisation is better led by the geriatrician. 
Table 5.1 (continued)
Phases of care Principles of care Care delivered
Rehabilitation 1.  Transfer of care out of 
the hospital with the 
right support in place
2.  Information sharing 
with patient and 
primary care providers
3.  Falls and fracture risk 
assessment and 
treatment
1.  Routine and regular multidisciplinary 
team meetings to discuss recovery and 
plan for post-hospital care
2.  Minimise delay and wait for community 
rehabilitation
3.  Identification of risk factors for falls and 
fractures Implementing individualised 
falls and fracture prevention plan
4.  Fall and fracture prevention followed up 
by a relevant clinical team
5.  Clear sharing of information with the 
primary care provider
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Appropriate organisation of ward rounds and the use of a common admission/
assessment proforma can support much of this MDT working. Many admission/
assessment proformas are available for download from sites such as the UK National 
Hip Fracture Database (NHFD) in its resources section [8].
However, in many countries the input from geriatricians, i.e., physicians with 
expertise in managing frail older people, is limited because either the number of 
practising geriatricians is small, or that geriatric medicine is still not recognised as 
its own medical specialty. In such a situation, geriatric medicine competencies can 
be acquired by other physicians, such as hospital internists or general physicians, to 
support the care of older patients with hip fractures. An example of geriatric medi-
cine competencies in orthogeriatric care is listed in the table below (Table 5.2).
5.2.3  Step 3: Analyse and Review the Patient Pathway
The key MDT members identified in the earlier step will also form the steering 
group that will review the whole hip fracture pathway, determine the overall strat-
egy (short, medium and long term aims), review quality improvement work and 
discusses clinical governance issues through regular meetings. In practice, the ini-
tiation and leadership of such a steering group require the existence of just a few 
champions—people who have realised how much better and more cost-effective the 
multidisciplinary approach can be, especially for hip fracture patients, which are the 
most numerous and costly patient group. Although the steering group itself needs to 
be kept to a manageable size in order to have efficient meetings, it is important that 
the wider healthcare workers involved in the whole hip fracture pathway are engaged 
Table 5.2 Geriatric medicine competencies in the management of hip fractures. Adapted from 
training requirements for UK specialist trainees in Geriatric Medicine in Orthogeriatrics [9]
Orthogeriatric medicine competencies
Awareness of the different models of orthogeriatric care and the evidence base of their 
evaluation
Understanding the impact of hip fracture on the older person
Understanding of surgical and anaesthetic issues related to hip fracture care
Preoperative optimisation of acute illnesses and chronic medical conditions
Management of postoperative care and complications (delirium, continence issues, tissue 
viability, pneumonia, thromboembolism, anaemia, acute kidney injury and cardiovascular 
complications)
Recognising the role of palliative and end of life care
Nutritional assessment and intervention
Knowledge of appropriate assessment tools for mobility, daily living and function
Planning rehabilitation goals and transfer of care (discharge planning)
Knowledge of the causes and management of falls and fragility fractures
Knowledge of the role of the Fracture Liaison Service and its evidence-base
Ability to work in a multidisciplinary team and value the role of different team members
Leadership and management skills in interdisciplinary and multi-agency working
Understanding of the role of quality improvement, audit and morbidity/mortality reviews
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on an occasional basis. This helps to raise the general level of knowledge and foster 
commitment among the wider MDT.
The steering group needs to decide how to operationalise the orthogeriatric ser-
vice and how each phase of care should be delivered. This is determined by research, 
consensus of good clinical practice and clinician experience (subsequent chapters of 
this book describe these good practices in more detail in each phase of care). Even 
at this planning stage, there needs to be engagement with healthcare managers and 
relevant stakeholders.
When analysing and addressing gaps in care, there are two managerial strategies 
that have been recognised to support this process. One, the “five whys,” [10] is a 
sequential means of addressing the superficial, symptomatic problems that are 
immediately obvious and then breaking them down in stages to get to the real under-
lying issues. Asking the question “why?” five times often reveal problems that the 
service user was previously unaware of. The second strategy is to perform a SWOT 
(strengths, weaknesses, opportunities and threats) analysis [11]. This allows the 
organisation to concentrate on internal factors (strengths and weaknesses of the 
existing service) and external factors (opportunities and threats that the new service 
provides). This gives a very clear global view of the situation and often reveals 
issues that were previously not considered. Both analyses rely on the steering group 
brainstorming, which circumvents the bias of a single proponent.
5.2.4  Step 4: Evaluate the Resources Required to Drive Change 
Within the Organisation
The resource required is more than just the finances needed to establish the service. 
Devised in 1980 by Waterman and colleagues, the “Seven S” model (Fig. 5.1) is a 
way of thinking holistically about the resources required to drive change within the 
organisation to achieve the components of optimal hip fracture care [12]. Each “S” 
must be addressed in order to meet management criteria:
 – Staff—Are the right staff members in place to facilitate the introduction of the 
new orthogeriatric service? Are more or fewer staff required? Means of appropri-
ate recruitment need to be considered.
 – Skills—Do the staff have the necessary expertise? Do they require more training?
 – Structure—Does the existing organisational structure lend itself to supporting 
this venture? The answer in most acute hospitals is “yes” as most surgical depart-
ments are already performing hip surgery. This is a natural evolvement of an 
existing service.
 – Shared values—All parties involved in the change have to truly believe in the 
process in order for it to be implemented smoothly. Management, ward, theatre 
staff, and surgeons all need to back the venture, and this will only happen if all 
parties are involved in the whole process from its conception to its execution. 
There must be an opportunity for discussion and debate.
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 – Style of management—Is the current management style appropriate to oversee 
this? The orthogeriatric service needs to be driven predominantly by the core 
MDT with management as willing co-partners; a management autocracy here is 
not appropriate.
 – Strategy—Are the steps in place to facilitate change? All staff providing hip frac-
ture care need to know about the patient pathway; patients need to be informed 
about new services, and ward staff have to change existing care protocols to 
make them more specific. A global, long-term strategy is required to ensure 
success.
 – Systems—This encompasses all aspects from information technology to patient 
support. Existing systems may need to be adapted.
5.2.5  Step 5: Develop the Business Case 
for the Orthogeriatric Service
The previous steps and information gathered up to this point should provide the 
basis for the business case for the planned orthogeriatric service. The business case 
is a concise document that will take the recipient, usually the relevant healthcare 
managers, on a journey from conception of the idea (justify why it is required) to 
delivery of the service (how it can be delivered). It aims to persuade those in charge 
of finances and service provision how an orthogeriatric service can benefit the 
patient, department, hospital and wider organisation. It must leave no stone unturned 








Fig. 5.1 The seven S 
model developed by Peters, 
Philips and Waterman. 
(Adapted from Business 
Horizons [12])
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is feasible and can be realistically delivered. The business case should be broken 
down into several subheadings and should include:
 – Project title
 – Summary statement
 – Background
 – Description of the service
 – Benefits analysis
 – Project planning
The United Kingdom National Hip Fracture Database website has a resource 
section (NHFD) [8], which includes an orthogeriatric care handbook and contains:
 – Suggested job plans for ortho-geriatricians and specialist nurses in 
orthogeriatrics
 – Links to publications describing different models of orthogeriatric care
 – Model business cases and links to publications demonstrating cost-effectiveness
5.2.6  Step 6: Implementing and Sustaining the Service
When the business case has been approved by the hospital board, which will include 
executive and non-executive members, managers, clinicians and financial represen-
tatives, the service may be started as either a small pilot of the whole orthogeriatric 
pathway or implementation of certain phases of the pathway (Table 5.1). The ser-
vice, overseen by the steering group, aims to implement the good practice that will 
be further described in subsequent chapters of this book.
The process does not stop with the implementation of the orthogeriatric service. 
It has to be followed by constant evaluation of the service and quality improvement 
work led by the steering group to sustain and develop it. The Plan, Do, Study, Act 
(PDSA) cycle, is a widely accepted and used framework for developing, testing and 
implementing change [13] (Fig. 5.2).
Example of a PDSA Cycle Used to Improve Care
Plan
Patients with hip fracture on anticoagulation waited longer to go to theatre 
compared to those not on an anticoagulant. A quality improvement project 
was performed to report on the scale of the problem and identify potential 
solutions.
Do
An analysis was conducted using hospital service level data and patient case 
notes retrospectively. Data collected on how much longer patients waited, its 
clinical impact and where these delays occurred.
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It is important to remember that a successful implementation of an orthogeriatric 
service does not guarantee its success. It needs to be sustained and developed. This 
has to be paced appropriately with constant re-evaluation of the pathway to ensure 
resources match the provision of service. The steering group and leadership within 

























Fig. 5.2 PDSA cycle. 
(Adapted from NHS 
Improvement [13])
Study
Patients on vitamin K antagonists (warfarin) waited almost 24 h longer and 
those on direct oral anticoagulants (DOACs) waited over 48 h longer than 
those not on any anticoagulation. These patients had a longer length of stay. 
There were delays in identifying these patients, administering vitamin K to 
reverse the effects of warfarin, delays in repeating the coagulation profile 
post-reversal, uncertainty over when the DOAC was last taken and variation 
in surgeons’ instructions on how long to wait for surgery after the last dose.
Act
A guideline on anticoagulation management in the peri-operative hip fracture 
period was written which addressed the reversal of warfarin and DOACs, 
monitoring of coagulation profile and when it is safe to operate. The admis-
sion documentation was altered to explicitly ask if the patient is on anticoagu-
lation and when it was last taken. The steering group sought consensus on 
time to theatre. These steps standardised anticoagulation management and 
reduce variation in practice. An audit was embedded into the guideline to 
benchmark clinical practice with published standards.
5 Establishing an Orthogeriatric Service
78
and improvement in healthcare [14–16]. In a report by the health service body, NHS 
Improvement, they highlighted six key factors to sustainability [14].
 1. Supportive management structure
 2. Structures (e.g., IT systems and infrastructure) to foolproof change so that 
embedding takes place
 3. Improvement supported by robust, transparent feedback systems + PDSA cycles
 4. Effective collaboration across many levels from managers to front line staff and 
a shared sense of the systems to be improved
 5. Culture of improvement with engaged staff and patients
 6. Formal capacity building programs through formal and informal training
5.2.7  Step 7: Collect Evidence of Service Improvement: Audit
The audit is a way of measuring what is being delivered against a defined quality 
standard. National audits such as the United Kingdom Scottish Hip Fracture Audit 
and the National Hip Fracture Database (NHFD) across England, Wales and 
Northern Ireland have allowed individual hospitals to continuously audit their care 
based on agreed quality standards and benchmark it against other units. These audits 
have been very useful in sustaining and driving improvement in hip fracture within 
hospitals and across the country overall. National audits exist in countries where 
orthogeriatric service is delivered routinely; however, in places where this is not the 
case, regular review of what is delivered using robust audit processes across the 
pathway still needs to be embedded into the service. Agreed audit standards by the 
steering group need to measure what is delivered (process and service outcomes) by 
the whole orthogeriatric service. These quality standards need to be important and 
realistically deliverable within the time frame allocated. This is different from clini-
cal outcome measures, such as length of stay, mortality and medical 
complications.
An Example of Audit Standards: Adapted from the Scottish Standards of Care 
for Hip Fracture Patients [17]
 1. Patients with a hip fracture are transferred from the Emergency 
Department to the orthopaedic ward within 4 h.
 2. Within 24 h of admission
 (a) Screening for delirium
 (b) Assessment of nutrition
 (c) Falls assessment
 (d) Pressure area assessment
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Figure 5.3 below illustrates the use of an audit cycle to measure and improve the 
assessment of delirium in patients with hip fractures [18].
Besides audit, all orthogeriatric services need to have a robust governance pro-
cess, where learning from harms, morbidity and mortality reviews happen regularly. 
This promotes a culture of open learning to improve care. Furthermore, hip fracture 
Preparation & planning
All patients ≥60 years admitted
with hip fracture has to be
screened for delirium using the





retrospectively of all patients
admitted in the last 2 months
for delirium screening and if it
triggered further
management according to
local delirium guidelines  
Making improvements
Not all patients were screened for delirium. When
it was identified, it did not always lead to further
management.
Delirium screening and management is now in the
admission/assessment proforma. Training




Four-montly snapshot audit of
10 case notes to maintain
improvement 
Fig. 5.3 Audit cycle of delirium screening and management
 3. Patients undergo surgical repair of their hip fracture within 36  h of 
admission.
 4. No patients repeatedly fasted in preparation for surgery. Clear oral fluids 
offered up to 2 h prior to surgery.
 5. Cemented hemiarthroplasty implants are standard unless clinically indi-
cated otherwise.
 6. An older patient receives a review by a geriatrician within 72  h of 
admission.
 7. Mobilisation has begun by the end of the first day after surgery.
 8. Every patient has a documented occupational therapy assessment com-
menced within 72 h of admission.
 9. Every patient has an assessment or a referral for their bone health within 
60 days.
 10. Multidisciplinary team meeting during their acute orthopaedic admission.
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management continues to develop and remains a subject of tremendous research 
interest. Thus, continuing professional development and training in this area is 
required to keep up to date with all its developments. Information sharing, network-
ing and specialist conferences provide an opportunity to utilise new information and 
good practice developed elsewhere to address specific clinical problems, for exam-
ple, reversal of anticoagulation and management of direct oral anticoagulants 
peri-operatively.
5.2.8  Step 8: Embrace the Support of Regional, National 
and International Organisations
In many countries, there is no national musculoskeletal agenda or policy. Hence, 
it is important to seek support elsewhere to highlight the importance of better 
fragility fracture care. The World Health Organisation’s report on ageing and 
health highlighted the importance of musculoskeletal health and preventing frac-
tures as part of its strategy towards healthy ageing [19]. Many national and inter-
national orthopaedic and geriatric medicine societies have adopted orthogeriatric 
co-management as a way of delivering better care for older people with hip frac-
tures. These societies have come together to support the work of the Fragility 
Fracture Network (FFN) and more recently its Global Call to Action [20]. The 
FFN’s annual Global Congress and Regional Expert Meetings are excellent 
opportunities to get good ideas and advice from colleagues tackling similar prob-
lems in different countries. In addition, the role of patient or public advocates can 
be a powerful tool in delivering the message of orthogeriatric care and needs to be 
encouraged. Many lay members already sit on national boards such as the UK’s 
Falls and Fragility Fractures Audit Programme panel. Hence, a way of sustaining 
an orthogeriatric service is by aligning local initiatives to a much larger national 
and international initiative.
5.3  Conclusion
This chapter has described a framework through eight steps to establish an orthoge-
riatric service for hip fractures. Establishing such a service is challenging, involving 
a high level of dedication, management and clinical staff coming together, and a 
great deal of commitment towards improving patient care. The growth in orthogeri-
atric services internationally has shown that setting this up is possible with the right 
approach and appropriate level of support. Orthogeriatric services have consistently 
delivered better care and outcomes for hip fracture patients and should be part of 
routine hip fracture management.
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Pre-hospital Care and the Emergency 
Department
Alex Ritchie, Andrew Imrie, Julia Williams, Alice Cook, 
and Helen Wilson
6.1  Pre-hospital Care
Hip fractures are considered a major global healthcare challenge [1] especially in 
older people with frailty, and this is likely to increase in the next few decades with 
estimates of the size of the problem being predicted conservatively at 4.5 million 
cases worldwide by 2050 [2]. The Healthcare Quality Improvement Partnership [3] 
estimate that in the United Kingdom around 76,000 hip fractures occur every year, 
and it is reasonable to assume that most of these patients will present through ambu-
lance services; this is a significant number of people requiring assessment, manage-
ment and treatment from ambulance staff. Whilst there may be differences in scope 
of clinical practices between (or within) countries relating to pre-hospital care of 
patients with hip fracture depending on differences in healthcare systems, skill mix 
of available clinical staff, and use of drugs and technology, the essential principles 
of management and treatment are likely to be similar.
In the United Kingdom, the first ambulance crew on scene may not include a 
paramedic. A non-paramedic crew will request paramedic back-up if required for a 
structured assessment and management of the patient including intravenous drug 
administration where required.
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This chapter will focus on principles of management of a patient with suspected 
hip fracture once any immediate time-critical life-threatening events have been 
dealt with. This is not to dismiss the severity of a hip fracture in an older person with 
frailty, as mortality rates within the first year are high (often due to multiple co- 
morbidities) [4]. Pre-hospital management of a patient with an isolated hip fracture, 
from the point of assimilation of the information gained during the secondary sur-
vey, is summarised in Fig. 6.1. This systematic assessment of the patient occurs 
after completion of a dynamic risk assessment of the scene and a primary survey.
6.1.1  Clinical Assessment: Primary Survey
To provide context and clarity, a primary survey in a pre-hospital trauma patient 
uses a systematic approach such as the R < C > ABCDE [3, 5] framework. This 
involves assessing the patient in a stepwise approach, correcting any complications 
that present themselves, before moving on to the next stage in the sequence:
• Response level
• Catastrophic Haemorrhage




• Exposure and environment
If the patient is presenting with areas of concern during the primary survey, the 
ambulance staff will attempt to correct those deficit areas. If this is not possible on 
scene, they may decide to undertake a time-critical transfer with a pre-alert to an 
appropriate receiving facility whilst continuing patient treatment en route if it is safe 
to do so and in accordance with local policies. This may mean that definitive treat-
ment of a patient’s hip fracture is delayed, whilst other interventions take a higher 
priority in, for example, a patient with an acute myocardial infarction or an acute 
stroke. A systematic primary survey usually takes an experienced paramedic around 
one minute to complete if no interventions are required during this assessment [5].
6.1.2  Clinical Assessment: Secondary Survey
Once it has been established from the primary survey that there is no immediate 
threat to life, the paramedic (or other attending ambulance staff) will complete a 
comprehensive secondary survey whilst still being mindful of the need for this 
patient to get to definitive care in a timely manner. This process includes acquiring 
a patient history as well as undertaking a ‘head to toe’ physical assessment and 
documenting a full set of vital signs. The latter will contribute to the assessment of 
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Pre-hospital Management of
Suspected Fractured Neck of Femur
Based on in-depth history and full secondary assessment, the crew identifies
some or all of the following:
• Moderate or severe pain
• Shortened and/or externally rotated leg and/or deformity
• Pain to hip &/or referred pain to knee
• Unable to straight leg lift
• Unable to weight bear
• Clinician suspects hip fracture
Cautions:
• Has this patient fallen?
• Has this patient had a long-lie prior to assessment?
• Is this patient on anti coagulant or anti platelet theraphy?
• Has this patient had a previous fracture or prosthesis to affected hip?
• Does this patient have a diagnosis of osteoporosis and/or arthritis and/ or
 malignancy?
Management: Non Paramedic Crew
• Management of haemorrhage if present
• Check presence and quality of pedal and popliteal pulses
• Monitor vital signs
• Regular assessment of pain levels
• Entonox (or appropriate analgesia within local scope of practice)
• Request Paramedic assistance
• Assess for compromised skin integrity and manage accordingly
• Splinting and/or immobilisation of affected limb
• Optimise patient for surgery, consider as Nil By Mouth
• Extricate patient supine, on a orthopaedic scoop or vacuum mattress
Transportation:
• Patient supported effectively with
 immobilisation of affected limb
• Pre-Alert Trauma Unit/Emergency
 Department
• Smooth transportation of patient
• Ensure patient comfort is
 considered throughout journey
• Effective and structured handover
 the patient to trauma Unit/ED staff
Transportation:
• Patient supported effectively with
 immobilisation of affected limb
• Pre-Alert to Local Fast-track pathway
 receiving unit - this may involve
 bypassing Trauma Unit/ED and going
 direct to an alternative specified
 destiination (e.g. ward or radiology) OR
 the Fast-track may be initiated within
 the Trauma Unit/ED
• Smooth transportation of patient
• Ensure patient comfort is considered
 throughout journey
• Effective and structured handover the
 patient to Fast-track receiving staff






• Allergy to local anaesthetic
• Infection at injection site
• Previous femoral vascular
 surgery
• Patient connot report
 complications (eg. severe
 dementia, confusion)
• High risk of compartment
 syndrome
If FICB contraindicated,
consider IV Morphine - as per
local policy
(1) At the time of writing,
paramedic administered FICB
is not standard practice in the
UK
Reassess patient’s pain at




such as positioning and






Refer to local policies
Mild - Moderate Pain
• Endonox, PRN - IH
• Methoxyflurane, 3ml - IH
• Paracetamol, 1g - IV
Severe Pain
• Morphine, 2-10mg - IV
• Ondansetron, 4mg - IV (or
 alternative anti-emetic for
 prophylactic prevention of
 nausea)
Management: Paramedic Crew
Continue with management identified above, additional elements to consider:
• IV Access
• IV Paracetamol (consider IV Morphine, if pain connot be controlled via other
 methods)
• IV Fluid (250ml bolus Initially)
• Consider Oxygen therapy, to target 94-98% or 88-92% in COPD patients -
 post Morphine







Fig. 6.1 Pre-hospital management of a suspected fractured neck of femur post-secondary survey
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the patient’s National Early Warning Score 2 (NEWS2) which will provide baseline 
information for the hospital to monitor any changes in the patient’s condition.
6.1.3  Patient History
As part of the secondary survey, gaining a patient history as soon as possible after 
the fall is likely to give the most accurate account. History taking should be struc-
tured and include details of the fall and events leading up to it, the past medical 
history, allergies and medications and a social history [5, 6]. Global characteristics 
of the patient and their environment are noted, including general appearance, living 
arrangements and level of independence. This information is essential to support 
subsequent discharge planning.
Patients with a fall and a ‘long lie’ [7], which is considered anything in excess of 
one hour, are at risk of hypothermia, compromised skin integrity due to unrelieved 
pressure, rhabdomyolysis and aspiration pneumonia [7–9].
Early pain assessment and management is a key role for ambulance staff [10]. 
Classically, in patients with a hip fracture, there is pain on movement of the leg, in 
the groin and/or thigh, with pain referred to the knee [11].
Establishing a list of current medications and any known drug allergies is impor-
tant for ongoing management. Recognition of anti-platelet or anticoagulant therapy 
is essential. Ambulance staff need to establish whether the patient has taken any 
analgesics recently, before administration of further doses.
6.1.4  Physical Assessment and Vital Signs
Early establishment of the patient’s vital signs is recommended to identify possible 
intercurrent illness, monitor the patient’s progress and recognise any deterioration in 
their clinical status. Basic observations should include blood glucose testing to rule out 
hypoglycaemia. The assessment of the limb should include inspection and palpation, 
comparing it to the uninjured side [6], examining for irregularities/deformities, swell-
ing or bruising. Classically, with a hip fracture there is shortening and external rotation 
of the leg. Undisplaced hip fractures may have no signs, but patients may complain of 
pain on internal rotation and will be unable to straight-leg raise the affected limb [12]. 
Patients may be able to get up but then are unable to weight bear due to pain. In older 
people presenting with these signs and symptoms, ambulance crews should have a low 
threshold for transferring the patient to definitive care for radiological assessment.
If the emergency call relates to a fall where no clear extrinsic reason can be identi-
fied, then a 12-lead ECG should be performed, and a brief neurological assessment 
such as FAST (Face/Arm/Speech Test) should be undertaken to exclude stroke/TIA [7].
This information will provide the paramedic with relevant information to develop 
differential diagnoses and formulate a management plan whilst always being mind-
ful that time is a factor for these patients and extended time on scene if they have a 
hip fracture may not be beneficial to their overall outcomes.
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6.1.5  Management of Pain
Pain management should include non-pharmacological options such as splinting, 
immobilisation and positioning in addition to the use of pharmacological agents, 
always with continual assessment of the level of the patient’s pain.
Consideration needs to be given to both static pain (when the patient is at rest) 
and dynamic pain (when the patient is moving or being moved). Adequate analgesia 
should be given prior to moving the patient when transferring them from the scene 
of the injury to the ambulance and during transportation to hospital. Pain rating 
scales may be used to assess the efficacy of any drugs or techniques used to control 
and reduce pain. There are many different pain scales available [5–7, 13], but 
broadly there are Numeric Rating Scales (NRS) where the patient is asked to score 
their pain between 0 and 10 with 10 being the ‘worst level of pain’; Visual Analogue 
Scales (VAS) where patients choose any point on a line usually between 0 and 100 
with 0 being ‘no pain’ and 100 being the ‘worst level of pain’; Faces Pain Scale 
(frequently used with children and people with some level of cognitive impairment) 
where the faces at one end of the continuum are happy faces and then gradually 
change to faces in torment; and a Verbal Rating Scale (VRS) where people align 
with statements such as ‘No Pain’, ‘Mild Pain’ etc. [14].
Whatever scale is used, it is essential to assess pain levels both before and after 
intervention to ensure effective management.
Choice of analgesia may in the first instance depend on the skill mix of the ambu-
lance crew. In the United Kingdom, if a non-paramedic crew is in attendance the most 
usual quick acting analgesic offered to the patient is likely to be Entonox which was 
introduced into UK ambulance services in 1970 [15]. Entonox is fast acting and rapidly 
excreted, but there can be some challenges to its use with older patients with frailty. 
The delivery device for Entonox is a mouthpiece and a demand valve which requires 
respiratory effort and coordination; this is not suitable for all patients. The alternative 
delivery route is via a face mask [16] which can be considered if patients struggle with 
the mouthpiece. Ideally, the patient should be able to hold the mask independently with 
Entonox being self-administered, but again this is not possible for all patients. If a 
paramedic is available, then intravenous paracetamol should be considered, as it has 
been shown to be comparable in analgesic effect to that of morphine when adminis-
tered for pain control in isolated limb trauma [17]. It is important to ensure that intra-
venous paracetamol is given at appropriate doses in low-weight patients.
Another approach to managing pain in isolated hip fracture is paramedic- 
administered Fascia Iliaca Compartment Block (FICB) delivered in the pre-hospital 
setting. This is a new consideration in relation to paramedics’ scope of practice and 
it is not yet routine in the United Kingdom. FICB is covered in more depth later in 
this chapter. A feasibility trial of paramedic-administered FICB has been carried out 
in Wales [18], and the early findings are positive; funding has been approved for a 
fully powered multi-centre randomised controlled trial of paramedic-administered 
FICB in pre-hospital settings starting in October 2020.
If the patient’s pain is not controlled, and if there is a paramedic available, then 
intravenous morphine may be considered. This should be started at the lowest 
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possible dose and titrated to therapeutic effect. It should be emphasised that opiates 
are often associated with significant side effects particularly in older patients with 
frailty and are not recommended as the drug of first choice in this age group [7]. 
Concurrent prophylactic use of an anti-emetic is recommended due to high inci-
dence of nausea associated with opioids [5]. Careful observation of vital signs 
should be undertaken post administration of intravenous morphine, as it is a central 
nervous system suppressant. ECG and blood pressure monitoring are advised to 
detect any early changes. Additionally, the patient may need supplemental oxygen 
post-morphine administration, as it is a respiratory depressant. Target oxygen satu-
ration in adults is between 94% and 98% [7] unless they are diagnosed with COPD 
when target saturations will usually range from 88% to 92% SPO2.
Non-pharmacological techniques of pain management include positioning the 
patient carefully and ensuring limbs are well supported. Splinting and immobilisa-
tion can help to reduce pain as well as protect from further internal damage to blood 
vessels and/or nerves. Current recommendations are to use padding between the 
legs for the whole length of the leg and then to use broad fold bandages. The ban-
dages should be applied in sequence with a figure of eight around the feet and ankles 
being placed first of all. This will help with gentle manual traction to straighten the 
leg and bring it into position. Then, there should be two broad fold bandages placed 
above the knee and two below the knee to securely keep the legs in alignment and 
minimise movement [7].
Successful pain management for these patients is likely to employ a combination 
of pharmacological and non-pharmacological approaches.
6.1.6  Fluid Replacement
Older patients with frailty are often dehydrated and should be given intravenous 
fluids. Caution needs to be exercised in patients with a history of heart failure. In the 
United Kingdom, the recommendations recommend a loading volume of 250 mls of 
crystalloids in the form of intravenous sodium chloride 0.9% [7] to improve tissue 
perfusion and combat dehydration, but each patient’s needs will be different. 
Another indication for administration of intravenous fluids is related to trauma and 
possible haemorrhage. Paramedics need to be guided by local policies and practices 
relating to fluid replacement therapy, as these will determine what options they have 
in management of the haemodynamic status of the patient [5–7, 19].
Traditionally, patients have been kept nil by mouth in anticipation of surgery, but 
most units would now advocate feeding the patient until a definite time for surgery 
is confirmed, to avoid long periods of starvation.
6.1.7  Extrication
Ambulance staff must consider the best method of transferring the patient with a hip 
fracture into the ambulance and transporting them to a place of definitive care. A 
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carry chair is not appropriate with the risk of further damage at the site of injury and 
is likely to be extremely painful for the patient [19]. An orthopaedic scoop stretcher 
is a good option to get a patient from the floor onto a trolley without the need to 
log-roll the patient. If the patient has to be taken downstairs, however, the scoop 
stretcher may be more difficult to use, and the crew may need to request additional 
staff to do this safely. Deployment of a vacuum mattress can also be considered as 
an adjunct to extrication, but, at times, there may be limited options [19].
6.1.8  Transportation
Fast-track hip fracture care has been developed in some countries, but there is no 
standardisation. Further research is required to identify which components, at what 
stage, and in what combination of the fast-track pathway have the most significant 
impact on patients’ outcomes and experiences [20]. This should include research in 
pre-hospital care, involving paramedics and other ambulance staff.
In the United Kingdom, there are a growing number of fast-track pathways for 
patients who have a suspected hip fracture. In some regions, after a pre-alert call 
from the ambulance crew to the hospital, patients will by-pass the Emergency 
Department and go straight to radiology or a specialist ward to reduce time to defin-
itive treatment. Other areas rely on the pre-alert call from the ambulance staff to the 
receiving unit to ensure the patient is fast-tracked through the Emergency 
Department [7].
Key principles of patient management during transportation revolve around con-
tinual monitoring of the patient’s vital signs. Equally important is to re-assess pain 
levels and try to minimise exposure to protracted pain through a combination of 
appropriate pharmacological interventions in conjunction with effective splinting 
and immobilisation of the limb, comfortable positioning of the patient and, as far as 
is possible, a smooth, controlled approach to driving to avoid the patient being 
exposed to unnecessary sudden movements and jolts.
Effective handover to the receiving unit staff is essential and is frequently per-
formed using various frameworks such as IMIST-AMBO [21] (Identification of 
patient, Mechanism of injury/medical complaint, Injuries/information relative to the 
complaint, Signs, vitals and GCS, Treatment/response to treatment, Allergies, 
Medications, Background history and Other (social) information), developed in 
Australia. It has been shown, amongst other things, to improve the quality of informa-
tion, shorten the duration of handover and reduce the number of questions asked after 
the handover. In the United Kingdom, ATMIST (Age, Time of onset, Medical com-
plaint/injury, Investigation, Signs and Treatment) is the recommended mnemonic [7] 
which contains the relevant clinical information for an effective handover. There is 
still a need for further evidence to establish whether standardised frameworks consis-
tently achieve improved performance in this area and, if so, to what degree [22].
Pre-hospital clinicians have an important role in the management of patients with 
hip fracture. They are well placed to get a clear account of the patient’s fall, comor-
bidities and circumstances and handover of this information to the hospital team can 
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save time and repetition. Early appropriate management of pain and hydration can 
also influence peri-operative complications. It is important that pre-hospital staff 
and hospital staff work and learn together, to continually improve patient care.
6.2  The Emergency Department
As soon as a patient with suspected hip fracture arrives, triage assessment should 
ensure that the patient is cardiovascularly stable, using an early warning score. A 
brief review of the cause of the fall is essential to ensure that unstable medical con-
ditions such as dehydration, sepsis, gastro-intestinal haemorrhage, stroke or cardiac 
syncope are not missed.
Most hospitals in the United Kingdom now have a fast-track pathway for patients 
with suspected hip fracture [23]. This enables patients who are stable at triage to be 
prioritised for X-ray. The current targets from the Royal College of Emergency Medicine 
are that 90% of X-rays completed should be within 60 minutes of arrival and 75% of 
patients with a hip fracture should be referred within 120 minutes of arrival [24].
For patients with frailty or those with a history of respiratory disease, a baseline 
chest X-ray should be performed at the same time. In patients with known malig-
nancy or concerns about pathological fracture, a full-length femur view is required 
to assess for lytic lesions and plan surgery.
Blood should be taken early for routine testing, ideally with point-of-care testing 
of haemoglobin and lactate to dictate early management. A significant proportion of 
patients will require blood transfusion in the peri-operative period, and group-and- 
save samples should be sent routinely.
Those with complex fractures or those on anti-platelets or anticoagulants may 
bleed significantly into the fracture site, and resuscitation with intravenous fluids 
should be commenced early, with consideration of blood transfusion in appropri-
ate cases.
6.2.1  Nutrition and Hydration
Patients should be encouraged to eat and drink if able, until 6 hours before planned 
surgery. For elective patients, there is evidence to suggest that it is safe to continue 
with clear oral fluids up until 2–3 hours pre-surgery [25]. Oral carbohydrate loading 
drinks are actively encouraged for elective patients with evidence from enhanced 
recovery programmes. However, care must be taken with frail older patients with 
fragility fractures, as some will have required opiates for pain control and may have 
delayed gastric emptying.
Most patients with frailty are at high risk of malnutrition and should not be kept 
nil by mouth unnecessarily. Those who have had a long lie after their fall, or who 
have intercurrent illness, are likely to be dehydrated, and this should be addressed 
with appropriate fluid resuscitation. Others with pain or delirium may not manage 
adequate oral fluids and should have maintenance intravenous fluids prescribed. 
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Caution must be taken in those with decompensated heart failure or fluid overload 
from other conditions.
6.2.2  Management of Pain
Pain from a fracture is best managed by initial immobilisation and fixation where 
possible to aid healing. Immobilisation in plaster or with traction without surgery 
has significant risks in frail patients, as skin integrity is often poor. Immobility often 
rapidly leads to poor oral intake, generalised muscle weakness, orthostatic pneumo-
nia, thromboembolic disease, incontinence and skin breakdown. As such, a decision 
for early surgery is usually the best option.
6.2.3  Ongoing Analgesia
Pain leads to distress and is the symptom that people fear the most. It may be a key 
feature in the development of delirium in those at risk.
As previously discussed, it is important to monitor pain both at rest (static pain) 
and on movement (dynamic pain), as even those immobilised still experience pain 
during personal care and toileting. Pain should be measured, ideally using a vali-
dated score on admission and after 30 minutes of administering analgesia, to ensure 
effectiveness [26]. Ongoing review of pain should form part of routine nursing 
observations. Paracetamol should be continued every 6 hours. It is reported to have 
very few side effects and may also be effective in reducing delirium [27].
Opioids such as Codeine, Tramadol and others have significant side effects and 
are poorly tolerated by older people causing nausea, vomiting, constipation and 
confusion and should be avoided.
Opiates may be required but should be used in the lowest possible dose to avoid 
nausea, vomiting, sedation and respiratory depression. Older patients with poor 
renal function may not metabolise opiates effectively, and even small doses can 
cause prolonged side effects.
Non-steroidal anti-inflammatory drugs (NSAID) should only be used with 
extreme caution. Trauma and poor oral intake increase the risk of gastric irritation 
and bleeding and this may be exacerbated with the use of NSAIDs. Those on anti-
hypertensive medication are at high risk of renal impairment with NSAIDs.
6.2.4  Local Nerve Blocks
Local nerve blocks are increasingly being used to manage both static and dynamic 
pain and to reduce the requirements for opiate analgesia.
NICE guidelines state that nerve blocks should be used where possible to limit 
the use of systemic analgesia [28]. For hip fracture, both femoral nerve blocks and 
fascia-iliaca compartment blocks (FICB) have been shown to be effective [29]. 
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Single dose fascia-iliac a blocks given in the pre-operative period significantly 
reduce the post-operative and total analgesic requirements. These patients experi-
ence lower rates of delirium and those that manage to return directly home, do so 
more quickly, reducing the cost of inpatient stay but also lessening the burden of hip 
fracture on older comorbid patients [30].
Traditionally performed as part of the anaesthetic, these procedures are being 
used earlier to manage pre-operative pain in the first 8–16 hours. FICB is a low-
skill, inexpensive procedure which may be performed by trained individuals 
including non-physician practitioners as outlined in a position statement by the 
Association of Anaesthetists of Great Britain and Ireland [31]. The fascia–iliaca 
compartment is a potential space containing the iliacus muscle, the femoral nerve 
and the lateral cutaneous nerve of the thigh. A single high-volume injection using 
30 mls (for under 55 kg) to 40 mls (over 55 kg) of 0.25% levobupivacaine local 
anaesthetic, injected through the fascia lata and into the fascia iliaca compart-
ment, will affect the femoral nerve, the lateral femoral cutaneous nerve and, to 
some extent, the obturator nerve. These supply the medial, anterior and lateral 
aspects of the thigh and the femoral head. Although this can be performed with-
out ultrasound by trained practitioners with good effect, a small study suggests 
that ultrasound guidance, where available, may improve efficacy from 47% to 
60% up to 82–95% [32].
Guidelines recommend that observations need to be performed for 30 minutes 
following a nerve block. As the fracture pain is relieved, the side effects of previ-
ously administered morphine may become apparent as respiratory depression, with 
fatal consequences [33].
6.2.5  Skin Care
Traction is rarely used in hip fracture, as it offers little benefit and is poorly tolerated 
in those with frail skin.
There is a high risk of skin breakdown and pressure ulcers in those who are 
immobile, particularly in those with low body weight, malnutrition, poor skin and 
incontinence. Patients with diabetes or neuropathy have an increased risk.
Pressure-relieving mattresses should be used where available to minimise risk of 
pressure damage.
Urinary catheters may be considered for short-term use pre-operatively to help to 
minimise skin damage and reduce the need for painful movement.
6.2.6  Referral for Early Surgery
An orthopaedic assessment should occur as soon as the X-rays are available, and 
if a fracture is confirmed, a proposed time for an early operation should 
be agreed.
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6.3  Summary
In general, patients with hip fracture need early assessment and initial management 
of pain. This can be initiated in the pre-hospital setting to reduce distress associated 
with transfer to hospital. The principles of assessment, management and optimisa-
tion have an increasing evidence base, but the patient pathway may vary with differ-
ent roles of healthcare practitioners in different healthcare systems.
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7.1  Pre-operative Medical Assessment
Comprehensive Geriatric Assessment (CGA) has a strong evidence base in reducing 
mortality, increasing the number of patients discharged back to their own homes and 
reducing length of stay [1]. This approach should form the basis of assessment for 
any older person with frailty in hospital.
The pre-operative medical assessment forms part of an interdisciplinary review 
to understand the medical conditions that a patient may have in the context of their 
functional ability. The medical history can be evaluated by physicians, anaesthe-
tists, peri-operative physicians, orthogeriatricians, or any frailty practitioner with 
skills in developing a clear understanding of the implications of co-morbidities on 
an individual’s ability to function in addition to gauging the likely impact of trauma, 
anaesthesia and surgery.
In addition, therapists often conduct initial assessments to gather information 
about mobility, activities of daily living, cognition, mood, environmental and social 
circumstances.
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7.2  Information Gathering
This can be more complex than it seems with older patients often unaware of their 
personal medical history, previous investigations or reasons for prescribed medica-
tions. A significant proportion also has cognitive impairment and is unable to pro-
vide information. Collateral history from carers, the primary care physician, 
previous hospital medical notes, previous imaging and pathology results are key to 
piecing together a complete picture.
Having a standardised clerking proforma can help to ensure that all necessary 
information is captured, including a pre-operative assessment of cognition. This 
together with collateral from family/friends/carers can identify those with estab-
lished dementia in addition to those with likely undiagnosed dementia. These 
patients are at particularly high risk of developing peri-operative delirium. Proactive 
orthogeriatric management has been shown to reduce the incidence of delirium after 
hip fracture by one-third and severe delirium by a half [2].
Studies have looked at using haloperidol routinely peri-operatively in those at 
risk of delirium. A randomised placebo-controlled trial of 430 patients given either 
placebo or haloperidol 1.5 mg/day showed no reduction in incidence of delirium, 
but it did reduce the severity and duration of delirium with a reduction in length of 
stay. Its routine use is not recommended [3].
The 4AT is a useful tool for recognising and monitoring delirium [4]. It is a 
simple score which can be performed with good reliability by all staff and requires 
no specific training. It has been validated in patients with hip fracture [5] and should 
be a routine part of hip fracture management.
A description of an individual’s functional ability adds to an understanding of the 
impact and severity of co-morbidities, particularly with regard to cardiac and respi-
ratory disease. This is often described in metabolic equivalents (METS) with one 
MET being defined as the amount of oxygen consumed while sitting at rest and is 
equal to 3.5 mL O2/kg/min [6]. Those able to undertake activity such as easily man-
aging a flight of stairs (four METs or more) are unlikely to have significant cardio-
respiratory disease and have low cardiovascular risk (see Table 7.1).
Table 7.1 Metabolic equivalents
Physical activity METs
Sitting reading/watching television 1.0
Washing and dressing independently 2.1
Walking slowly on flat 2.3
Gentle household activity, e.g., cooking/cleaning 2.5
Walking a small dog (3 km/h) 2.7
Light static cycling/bowling 3.0
Gardening or outdoor activity 3.6
Walking quickly (5 km/h) 3.6
Climb flight of stairs without stopping 4.0
Dancing 4.5
Playing tennis/racquet sports 8.5
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Those with low levels of activity may have asymptomatic underlying cardiovas-
cular disease or may be limited by musculoskeletal disorders including arthritis, 
osteoporosis with kyphosis, sarcopenia or indeed obesity.
7.3  Cardiovascular Disease
Patients with a history of ischaemic heart disease are clearly at risk of peri-operative 
cardiac events. Cardiovascular risk factors should also be considered including the 
presence of diabetes, hypertension and smoking.
The Goldman cardiac risk index [7] or the Revised Cardiac risk index [8] may be 
used to identify high-risk patients and predict the likelihood of peri-operative car-
diac event or death.
A baseline electrocardiogram may give indications of asymptomatic cardiac dis-
ease with left bundle branch block or evidence of q waves or poor r-wave progres-
sion in the anterior leads.
An echocardiogram will give an indication of regional wall abnormalities from 
myocardial infarction, an estimate of left ventricular function and an indication of 
underlying valvular heart disease. This information can assist with risk stratification 
but should not delay surgery.
Patients with suspected coronary artery disease should be discussed with an 
anaesthetist. Unless a patient is symptomatic with cardiac chest pain, surgery should 
not be delayed to perform cardiac investigations. Routine troponin measurements 
are not helpful and do not correlate with early mortality [9]. Those already on beta 
blockers should continue their usual dose pre-operatively unless there is significant 
bradycardia or hypotension. Attention to haemoglobin levels is important, as peri- 
operative anaemia may increase cardiac strain and increase the risk of a car-
diac event.
7.3.1  Valvular Heart Disease
Cardiac murmurs are often present in older people, with insignificant aortic scle-
rosis or mild mitral regurgitation being the most common. A large retrospective 
study showed that 6.9% of patients with hip fracture had previously undiagnosed 
significant aortic stenosis [10]. This may influence the type of anaesthetic and the 
need for invasive cardiac monitoring. Significant aortic stenosis is suspected if 
the patient has an ejection systolic murmur in the aortic area in combination with 
a history of angina on exertion, unexplained syncope or near syncope, a slow ris-
ing pulse clinically in the brachial artery and an absent second heart sound or 
LVH on the ECG without hypertension. Patients with significant aortic stenosis 
require careful fluid balance and are at high risk of pulmonary oedema. 
Echocardiography should not delay timing of operation but may be useful if 
readily available.
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7.3.2  Heart Failure
Many older patients will have a history or symptoms in keeping with poor ven-
tricular function on a background of hypertension, ischaemic heart disease, valvu-
lar heart disease or atrial fibrillation. The mainstays of medical treatment are 
diuretics, ACE inhibitors, angiotensin receptor blockers, beta blockers, aldoste-
rone antagonists and a combination of hydralazine and nitrates. Increasingly, 
therapies for heart failure include electrophysiological interventions such as car-
diac resynchronisation therapy (CRT), pacemakers with or without implantable 
cardioverter–defibrillators (ICDs). A recent echocardiogram can be useful to 
evaluate the severity of left ventricular dysfunction but should not delay opera-
tion. Severity can usually be gauged from the history, symptoms and required 
medication.
Those who are euvolaemic should undergo early surgery, omitting heart failure 
medication until 48–72 h post-operatively to reduce the incidence of symptomatic 
low blood pressure preventing mobilisation. Caution should be observed with 
administering intravenous fluid. Anaemia should be managed proactively to main-
tain haemoglobin levels above 100 g/L. Once able to transfer out of bed medication 
can be slowly re-introduced. These patients often develop increasing peripheral 
oedema 5–7 days post-operatively and may require an increased dose of diuretics 
for a period of time.
Patients with decompensated heart failure and fluid overload at presentation need 
careful attention. Those with acute left ventricular failure need stabilising before 
theatre. This is often associated with an acute ischaemic event. Anti-platelet and 
anti-coagulant therapy may cause increased blood loss at the fracture site and should 
only be started with caution for acute cardiac ischaemia. Discussion with cardiolo-
gists regarding appropriate intervention and an individualised decision about timing 
of surgery should be made.
Those with poor right ventricular function and fluid overload need high-dose 
diuretics with close monitoring of peripheral oedema, weight and renal function. 
This is often associated with hyponatraemia, hypotension and renal impairment and 
requires close observation. Correction to achieve a euvolaemic state often takes 
5–10 days. It is usually better to proceed with surgery and manage the decompen-
sated heart failure in the post-operative period. Significant peripheral oedema in the 
thigh however may increase the risk of wound breakdown.
7.3.3  Conduction Defects, Pacemakers and Implantable Cardiac 
Defibrillators (ICD)
Conduction defects seen on the 12-lead ECG are very common in older people. 
Temporary pacing is only indicated if a patient has complete heart block or has had 
syncope related to tri-fascicular heart block. First-degree heart block, bundle branch 
block and ectopics are of unlikely significance if asymptomatic and do not require 
pre-operative investigation.
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Pacemakers have become increasingly sophisticated, and a basic knowledge of 
different devices and their indications is required to aid the acute management of 
patients with fragility fracture. All patients with pacemakers have routine annual 
checks, and a pre-operative check is only required if there is concern about malfunc-
tion or if it has not been checked within 12 months.
It is important to understand the reason for the device and whether the patient is 
pacemaker dependent. External pacing equipment and a defibrillator must be avail-
able during surgery. The use of surgical diathermy/electrocautery can give rise to 
electrical interference, and this can present additional risks when used in patients 
with pacemakers and ICDs. Energy can also be induced in heart lead systems caus-
ing tissue heating at lead tips through high-frequency current [11]. The manufactur-
ers recommend avoiding surgical diathermy if surgery is occurring within 50 cm 
from the device. If diathermy is deemed essential, then the use of bipolar diathermy 
with short bursts of energy minimises the risk. Where available, the use of a har-
monic scalpel should be considered.
If a cardiac technician is available, then an ICD can be turned onto monitor only 
mode to prevent shock delivery during surgery. Otherwise ICDs should be turned 
off by placing a magnet over the device which should be secured with micropore 
tape. Any sustained ventricular tachycardia or ventricular fibrillation intraopera-
tively should be managed with external defibrillation. Post-operatively, the magnet 
should be removed, and the patient monitored until the device has been checked.
7.3.4  Atrial Fibrillation (AF)
Public campaigns such as ‘know your pulse’ have increased public awareness of the 
risk of stroke from atrial fibrillation. Patients with permanent AF and a controlled 
ventricular rate should continue with rate control medication (usually a betablocker, 
dioxin or verapamil) pre-operatively, with their usual dose administered on the day 
of surgery. Some patients are known to have paroxysmal atrial fibrillation (PAF). 
Amiodarone, flecainide or beta blockers are often used to try and maintain sinus 
rhythm and prevent PAF. Periods of fast atrial fibrillation are commonly induced by 
trauma, anaesthesia and a stress response.
Those with new AF, persistent AF or PAF with a fast ventricular rate need review. 
Tachycardia may be due to pain, a cardiac event or sepsis and a 12-lead ECG, mea-
surement of lactate and inflammatory markers is advised. Those with no evidence of 
inter-current illness may simply have new AF or poor rate control. Correction of 
dehydration and electrolyte imbalance should be initiated immediately. If the rate 
remains persistently above 110 bpm, then urgent rate control may be required pre- 
operatively. Digoxin loading often takes 24 h to establish rate control. New pre-
scription of betablockers is not advised pre-operatively due to concerns about 
hypotension. Short-acting intravenous metoprolol may be used with caution. The 
most effective method for rapid rate control is with intravenous amiodarone. This is 
usually administered with a slow bolus of 300 mg over 1 h followed by a 24-h infu-
sion of 0.5 mg/kg/h (450 mg in 500 mL normal saline). This must be administered 
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through a large bore cannula and ideally into a central line with cardiac monitoring. 
Cardiology advice may be required for complex patients.
7.4  Management of Anticoagulants and Anti-platelets
Anti-platelets are mainly used for secondary prevention of stroke, in peripheral vas-
cular disease and following cardiac events. Anti-platelet agents cause irreversible 
platelet dysfunction and recovery only occurs with production of new platelets over 
7–10 days. However, delay for urgent surgery, such as fractured neck of femur fixa-
tion, is not recommended [12]. With regard to choice of anaesthesia, aspirin is usu-
ally of little consequence, and SIGN guidance supports central neuraxial blockade 
in aspirin monotherapy [12]. Clopidogrel monotherapy should not delay surgery 
[13] and indeed should not be a contraindication to spinal or epidural anaesthesia, 
with little evidence for increase in rates of vertebral canal haematoma [12]. General 
anaesthesia should be considered for patients taking dual anti-platelet therapy [12]. 
Prophylactic peri-operative platelet transfusions are not necessary and should only 
be considered if there is excessive surgical bleeding [12].
Up to 40% of patients admitted with a hip fracture will be anticoagulated [14]. 
Direct oral anticoagulants (DOACs), such as apixaban, rivaroxaban, edoxaban and 
dabigatran, are currently prescribed more commonly than warfarin in the United 
Kingdom [15]. They have the advantage of fewer drug interactions, do not require 
plasma level monitoring for dosing and are effective and relatively safe [16].
In patients taking warfarin, AAGBI guidance recommends proceeding with sur-
gery under general anaesthesia when the INR has been reduced by intravenous vita-
min K to less than 2.0 [17]. Spinal anaesthesia and surgery are considered safe with 
an INR < 1.5 [17].
Guidance for anaesthesia and surgery on patients with a hip fracture receiving 
DOACs is currently lacking. European and Scandinavian guidelines have advocated 
a pragmatic pharmacokinetic model with the passage of two half-lives between drug 
discontinuation and central neuraxial blockade [17].
The factor Xa inhibitors apixaban and rivaroxaban have a reversal agent, andex-
anet alfa, but it is only licenced for life-threatening bleeding and not routine use. The 
ANNEXA-4 study demonstrated effective clinical haemostasis with andexanet alfa, 
but thrombotic events occurred in 18% of patients during the 30-day follow- up [18].
Dabigatran, the direct thrombin inhibitor, has a licensed safe reversal agent, 
idarucizumab.
Traditional coagulation tests such as PT/INR and APTT are not sensitive in mon-
itoring DOAC plasma activity [17]. Furthermore, the INR can be normal when 
clinically relevant plasma levels of DOAC are present. Therefore, traditional coagu-
lation tests are not recommended. Plasma Xa assays are accurate but not commonly 
available in many hospital laboratories, and without an evidence base to guide the 
correlation of plasma levels to neuraxial performance safety, their use is limited. 
Conversely, clinical activity of dabigatran can be monitored easily and reliably 
through plasma thrombin time.
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With the secondary analysis of the national audit project ASAP 1 showing no 
difference in 30-day mortality between patients who received a general anaesthetic 
versus a spinal anaesthetic for hip fracture surgery, for many patients general anaes-
thesia is an acceptable alternative to spinal anaesthesia [19]. However, this is not a 
straightforward decision and should be made on an individual basis depending upon 
type of anticoagulant, renal function, the type of surgery required, anticipated blood 
loss, pain control and risk of immobility.
Table 7.2 gives details of suggested management for different anticoagulant 
medications.




Acceptable to proceed 
with spinal
Warfarin 4–5 days 5 mg vitamin K intravenously 
and repeat INR after 4–6 h. 
This can be repeated or 







Monitor for blood loss
Consider platelet transfusion if 
concerns regarding bleeding
If anti-platelet 












3–7 h Last dose 12–24 h pre-op.
Monitor for blood loss
24 h
Ticagrelor 8–12 h Proceed with surgery with 
general anaesthetic
Monitor for blood loss
Consider platelet transfusion if 
concerns regarding bleeding
5 days or post platelet 
transfusion at least 




Proceed with surgery Continue
Rivaroxiban 7–10 h Surgery and anaesthesia 24 h 
after last dose if renal function 
normal
2 half-lives/24 h after 
last dose if renal 
function normal
Dabigatran 12–24 h Surgery and anaesthesia if 
thrombin time normal
or idarucizumab for immediate 
reversal if thrombin time 
prolonged
If thrombin time 




Apixiban 12 h Surgery and anaesthesia 24 h 
after last dose if renal function 
normal
2 half-lives/24 h after 
last dose if renal 
function normal
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Understanding the reason for anti-platelet/anticoagulant medication is essential 
in managing peri-operative risk of thromboembolic events. Patients with cardiac 
stents are at high risk of thrombosis and cardiac events and anti-platelet medication 
should either continue or be stopped for the shortest possible time.
Patients with mechanical heart valves (particularly mitral valves), known AF 
with recent stroke and recent DVT or PE are at high risk of peri-operative thrombo-
embolic complications and bridging strategies should be considered. Treatment- 
dose subcutaneous low-molecular-weight heparin can be given until 24 h before 
surgery or intravenous unfractionated heparin until 2–4 h before surgery. The latter 
requires careful monitoring with 4–6 hourly APTT levels to ensure correct dosing.
Temporary insertion of an inferior vena cava filter should be considered for those 
with recent proximal DVT or PE.
Tranexamic acid has been shown to reduce the need for transfusion in a small 
study of patients with hip fracture with no difference in 3-month mortality [20], but 
in a similar small study, there appeared to be a significant increased risk of throm-
boembolic events [21]. A meta-analysis involving almost 600 patients suggested 
that Tranexamic acid administration reduces blood loss and transfusion rates with 
no significant difference in thrombotic events. The authors recommended a large, 
high-quality randomised control study to ensure safety and to establish clarity 
regarding the optimal regimen, dosage and timing before wide recommendation for 
use in hip fracture surgery [22].
7.5  Anaemia
Anaemia on admission is an independent predictor of poor outcome and is present 
in about 10–12% of those presenting with hip fracture [23]. It often reflects underly-
ing disease such as malignancy, chronic kidney disease or poor nutrition. It is 
important to send blood for haematinics pre-transfusion to aid diagnosis and subse-
quent management. Macrocytic anaemia should not be transfused without an under-
standing of the cause and in liaison with haematologists. Although the evidence is 
controversial, most clinicians would aim for a pre-operative haemoglobin of at least 
100 g/dL.
It is possible to predict blood loss depending upon the type of fracture with intra-
capsular fractures losing about 1000 mL, extracapsular about 1200 mL and intertro-
chanteric or subtrochanteric up to 1600 mL [24]. This may be greater in those on 
anti-platelet therapy or anti-coagulants.
The FOCUS study was a large randomised controlled trial comparing liberal 
transfusion with restrictive transfusion in patients following hip fracture which 
showed no difference in mortality, ability to walk across a room at 60 days or length 
of hospital stay [25]. However, a decision about transfusion trigger should be made 
on an individual basis pre-operatively, taking into account frailty, cardiorespiratory 
reserve and levels of function. Usual practice is to keep haemoglobin above 80 g/dL 
for those who are well and to aim for a haemoglobin of above 100 g/dL for those 
with poor cardiorespiratory reserve.
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Intravenous iron pre-operatively has been evaluated but its effects are not suffi-
cient or quick enough to reduce the need for blood transfusion in the first week after 
surgery [26].
7.6  Diabetes
Poor glycaemic control in the peri-operative period can lead to dehydration and 
poor wound healing with prolonged hyperglycaemia. Hypoglycaemia can also have 
serious consequences contributing to delirium, falls and seizures.
In the pre-operative period, patients with fragility fracture are often reluctant to 
eat due to pain, immobility and side effects of analgesia. Immobility may lead to 
reduced calorie requirements but pain and stress result in hyperglycaemia.
It is important to review diabetes medication pre-operatively and to monitor the 
blood sugar levels regularly. The AAGBI have produced comprehensive guidelines 
for peri-operative management of diabetes [27]. Patients who have taken long- 
acting oral hypoglycaemics or long-acting insulin need close monitoring and may 
need slow 5% glucose infusion if being kept nil by mouth for surgery.
Pre-operative carbohydrate loading or high-sugar dietary supplements should be 
withheld in patients with diabetes as these may lead to poorly controlled blood 
sugar levels.
Most patients on oral hypoglycaemics can be managed by simply omitting usual 
medication on the day of surgery (NB: there is no need to stop pioglitazone). 
Metformin should be withheld for 48 h in anyone at risk of renal impairment, as 
there is an association with lactic acidosis. If pre-operative blood sugars rise above 
12 mmol/L, consider variable-rate intravenous insulin infusion (VRIII). Oral medi-
cation should restart as soon as the patient is able to eat and drink.
Those usually on short-acting or combined insulin preparations should omit their 
usual insulin dose and start on VRIII pre-operatively with intravenous fluid. This 
should be 5% glucose if the blood sugars are low. For patients with type I diabetes, 
insulin should never be stopped completely.
Long-acting insulin analogues (Glargine, Lantus, Detemir or Levimir) can be 
continued in the peri-operative period, with some people advocating reducing the 
dose by one-third.
It is important to make a post-operative plan and to withdraw the VRIII as soon 
as the patient is eating and drinking, to avoid fluid overload and electrolyte distur-
bance. Normal insulin doses may need adjusting until the patient is eating, drinking 
and mobilising normally.
7.7  Chronic Kidney Disease (CKD)
CKD is common in older people and can be associated with excess surgical morbid-
ity [28]. It is important to establish the duration of CKD and baseline renal function. 
CKD may reflect impaired excretory function with raised urea, creatinine and 
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metabolic products. In addition, there may be impaired synthetic function resulting 
in acidosis, hyperkalaemia, hypertension and oedema. CKD also results in reduced 
erythropoietin with anaemia and reduced hydroxylation of vitamin D causing hypo-
calcaemia and hyperphosphatemia. Platelet dysfunction is common in CKD, 
increasing the risk of bleeding.
Anaemia and metabolic abnormalities should be corrected to acceptable limits 
pre-operatively. Fluid overload is difficult to correct pre-operatively but those with 
end stage renal disease who are dialysis dependent should be dialysed within 24 h 
pre-operatively to reduce fluid overload.
Many drugs are excreted by the kidneys and can accumulate in patients with 
CKD.  These may require dose adjustment or administration interval adjustment 
and, in some cases, avoided completely.
Anaesthesia often results in hypotension and a significant reduction in renal 
blood flow with worsening of renal function in the post-operative period. It is essen-
tial that anaesthetists are aware of patients with CKD who have poor renal reserve 
so that they can make every effort to prevent hypotension.
Patients with CKD often have concomitant ischaemic heart disease and continu-
ation of beta blockers and correction of anaemia may help to reduce the incidence 
of cardiovascular events.
7.8  Respiratory Disease
Predicting those who are at highest risk of post-operative complications enables 
pre-operative intervention and optimisation. All patients with hip fracture are at risk 
of atelectasis and of chest infection which is one of the reasons for early operation 
and mobilisation. Those with underlying lung disease or smokers with undiagnosed 
lung disease have a higher risk. Low serum albumin, recent weight loss and depen-
dency are also associated with increased risk [29].
Opiate analgesics and anaesthetic agents can reduce respiratory drive resulting in 
hypoxia, hypercapnia and atelectasis and should be used with caution.
Obesity also contributes to reduced gas exchange through reduced lung volume 
and in severe cases can lead to hypercapnic respiratory failure, but there is no evi-
dence that patients with hip fracture and a high BMI have an increased rate of post- 
operative complications [30].
Cor pulmonale and pulmonary hypertension carry significant morbidity and 
mortality.
Pre-operative clinical assessment, chest X-ray and arterial blood gases give 
important baseline information.
Exacerbations of chronic obstructive airways disease may need treatment and 
optimisation pre-operatively, but most respiratory infections should not delay oper-
ation unless accompanied by sepsis, cardiovascular compromise or very high oxy-
gen requirements.
The choice of anaesthetic is discussed in Chap. 8.
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7.9  Medication Review
In some countries, medicine reconciliation soon after admission is undertaken by a 
pharmacist. Understanding how a patient manages a complex regime is important, 
giving insight into cognition and compliance. Specific medication may suggest cer-
tain diagnoses, but care should be taken in making assumptions.
All regular medication should be written up on the drug chart with the indication 
for each drug and clear documentation of which should be continued or withheld 
pre-operatively. Most older patients with frailty admitted with fragility fracture will 
be volume depleted, and it is important to withhold medications which could con-
tribute to renal hypoperfusion and acute kidney failure in the peri-operative period 
(e.g. diuretics, ACE inhibitors, anti-hypertensives).
Long-term sedatives (e.g. benzodiazepines, antipsychotics) should be reviewed 
and possibly reduced in the immediate peri-operative period, as many of the anaes-
thetic drugs will also cause sedation. However, they should not be stopped abruptly 
or withheld for prolonged periods of time.
Other medications must be given on the morning of surgery with a small sip of 
water (e.g. beta blockers for angina or rate control, anticonvulsants and medication 
for Parkinson’s disease).
Some medications need reviewing and adjusting during the peri-operative period 
(see anticoagulants and anti-platelets and management of diabetes). Patients on 
hydrocortisone for pituitary failure or long-term low-dose steroid with possible 
adrenal failure should be given an increased dose usually 50 mg of hydrocortisone 
on induction via intramuscular or intravenous route and three times a day for the 
first 24 h). Inhalers may be changed to nebulisers for better delivery while a patient 
is immobile in bed.
Every prescribed medication should have a clear ongoing indication and benefits 
of the medication should outweigh the risks. Hospital admission with multidisci-
plinary input is an opportunity to review this. It is an important aspect of compre-
hensive geriatric assessment and takes considerable time. It should start 
pre-operatively but will need to continue to be reviewed and adjusted in the post- 
operative period.
Considerable thought should be given to medication that may contribute to falls 
(see Chap. 16).
7.10  Preventing Complications: Thromboembolic Events
Patients with fragility fracture are considered at particularly high risk of thrombo-
embolic events, due to the effects of trauma, surgery and immobility. Older patients 
with frailty may have other co-morbidities such as heart failure or a history of 
thromboembolic events that increase this risk further. UK NICE guidelines recom-
mend daily prophylactic-dose low-molecular-weight heparin (LMWH) for all hos-
pitalised patients unless there are specific contraindications [31]. LMWH should be 
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prescribed on admission but omitted if the patient is going to surgery within 12 h. If 
there is likely to be a delay to surgery, pre-operative dosing should be considered 
taking into account risks of bleeding further into the fracture site.
The incidence of symptomatic venous thromboembolic events (VTE) is between 
1% and 9% and symptomatic pulmonary emboli (PE) 0.2–1.7% following hip frac-
ture surgery. However, the risk of significant bleeding with LMWH is 0.8–4.7% [32].
There is no good evidence for compression stockings in patients following hip 
fracture, and the potential harm in patients with poor skin and circulation should not 
be underestimated. Local policies should be followed, but with a review of risks and 
benefits in each individual patient.
7.11  Antibiotic Prophylaxis
Antibiotic prophylaxis is strongly recommended for surgical management of frac-
tures to help to prevent deep wound infection. Each hospital will have its own policy 
to reflect likely pathogens and local patterns of resistance. This usually involves a 
single dose pre-operatively and 24-h cover post-operatively. Antibiotic choice may 
vary for patients who have fallen and fractured while in hospital or from a nursing 
home environment where the incidence of drug resistance is higher.
7.12  Appropriate Ceilings of Care
Many patients with fragility fracture have significant frailty and a quarter are in their 
last year of life. It is important that they and their next of kin have a realistic under-
standing of which treatments may result in benefit and which are likely to cause 
harm or distress. Organ failure as a result of end-stage chronic disease is usually 
irreversible, and under these circumstances organ support in an intensive care unit 
setting is likely to be ineffective and therefore inappropriate. Where there is a revers-
ible element to organ failure, decisions regarding invasive treatments should be dis-
cussed in anticipation pre-operatively where possible.
Cardiopulmonary resuscitation in the event of cardiac arrest is unlikely to be 
effective in those with poor physiological reserve and an anticipatory form (Do Not 
Attempt Cardiopulmonary Resuscitation or DNACPR form) is required in some 
countries.
Many older people do not wish to receive life-prolonging treatments and may 
have discussed this with relatives or completed an advanced care plan. It is impor-
tant to discuss this with the patient and their next of kin during the pre-operative 
assessment to ensure that all are aware of the patient’s priorities. A DNACPR order 
may be reversed in the immediate peri-operative period, in theatre and in recovery 
area to ensure that recovery from anaesthesia is complete and does not contribute to 
cardiac or respiratory compromise. The use of drugs and techniques often used as 
part of CPR may be indicated in the short-term [33].
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7.13  Conclusion
Pre-operative assessment of patients with fragility fracture requires skill, time and 
effort. It is best achieved through multi-disciplinary review and information gather-
ing to provide a clear and accurate understanding of a patient’s background. Many 
patients require adjustments to medications in peri-operative period and for some 
urgent optimisation is necessary. For the majority of patients, proceeding with sur-
gery without delay is in their best interests, as most intercurrent conditions are not 
rapidly reversible and medical instability will progress with poorly controlled pain 
from the fracture and an inability to sit upright. The AAGBI have produced guide-
lines on acceptable reasons to delay surgery [34]—see Table 7.3. Good pre- operative 
assessment includes shared decision-making with regard to the best form of man-
agement for that individual, taking into account the risks and benefits in addition to 
the patient’s priorities. Evidence-based protocols and guidelines are important, but 
ultimately this process requires clinical judgement and should involve a senior and 
experienced team.
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Traditionally, perioperative care of elderly patients requiring surgical hip fracture 
fixation was less than exemplary. Patients were administered relatively large 
amounts of opioid analgesia before surgery, which itself was often delayed for more 
than 48 h for ‘organisational’ or ‘anaesthetic’ reasons. A significant proportion of 
patients were not operated on, because the perioperative risk of death was perceived 
to be too high, and so received conservative management (bedrest). Patients under-
going surgery would be anaesthetised and operated on by junior clinicians, who 
administered heavy-handed general anaesthesia with opioid analgesia and used a 
wide variety of surgical techniques and implants. Postoperative care was coordi-
nated by orthopaedic surgeons, and generally delivered in a passive and intermittent 
manner. Mortality and morbidity were high, and length of postoperative inpatient 
stay was long.
This approach to care, however, was economically unsustainable given the rap-
idly changing demographics of developed (and, increasingly, developing) countries. 
Although the prevalence of hip fracture has remained stable or has fallen slightly, 
increased longevity has led to an increase in the number of elderly patients present-
ing with hip fracture. As a result, several European countries began to develop 
orthogeriatric services, to streamline and coordinate hip fracture care pathways.
S. M. White (*) 
Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
This chapter is a component of Part 2: Pillar I.
For an explanation of the grouping of chapters in this book, please see Chapter 1: ‘The 
Multidisciplinary Approach to Fragility Fractures Around the World—An Overview’.
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8.2  The Relationship Between Anaesthetist 
and Orthogeriatrician
Reconfiguration towards multidisciplinary, orthogeriatrician-led care has probably 
delivered the greatest improvement in hip fracture outcomes in the last two decades. 
The main benefit of this model is that it allows for continuous, specialised medical 
care throughout the perioperative period, delivered by anaesthetists and 
orthogeriatricians.
There are three phases to perioperative care, the preoperative, intraoperative and 
postoperative phases (Fig. 8.1).
The preoperative phase describes the period from fracture to the patient’s arrival 
in theatres for surgery. Hip fracture is painful, if not always at rest, then usually on 
movement. Surgical fixation is the only method of providing analgesia and remo-
bilisation in the long term, for which reason it should always be considered an 
option in preference to non-operative management. Conservative treatment carries 
the additional risks of immobility—thromboembolism, pressure ulceration and loss 
of independence. The aim of the preoperative phase, therefore, is to facilitate prompt 
preparation for surgery. Coordinated orthogeriatric/anaesthetic care enables stan-
dardised preoperative assessment (e.g., delivered according to an agreed proforma, 
detailing history, examination, preoperative investigations and blood cross- 
matching), risk assessment using scoring systems, analgesia provision according to 
agreed protocols, fluid resuscitation and organisational and patient-centred prepara-
tion for surgery.
Intraoperatively, the aim of anaesthesia is to mitigate the pathophysiological 
effects of surgery without destabilising the patient’s physiology. These patients are 






Fig. 8.1 Changes in functional capacity after hip fracture in the three phases of the inpatient epi-
sode, with traditional anaesthetic and perioperative care (blue line), compared to proactive multi-
disciplinary care (red line). See text
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are usually frail and elderly (and have limited physiological reserve), and have one 
or more comorbidities for which they take one or more drugs; cognitive dysfunction 
is also common. Conceptually, anaesthesia is less about getting high-risk patients 
through 0.5–2  h of major, emergency surgery, but more about normalising the 
patient’s (patho)physiology so that they are able to return to their normal function 
within hours following the surgery.
National audits have shown that a wide variety of anaesthesia techniques are 
used because of a result of personal preference and the lack of conclusive evidence 
for superiority of one technique over another [1, 2]. However, observational studies 
and meta-analysis indicate certain anaesthesia techniques probably improve the out-
come [3, 4]. Of potentially greater relevance is the idea that hospitals should adopt 
standardised anaesthesia protocols, so that postoperative care and the management 
of inevitable complications of anaesthesia and surgery become predictable for 
orthogeriatricians.
Postoperatively, orthogeriatric care aims to remobilise, re-enable and remotivate 
patients in preparation for hospital discharge, ideally back to their place of resi-
dence before fracture. The early postoperative phase is critical, as delayed remobili-
sation is associated with a prolonged duration of inpatient stay. Good anaesthesia 
care facilitates early recovery, by providing non-opioid analgesia, and avoiding 
delirium, hypotension and anaemia.
Figure 8.1 shows a reconceptualised timeline of what joint anaesthesia/orthoge-
riatric care should aim to achieve. The blue line represents traditional anaesthesia 
care. The patient’s functional condition has been declining for some time, until they 
fall and break their hip (‘X’), at which point they become entirely dependent. They 
are taken to hospital but receive minimal care until surgery, and so experience no 
functional improvement.
Intraoperatively, the fracture is fixed, analgesia, fluids/blood are given, the blood 
pressure monitored, and the patient’s functional status improves, which continues 
into the immediate postoperative period. However, perhaps the patient develops 
delirium or feels too nauseous to remobilise for several days in the early postopera-
tive period, as a result of reliance on postoperative opioid analgesia. They recover 
function in the following few days, but then develop pressure sores or suffer a pul-
monary embolism related to their prolonged bedrest, and their functional recovery 
is delayed again. Eventually, they recover, not quite to their pre-fracture level of 
function but enough to be discharged from hospital. However, their relatives report 
that the patient ‘was never quite the same’ after this episode, with a slow ongoing 
decline in function after discharge (dotted lines).
In contrast, proactive multidisciplinary care (red line) aims to return patients 
quickly to their pre-fracture functional status. Simple resuscitation (analgesia, flu-
ids, food) decreases the relative decline in function after fracture, and may indeed 
begin to improve function preoperatively. The patient undergoes surgery sooner and 
for a shorter period, during which resuscitation and normalisation of function con-
tinues using standardised anaesthesia. The patient’s functional status rapidly returns 
to pre-fracture levels, there are no immobilising complications, the patient is dis-
charged from hospital sooner and remains ‘well’ after discharge.
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8.3  Preoperative Care
International consensus recommendations published by the Fragility Fracture 
Network in 2018 detail the organisational and interdisciplinary aspects of anaesthesia 
care that hip fracture patients should be expected to receive in any hospital worldwide 
[5]. These were endorsed in the 2020 update of the 2012 Association of Anaesthetists 
UK guidelines, developed in association with the British Geriatrics Society [6]. 
Recommendations include the delivery of care by a multidisciplinary team of senior 
clinicians, fast-track hospital admission to an acute orthopaedic/hip ward, the provi-
sion of daily, and protected trauma lists that prioritise hip fracture surgery.
Several aspects of preoperative care involve coordinated anaesthetic and ortho-
geriatric input, including analgesia provision, preoperative preparation and ethical/
legal considerations.
8.3.1  Preoperative Analgesia
Hip fractures are usually low impact injuries sustained after a fall from standing 
height onto osteoporotic bone. Extracapsular fractures (intertrochanteric, subtro-
chanteric) are more painful than intracapsular fractures (subcapital, transcervical, 
basicervical), due to the greater degree of periosteal disruption.
Approximately a third of the fractures are associated with mild pain, a third with 
moderate pain and a third with severe pain. Fractures are usually more painful on 
movement, for example when the affected leg is raised passively by 20°.
After admission to the hospital, pain is often poorly assessed. Numerical rating 
scales do not adequately describe pain duration or quality. Assessment needs to take 
place at rest and on movement, before and after the administration of analgesia. 
Communication difficulties (deafness, blindness, hemiplegia) can make assessment 
difficult, as can cognitive impairment related to dementia, or narcotic analgesia 
administered in the prehospital phase.
Standardised analgesia protocols ensure that pain is properly assessed and appro-
priately treated, such that analgesia is provided without opioid-induced cognitive 
compromise. In turn, this facilitates other aspects of preoperative care, such as phys-
ical assessment, communication, eating and drinking and self-care.
Paracetamol (acetaminophen) is an effective analgesic that is well tolerated by 
hip fracture patients, and should be prescribed routinely throughout the periopera-
tive period.
Renal dysfunction is common (~40%) among this patient group, and so non- 
steroidal anti-inflammatory drugs (and codeine and tramadol) should be used with 
caution, or avoided completely.
Opioid analgesics are effective, but can affect cognition and increasingly so with 
older age and/or declining renal function (in such patients the dose should be 
reduced and the dosing interval prolonged). Depending on the availability, buprenor-
phine, fentanyl and oxycodone may be preferable to morphine for long-term use.
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Preoperative peripheral nerve block has become generally accepted as an 
analgesic method that minimises the administration of cognition-impairing opi-
oid analgesics [7]. The sensory innervation of the hip involves the femoral, obtu-
rator and sciatic nerves, and the skin surrounding the operative incision site, the 
lateral cutaneous nerve of the thigh. Femoral nerve block and fascia iliaca blocks 
have been used successfully to reduce pain and limit opioid use preoperatively. 
Although the efficacy of both blocks is improved by nerve stimulation and (more 
so by) ultrasound location [8], requiring additional equipment and expertise, 
both methods have proven to be relatively easy to learn by junior non-anaesthe-
tists, and allied health professionals, such that their protocolised administration 
by orthogeriatricians should be possible without anaesthetic input. Although 
additional expertise is required, tunnelled femoral nerve/fascia iliaca catheters 
can be used to provide prolonged non-opioid analgesia in defined patients for 
whom surgery is not an option, or where surgery may be delayed for medical 
reasons.
8.3.2  Preoperative Preparation
Hip fracture patients are often frail and old, with multiple comorbidities demanding 
polypharmacy. Any of these factors alone or in combination may have contributed 
to the fall that preceded the fracture, but it is only rarely that the outcome benefits 
of attempting to improve any of these factors outweigh the risk of delaying surgery. 
Instead, anaesthetists need reassurance from orthogeriatricians that the patient is 
appropriately fit for anaesthesia and surgery—‘normalised’ rather than ‘opti-
mised’—and encouragement that risk is best managed by administering an appro-
priate anaesthetic. Orthogeriatricians should understand what an ‘appropriate’ 
anaesthetic involves (see later), and discuss this with anaesthetists who are less 
familiar with anaesthetising hip fracture patients, and so more likely to cancel 
patients for medical reasons, delaying surgery.
The Association of Anaesthetists guidelines detail common patient problems 
that can increase the risk of anaesthesia or its conduct, such as anticoagulation, 
valvular heart disease, pacemakers and electrolyte abnormalities, and recommend 
how these should be managed preoperatively [6]. Similarly, generic algorithms 
are available online that can be modified according to institutional protocols [9]. 
These are intended as aides-memoire for preoperative patient preparation, and are 
not intended to replace direct communication between anaesthetist and 
orthogeriatrician.
Most usefully, the Association guidelines identify acceptable and unacceptable 
reasons for delaying surgery in order to treat certain conditions (Table 8.1). Even so, 
‘acceptable’ is not synonymous with ‘obligatory’, and surgery may still proceed 
even if these are present, if the additional risk is managed appropriately. These rec-
ommendations serve as a useful starting point when anaesthetists and orthogeriatri-
cians convene to discuss the timing of surgery.
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8.3.3  Ethical and Legal Considerations
Hip fracture in elderly patients is associated with significant mortality, morbidity, 
psychosocial change and reduction in quality of life, although intraoperative mortal-
ity is uncommon (<0.5%). Traditionally, discussion between doctors, patients and 
relatives about the risks and benefits of the various surgical options and recovery 
approaches has been limited, and hampered by difficulties quantifying risk. National 
validation of the Nottingham Hip Fracture Score (NHFS) (Table 8.2) supports its 
use as a risk adjustment for estimating 30-day mortality after hip fracture, in addi-
tion to other evidence for its value in predicting 1-year mortality and likelihood of 
early hospital discharge [10, 11]. The NHFS serves as a useful starting point when 
discussing risk, but requires patient-specific adjustment. This is best achieved by 
preoperative communication between the anaesthetist and orthogeriatrician so that 
Table 8.1 Acceptable and unacceptable reasons for delaying hip fracture surgery [6]
Acceptable Unacceptable
•  Haemoglobin concentration <8 g dL−1
•  Plasma sodium concentration <120 or >150 mmol L−1 and/or 
potassium concentration <2.8 or >6.0 mmol L−1
•  Uncontrolled diabetes
•  Uncontrolled or acute onset left ventricular failure
•  Correctable cardiac arrhythmia with a ventricular rate >120 
beats min−1
• Chest infection with sepsis
• Reversible coagulopathy
•  Lack of facilities or 
theatre space
•  Awaiting 
echocardiography
•  Unavailable surgical 
expertise
•  Minor electrolyte 
abnormalities




Predicted 30-day postoperative 
mortality (%)
Age 66–85 years 3 0 0.4
Age 86 years or older 4 1 0.6
Male 1 2 1.0
Hb less than or equal to 10 g dL–1 on 
admission to hospital
1 3 1.7
Abbreviated mental test score ≤6/10 at 
hospital admission
1 4 2.9
Living in an institution 1 5 4.7
More than one co-morbidity* 1 6 7.6
Active malignancy within last 20 years 1 7 12.3
Total score 8 18.2
9 27.0
10 38.0
A score out of ten is calculated by summating weighted points for eight criteria (left). The total 
score is used to predict the risk of a patient dying within 30 days of hip fracture surgery (right). 
Comorbidities (*) include myocardial infarction, angina, atrial fibrillation, valvular heart disease, 
hypertension, cerebrovascular accident, transient ischaemic attack, asthma, chronic obstructive 
pulmonary disease and renal dysfunction
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discussions with patients and their relatives accurately reflect the possible outcomes 
of their decisions about treatment.
Similarly, anaesthetists should be involved in discussions about perioperative 
resuscitation status and/or treatment boundaries, which should be confirmed before 
every patient undergoes surgery.
Anaesthetic input is also of value when developing patient information literature, 
for instance, describing what analgesia, antiemesis and anaesthesia interventions 
the patient can expect to receive.
8.4  Intraoperative Care
In a similar fashion to anaesthetists needing to understand the importance of frailty 
to orthogeriatric management, orthogeriatricians need to understand how anaesthe-
sia affects postoperative outcome.
Anaesthesia delivered sympathetically to a patient’s age, frailty and comorbidity 
can help re-enable patients after hip fracture surgery by improving analgesia, remo-
bilisation, eating and drinking and cognitive function.
Ideally, in the immediate postoperative period, patients should be sitting up, con-
versing coherently, drinking and eating, pain free and disconnected from oxygen, 
intravenous fluids and urinary catheters (all of which impede remobilisation). 
Although it is not always possible to achieve each of these factors, the aim is to 
administer anaesthesia in such a way as to facilitate as many as possible.
Evidence for the effect of anaesthetic interventions remains limited. Previously, 
debate has centred mainly on whether general anaesthesia or spinal anaesthesia 
(with or without sedation) is preferable in terms of outcome. Randomised controlled 
trials have proved inconclusive for several reasons: ‘general’ and ‘spinal’ anaesthe-
sia can describe a myriad of different techniques, a 2 h period of anaesthesia is 
probably unrelated to mortality 30 days later, early mortality (within) 5 days is an 
infrequent outcome for which very large trials would be needed to detect any differ-
ence, inclusion and exclusion criteria significantly affect selection bias, equipoise is 
lacking (most anaesthetists think one or other technique is ‘best’) and recruitment to 
follow up is complex [12]. Standardising the outcomes measured in studies should 
improve comparisons between techniques during meta-analyses [13]. With the 
advent of ‘Big Data’, regional and national observational studies have been con-
ducted, but have so far failed to find consistent benefits of one technique over 
another, at least in terms of mortality [1, 2, 14].
8.4.1  General or Spinal Anaesthesia?
General anaesthesia involves the administration of narcotic and hypnotic anaes-
thetic agents that render a patient unconscious for the duration of surgery. The 
patient requires airway support, regardless of whether they are allowed to breathe 
spontaneously or are paralysed and their lungs ventilated artificially.
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Spinal anaesthesia is effectively a reverse dural tap, in which 1–3 mL of local 
anaesthetic (usually bupivacaine) is injected through a fine bore needle into the 
subarachnoid cerebrospinal fluid in the lumbar region, providing analgesia, akinesia 
and anaesthesia below the umbilicus for several hours. Additional sedation is usu-
ally administered, either as a bolus or continuously.
Recent meta-analyses, RCTs and large observational studies report conflicting 
results about whether mortality is lower after general or spinal anaesthesia [2, 3, 
14]. However, there is greater consensus in terms of postoperative morbidity and 
cost, favouring spinal over general anaesthesia. Anecdotally, anaesthetists would 
prefer to have spinal anaesthesia themselves if they needed hip fracture surgery, 
orthogeriatricians report better patient recovery after spinal anaesthesia, and phys-
iotherapists report easier patient remobilisation after spinal anaesthesia. Results 
reported from imminent RCTs (REGAIN, REGARD, iHOPE) should add further 
information to this determination.
However, of greater relevance than whether spinal or general anaesthesia is better for 
patients is how well that anaesthesia is delivered. Although there are theoretical and 
experimental reasons for avoiding general anaesthesia (and sedation) in the elderly, the 
effect of these is seemingly small compared to numerous other adverse effects of anaes-
thesia and surgery, including hypotension, pain and analgesia, hypoxia and anaemia. 
Instead, anaesthetists should focus on careful monitoring of patients during surgery and 
the provision of appropriate interventions to normalise physiology, for example fluid 
and vasopressor therapy, depth of anaesthesia/cerebral oxygenation monitoring.
Future research has begun to focus on early postoperative outcomes that are 
more anaesthesia-specific, such as pain, hypotension and delirium (e.g., ASCRIBED, 
HIP-HOP and RAGA-delirium RCTs), and clearer definition of the anaesthetic 
techniques compared (e.g., self-ventilating general anaesthesia + nerve block vs. 
opioid-free, low-dose spinal anaesthesia + local anaesthetic infiltration without 
sedation).
8.4.2  Peripheral Nerve Block
Peripheral nerve blockade (fascia iliaca, femoral nerve, lumbar plexus blocks, or 
local anaesthesia infiltration) should always be administered with either general or 
spinal anaesthesia, as part of a multimodal analgesia protocol that aims to minimise 
opioid co-administration [5, 6, 15, 16].
Theoretically, fascia iliaca blocks may provide better analgesia of both the hip 
and surgical incision site intraoperatively, without dense blockade of the femoral 
nerve, which can prolong and impair remobilisation. Administered beforehand, a 
fascia iliaca or femoral nerve block can reduce sedation requirements when posi-
tioning patients laterally for spinal anaesthesia administration, and precludes the 
need to co-administer subarachnoid opioids, which can cause itching, respiratory 
depression and urinary retention postoperatively.
Co-administration of peripheral nerve blockade beforehand reduces age-adjusted 
maintenance doses of general anaesthesia.
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8.4.3  Spinal Anaesthesia
The aim of spinal anaesthesia is to achieve unilateral blockade on the operative side 
to a sensory level of ~T10–12 for ~2  h maximum operating time, whilst avoiding 
excessive hypotension related to spinal-induced sympatholysis. This can be achieved 
using opioid-free 1–1.5 mL subarachnoid 0.5% hyperbaric bupivacaine [17], but 
these doses are administered to fewer than 20% of patients receiving spinal anaes-
thesia. Instead, anaesthetists commonly administer in excess of 2 mL 0.5% bupiva-
caine [14, 18], which is associated with greater relative falls in blood pressure from 
pre-spinal baseline and a wider range of blood pressure reductions compared to 
lower doses, changes that can persist into the early postoperative period and prevent 
patients from sitting out of bed or standing up after surgery. Orthogeriatricians have 
an important role in encouraging anaesthetists at their institutions to use lower doses 
of spinal anaesthesia.
8.4.4  Sedation
Similarly, orthogeriatricians have a role in encouraging anaesthetists to consider 
using less, or no, sedation during spinal anaesthesia.
Commonly, patients co-administered spinal anaesthesia and peripheral nerve 
block sleep through surgery, because the relative narcotic effect of preoperative opi-
oids increase when pain is alleviated during spinal anaesthesia, and patients are 
often sleep deprived from the night preceding surgery.
If patients request sedation or sedation is necessary for patient comfort and 
immobility during surgery, then the minimum amount should be used for the short-
est time, to avoid accumulation and sedation in the postoperative period.
Several papers have shown that sedative infusions result in general anaesthesia 
(without airway support) in a significant proportion of hip fracture patients [19], and 
so sedation may better be limited to small bolus administration during key periods 
of surgery (jigsawing, hammering, relocation). Depth of anaesthesia monitors 
should probably be used to guide sedation if infusions are to be administered.
Theoretically, propofol is the sedative of choice, as it is metabolised rapidly, its 
metabolites are inert (unlike midazolam) and it does not cause prolonged cognitive 
impairment (unlike ketamine). There is no evidence supporting the use of combina-
tions of sedatives, although this is common practice.
8.4.5  General Anaesthesia
Older patients are sensitive to the cardiovascular effects of general anaesthesia (neg-
ative inochronotropicity and peripheral vasodilation). Hypotension is more com-
mon during general anaesthesia compared to spinal anaesthesia, but decreasing the 
amount of inhalational or intravenous anaesthetic agent administered during sur-
gery can reduce its prevalence. Moreover, compared to younger patients, the elderly 
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require lower doses of drugs to maintain anaesthesia, particularly when a peripheral 
nerve block is administered preoperatively.
Minimising hypotension while maintaining anaesthesia without awareness can 
be achieved using depth of anaesthesia monitors (e.g., bispectral index (BIS) and 
E-Entropy), and it has been recommended that these be used during any type of 
general anaesthesia in older patients [5, 6]. Alternatively, a Lerou nomogram can be 
used to adjust inhalational anaesthesia agent dose for age, or age-adjusted doses 
programmed into a total intravenous anaesthesia syringe pump.
One of the enduring debates among anaesthetists concerns whether the airway of 
a hip fracture patient administered general anaesthesia should be supported using a 
laryngeal mask airway, thereby avoiding the pathophysiological effects of mechani-
cal ventilation, or should be intubated, to avoid the risk and consequences of aspira-
tion pneumonia. Respiratory failure is significantly more prevalent after general 
compared to spinal anaesthesia, and use of paralysing agents is dose-dependently 
associated within an increased risk of postoperative respiratory complications, but 
it remains unclear whether hip fracture patients benefit more by avoiding aspiration 
or by avoiding mechanical ventilation.
8.4.6  Avoiding Ischaemia
Both general and spinal anaesthesia are associated with a high prevalence of hypo-
tension during anaesthesia for hip fracture surgery, general more so than spinal 
anaesthesia, and postoperative mortality correlates with increased relative fall in 
blood pressure [14, 18]. Hypotension can be predicted, and ameliorated by admin-
istering less anaesthesia, monitoring blood pressure closely, avoiding preoperative 
dehydration, and administering fluids and vasopressors appropriately.
Hypothetically, avoiding hypotension should reduce the prevalence of postopera-
tive complications related to organ ischaemia, such as confusion/delirium [20], dys-
rhythmia, acute kidney injury and poor remobilisation. Ischaemic complications may 
further be attenuated by ensuring adequate postoperative oxygen saturations (e.g., by 
providing (nasal) oxygen if SpO2 ≤ 95%), avoiding excessive anaemia (e.g., by mea-
suring blood haemoglobin concentration immediately after surgery and on day 1, and 
considering transfusion) and providing adequate pain relief (to reduce oxygen uptake). 
Note that simply by reducing anaesthetic dose reduces the prevalence of hypotension, 
requiring reduced fluid administration, in turn causing less dilutional anaemia, and so, 
in combination with additional peripheral nerve blockade, less ischaemia.
8.4.7  Bone Cement Implantation Syndrome (BCIS)
BCIS describes a complication occurring during surgical instrumentation and/or 
cementing of the femoral canal, and is characterised by cardiorespiratory compro-
mise/arrest. It occurs in about 20% of hip fracture operations in which cement is 
used, and results in cardiopulmonary arrest in about 0.5% [19, 21].
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The AAGBI, British Geriatric Society and British Orthopaedic Association have 
published multidisciplinary guidelines highlighting the need for joint decision- 
making, team working and attention to detail during the peri-operative period [22].
Of particular importance is the need to identify patients who are at higher risk of 
BCIS, including those who are very elderly, male, taking diuretic medication and 
have comorbid cardiorespiratory disease (particularly acute lung pathology).
Compared to uncemented prostheses, the use of cemented prostheses for hip 
fracture repair increases the likelihood of pain-free mobility after surgery and 
reduces the risk of re-operation. However, the guidelines recommend that surgeons, 
anaesthetists and orthogeriatricians discuss preoperatively whether the benefits of 
using a cemented prosthesis outweigh the risk of BCIS.
8.4.8  Standardisation of Anaesthesia
Clinical outcomes and other measures of care quality have gradually improved in 
the United Kingdom after hip fracture repair over the last decade. This has resulted 
from the general standardisation of care, with payments to hospitals for care sup-
plemented by a bonus if they are sure that the defined care targets were met (‘pay-
ment by results’). Conspicuously absent are targets related to anaesthesia, which 
combined with an ongoing lack of research evidence and lack of formal profes-
sional training in how to anaesthetise hip fracture patients, has meant that there 
continues to be a wide national variation in anaesthesia practice for hip fracture 
[1, 2, 12, 15].
Of course, a lack of standardisation may not matter—anaesthesia may have little 
effect on outcome after hip fracture—but this is unlikely to be the case, given that 
anaesthesia is administered at the most critical phase of a patient’s recovery after 
hip fracture and has an immediate effect on the trajectory of recovery postopera-
tively. Until better evidence becomes available, it seems prudent, however, to reject 
the tacit acceptance of poor, outlying care in support of current evidence-based 
standardised care as a method for improving safety, in a similar fashion to providing 
standardised anaesthesia care as part of Enhanced Recovery Protocols.
Although there is some evidence supporting the use of protocolised rather than 
physician-individualised, there is no evidence supporting physician-individualised 
care over protocolised care.
In healthcare, standardisation is particularly beneficial when implementing 
evidence- based care for large numbers of patients with a similar disease process, for 
whom current treatment is costly, has poor outcomes and is recognised profession-
ally as being of sub-optimal quality—all of which apply in hip fracture.
Standardisation ensures high reliability, consistent, cheaper, higher quality care 
for the majority of patients, and—most importantly—that the basics of care are not 
overlooked. Furthermore, standardisation enables monitoring and continuous 
improvement by amending standards in an evidence-based fashion, reductions in 
artificial variations in care (caused by slips, lapses or lack of knowledge) whilst 
improving focus on natural variation in care (caused by differences between 
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patients) and identification of consistently poor performance, areas for future 
research and educational needs.
Standards for anaesthesia are currently available online (www.hipfractureanaes-
thesia.com), based on best available current evidence and consensus opinion, 
describing the rationale behind their formulation and identifying areas for further 
research. As developed, these standards also provide a method of understanding 
why individual anaesthetists have deviated from standard practice.
Orthogeriatricians are encouraged to engage anaesthetic colleagues in following 
these standards, undertaking research in improving them further and engaging in 
continuous quality improvement cycles, with the aim of optimising care in the criti-
cal early postoperative period. This is a mutually cooperative process, as anaesthe-
tists and orthogeriatricians should work together to measure and monitor preoperative 
care, with the aim of optimising the patient pathway from fracture to early surgical 
fixation.
8.5  Postoperative Care
Much of anaesthetic involvement in the postoperative phase has been described 
earlier. Irrespective of whether the patient has been administered general or spinal 
anaesthetic (with/without sedation), the orthogeriatrician should expect to receive a 
patient back on the acute orthopaedic ward/hip fracture unit who is immediately 
ready for re-enablement (resuming activities of daily living) and suitable for reha-
bilitation to their former place of residence.
The 2012/20 AAGBI guidelines detail the management of common early postop-
erative complications, including pain, oxygenation, fluid balance and delirium [6]. 
These are essentially continuations of the primary aims of anaesthesia in the hip 
fracture population, namely the avoidance of ‘ischaemia’ through appropriate pain, 
blood pressure, oxygen, fluid and blood management, so that the consequences of 
‘ischaemia’—delirium [23], heart pump or rhythm disturbance, acute kidney injury, 
delay in remobilisation—are avoided.
Gut disturbances are common after hip fracture surgery and often overlooked. 
Nausea and vomiting delay resumption of oral feeding. Constipation occurs in the 
majority of patients, particularly those who are dehydrated, not eating or dehy-
drated. Malnutrition is common especially in frail patients and the cognitively 
impaired, and close attention to dietary intake is essential to patients’ 
re-enablement.
The role of high dependency or intensive care remains uncertain after hip frac-
ture. Certainly, it is never ethically justified to deny access to these facilities based 
on a hip fracture patient’s age, and in any other group of patients with a similar 
30-day postoperative mortality (or indeed mortality >1%, e.g., patients requiring 
emergency laparotomy), critical care facilities are much more routinely accessed. 
Indeed, planned admission is important in patients with a pre-operatively identifi-
able need for single/dual system support postoperatively, when this cannot be 
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achieved to the same degree on an acute orthopaedic ward; for example patients 
with COPD, acute lung injuries (infection, embolism) and acute left ventricular 
failure will benefit from critical care. Patients for whom critical care admission is 
planned have good outcomes compared to patients for whom critical care admission 
is unplanned, but this reflects the likelihood of intraoperative complications such as 
bone cement implantation syndrome, on table cardiac arrest or cerebrovascular 
accident, or massive haemorrhage.
However, adopting systems of orthogeriatric care allows a greater number of 
elderly patients with comorbidities to receive ‘acute’ medical care on acute ortho-
paedic wards after hip fracture surgery, rather than taxing precious critical care 
resources. Furthermore, orthogeriatric services are able to coordinate step-down 
care, reducing the duration of critical care admission. Having managed the patient 
preoperatively, orthogeriatricians may have a more pragmatic approach to normal-
ising patients back to their previous physiological condition, in comparison to the 
more critical care approach of optimising organ function, although this assertion 
requires further research.
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Hip Fracture: The Choice of Surgery
Henrik Palm
9.1  Aim of Surgery
The aim of hip fracture surgery is to allow immediate mobilization with full weight- 
bearing, aiming to achieve the previous level of function, ranging from maintaining 
normal walking in self-reliant elderly patients to pain relief in chronic bedridden 
nursing home residents. Three in four patients are expected to live beyond the first 
post-operative year, so proper surgery is required to alleviate an otherwise long- 
standing suboptimal functional level. Surgery is technically challenging, with body 
weight transfer through a broken oblique column, often with reduced bone quality 
due to osteoporosis—thus the risk of reoperation is high. A poorly operated hip 
fracture often leads to unequal leg length, pain and irreversible mobility loss, greatly 
influencing the quality of life.
9.2  Fracture Types
Hip fractures are divided into different types by the use of classification systems. A 
fracture classification should ideally have a high degree of reliability and reproduc-
ibility, be generally accepted, and have a prognostic validity in the clinical situation.
Historically, several classification systems have been proposed, but the following 
are the most commonly used in the literature. Hip fracture classifications are based 
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on radiographic fracture patterns, while previous hip surgery, arthritis, cancer, dys-
plasia, bone quality, soft tissue and pain are normally not taken into account.
Hip fractures cover proximal femoral fractures predominantly located up to 5 cm 
distal to the lesser trochanter and are classified by fracture anatomy on plain radio-
graphs (Fig. 9.1), if necessary supplemented by CT or MRI [1].
The hip joint capsule divides fractures into two main categories with an almost 
equal patient distribution: (1) Intra-capsular femoral neck fractures and (2) extra- 
capsular basicervical, trochanteric and sub-trochanteric fractures.
9.2.1  Intra-capsular Fracture Types
In a fragility fracture context, intra-capsular hip fractures are in fact through the 
femoral neck, as femoral head fractures are uncommon in the elderly.
Femoral neck fractures are at risk of non-union with/without mechanical col-
lapse due to insufficient fixation and/or avascular necrosis of the femoral head. In 
adults, the femoral head is primarily supplied by the distal recurrent vessels entering 
the femur on the shaft side of the fracture. Avascular necrosis is caused by isch-


















Fig. 9.1 Antero-posterior 
radiograph of the right side 
proximal femur showing 
the anatomy and fracture 
positions. FNF femoral 
neck fracture, TF 
trochanteric fracture, 
Sub-TF sub-trochanteric 




fracture-line or by a temporary arterial impingement, caused by vessel stretching or 
intra-capsular hematoma. Preoperative scintigraphy, electrode measurement and 
arthroscopic visualization of ischaemia have been tested but lack prognostic value. 
Since ischaemia could be temporary, acute reposition within hours (may be supple-
mented by hematoma emptying) has been suggested [2, 3].
Femoral neck fracture classification has historically been contentious with 
several different systems, primarily based on fracture displacement seen in the 
anterior–posterior radiographs. Garden’s Classification (Fig. 9.2) has in the last 
half a century been the most widespread. Fractures are divided into four stages 
based on fracture displacement [4]. Garden’s classification has only fair inter-
observer reliability when using all four stages, but moderate to substantial if 
dichotomized into just undisplaced (Garden I–II) or displaced (Garden III–IV) 
fractures [5].
In addition, a vertical fracture line in the anterior–posterior radiograph or poste-
rior wall multi-fragmentation, femoral head size and posterior tilt angulation seen in 
the lateral radiograph are believed to influence outcome [6–9]. However, the dual-
ism of undisplaced versus displaced (with reference to Gardens stages I–II vs. III–
IV) remains the most consistent predictor of failure and the most widespread 
fracture classification, with respectively around one-third and two-third of femoral 
neck fractures [10, 11].
9.2.2  Extra-capsular Fracture Types
Extra-capsular fractures are at risk of mechanical collapse and non-union due to 
insufficient fixation. The fracture line is anatomically located laterally to the nutri-
ent vessels to the femoral head, so avascular necrosis is rarely seen, but muscle 
attachments often dislocate the fragments and bleeding into surrounding muscles 
can be severe and life-threatening. Classification systems are primarily based on 
fracture-line location and number of fragments.
Basicervical fractures are a few percent of borderline cases between the intra- 
and extra-capsular fractures, anatomically positioned on the capsular attachment 
Stage I: Incomplete II: Complete III: Partial displacement IV: Full displacement
Fig. 9.2 Garden’s classification. (Reproduced with permission and copyright © of the British 
Editorial Society of Bone and Joint Surgery)
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line. The AO/OTA classification describes them as intra-capsular, but biomechani-
cally they behave like the extra-capsular fractures [12]—except for the risk of rota-
tion of the medial segment due to lack of muscle attachments.
Trochanteric fractures cover the trochanteric area from the capsule until just 
below the lesser trochanter. The often-used unnecessary prefixes per-, inter- and 
trans- are undefined, confusing and unhelpful for classification.
The AO/OTA Classification (Fig. 9.3) from 1987 is nowadays the most wide-
spread. It divides the 31-A trochanteric area into nine types by severity (1-2-3, each 
subtyped.1-.2-.3) [13].
Femur, proximal, pertrochanteric simple (only 2 fragments) (31-A1)
1. Along intertrochanteric
 line (31-A1.3)
2. Through the greater
 trochanter (31-A1.1)
    (1) nonimpacted
    (2) impacted
3. Below lesser
trochanter (31-A1.2)
Femur, proximal, trochanteric fracture, pertrochanteric multifragmentary (always have posteromedial
fragment with lessor trochanter and adjacent medial cortex (31-A2)
1. With 1 intermediate
 fragment (31-A2.1)
2. With several intermediate
 fragments (31-A2.2)
3. Extending more than
    1 cm below lessor
trochanter (31-A2.3)
Femur, proximal, trochanteric area, intertrochanteric fracture (31-A3)




(1) extending to greater
      trochanter
(2) extending to neck




Fracture type 31-A1 covers the simple two-part fractures, while 31-A2 demands a 
detached lesser trochanter, with an intact (31-A2.1) or a detached greater trochanter (31-
A2.2-3). 31-A3 covers fracture lines through the lateral femoral wall—defined as the 
lateral cortex distal to the greater trochanter—in which the subgroup 31-A3.1 represents 
the reverse fracture and 31-A3.2 the transversal, while the most comminuted 31-A3.3 
fracture demands both a fractured lateral femoral wall and a detached lesser trochanter.
The AO/OTA classification covers most fractures within previous classification 
systems, except the few trochanteric fractures with a detached greater trochanter 
and an intact lesser trochanter. The reliability when using all nine types is poor, but 
increases to substantial if only classifying into the three main groups (A1-2-3) [14].
Subtrochanteric fractures are positioned distally to the trochanters, and constitute 
around 5% of all hip fractures. These have historically been classified by as many as 15 
different systems, most often into the 8 types from 0 to 5 cm below the lesser trochanter 
by Seinsheimer or the 15 types from 0 to 3 cm in the AO/OTA classification for femoral 
shaft fractures, the type 32ABC(1-3).1 sub-division. A review doubts the value of such 
division and proposes simplicity into: (1) a stable two-part and unstable, (2) three-part 
and (3) more comminuted fractures from 0 to 5 cm below the lessor trochanter, without 
involvement of the trochanters. It however still has to be established whether this easier 
classification is useful and necessary for decision-making and prognosis [13, 15, 16].
9.3  Implants
There are two major strategies for treating hip fractures, prosthesis or osteosynthe-
sis. A prosthesis involves removing the fracture site, and replacing the femoral head 
with a hemi-arthroplasty or total hip arthroplasty, the latter also including an acetab-
ular cup. An osteosynthesis involves reducing bone fragments to an acceptable posi-
tion and retaining them until healing—usually with parallel implants, sliding hip 
screw or intramedullary nail (Fig. 9.4).
Parallel Implants Sliding Hip Screw Intramedullary Nail Hemi-Arthroplasty Total Hip Arthroplasty 
Osteosyntheses Prostheses
Fig. 9.4 The main implant groups for hip fracture surgery
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Prostheses are inserted with the patient supine or lateral depending on the surgi-
cal approach, while osteosynthesis is always performed through one or more lateral 
approaches, with the patient supine on a traction table and the use of a radiographic 
image-intensifier. There are pros and cons for all implants, but all are dependent on 
proper use, which is why well-defined implant position measurements are needed 
for optimal evaluation of one implant against another.
Parallel implants are inserted with limited operative bleeding and soft tissue 
damage through a few lateral stab incisions or a single <5 cm incision. In spite 
of many clinical and cadaver studies, choice (screws/hookpins) and number 
(2/3/4) of implants lack consensus [17]. Parallel implants permit fracture com-
pression and they should be inserted as vertically as possible and in different 
head quadrants. Furthermore, the posterior implant should have posterior cortex 
contact and the inferior implant calcar contact to achieve three-point fixation 
that best supports weight transfer from (1) the subchondral bone to (2) a calcar 
seat and (3) a lateral femoral cortex counterpoint [18]. The main reasons for 
failure are non-union, with or without mechanical collapse, due to insufficient 
fixation and/or avascular necrosis. Also, a femoral neck shortened heling posi-
tion is associated with poor functional outcome [19]. Salvage normally neces-
sitates a hip prosthesis or, depending on the patient’s demand, a simple removal 
of the femoral head. A new fall can result in fractures around the parallel 
implants, which should be reoperated with a sliding hip screw or an intramedul-
lary nail.
Sliding hip screws have been the Gold Standard for treating trochanteric frac-
tures for several decades—but have recently also gained ground for femoral neck 
fractures [17]. After reduction, the femoral head fragment is held by a large diam-
eter screw, which can slide inside an approximately 135° angle plate attached later-
ally to the femoral shaft. The implant is inserted under the lateral vastus muscle 
through a single lateral approach, around 10  cm long depending on chosen 
plate length.
To reduce the risk of cut-out of the screw into the hip joint, it should be posi-
tioned centrally or central-inferiorly in the femoral neck with the tip attached 
subchondrally in the femoral head, providing a short so-called tip-apex distance 
[20]. Beyond cut-out, the common reasons for failure are mechanical collapse, 
with or without non-union and a distal peri-implant fracture. Depending on femo-
ral head bone status, salvage can be an intramedullary nail or a distally seated hip 
prosthesis.
Intramedullary nails have, during the last decade, outnumbered sliding hip 
screws as treatment for trochanteric fractures [21]. After reduction, the femoral 
head fragment is held by a large diameter screw, which can slide at an angle of 
approximately 130° through an intramedullary nail with 1–2 distal locking screws. 
The nail is inserted at the greater trochanter tip, through a 5-cm lateral incision, with 
the sliding and locking screw(s) inserted by use of a guide through stab incisions in 
the lateral vastus muscle. A central-inferior position in the femoral head and a short 
tip–apex distance for the threaded types is important, while the new bladed types 
might need more distance [22, 23].
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Some old nails had a reputation for risking a shaft fracture, but newer nails have 
moved beyond this, although the many new smaller designs, with different screw, 
blade, sleeve, locking and anti-rotation mechanisms, lack convincing clinical evi-
dence so far [24, 25].
Reasons for failure are the same as for the sliding hip screws, and salvage can 
be a distally seated hip prosthesis for bone collapse. In case of a distal peri-
implant fracture, a longer nail or a condylar plate can be used, depending on the 
nail length.
Prostheses involve a metal femoral head replacement attached by a stem seated 
in the shaft cavity. To fit individual patients’ anatomy, implants are modular and 
assembled during surgery; thus mono-blocks are no longer recommended [26]. 
Reoperations are primarily caused by repeated dislocations or by a peri-prosthetic 
fracture (produced during insertion or subsequent to a new fall). For dislocations, 
closed reduction is the norm, but reposition or modification with a low-range-of- 
motion constrained liner is necessary in recurrent cases. Peri-prosthetic fractures 
are treated with circumferential wires and/or a plate, and a loose prosthesis is 
changed or removed depending on the patient’s demands.
Hemi-arthroplasties (HA) traditionally have reduced dislocation rate, shorter 
operating time and less blood loss than a total hip arthroplasty. Reports of acetabular 
chondral erosion, following unipolar HA, have encouraged bipolar heads with an 
additional ball joint—their efficiency is, however, still debated [27–29].
Total Hip Arthroplasties (THA) also replace the acetabular cartilage, theoreti-
cally a source of pain and thus reduced functional ability. THAs might provide a 
better result than HAs in active, independent living, and cognitively intact patients, 
but more studies are warranted [28, 30–33]. Despite the higher implant price, the 
total cost of using THA could be lower when taking complications and function into 
account, in the healthiest patients [34]. THAs, however, have an increased disloca-
tion risk [28, 30, 31, 35], which might be reduced by the technically demanding new 
dual-mobility type [36–38].
Beyond optimal implant positioning, the dislocation rate following both HA 
and THA might be reduced to 1–3% of patients if using the antero-lateral 
approach, compared to 4–14% if using the postero-lateral approach, although the 
latter can probably be improved by an optimal capsular and muscle repair [39–
41]. The only randomized study, however, found no difference in dislocation rate 
between the two methods [42], and a register study found that the consequences 
of surgical approach for soft tissue, pain and mobility might be minimal [43]. It 
may be that dual- mobility cups can justify the continued use of the postero-lat-
eral approach [36–38].
Cementation is associated with more dislocations in some studies but less in 
others. Cementation seems to improve patient mobility, reduce pain and the rate 
of peri-prosthetic fractures (1–7% for uncemented prostheses), although only a 
few studies include the newer hydroxyapatite-coated surfaces. Cementation 
probably increases risk of air embolism, blood loss and operation time, but reg-
istries have shown that a higher acute mortality appears to equilibrate after a 
couple of months [2, 28, 29, 44–46].
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9.4  Surgical Management
Patients should receive their operation as soon as possible, because the negative 
impact on body functions, while waiting for surgery, appears to be significant. 
Surgery on the day of, or the day after admission (less than 36 h) is recommended, 
although studies to prove this are difficult, because stratification by comorbidities is 
challenging [47–51].
Surgical drains [52], and pre-operative traction is no longer recommended [53]. 
Conservative treatment should be avoided in modern healthcare systems [54], 
except in the case of few terminally ill patients who can be kept pain-free by anal-
gesics in their last few days of life.
Patients sustaining a metastatic fracture should be identified, the cancer investi-
gated and the proximal femur fixed in a way that takes into account the growing 
cancer, normally by use of a long nail or a distally seated THA.
Prophylactic antibiotic treatment should be given. Deep infection is rare 
(Table 9.1), but potentially devastating, often with several procedures and implant 
removal. While treating the infection, an external fixator can be used to keep extra- 
capsular fractures reduced. Predictors of infections are primarily the surgeon’s 
experience and the operation duration [55, 56].
9.4.1  Intra-capsular Operations
The overall choice stands between (1) femoral head removal and insertion of a pros-
thesis, or (2) femoral head preservation by internal fixation, wherein the main over-
all predictor for failure is initial fracture displacement [3]. However, patient age, 
co-morbidity, mobility demands and so on should also be taken into account in the 
choice of implant. Patients should be asked about pre-fracture hip pain and a THA 
is chosen if hip arthritis coexists.
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Undisplaced femoral neck fractures may be complicated by non-union, with 
or without fracture collapse and, after a minimum of 3–6 months, radiographically 
evident avascular necrosis of the femoral head (Table 9.1). Around three-quarters of 
the undisplaced fractures are treated with parallel screws or pins, which appears to 
be adequate [3, 17]. The sliding hip screw is comparable and enables a more stable 
fixation due to the fixed angle attachment when three-point fixation is unachievable 
due to a vertical and/or basal fracture line—but necessitates a larger incision. Also, 
posterior tilt might increase the reoperation rate [7, 8], suggesting that this may be 
an indication for prosthesis, rather than osteosynthesis.
Displaced femoral neck fractures are followed by the same complications after 
internal fixation as the undisplaced—but at a higher rate (Table 9.1).
If using internal fixation, the fracture must be anatomically reduced within a 
short time and the implants optimally positioned. Prostheses are now the most com-
mon treatment for displaced fractures, with improved results (Table 9.1) varying 
with the approach, cementation and THA/HA [2, 17, 18, 21, 44, 45, 57, 58].
A large number of studies report a significantly lower reoperation rate following 
a prosthetic replacement. Newer studies also find less pain, better hip function and 
higher patient satisfaction after a prosthesis. However, this is at the expense of a 
greater primary operation (operating time, soft tissue damage, blood loss and impact 
on body functions) resulting in a higher immediate mortality. Fortunately, this 
appears to equilibrate later [2, 29, 57–59].
Using internal fixation for all displaced fractures, with the insertion of a prosthe-
sis later if required, is not recommended as a salvage prosthesis insertion has a 
much higher complication risk than a primary. Prostheses, however, have a shorter 
lifetime in mobile young patients who might outlive their prosthesis once or more. 
It has therefore been suggested to use an internal fixation in the younger patients, 
THA in active patients aged around 65–80  years and HA in the oldest. [2, 29, 
35, 60].
The subgroup of demented patients might benefit more from internal fixation—
their functional scores are generally low—but the literature is so far limited [61, 62]. 
Osteosynthesis in most fragile patients, who are demented or have a high risk of 
dying on the operation table, should however be used with caution, as the fixation 
often turns out to be inadequate and painful in the short term—requiring a reopera-
tion—if the patients live longer than expected. In a few selected bedridden, oldest 
patients, a simple removal of the femoral head can be chosen as the primary proce-
dure to reduce fracture pain and eliminate complications.
9.4.2  Extra-capsular Operations
Basicervical fractures are treated with a sliding hip screw, attached to a short lat-
eral plate. Parallel implants are insufficient because of the lack of implant support 
by the calcar bone area [12].
Trochanteric fractures may be complicated by a non-union or mechanical col-
lapse in 1–10% of patients. The pull of muscles often displaces fragments, while a 
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near-anatomical reduction is necessary for the majority of weight to pass through 
the bone. Use of retractors and/or a posterior-reduction device on the fracture table 
is recommended to prevent sagging of the fracture.
During the early post-operative months, an inadequate reduction and implant 
position may lead to femoral shaft medialization and femoral head varus posi-
tion with risk of a screw cut-out, pain and a shortened femoral neck- and leg-
length. The overall rate of reoperation is 2–10%. [25, 63–65]. A salvage 
prosthesis can be inserted primarily, but this is challenging due to the damaged 
bone stock.
The choice of implant is between the sliding hip screw and an intramedullary 
nail but, after many cohort studies and more than 40 RCTs since the past three 
decades, the comparison remains inconclusive overall. The current status appears 
to be that, although the sliding hip screw remains the recommended implant, nails 
might have an advantage on mobility or in the more unstable trochanteric fracture 
[24, 66, 67]. The Norwegian national registry reported fewer reoperations after 
sliding hip screws in 7643 stable (AO/OTA type 31A1) and after nails in 2716 
unstable trochanteric fractures (AO/OTA type 31A3) [64, 65]. However, a system-
atic review of the six RCTs on a total of 265 patients with AO/OTA type A3 frac-
tures found comparable fracture healing complication rates for sliding hip screws 
and intramedullary nails—and more RCTs on fracture subgroups are war-
ranted [68].
Often lateralization and femoral neck shortening are seen following the unstable 
trochanteric fractures, probably due to a lack of a buttress from the lateral femoral 
wall. A trochanteric buttress shield might prevent lateralization, but the evidence is 
not convincing and the method demands a much larger incision than simply insert-
ing the well-known intramedullary femoral nail. The sliding hip screw might be 
insufficient for fractures with a detached greater trochanter (AO/OTA type A2.2 and 
A2.3) as the resulting thin lateral femoral wall is at risk of per-operative fracture. 
The integrity of the lesser trochanter does not seem to influence outcome, and unsta-
ble trochanteric fractures should probably thus be defined by a detached greater 
trochanter or a lateral femoral wall fracture (AO/OTA type 31A.2.2-2.3  +  A3) 
[69, 70].
So far knowledge is limited on whether the use of the longest possible nail can 
reduce risk of later shaft-fractures, although femoral shaft bending, entry-point and 
distal locking appears more challenging in long nails [71].
Sub-trochanteric fractures are nowadays most often treated with a long nail, 
which is probably beneficial with reoperation rates declining by 5–15%. Most lit-
erature, however, also included the AO/OTA 31A3 fractures, due to difficulties of 
differentiation and more knowledge is needed. Circumferential wires can be added 




9.5  Surgical Algorithms and National Guidelines
As indicated earlier, the published evidence in the last decades has created a 
degree of consensus for the surgical treatment of hip fractures. In everyday 
clinical practice, the exact choice of implant however often remains uncertain, 
and an easily used surgical algorithm for all hip fracture patients might be 
warranted.
Younger, less experienced surgeons probably feel more confident when guided 
by a strict algorithm, while older surgeons could feel that their individual right of 
choice is being restricted. It is, however, important to underline that a treatment 
algorithm does not negate the individual surgeon’s responsibility for the individual 
patient. A surgeon still has the right and duty, now and then, to defy a guideline due 
to individual circumstances, but the decision to do so should be justified in the 
patient record.
Creating an algorithm that embraces the heterogeneous group of hip fracture 
patients is challenging, and the balance between detail and usability must be 
considered. Many published articles recommend treatment for some aspects, but 
only a few authors have published comprehensive decision-tree algorithms for 
hip fracture surgery—among which the simple, exhaustive and exclusive 
Copenhagen Algorithm (Fig. 9.5) appears to be the best scientifically evaluated 
[9, 73].
National guidelines including surgery have emerged in Australia, New Zealand, 
United States and most European countries during the last decades. Consensus is 
widespread for some overall recommendations based on the same evidence.
Among the intra-capsular fractures, all recommend internal fixation for undis-
placed femoral neck fractures and to some extent prosthetic replacement for the 
displaced in elderly patients. Among the extra-capsular fractures, the sliding hip 
screw is recommended for the stable (often defined as AO/OTA type A1) while a 
nail is recommended for the unstable fractures (often defined as AO/OTA type A3 
and further distal). The purpose of national guidelines is to recommend evidence- 
based surgical treatment for improving outcome. National hip fracture registries 
have gained ground, especially in the last decades, to enable continued evaluation 
of treatment quality and the identification of positive and negative outliers. [10, 
73, 74].
The multidisciplinary global fragility fracture network has now the strategic 
focus of facilitating national (or regional) consensus guidelines including quality 
standards and systematic performance measurement—and offers an easily used 
minimum data set for hip fracture audit [74]. Hopefully, such knowledge dissemina-
tion not only helps to overcome barriers to implementation, but also to globally 
spread evidence-based national guidelines, standards and registries for improving 
the surgical quality.
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Proximal Humeral Fractures: The Choice 
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10.1  Aim of Treatment
The overall aim of shoulder fracture treatment is to reduce pain and regain the best 
possible function. Most patients do not regain previous shoulder function, some 
patients had an impaired shoulder function prior to the injury, and some patients 
suffer persistent pain, whether treated surgically or non-surgically.
Generally, pain-free function at shoulder level should be the goal of treatment, 
allowing daily activities. The achievable treatment result may vary widely and the 
aim of treatment should be part of the shared decision-making.
Most proximal humeral fractures eventually heal, and non-union is seen in only 
1.1% of all fractures [1]. However, malunion is inevitable when displaced fractures 
are treated non-operatively in adults. This does not entail poor function or pain. 
Satisfactory patient-reported outcomes can often be obtained without restoring 
anatomy or replacing the joint with a prosthesis. Radiographic outcomes, range of 
motion and surgeon-administered outcome measures do not necessarily reflect the 
needs of the older patient suffering a shoulder fracture.
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10.2  Evidence and Literature
The evidence base for the management of proximal humeral fractures has been 
weak until recently. The increasing amount of literature has so far mostly been 
unable to inform clinical practice, due to poor methodological quality with only 
about 3% randomised clinical trials [2]. Consequently, different approaches can be 
found nationally, regionally and even between care providers at the same institution.
Although the latest Cochrane review [3] reported that surgery was not superior to 
non-surgical management for most proximal humeral fractures, less than 5% of the 
scientific literature on proximal humeral fractures deals with non-surgical treat-
ment, while more than 70% deals with surgical treatment modalities [2]. Also, 
increased surgical activity has been reported [4] and in some parts of the world lock-
ing plates remains the gold standard treatment in displaced fractures among the 
elderly [5]. In recent years, the reverse total shoulder arthroplasty has gained popu-
larity, but strong evidence has still to support this practice.
In the following paragraphs, we outline recent evidence-based principles for the 
management of these difficult fractures.
10.3  Epidemiology
Proximal humeral fractures are common and account for 4 to 6% of all human frac-
tures [6]. Among the non-vertebral fractures, they are third only to the wrist and hip 
fractures and, like these, are closely associated with osteoporosis. The lifetime risk is 
13% for a woman aged more than 50 years and around half of the patients have sus-
tained a previous fracture [7]. A three-fold increase in incidence has been reported 
between 1970 and 2002 [8] and the incidence in women aged more than 80 years is 
as high as 520/100,000 per year [9] but seems to have stabilised in recent years [10].
Previously, it was believed that most proximal humeral fractures were minimally 
displaced [11]. However, recent epidemiological studies have unequivocally 
reported that most fractures are displaced [6, 12, 13] and the complexity of the frac-
tures seems to increase with advanced age [14].
10.4  Fracture Classification
Proximal humeral fractures have been classified since the earliest known medical 
texts [15]. From 1970 the most commonly used classification system for proximal 
humeral fractures has been the Neer classification [11] followed by the AO classifi-
cation [16]. Both classification systems describe morphological aspects of the frac-
ture anatomy in an ordinal framework aiming to support diagnostics, treatment and 
prognostics.
The Neer classification (Fig. 10.1) is based on the description of four ana-
tomical segments of the proximal humerus, as they appear on plain 
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anterior–posterior radiographs: (1) the humeral shaft, (2) the articular part of 
the humeral head, (3) the greater tuberosity and (4) the lesser tuberosity. If any 
of the four segments are displaced more than 1 cm or angulated more than 45°, 
the fracture is considered displaced, while all other fractures are categorised as 
minimally displaced fractures regardless of the number of fracture lines. 
According to the number of displaced segments, the fractures are termed 2-part, 
3-part or 4-part.
This description is further qualified according to the involved segments, for 
example, 2-part surgical neck fracture (Fig. 10.2a), 3-part greater tuberosity fracture 




























































Fig. 10.1 Neer’s classification with prevalence and the average age in each category. (Reproduced 
with permission from Acta Orthop)
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(Fig. 10.2b) or 4-part fracture involving all segments (Fig. 10.2c). Eighty-six per-
cent of all proximal humeral fractures are either minimally displaced (49%), 2-part 
surgical neck fractures (28%) or 3-part greater tuberosity fractures (9%) [6].
Additional information about fracture anatomy can be obtained by adding axil-
lary radiographs, CT-scans or 3D-CT scans. Numerous observer studies have dem-
onstrated poor agreement between and within observers using the Neer classification 
and the AO classification even on very basic observations of displacement and dis-
location [17]. Thus, the value of the classification of proximal humeral fractures in 
clinical decision making and research remains a challenge. The different use of 
classifications might explain the discrepancies in results and recommendations. 
Moreover, it has been difficult to establish a translation between the two commonly 




Fig. 10.2 Non-surgical healing of different types of proximal humeral fractures. (a) Displaced 
2-part fracture of the ‘surgical neck’ treated non-surgically in an 81-year-old female nursing home 
resident suffering severe Parkinson’s disease. Radiographs at admission (left image) and at 
3 months (right image). The patient was pain-free and mobilised in a walker. Good healing but 
severe malunion was seen after 3 months. (b) Displaced 3-part greater tuberosity fracture treated 
non-surgically in a healthy 75-year old female. Radiographs at admission (left image) and 6 months 
(right image). The patient was independent living and pain-free. A slight decrease in strength in 
above shoulder activities was found but the patient achieved a full range of motion. (c) Displaced 
4-part fracture treated non-surgically in a 66-year old female. Radiographs at admission (left 
image) and 4 months (right image). The patient was a pain-free function at shoulder level and self- 
reliant in all daily activities
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The integrity of the rotator cuff is rarely assessed in trauma imaging. With 
advanced age, the incidence of degenerative rotator cuff tears increases. The prog-
nostic importance of concomitant rotator cuff lesions is not known.
10.4.1  Minimally Displaced Fractures
For clinical purposes, proximal humeral fractures are often simply divided into the 
two main groups explained earlier, the minimally displaced fractures and the dis-
placed fractures.
There is consensus that minimally displaced fractures can be managed non- 
operatively with short immobilisation in a sling followed by early exercises. Strong 
evidence is sparse, but randomised trials so far have reported the best results follow-
ing early mobilisation initiated after 1 week [19–22].
10.4.2  Displaced Fractures
The optimal treatment of displaced proximal humeral fractures has been a matter of 
controversy for decades. Recommendations have changed over time according to 
patients’ and surgeons’ preferences and influenced by the interests of implant providers.
It has proved difficult to demonstrate any beneficial effect of surgery in ran-
domised trials. An increasing number of trials have reported no difference in func-
tional outcome between surgical and non-surgical management and surgery seems 
to cause an increased risk of subsequent supplemental surgery. A Cochrane review 
included almost 2000 patients from randomised trials and could not find any bene-
fits of surgery compared to non-surgical management [3]. The studies included dis-
placed 2-part, 3-part and 4-part fractures. No evidence-based recommendations 
cover fracture-dislocations, articular fractures and isolated tuberosity fractures.
10.5  Treatment
Based on age, comorbidity, functional demand, fracture pattern, bone and soft tissue 
quality and patient preferences a shared treatment decision can be achieved. Based 
on the high-quality evidence available [3] non-surgical management should be the 
treatment of choice in minimally displaced fractures as well as in displaced 2-, 3 and 
4-part fractures in older patients. Management of articular surface fractures, 
fracture- dislocations and isolated tuberosity fractures is not covered by high-quality 
evidence and these fractures may benefit from surgery (Fig. 10.3).
The use of locking plates in displaced 2-part fractures cannot be recommended, 
as current high-quality evidence suggests no benefits compared to non-surgical 
management [23]. Head-preserving osteosynthesis with locking plates in complex 
fracture patterns and poor bone quality has been accompanied by high complication 
and reoperation rates [24, 25] and cannot be recommended.
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If humeral head replacement with the use of a prosthesis is needed, a reverse total 
shoulder arthroplasty seems to lead to a better functional outcome than hemiarthro-
plasty [26]. The superiority of reverse shoulder arthroplasty compared to non- 
surgical management has still to be demonstrated in high-quality studies, but results 
from the first randomised trial indicate that benefits are minimal in 3-, and 4-part 
fractures if patients are aged more than 80 years [27].
10.5.1  Non-surgical Treatment
Based on the available high-quality evidence [3] and the prevalence of fracture cat-
egories reported [6] more than 85% of all proximal humeral fractures can be man-
aged without surgery. As previously mentioned, less than 5% of the scientific 
literature on proximal humeral fractures deals with non-surgical management [2] 
and more such studies are warranted, including a focus on pain relief, bandaging 
methods and systematic training programs.
Several randomised trials have however compared early and late mobilisation 
in non-surgical cases and reported less pain and better function when initiating 
training within the first week [20–22]. Early mobilisation can be recommended in 
most patients except in unstable 3- and 4- part fractures and in tuberosity frac-
tures. In such cases, secondary displacement should be ruled out by outpatient 
visits, radiographs and controlled loading. The clinical effects of supervised train-
ing, home training or no structured training in older patients with proximal 
humeral fractures have been sparsely studied. Studies on time for the relief of pain 
are warranted, but our opinion is that most patients experience pain relief after 2 




Locking Plate Locking Nail Hemi-Arthroplasty Reverse Arthroplasty
Prostheses
Fig. 10.3 The main treatment groups for proximal humeral fractures
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10.5.2  Surgical Management
Randomised trials and meta-analyses focusing on displaced 2-, 3- and 4-part frac-
tures have been unable to demonstrate superiority of surgery compared to non- 
surgical management [3]. There might however be a place for evidence-based 
surgery in older patients with fracture-dislocations, articular surface fractures and 
fractures with no contact between the bony fragments.
If surgical management is decided, osteosynthesis with a locking plate, or intra-
medullary nail can be an option if the humeral head can be preserved and tuberosity 
fixation is possible. If head-preserving surgery is not possible a joint prosthesis can 
be considered. Since the 1950s replacement of the humeral head with a shoulder 
hemiarthroplasty has been preferred, but within the last 20 years, the reverse total 
shoulder arthroplasty has gained increasing popularity as the outcome is less depen-
dent on tuberosity fixation.
10.6  Complications
It is well known that complications can follow surgery. However, complications 
after non-surgical management are not systematically reported in the scientific lit-
erature. Most terms and definitions concern radiographic appearance of the fracture 
and their relation to functional outcome and patient satisfaction is poorly under-
stood. Consensus-based and validated complication terms are needed [28]. Reported 
complications include shoulder stiffness, nonunion, malunion, avascular necrosis of 
the humeral head and persistent pain. Also, the implant itself can be mal-positioned 
primarily, or subsequently as a result of fracture collapse and/or avascular necrosis 
of the humeral head.
In cases of failed non-surgical management, as well as in failed osteosynthesis 
(Fig.  10.4), a reverse total shoulder arthroplasty represents a salvage option. 
Observational studies thereof have reported good pain relief and reasonable func-
tion regardless of tuberosity status.
10.7  Outcome Assessment
Large registry-based studies have reported low revision rates (about 4%) after 
shoulder arthroplasty for fractures [29]. However, the patient-reported outcome has 
been less promising, suggesting a possible discrepancy between implant survival 
and patient satisfaction, as well as between the surgeons’ and the patients’ perspec-
tive on outcome [30].
Most clinical studies report patient outcomes using observer-administrated 
instruments like the Constant-Murley score [31]. These scoring systems are surgeon- 
derived and tend to emphasise ‘objective’ measures like the range of motion and 
strength. It is our impression that patients’ focus is more directed towards ADL 
(independent living) and social and emotional aspects of life (holding 
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grandchildren, having dinner with family and friends, caring for disabled relatives). 
By focusing on ‘objective’ matters and radiographic appearance of fracture healing 
healthcare providers may fail to support important preferences of the patients.
Development of patient-related shoulder specific outcome assessment instru-
ments (e.g. OSS, WOOS, ASES) and the use of generic quality of life measures (e.g. 
EQ-5D, SF-36) for patient evaluation have added to our knowledge of patient pref-
erences. However, the shared decision making on treatment modalities and func-
tional goals for the individual patient remains essential for healthcare providers.
10.8  Conclusions
There are many important aspects when treating an older patient with a proximal 
humeral fracture (Table 10.1).
Evidence-based management of proximal humeral fractures in the elderly should 
be based on high-quality clinical studies, as well as well-conducted systematic 
a b
Fig. 10.4 Proximal humeral fracture complications subsequent to osteosynthesis. (a) 
Complications in a displaced 3-part greater tuberosity fracture managed with a locking plate. The 
humeral head has collapsed due to avascular necrosis. The screws are locked in the plate and sub-
sequently penetrate the glenohumeral joint causing cartilage erosion and pain. (b) Complications 
in a displaced 2-part proximal humeral fracture fixated with a humeral locking nail. The fracture is 
mal-reduced and a locking screw is protruding into the glenohumeral joint
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reviews and meta-analyses. Long term follow-up data on benefits and harms should 
be provided by national and international registries. The implementation of 
evidence- based recommendations should be facilitated by national, regional and 
local guidelines and validated algorithms based on the best available evidence. 
Resource allocation for patient care and research should be guided by the best evi-
dence and the need for additional knowledge.
Patient preferences should be included at all levels of decision making from the 
design of research protocols to the development of patient-derived outcome mea-
sures. Not least, the treatment strategy for the individual older patient in the every-
day clinic should be decided with the patient and relatives, and based on patient 
preferences, comorbidity, functional level, age and bone quality.
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Older patients with hip fractures are a heterogeneous population [1]. Only 15% are 
fully independent and with a low level of comorbidity prior to fracture occurrence, 
while the broad majority presents multiple comorbidities and some frailty-related 
characteristics. Despite advances in surgical and anaesthetic techniques over time, 
the risk of complications after hip fracture surgery remains high. The main goal of 
the post-operative management is to prevent or promptly detect complications in 
order to reduce morbidity and mortality. A second goal is to mobilise patients as 
soon as practical in order to avoid the risks of immobilisation and to foster the 
recovery of pre-fracture walking ability.
11.1  Multidisciplinary Management
The high clinical and functional complexity of hip fracture older patients requires a 
multidisciplinary approach. Orthogeriatric co-management currently is the standard 
of care, having been shown to diminish in-hospital stay, time to surgery, in-hospital 
complications and in-hospital mortality, compared to traditional care [1–5]. 
Following this model, the orthopaedic surgeon and the orthogeriatrician (a geriatri-
cian skilled in the management of older adults with orthopaedic issues) share 
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responsibility and leadership from admission to discharge. The traditional roles are 
maintained, with the orthopaedic surgeon assessing the trauma and managing the 
fracture, and the geriatrician responsible for medical issues and coordinating dis-
charge. Several other healthcare professionals (anaesthesiologist, therapists, spe-
cialist nurses, nutritionist and social worker) may be included in the interdisciplinary 
team during the pathway of care.
In the post-operative period, most needs of older patients with hip fractures are 
related to medical or geriatric issues; therefore the geriatric team usually contributes 
to joint preoperative patient assessment, and increasingly takes the lead in post- 
operative medical care. The orthopaedic surgeon is involved in any issue regarding 
the surgical site. On the basis of local organisational features, different orthogeriat-
ric models may be implemented, although a dedicated orthogeriatric ward seems to 
have more consistent results in reducing mortality, compared to other models of 
orthopaedic/geriatric collaboration [4]. In any case, whatever type of ward the 
patient is admitted to, it is important that a coordinated multidisciplinary approach 
ensures continuity of care and responsibility across the clinical pathway from 
admission to discharge. Former experience, characterised by the use of a geriatric 
consulting team without continual responsibility for care, demonstrated only small 
benefits compared to traditional care, and that approach should now be considered 
outdated [5].
Essential quality standards related to the organisation of orthogeriatric collabora-
tion include senior experience of the members of the team, clinical and service 
governance responsibility for all stages of the pathway of care, established proce-
dures for communication between different specialists including briefings and 
meetings, development of shared protocols for the main features of the periopera-
tive phase, continued multidisciplinary reviews, integration with a centre for bone 
health for secondary prevention and liaison with primary care and social ser-
vices [6, 7].
11.2  Predicting the Risk of Post-operative Complications
As described in Chap. 7, a key goal of pre-operative orthogeriatric co-management 
is to identify, and where possible prevent, conditions that predispose to post- 
operative complications. Several studies have focused on identifying patients at risk 
after hip fracture surgery [8]. The risk of 30-day mortality has been also explored 
using scoring systems, some of them very simple, such as the Nottingham Hip 
Fracture Score [9], which includes relatively few variables.
Specific predictors related to patient risk are not fully consistent, mainly because 
of a different selection of potential factors across studies. Indeed, patients with the 
highest pre-fracture comorbidity and disability are those at greater risk of develop-
ing clinical complications postoperatively. From an operational point of view, most 
of the individual preoperative parameters are non-modifiable risk factors. They are 
useful for identifying patients that require high attention and intensive care. The 
American College of Surgeons together with the American Geriatrics Society 
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recommends the preoperative evaluation of the older patient for frailty syndrome 
[10]. This has been defined as a syndrome with multiple reduced physiologic func-
tions that increases an individual’s vulnerability for developing increased depen-
dency and/or death. Evidence suggests that frailty, measured with different 
instruments including those based on Comprehensive Geriatric Assessment, pre-
dicts post- operative mortality, complications and prolonged length of stay [11]. 
Among the hip fracture population, about one-third of patients have significant 
frailty with a high risk of poor outcomes, one-third with no markers of frailty, and 
about one-third with an intermediate condition [12].
In clinical practice, a very high risk of complications and short-term mortality is 
observed in very sick patients with severe organ failure, such as a person with a his-
tory of ascites, or end-stage chronic kidney disease on dialysis or dyspnoea at rest 
[13]. A substantial increase in mortality occurs mainly in severe conditions [14]. 
Similarly, patients suffering from congestive heart failure or chronic obstructive 
pulmonary disease are at higher risk of poor outcomes depending on the severity of 
the underlying disease. Finally, a history of disseminated cancer and full functional 
dependency increases three to four times the likelihood of death within 30 days [13].
Malnutrition and sarcopenia are other conditions that can increase the occur-
rence of post-operative complications, but they mainly affect the likelihood of 
achieving a complete functional recovery. On the other hand, obesity is also associ-
ated with negative outcomes. A simple parameter as the BMI shows a U-shaped 
relationship with respect to the risk of post-operative complications [15], with the 
highest rates occurring in low-weight (BMI < 20) and morbidly obese (BMI > 40) 
patients. In particular, the risk of deep surgical site infection increases linearly with 
increasing BMI.
Among routine admission laboratory testing, several parameters have been found 
related to negative outcomes including low haemoglobin level, high creatinine 
value, electrolyte derangements or high Brain Natriuretic Peptide, all of which may 
be considered an expression of an underlying disease. Probably the most studied 
laboratory predictor of post-operative outcome is albumin level. There is consistent 
evidence that albumin lower than 3.5 g/dL is associated with two to three times risk 
of post-operative complications and mortality [16]. Albumin has commonly been 
studied as a dichotomous variable, but some data suggest an increasing risk with 
decreasing values. Serum albumin level is a well-established serum marker of nutri-
tional status, but it is a better predictor of post-operative outcomes than other nutri-
tional indicators, including nutritional assessment [16]. In fact, albumin may have a 
wider implication, since it is also a negative acute-phase protein, and hypoalbumin-
emia might represent an increased inflammatory status of the patient—also poten-
tially leading to poor outcomes [17].
Beyond patient-related risk factors, several potentially modifiable process fac-
tors may affect the rate of post-operative complications. The most consistently dem-
onstrated across the various studies have been timing of surgery and multidisciplinary 
management, while inconsistent effects have been found for anaesthetic type and 
transfusion strategy [8]. A study based on the National Danish Database, analysing 
post-operative process performance measures, found that mobilisation of patients 
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within 24  h postoperatively was the process with the strongest association with 
lower 30-day mortality, readmission risk and shorter length of stay [18].
11.3  Early Mobilisation
One of the quality standards developed by NICE for improvement of hip fracture 
management states that adults with a hip fracture should start mobilisation, at least 
once a day, no later than the day after surgery [6]. That means assisting patients to 
quickly re-establish the ability to move between postures, to maintain an upright pos-
ture and to ambulate with increasing levels of complexity. Shortening the time of bed 
rest after hip fracture surgery contributes to a reduction of the length of hospital stay 
and complications such as thrombosis, pneumonia, respiratory failure, delirium and 
pressure sores. Early mobilisation impacts especially on the long-term functional sta-
tus and improves the likelihood of achieving full ambulation recovery [19]. Analyses 
of data from large databases confirm that patients mobilised on the day of, or the day 
following surgery have better mobility function 30 days after discharge [20].
Mobilisation involves an early physiotherapist assessment. However, support with 
mobilisation can be given either by the physiotherapist or by the nursing team, when 
the physiotherapist is not present [20]. The NICE quality standard recommends that 
local arrangements (teams) should monitor the accomplishment of early mobilisation 
by calculating the proportion of hip fracture operations in which the person starts 
mobilisation within 24 h from surgery [6]. A useful and widespread tool for monitor-
ing basic mobility during acute hospitalisation is the Cumulated Ambulation Score 
(CAS) that assesses the ability to get in and out of bed, rise from a chair and walk 
around indoors with a walking aid during the first three post- operative days [21]. With 
suitable rehabilitation programmes addressing critical issues in the post-operative 
phase, almost 80% of patients who were able to walk before fracture achieve the abil-
ity to walk with aid within the first two post- operative days [22].
Pre-injury functional status and baseline characteristics of patients may clearly 
affect inpatient rehabilitation as well as final outcomes. Subjects walking with assis-
tive devices before fracture may need more time to be able to transfer postopera-
tively. Delayed time to mobilisation may be also due to system factors, such as 
fewer physiotherapists available during the weekends, which may explain why 
patients undergoing surgery on Friday have a higher risk of delayed mobilisation 
[22]. Also, surgery performed after 24 h from arrival has been reported to delay the 
recovery of post-operative ambulatory function, although this finding is not consis-
tent across studies [23, 24].
An essential condition to achieve the goal of early mobilisation is a stable surgical 
repair, allowing the patient to bear weight as tolerated. When deciding about weight-
bearing after surgery, orthopaedic surgeons should take into account that any restric-
tion has the potential to affect recovery and that unrestricted allowance of immediate 
full weight-bearing should be the standard protocol for the aftercare following frac-
ture fixation in geriatric patients with hip fracture. In addition, it has been proven that 
older patients treated for hip fractures are not able to adequately follow any 
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weight-bearing restrictions [25], so the patients should be either weight- bearing as 
tolerated or non-weight-bearing if there is real concern about fixation stability.
In a recent observational study, the most frequent reasons for not completing 
planned physiotherapy, and not regaining basic mobility independence during the 
first three post-operative days, were poorly controlled pain and fatigue [26]. The 
latter is one of the most common limiting symptoms and may occur for multiple 
reasons such as incomplete volume adequacy, low haemoglobin level or the overall 
impact of surgery on a patient with frailty. To support early mobilisation, clinicians 
have to face two main issues: adequate pain control and prevention of post-operative 
hypotension. Coordinated care pathways addressing both clinical and system issues 
with the goal to improve functional outcomes after hip fracture surgery should be 
developed and implemented.
11.4  Pain Management
Standard protocols to manage hip fracture-related pain are currently based on mul-
timodal analgesia that includes a panel of drugs such as IV acetaminophen, prega-
balin, oxycodone and—very cautiously—nonsteroidal anti-inflammatory drugs, 
along with nerve block methods (e.g. femoral nerve or lumbar plexus block or con-
tinuous epidural block). Multimodal analgesia offers the advantage of reducing opi-
ate consumption, which has been associated in older patients with nausea, vomiting, 
sedation, delirium and respiratory depression, particularly in debilitated patients or 
those with compromised respiratory function [27]. Appropriate parenteral analgesia 
should start in the Emergency Department and the presence of pain should be regu-
larly checked throughout the peri-operative period in order to ensure that the patient 
is feeling comfortable. The fascia iliaca compartment block is now quite common, 
as supplementary pain management in the preoperative phase and seems to have a 
greater analgesic effect than opioids during movement [28].
Postoperatively, pain is generally higher in patients with trochanteric fractures 
treated with intramedullary nail than in those with femoral neck fractures who 
underwent total or partial hip replacements. Nevertheless, patients should continue 
most of the medications that they received preoperatively. Particularly useful is con-
tinuous peripheral nerve block analgesia, through a catheter placed pre- or intra- 
operatively, connected to a small portable pump, and maintained for some days after 
surgery. These procedures may offer advantages in early mobilisation since they are 
more effective than systemic drugs in making the patient feel comfortable enough 
to ambulate and fully participate in their rehabilitation therapy [27].
11.5  Post-operative Hypotension and Fluid Management
A significant drop in blood pressure can occur early in the post-operative phase, 
with a further drop when the patient is taking part in rehabilitation, during weight- 
bearing and in the standing position. In some cases, this may produce symptomatic 
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hypotension, reducing participation in rehabilitation. Several factors may contribute 
to post-operative hypotension in older adults; these include:
• The effect of ageing, decreasing the ability to compensate and maintain pressure 
homeostasis when the body is stressed.
• Anaemia due to acute blood loss.
• Dehydration secondary to poor oral intake of fluids.
• The effects of anaesthetic agents.
• The side effects of drugs frequently used in the post-operative phase (e.g. opiates 
and antiemetics).
Strategies for preventing post-operative hypotension include medication adjust-
ment and fluid management. All antihypertensive drugs should be checked and 
stopped, starting from the preoperative phase, with the exception of beta-blockers 
and those with rebound effects like clonidine. Beta-blocker use should be continued 
during the perioperative phase, while it is no longer recommended for use in naïve 
patients, as was suggested by earlier studies. Preoperative introduction of beta- 
blockers can reduce myocardial complications, but may increase the rate of stroke 
and mortality, possibly due to hypotension [29]. The preoperative pharmaceutical 
review may also contribute to preventing the intra-operative blood pressure fall that 
has been found to increase the risk of death within 5 days after surgery [30]. 
Antihypertensive drugs discontinued before surgical intervention should be resumed 
in the post-operative period on the basis of the clinical condition and blood pressure 
values. In some cases, it can be advisable to resume these pharmacological agents 
only after discharge.
Providing adequate fluid therapy is one of the most important and challenging 
issues of the management of hip fractures in elderly patients. Fluid administration 
of 1000 mL is commonly initiated on arrival to compensate for blood loss and main-
tain basic requirements. During surgery, the anaesthetist usually administers intra-
venous fluids, on the basis of clinical judgement and according to clinical signs. In 
the post-operative phase, the administration of about 1.5–2 L of crystalloid is usual 
practice to attain and maintain intravascular volume [31]. The aim is clearly to opti-
mise cardiac output avoiding cardiovascular overload. In general, this practice is 
also safe in patients with acknowledged ventricular dysfunction, since the risk of 
dehydration and hypotension probably exceeds the risks of excessive volume 
administration. The only exceptions are:
• Patients with severe kidney failure or on dialysis, who require a cautious and 
controlled fluid administration with control and measurement of fluid balance.
• Patients with severe heart failure or previous episodes of acute pulmonary oedema.
Nevertheless, fluid management should be tailored. In clinical practice, the effect 
of a standardised fluid protocol should be weighed up by simple available clinical 
measures such as tissue turgor, heart rate, blood pressure and urine output, in order 
to decide whether less or extra fluid will provide benefits for the patient. Bedside 
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ultrasound may add further information by measuring inferior vena cava diameter 
and its collapsibility during one respiratory cycle, while more sensitive methods to 
assess fluid responsiveness using advanced haemodynamic monitoring techniques 
to detect cardiovascular changes are not routinely used.
11.6  Management of Postsurgical Anaemia
Anaemia has traditionally been attributed to surgical or post-surgical bleeding, but 
around 40% of patients with hip fracture have haemoglobin levels below population 
norms on admission, and values further drop before surgery with an average fall of 
0.9 g/dL after 1 day, greater in extracapsular than intracapsular fractures [32]. The 
maximum post-operative fall is often around 2–3 g/dL and usually occurs 3 days 
postoperatively.
Current guidelines, based on randomised controlled trials [33], recommend a 
restrictive transfusion strategy with a safe trigger threshold not greater than 8 g/dL 
of haemoglobin; as a result, the proportion of patients receiving packed blood cell 
transfusion has decreased over time. Furthermore, it has been suggested that blood 
transfusions may be harmful to patients, by reducing the recipient’s immune 
response and thereby increasing the susceptibility to infections [34]. However, 
blood transfusion should not be dictated by a haemoglobin trigger alone but should 
be based on an assessment of the patient’s clinical status. In particular, the presence 
of coronary artery diseases or specific signs of haemodynamic instability could sug-
gest a need to transfuse, despite a haemoglobin value greater than 8 g/dL. Some data 
also suggest that patients with significant frailty, such as nursing home residents, 
may have some benefit by a more liberal transfusion strategy [35]. On the other 
hand, in fit and independent patients an even more restrictive transfusion threshold 
of less than 7 g/dL of haemoglobin might not impair perioperative outcomes [36].
Post-operative anaemia in older subjects is not only related to blood loss during 
the surgical procedure but also to several other factors which include the effects of 
intravenous rehydration, inflammation-induced blunted erythropoiesis, pre-existing 
nutrient deficiency or poor post-operative nutrition that prevents the replenishment 
of iron stores. The administration of intravenous iron could reduce the need for 
transfusion but the effect on haemoglobin level in the at-risk days after surgery is 
small. Benefits have also been seen in post-operative infection and even mortality 
[37]. Intravenous iron should preferentially be used in post-operative anaemia man-
agement, whereas oral iron is of little value because of its even later effect and poor 
efficacy in functional iron deficiency when iron stores are normal and intestinal 
absorption suppressed. In some studies, subcutaneous erythropoietin has been 
administered along with intravenous iron but even, in this case, the effect is too slow 
to affect significantly the need for transfusion.
Pharmacological reduction of blood loss with tranexamic acid, which is widely 
implemented in elective orthopaedic surgery and major trauma, is becoming increas-
ingly popular for use in hip fractures too. Some early concerns on the safety in 
patients with frailty at high risk of thrombotic events seem not to be confirmed by 
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meta-analysis [38]. Either topical or systemic tranexamic acid, or the combined 
administration of both, have been used in older patients with hip fracture.
11.7  Nutritional Supplementation
Routine nutritional assessment is the standard procedure to draw attention to patients 
already malnourished on admission. In addition, a huge number of patients may 
undergo deterioration of their nutritional status during the hospital stay, due to increased 
energy expenditure related to metabolic stress, and reduced food intake related to lack 
of appetite, nausea and psychological factors. It has been estimated that in the post-
operative days, a quarter of patients ingest less than 25% of meals offered by the hos-
pital, and about half of patients consume between 25 and 50% of meals [39]. The 
current European and American guidelines recommend at least 1 g protein per kilo-
gram bodyweight per day and around 30 calories per kilogram bodyweight of energy 
for the majority of sick older patients to maintain nutritional status. In a recent survey 
on a cohort of geriatric orthopaedic patients, half of them with hip fractures, only 1.5% 
were able to achieve the energy need and only 21% the resting energy expenditure 
estimated at 20 calories per kg bodyweight per day [40]. Low dietary intake exposes 
patients to the risk of infections, pulmonary complications, pressure ulcers and impaired 
mobility resulting from muscle wasting and reduced muscle power.
Albeit based on low-quality studies, there is evidence that oral supplementation 
results in fewer complications and also affects mortality [41]. Protein supplementa-
tion started before or after surgery, in the form of a commercial protein powder or 
beverage package is a safe and relatively low-cost means to improve results and 
promote early rehabilitation. More aggressive nutritional interventions, such as a 
tube or parenteral feeding, should be reserved for patients with a low level of con-
sciousness, or to malnourished patients unable to eat.
Another part of the nutritional approach is the reduction of preoperative fasting 
time, in order to improve the comfort of patients and to attenuate the neuroendo-
crine stress response. Current guidelines have cut the hours of fasting to 6 h for 
solids and 2 h for clear liquids. An oral carbohydrate preloading beverage is also 
recommended 3 h prior to surgery to allow the patient to be in a metabolically fed 
state, which has beneficial effects on reducing insulin resistance and catabolism.
Inconsistent results have been found on the effect of vitamin D supplementation 
in the perioperative phase. However, vitamin D deficiency is largely prevalent in hip 
fracture subject and it has been associated with poor functional recovery in frail 
subjects [42]. The administration of 1000–2000 U per day is, in any case, part of the 
pharmacological interventions for osteoporosis that should be started before 
discharge.
To sum up, the nutritional approach includes:
• The reduction of preoperative fasting time to 6 h for solids and 2 h for clear liquids
• Offering an oral carbohydrate preloading beverage 3 h prior to surgery to allow 
the patient to be in a metabolically fed state
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• Implementing a protocol for pharmacologic management of post-operative nau-
sea and vomiting
• Nutrition training for health care staff in order to improve the quality and quan-
tity of feeding assistance
• Involvement of relatives (and volunteers) to help with mealtime assistance
• Providing multiple small meals and snacks throughout the day
• Protein supplementation before or after surgery, in the form of commercial pro-
tein powder or beverage package
11.8  Post-operative Medical Complications
Medical complications after hip fracture repair are very common and may signifi-
cantly influence even long-term outcomes, by increasing length of stay and delay-
ing functional recovery. Major complications affect about 20% of patients with 
hip fracture but up to 50% of patients may require pharmacological interventions 
due to clinical issues arising during the first post-operative days. Mortality at 
30 days, rather than in-hospital mortality, has been recognised as an important 
care quality indicator and is used by healthcare systems of several countries in 
Europe. The data from large national databases show that mortality within 30 days 
is approximately 6.9–8.2% [43–45]. The most common causes of death are respi-
ratory or cardiac failure and infections, mainly pneumonia or sepsis from other 
sources [46]. Since pre-existing organ dysfunctions are known risk factors, 
patients with a history of cardiac or lung diseases should be strictly monitored 
during the post-operative period, with attention particularly focused on signs and 
symptoms of organ deterioration or infections. Most of the severe adverse events 
occur early in the post- operative days. Myocardial infarction, stroke, pneumonia 
and pulmonary embolism are commonly diagnosed within a week from the sur-
gery, while surgical-site infection and deep vein thrombosis are often diagnosed 
later [47].
Only a few complications are probably really preventable, but some modifiable 
features of management may significantly improve outcomes:
• Avoiding surgical delay. Delay to surgery is an established risk factor for mortal-
ity and post-operative complications such as pneumonia and pressure ulcers 
[48]. Patients with significant frailty have likely the greatest advantages in reduc-
ing the time of immobilisation and in receiving an intensive approach [49].
• Implementing a standardised approach. In the post-operative phase, several 
issues should be regularly checked, and all patients should undergo standardised 
procedures. The best way to face the complex needs of older adults with hip 
fracture, to improve the quality of the interventions, to minimise errors and omis-
sions, and to reduce post-operative complications is to:
 – Define check-lists individualised for each healthcare professional that should 
guide healthcare decisions.
 – Standardise and implement specific protocols for the most common issues.
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Tailored and individualised interventions based on patients’ characteristics, 
specific needs or clinical instability should be an integral part of daily healthcare, 
but the overall post-operative management should be as highly standardised as 
possible. A general principle for each feature of the care should be an intensive 
approach for a limited time after surgery, followed by recovering of usual func-
tion as soon as possible, including removing tubes and catheters and shifting 
toward oral therapies. In this context, protocols, based on the best available evi-
dence, must be developed, shared, and implemented by the multidisciplinary 
team, taking into account local resources. A minimum set of standardised proto-
cols that should be implemented in the orthogeriatric setting include the 
following:
• Prophylaxis of venous thromboembolism
• Antibiotic prophylaxis
• Urinary catheter utilisation
• Pain control
• Skincare and pressure-relieving mattresses
• Constipation and stool impaction prevention
• Delirium prevention
• Post-operative haemoglobin monitoring and management of anaemia
• Malnutrition detection and correction/nutritional support
• Monitoring of vital physiological parameters
• Supplemental oxygen as appropriate
• Early mobilisation
11.9  Prevention and Management of Specific  
Complications
11.9.1  Delirium
Delirium is a common complication that affects about one-third of older patients 
with hip fracture in the perioperative period. It has a detrimental effect on func-
tional and clinical outcomes, producing longer length of hospitalisation and 
slow and incomplete recovery. All the known subtypes may occur after hip frac-
ture. In about two-third of the patients, delirium arises without agitation, as 
hypoactive or normal psychomotor variants, and therefore is often underdiag-
nosed [50]. Common symptoms of the hypoactive subtype are decreased levels 
of activity, speech and alertness as well as apathy, withdrawal and hypersomno-
lence. In contrast, the hyperactive or mixed variants are characterised by hyper-
activity, loudness, and psychomotor agitation, interfering with patients’ care 
and safety and can easily be diagnosed. To avoid missed presentation of delir-
ium all patients must be screened daily and assessed using standardised tools. 
Both geriatric nurses and physicians should be involved in the early detection of 
delirium.
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11.9.1.1  Prevention of Post-operative Delirium
Patients at risk of developing incident post-operative delirium can already be identi-
fied at hospital admission since a number of risk factors have been described [51]. 
Pre-fracture cognitive impairment is the most weighty risk factor, followed by respi-
ratory failure, low albumin, alcohol consumption and prevalent multiple comorbidi-
ties. The type of anaesthesia (particularly neuraxial vs. general anaesthesia) does 
not appear to affect the incidence of delirium, but deep sedation has been associated 
with a higher risk of post-operative delirium [52]. Thus, the use of intra-operative 
monitoring of the depth of anaesthesia and the choice of lighter sedation seems to 
be effective in reducing post-operative delirium.
Although prevention of delirium in hip fracture patients is possible with preop-
erative screening and simple interventions, nevertheless early consideration of all 
risk factors and prompt correction of clinical and laboratory abnormalities is man-
datory. This approach requires a multi-component intervention, with good adher-
ence by suitably-trained members of staff, physicians and nurses. When carefully 
applied, the multi-component intervention has been demonstrated to decrease the 
incidence of delirium by 40%, compared to traditional care, as well as reducing its 
duration and severity [53]. Taking into account that for delirium prevention, multi-
ple small interventions can provide substantial benefit, multi-component interven-
tions include:
• Monitoring of vital physiological parameters.
• Reduction of immobilisation and bed rest, mobilising by nursing staff as toler-
ated to the bathroom, taking meals at the table.
• Improved fluid and nutritional intake, dentures used properly, extra drinks.
• Supplemental oxygen to keep saturation >90%.
• Urinary catheters removed by post-operative day 2, unless otherwise ordered, 
post-void residual assessment.
• Improved sensory stimulation, appropriate use of glasses and hearing aids.
• Attention to bowel movements by scheduling laxatives.
• Promoting sleep by non-pharmacological measures, if needed trazodone should 
be used for night-time sedation while benzodiazepines should not be initiated 
(nor abruptly withdrawn).
• Cognitive activation with environmental aids (calendar, clock) or individual 
interventions.
• Involvement of relatives to support the patient.
• Post-operative blood tests to detect metabolic/laboratory abnormalities.
• Effective control of pain obtained with acetaminophen, non-opioid medication 
and nerve blocks rather than opiates, which may increase the risk of delirium.
Pharmacological prevention of delirium through the administration of a low dose 
of neuroleptic drugs is still a matter of debate [64]. Current evidence does not sup-
port the routine use of antipsychotics, albeit, in some trials, they demonstrated a 




11.9.1.2  Management of Post-operative Delirium
If delirium occurs, it should be borne in mind that it can represent the first symptom 
of an underlying/undercurrent complication, such as an infection, coronary syn-
drome, urinary retention, constipation or dehydration. Therefore, when a patient 
presents with a new episode of delirium, it is mandatory to undertake a comprehen-
sive clinical assessment, accompanied, as appropriate, by a complete laboratory 
diagnostic work-up and other specific diagnostic tests. Electrocardiogram and chest 
radiography may be part of the assessment, while neuroimaging is typically limited 
to patients with new focal neurologic signs.
The treatment includes addressing all modifiable contributors to delirium that are 
identified in the evaluation along with a full review of medications, stopping when 
possible those known to be associated with delirium. Moreover, non- pharmacological 
measures, listed in the prevention paragraph earlier, should be carefully pursued to 
help the patient recover from their brain dysfunction.
In case of agitation that can hamper the healthcare or rehabilitation, or even be 
dangerous for patient and caregiver, pharmacological treatment with antipsychotics 
is usually employed, but note that antipsychotics do not treat delirium, they simply 
reduce the symptoms. Antipsychotics should never be used in the hypoactive variant. 
These pharmacological agents should be used at the lowest effective dose, dosing 
regimens should be individualised for each patient, and the treatment effects should 
be monitored daily to correct the dose or discontinue the therapy when appropriate. 
The antipsychotics commonly used are haloperidol (0.25–2 mg oral or intramuscu-
lar), risperidone (0.5–2  mg oral), quetiapine (12.5–50  mg oral), olanzapine 
(2.5–10 mg oral). QT prolongation contraindicates all these drugs. Benzodiazepines 
should be avoided in patients with delirium, except for subjects with severe agitation 
and violent inclination, in which a short-acting formulation (e.g. midazolam 1–5 mg 
intravenous or intramuscular) may produce rapid tranquillisation. In patients with 
sleep deprivation, the drug of choice is trazodone (25–100 mg oral).
11.9.1.3  Post-operative Cognitive Dysfunction
Some patients experience a more subtle cognitive disorder, affecting a wide range 
of cognitive domains, particularly memory and executive function. This condition, 
dissimilar from delirium, is generally designated as post-operative cognitive dys-
function (POCD) and it may not be evident during the first post-operative days. 
Compared to delirium, POCD shows a less acute onset, is characterised by normal 
consciousness and may last weeks to months.
For an accurate diagnosis, neuropsychological testing is required, but, usually, a 
pre-fracture evaluation for comparison is lacking in patients with hip fractures. The 
incidence after hip fracture surgery is consequently not known while in older 
patients undergoing elective arthroplasty, a prevalence of approximately 10% has 
been found 3 months postoperatively [54]. There are many risk factors for POCD: 
advanced age, pre-existing cardiovascular disease and mild cognitive impairment. 
Patients with a level of education more than high school have a lower incidence of 
POCD compared to those with lower educational levels. In orthopaedic elective 
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interventions, a fast-track approach seems to reduce the incidence of POCD, at least 
early after surgery [55].
POCD is generally reversible, albeit, in some patients with persistent dysfunc-
tion, the apolipoprotein E4 genotype has been found, suggesting a link with the 
development of dementia [56]. Preventing strategies against POCD include 
reducing the preoperative stress response, monitoring of anaesthetic depth intra-
operatively, maintaining of perioperative hemodynamic stability, a multimodal 
analgesic approach with cautious use of opioids, early post-operative mobilisa-
tion, and all nursing measures described for preventing post-operative delir-
ium [55].
11.9.2  Cardiovascular Complications
Ischemic heart disease and cardiac failure account for more than one-third of early 
deaths after hip fracture [46] although the incidence of cardiac complications after 
hip fracture is quite variable in epidemiological studies, depending on the diagnos-
tic criteria considered.
11.9.2.1  Myocardial Infarction
Risk factors for the occurrence of myocardial infarction after hip fracture are all 
atherosclerotic conditions, not only a history of cardiac disease but also stroke or 
peripheral vascular disease [57]. Most patients do not experience typical chest pain, 
while they may present with delirium or congestive heart failure, or even be asymp-
tomatic. Therefore, high-risk subjects or those with suspicious symptoms although 
atypical should be assessed by recording an electrocardiogram (ECG) and measur-
ing troponin level. Patients with clear myocardial infarction should be considered 
for coronary angiography and cardiology review.
However, after hip fracture, a considerable number of patients show a subtle 
and isolated increase of troponin without meeting the full criteria of myocardial 
infarction that include significant ECG changes and/or new wall motion anoma-
lies and/or typical clinical symptoms. In some studies, up to one-third of patients 
show an increase of troponin just before or early after surgery, most of them with-
out ECG ischaemic changes [58]. Other clinical conditions associated with iso-
lated troponin increase, such as sepsis, pulmonary embolism, renal failure or 
acute respiratory failure, explain only a small proportion of such increases in this 
perioperative biomarker. The prognostic significance of an isolated small troponin 
increase in older patients with hip fractures is still uncertain, given the inconsis-
tent relationship with short- and long-term mortality [58, 59]. In one study a sub-
group of patients with a post-operative isolated increase of troponin >0.5 μg/L, 
considered a cut-off for more definite myocardial damage, were studied with 
coronary angiography [60]. All patients were found to have severe coronary dis-
ease and underwent percutaneous or surgical revascularisation with a significant 
improvement in 1-year survival.
11 Post-operative Management
168
11.9.2.2  Heart Failure
Congestive heart failure is another important post-operative complication, related to 
surgical stress, blood loss, transfusion, or inappropriate fluid administration. The 
onset may be either typical with dyspnoea, or insidious with a change in functional 
status, reduction of food intake or delirium.
Diuretic agents are frequently discontinued, as part of the pre-operative 
drug revision, in order to reduce the risk of dehydration and hypotension. It is 
important to bear in mind that in patients with ventricular dysfunction, diuresis 
may be loop diuretic dependent. Therefore, it may be advisable, in patients 
with pre-fracture congestive heart failure, to continue these pharmacological 
agents, or discontinue them only for a short period of time. Urinary output 
measurement is critical for hemodynamic assessment in the early post-opera-
tive days. Oliguria could be related either to inadequate volume restoration 
(most frequent in the first 24–48  h after surgery) or heart and renal failure. 
Thus, contrasting interventions, such as extra fluid or diuretics administration, 
require patient-specific decision making. Measurement of the N-terminal frag-
ment of brain natriuretic peptide (NT-proBNP) has been proposed to evaluate 
post-operative cardiac dysfunction [61], but it has a decreased specificity in 
older patients.
11.9.2.3  Supraventricular Arrhythmias
New onset atrial fibrillation is particularly frequent after hip fracture surgery occur-
ring in 3–6% of patients [62, 63]. A previous history of atrial fibrillation is the most 
consistent risk factor. The rapid ventricular rate in atrial fibrillation results in inad-
equate diastolic filling and a reduced cardiac output leading to hemodynamic insta-
bility. Atrial fibrillation may cause exacerbation of heart failure, poor exercise 
tolerance and thromboembolic events including stroke. The occurrence of atrial 
fibrillation in the early post-operative days has been consistently associated with a 
higher risk of mortality within 1 year after fracture [62, 63]. It could be a marker of 
greater vulnerability, rather than a complication increasing mortality directly. 
Moreover, evidence links atrial fibrillation after surgery as a risk factor for 
POCD [55].
Current treatment modalities include anti-arrhythmic medications, radiofre-
quency ablation, and anticoagulation. Beta-blockers can reduce the risk of this 
arrhythmia, but their beneficial effects should be balanced against the risk of drug- 
induced hypotension.
11.9.3  Infections
11.9.3.1  Post-operative Fever
Fever occurs frequently during the post-operative phase; it can either indicate the 
presence of an infection or be produced by a non-infective cause. The challenge is 
to identify which patients need immediate screening and which can be skilfully 
managed with a ‘wait and see’ approach.
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Surgery of any type causes significant cellular injury leading to the release of 
cytokines into the bloodstream and then fever, as a normal physiologic response. 
The more tissue is damaged, the greater is the cytokine release. Febrile events 
occurring within 2 post-operative days in the absence of localising symptoms should 
be closely monitored, but not acted upon, while they are more suggestive of infec-
tion when they occur later than the third post-operative day or if the temperature is 
greater than 38.5 °C and multiple fever spikes are observed [64].
Studies agree that investigations, particularly chest X-rays or blood and urine 
cultures, performed to study early post-operative febrile episodes without clinical 
symptoms or signs of infections are rarely positive and are therefore an inappropri-
ate use of hospital resources [65]. On the other hand, patients with hip fracture with 
a high degree of frailty, malnutrition, multiple comorbidities, polypharmacy, may 
have a compromised immune response that predisposes to infection. Early detection 
of pneumonia or urinary tract infections that are the most common post-operative 
infections is crucial, since a late diagnosis may have severe detrimental 
consequences.
Clinical judgement, based on the presence of signs and symptoms of infections, 
is the only guide to decide when diagnostic procedures and possibly antibiotic ther-
apy should be started. It should be also highlighted that infections in frail older 
adults may occur without fever, presenting with insidious onset symptoms, such as 
fatigue and delirium. Traditional biomarkers such as white blood cell count or 
C-reactive protein may be used to aid in the diagnosis but in the early post-operative 
days, these blood parameters lack sensitivity and specificity in discriminating 
inflammation due to a bacterial infection from that of surgical injury response. 
There is increasing evidence supporting the use of procalcitonin as a useful marker 
to detect bacterial infections in post-operative days [66, 67]. It is true that, following 
surgical tissue damage, procalcitonin may have a small and transient increase, but 
higher and persistent values have a high likelihood of being related to infections. 
However, at present, it is not clear which is the best cut-off with the most correct 
balance between specificity and sensitivity. When laboratory biomarkers are 
required for sepsis confirmation in the first days after hip fracture repair it is prob-
ably better to set a high procalcitonin threshold, that is, >0.9 ng/mL, as in trauma 
patients.
11.9.3.2  Pneumonia
Pneumonia and exacerbation of chronic lung disease occur in about 4% of older 
patients with hip fractures and account for one-third of post-operative deaths [46]. 
Predisposing factors are spending most of the day sitting or lying in bed, which 
leads to incomplete lung expansion and resulting atelectasis. Poor inspiratory effort 
may also be due to sedation or pain leading to difficulty clearing pulmonary secre-
tions. Moreover, dysphagia or an impaired swallowing function, frequent in frail 
older patients with declining brain function or decreased muscle mass, may worsen 
after surgery and cause aspiration and, consequently, aspiration pneumonia.
Patients with an admission diagnosis of COPD have about 2.5 times the risk of 
developing chest infections during a hospital stay and a substantial excess of 
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mortality compared with patients without COPD [68]. Other reported risk factors 
for post-operative pneumonia include disorders of the central nervous system, anae-
mia, diabetes and the use of medication that reduces alertness [69].
Measures and interventions to prevent pneumonia should be implemented in 
clinical practice in order to quickly restore the capacity of expansion of the lung–
chest wall and to avoid aspiration:
• Oral hygiene
• Control of gastroesophageal reflux
• Avoidance of excessive sedation
• Early ambulation
• Adequate nutrition
• Respiratory exercises improving the patient’s ability to take deep breaths
11.9.3.3  Urinary Tract Infection
Urinary tract infection is the most common complication after hip fracture surgery 
occurring in almost one-quarter of all patients. It has been associated with an 
increased incidence of delirium, prolonged length of hospital stay and even lower 
functional outcomes [70]. A urinary catheter is the single most important risk factor 
for this type of infection, but other causes are post-operative urinary retention or 
neurogenic bladder dysfunction.
Measures to prevent urinary tract infection are:
• Avoiding unnecessary placement of indwelling urinary catheters even 
intraoperatively.
• Removing a urinary catheter as soon as possible, preferably within the first post- 
operative day.
• Considering the use of intermittent catheterisation to relieve post-operative uri-
nary retention.
• Planning education of all healthcare professionals around a specific protocol on 
perioperative use of a urinary catheter and the management of post-operative 
bladder incontinence or retention.
• Early and repeated mobilisation.
Urinary retention is common among patients with hip fracture, and it is related 
to urinary infection, prostatic enlargement in males, underlying bladder dysfunction 
(e.g. diabetic neuropathy, Parkinsonism), and opiate use. Although it is uncertain if 
a premature removal of the indwelling catheter could favour urinary retention, it 
should be removed as soon as possible to prevent urinary infections and promote 
early mobilisation if necessary, patients can be managed through voiding methods, 
including intermittent catheterisation.
11.9.3.4  Surgical Site Infection
Surgical site infection is the third most frequent cause of infections, and it is dis-
cussed among surgical complications. It is less frequent compared to other infec-
tions, occurring in 2–4% of patients and usually later, often after discharge. 
G. Pioli et al.
171
Patient-specific risk factors are older age, poor nutrition, history of diabetes, smok-
ing, obesity, other concomitant infections and previous history of colonisation. 
Prevention measures include peri-operative antimicrobial prophylaxis using cefazo-
lin or other antimicrobial agents according to local guidelines, a number of hygiene 
measures minimising microbial inoculums, and clinical optimisation of the patients. 
Modifiable patient-related risk factors are malnutrition and uncompensated diabetes. 
Particularly, blood glucose levels greater than 200 mg/dL in the peri-operative period 
increase the risk of surgical site infection [71]. Furthermore, patients without a his-
tory of diabetes but showing stress-induced hyperglycaemia, with glucose levels 
greater than 220 mg/day, also have a higher risk of surgical site infection [72]. Close 
monitoring in the peri-operative period is required to detect and manage glucose 
fluctuations and is advised before meals. To achieve and maintain good control of 
glycaemia, fast-acting insulin or basal–bolus regime should be preferred in patients 
using oral diabetic agents before hospital admission, to limit the risk of hypoglycae-
mia or other metabolic derangements associated with oral diabetic agents.
11.9.4  Other Complications
Truly, this overview may not be comprehensive, describing the overall constellation 
of clinical complications presenting in older adults with hip fracture, but a number 
of other complications should be acknowledged (Table 11.1). Patients with frailty 
are characterised by an age-associated decline in physiological reserve and function 
Table 11.1 Standardised procedures and prevention/management protocols to be implemented 
for selected medical complications in hip fracture in older adults
Complication Main goal(s) Strategies prevention/management
Delirium Prevention •  Identify high-risk patients on admission
•  Check daily risk factors
•  Correct (when possible) modifiable risk factors
•  Remove delirium-causing medications
•  Monitoring of vital physiological parameters
•  Correct clinical/laboratory abnormalities
•  Control pain, limiting opiates usage
•  Reduce immobilisation and encourage time out of bed
•  Improved fluid and nutritional intake
•  Supplemental oxygen to keep saturation >90%
•  Remove any catheters and tubes as soon as possible
•  Attention to bowel movements
•  Promoting sleep by non-pharmacological measure
•  Cognitive activation with environmental aids
•  Involvement of relatives




•  Assess patients daily using a standardised tool
•  Look for underlying causes
•  Remove (when possible) underlying causes
•  Implement prevention strategies (see Prevention)





Complication Main goal(s) Strategies prevention/management
Post-operative 
hypotension
Prevention •  Discontinue or reduce doses of antihypertensive drugs 
and diuretics
•  Limit the use of hypotensive pharmacological agents
•  Transfuse patient according to established haemoglobin 
thresholds
•  Administer isotonic intravenous fluids pre-, intra- and 
postoperatively
•  Tailor fluid management through clinical measures/
bedside ultrasound or advanced haemodynamic 
monitoring techniques if necessary and available
Coronary 
artery disease
Prevention •  Check for risk factors
•  Identify high-risk patients on admission
•  Continue antiplatelet drugs in the perioperative period 
(in high-risk patients)
Early detection •  Check for atypical signs/symptoms of ischemia
•  Measure troponin and ECG in patients with typical or 
atypical signs/symptoms
•  Monitor troponin regularly in high-risk patients
Heart failure Prevention •  Continue beta-blockers
•  Continue loop diuretics if possible (alternatively, 
discontinue them briefly and resume rapidly)
•  Manage fluid administration carefully, checking 
pulmonary status and early signs/symptoms of acute 
failure
•  Measure urine output in the early post-operative days in 
high-risk patients
Pneumonia Prevention •  Nutritional supplementation
•  Avoid excessive sedation
•  Maintain adequate oral hygiene
•  Control of gastro-oesophageal reflux
•  Detect swallowing disorders and modify food 
consistency
•  Early surgical repair and ambulation
•  Deep breathing exercises
Early detection •  Check daily for typical and atypical signs/symptoms
•  Laboratory tests and/or chest X-rays in patients at high 
risk or with clinical signs/symptoms
•  Measure procalcitonin in selected high-risk patients
Urinary tract 
infection
Prevention •  Avoiding unnecessary placement on indwelling urinary 
catheters even intraoperatively
•  Remove the urinary catheter within the first post-
operative day
•  Considering the use of intermittent catheterisation to 
relieve post-operative urinary retention
•  Early and repeated mobilisation
•  Planning education of all healthcare professional on the 
management of perioperative use of a urinary catheter 
and post-operative bladder incontinence or retention
•  Optimise diabetes control
Early detection •  Check daily for typical and atypical signs/symptoms
•  Laboratory tests and/or urine culture in patients at high 
risk or with clinical signs/symptoms
•  Measure procalcitonin in selected high-risk patients with 
signs/symptoms of urinary sepsis
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across multi-organ systems. Thus, almost every organ is vulnerable, and patients 
with hip fractures are at risk of multiple adverse health outcomes.
11.9.4.1  Acute Kidney Injury (AKI)
Another very common post-operative complication is a transient worsening of renal 
function, particularly in patients with pre-fracture impairment of glomerular filtra-
tion. Interestingly patients with stage 1 and 2 AKI have similar survival curves but 
worse when compared to those with no AKI [73], suggesting that a post-operative 
deterioration of renal function is probably a marker of frailty rather than the direct 
cause of death. Close monitoring of renal function should be undertaken in the early 
post-operative days, taking into account the fact that creatinine level overestimates 
glomerular filtration rate due to the age-related loss of skeletal muscle mass. 
Estimation of the kidney function with the Cockcroft-Gault method may be useful, 
being more accurate. Electrolyte imbalances, especially hyponatremia and hypoka-
laemia, are described frequently and should be promptly corrected.
Table 11.1 (continued)
Complication Main goal(s) Strategies prevention/management
Surgical site 
infection
Prevention •  Peri-operative antimicrobial prophylaxis according to 
guidelines
•  Hygienic measures in the operating room
•  Hygienic measures in the management of surgical site 
minimising the risk of microbial inoculums
•  Improve malnourishment with nutritional 
supplementation




Prevention •  Identify patients with chronic kidney disease on 
admission
•  Monitor perioperative glomerular filtration rate
•  Manage fluid administration, preventing dehydration and 
volume overload
•  Avoid nephrotoxic drug use, including NSAID and 
certain antimicrobial agents
•  Avoid intraoperative and post-operative hypotension
Urinary 
retention
Prevention •  Avoid anticholinergic medications
•  Manage constipation
•  Early detection and prompt treatment of urinary infection
•  Promote early mobilisation
Constipation Prevention •  Promote early mobilisation
•  Reducing opioids for pain control
•  Increasing fluid intake to 1.5 L/day
•  Reducing fasting time and planning a nutritional support 
postoperatively
•  Use laxative when appropriate starting on the day of 
surgery
Pressure ulcers Prevention •  Use special beds and equipment to relieve pressure in 
patients at risk
•  Improve malnourishment and use nutritional 
supplements
•  Reduce time to surgery and promote early mobilisation
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AKI is potentially preventable in some patients and important measures that 
should be implemented are:
• Avoidance of nephrotoxic drugs including non-steroidal anti-inflammatory drugs 
and nephrotoxic antibiotics.
• Appropriate management of fluids, avoiding hypovolaemia by reducing fasting 
times and by intravenous fluid administration before surgery so that the patient 
does not arrive in theatre with dehydration.
• Prioritising intraoperative blood pressure control avoiding intraoperative hypo-
tension, irrespective of the type of anaesthesia.
• Temporary discontinuation of antihypertensive drugs, particularly angiotensin 
converting enzyme (ACE) inhibitors and angiotensin receptor blockers (even if 
not nephrotoxins per se) especially when AKI or hypotension has developed.
Dialysis-dependent patients are a subgroup of patients with significant frailty 
and with a high risk of post-operative complications, particularly pneumonia and 
sepsis/septic shock [74]. Intra-hospital and 30-day mortality rates are 2.5-fold 
higher than non-dialysis patients. A challenging issue in these patients is well- 
judged fluid administration in the perioperative period, avoiding both hypovole-
mia and cardiovascular overload. A team approach, involving an expert 
nephrologist and orthogeriatrician is essential to reduce early complications and 
early mortality.
11.9.4.2  Gastrointestinal Complications
Common gastrointestinal complications after hip fracture surgery include dyspep-
sia, constipation, paralytic ileus and haemorrhage.
The reported incidence of perioperative acute upper gastrointestinal bleeding 
varies widely in the literature but nowadays seems low [75]. Pre-existing peptic 
ulcer disease and non-steroidal anti-inflammatory drugs are known risk factors 
while post-operative use of aspirin is not likely to be a strong risk factor. 
However, it is possible that the combination of an antiplatelet agent and a pro-
phylactic low molecular weight heparin may exacerbate upper gastrointestinal 
bleeding. A suspicion of gastrointestinal bleeding requires prompt endoscopic 
evaluation.
Most patients following hip fracture surgery have problems with the evacuation 
of faeces during the first post-operative days and a normal defecation pattern is re- 
established only after several days [76]. In orthopaedic surgery, the effects of con-
stipation on patients are often minor, but sometimes prolonged bowel dysfunction 
can lead to faecal impaction or post-operative ileus.
Although post-operative nausea and vomiting are rarely associated with a life- 
threatening condition, they are frequent undesirable side effects of surgery and 
anaesthesia. Several drugs have been studied to prevent such unpleasant symptoms 
and the most effective seems to be dexamethasone given pre or intraoperatively at 
the time of anaesthesia [77].
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General measures to prevent gastrointestinal complications are:
• Reducing fasting time (i.e. 2 h for clear liquids) and planning nutritional support 
postoperatively (i.e. oral nutritional supplement drinks) effective in preventing 
gastrointestinal stress ulceration, post-operative nausea and vomiting and 
constipation.
• Increasing fluid intake to 1.5 L/day.
• Early and appropriate mobility.
• Introduction of proton pump inhibitors in patients at risk of bleeding or their 
continuation if previously taken.
• Avoiding NSAIDs in patients at high risk of bleeding; however, aspirin should 
not be stopped if it was a regular pre-fracture medication.
• Reducing the use of opioids for pain control.
• Introduction of a laxative, starting on the day of surgery.
11.9.4.3  Pressure Ulcers
Even with the widespread dissemination of nursing protocols, based on attentive 
skincare and on the use of special bed equipment to relieve pressure, the incidence 
of pressure ulcers is still approximately 10% which doubles when grade 1 is included 
[78, 79]. Several features of management have been found to negatively affect the 
occurrence of pressure ulcers, such as the use of traction and foam splints, while 
frequent manual repositioning has a positive effect. However, the best strategy for 
reducing pressure ulcers in patients with hip fracture is shortening the time of bed 
rest by means of early surgery and mobilisation, along with protein-caloric 
supplementation.
11.10  Final Remarks
The management of older patients with hip fracture in the post-operative phase 
requires a comprehensive orthogeriatric approach. Frailty and comorbidity in com-
bination with the hip fracture and surgical repair procedures create a degree of vul-
nerability that cannot be faced using traditional care models. Currently, orthogeriatric 
management for patients with a fragility fracture is the gold standard of care all over 
the world, to prevent complications where possible, or manage them appropriately 
when they occur. For acute conditions, such as hip fracture, the healthcare needs do 
not cease after the acute phase, as most patients require treatment in the post-acute 
phase for further clinical stabilisation and rehabilitation. The susceptibility to com-
plications for these patients may last for several weeks after surgical repair. Thus, 
discharge destination should match the stability and vulnerability of the patient, his/
her rehabilitation program and goals, and the pre-existing level of independence, to 
ensure long-term positive clinical outcomes. Discharge planning based on discharge 
needs, patient social supports, patient and family desires is a crucial point in acute 
management. In recent years, the appropriateness of post-acute settings has become 
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a topic for debate. Similar patients with hip fracture discharged to different post- 
acute settings (i.e., home-based rehabilitation, post-acute care facilities and inpa-
tient rehabilitation) seem to have different outcomes [80, 81]. The quality of care of 
post-acute and rehabilitation facilities is another variable that may affect long-term 
outcomes. Outcomes and standards of care should be monitored in the acute care 
setting as well as in post-acute care.
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12.1  The Need for Increased Provision 
of Rehabilitation Worldwide
The World Health Organization has recently highlighted a substantial unmet need 
for rehabilitation worldwide, with a 2017 Call-to-Action to increase the role of 
rehabilitation in health care as an essential component of integrated health services 
[1]. It was acknowledged that there is a profound unmet need for rehabilitation, 
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particularly in LMICs. There was a call for greater access to rehabilitation services 
recognising it as an essential part of the health system rather than an optional extra. 
Rehabilitation is “an investment in human capital that contributes to health, eco-
nomic and social development” and there is under-prioritisation by governments 
with an absence of planning for services at a national and subnational level. The call 
to action includes “greater awareness and advocacy, increased investment into reha-
bilitation workforce and infrastructure, and improved leadership and governance 
structures”. This includes increasing networks and partnerships in rehabilitation, 
particularly between LMICs and high-income countries.
12.2  The Principles of Rehabilitation Programmes  
after Hip Fracture
After a hip fracture operation, an older person’s recovery is enhanced if they are 
provided with an optimistic, well-coordinated rehabilitation programme. Recovery 
after hip fracture starts on admission when the patient and family receive realistic 
information on the likely course and time of discharge. The earlier patient goals and 
expectations can be explored and information on barriers or supports for recovery 
of independence identified, the more likely it is that an individual will retain a sense 
of control and self-efficacy which is likely to be associated with better outcomes [2, 
3]. Consistent information on the planned rehabilitation programme is important as 
most people will have a recovery pathway which extends for several months across 
hospital and community settings [4].
During the acute hospital stay (ideally on an orthogeriatrics ward), along with 
secondary prevention treatments for osteoporosis, a rehabilitation pathway should 
be established and outlined to the patient and family. Rehabilitation involves diag-
nosing and treating impairments, preventing and treating complications, slowing 
loss of function and where this is not possible, compensating for lost functions (e.g. 
prescribing walking aids, bathroom adaptations, additional home help) [5]. Several 
systematic reviews and meta-analyses have demonstrated that rehabilitation pro-
grammes improve outcomes for patients after hip fracture compared to simply let-
ting time take its course [6–8]. However, the components of recovery/rehabilitation 
programmes vary, including the length of time and the settings where programmes 
are delivered (home, inpatient units, outpatients). Standard management of hip frac-
ture patients also varies between different countries. An audit in the UK reported 
that 70% of hip fracture patients receive orthogeriatrician assessment and 92% a 
falls assessment. These figures were only 27% for orthogeriatrician assessment and 
4% for falls assessment in a tertiary hospital in Beijing [9].
In clinical practice, the cornerstone of a rehabilitation approach is a team of vari-
ous disciplines (physiotherapy, occupational therapy, nutrition, social work, psy-
chology, medicine) who meet regularly, set goals, review progress towards these 
goals with the patient and assess outcomes. The chance of recovery is maximised if 
the following elements are incorporated into the clinical approach:
• Assessment: identification of problems to be addressed, which involves under-
standing the premorbid level of functioning and understanding the current 
comorbidities (e.g. delirium).
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• Goal-setting: identifying what can be improved and what cannot. In particular, 
assessing what level of mobility and independence in bathing and dressing is 
likely to be achieved in the short, medium and long term. Similarly, identifying 
what informal and formal supports are available to help recovery.
• Treatment: intervening to improve medical and functional problems (such as 
pain, vitamin D deficiency, undernutrition, depression) as well as physical and 
psychosocial interventions to meet the rehabilitation goals.
• Evaluation: reviewing the effectiveness of interventions (i.e. reassessment).
• Planning: organising support services; providing self-management strategies for 
patients and carers.
The World Health Organization (WHO) International Classification of 
Functioning, Disability and Health (ICF) framework provides a standardised frame-
work for the classification and description of health, functioning and disability [10]. 
It moves away from the idea that disability is simply the consequence of disease or 
ageing towards an approach that acknowledges factors created by the social envi-
ronment and it attempts to explicitly identify barriers and facilitators to social inclu-
sion. Functioning and disability are seen as multidimensional concepts, relating to:
• Body functions (physiological and psychological functions of body systems) and 
structures (anatomical parts of the body such as organs, limbs and their 
components);
• Activities people do and the life areas in which they participate;
• Factors in people’s environment (physical, social and attitudinal) which can be 
barriers or facilitators to functioning.
If this approach is applied to a person who suffers a hip fracture, their disability 
will be assessed and ranked according to the ICF framework components of health 
domains (e.g. seeing, hearing, walking, memory) and health-related domains (e.g. 
their ability to access transport, their level of education and social interactions). 
Figure 12.1 shows an individual’s functioning or disability as a dynamic interaction 
between health conditions and contextual factors, which encompass both environ-
mental and personal factors [10].
12.3  What Is Known about the Pattern of Recovery Following 
Hip Fracture?
Talking to people with hip fractures and their families and providing realistic infor-
mation on approximate expected recovery trajectories allows them to plan. However, 
it is complex for clinicians to apply evidence from cohort studies to individual 
patients as the cohorts are heterogeneous and patients have received varying 
amounts and types of rehabilitation.
Cohort studies suggest that following hip fracture, only 40–60% of people who 
survive are likely to recover their pre-fracture level of mobility [11]. Up to 70% may 
recover their level of independence for basic activities of daily living, but this is vari-
able and less than half of all people experiencing hip fracture may regain their ability 
to perform instrumental ADLs. In Western nations, approximately 10–20% of 
patients move to a residential care facility following hip fracture. The extent to which 
these outcomes can be improved with greater access to rehabilitation is not clear.
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Magaziner et al. described the sequence of recovery across eight different func-
tional abilities following hip fracture [12]. Upper extremity activities of daily living, 
depression and cognitive function reached maximum recovery within 4 months. 
Most recovery of gait and balance occurred in the first 6 months, with maximum 
recovery occurring by 9 months; recovery of instrumental ADLs (such as shopping, 
preparing meals, house cleaning and handling money) took up to a year. It also took 
approximately a year for recovery of lower limb function and just over 14 months 
for walking 3  m without assistance. It seems that the majority of patients who 
recover their pre-fracture walking and basic activities of daily living do so within 
the first 6 months after fracture [13], but the role of long-term therapy in recovery 
pathways is yet to be well investigated.
In LMICs outcomes may be poorer due to reduced rates of optimal manage-
ment, particularly due to reduced access to rehabilitation services [1]. In many 
LMICs standard hip fracture management pathways are not established [14]. 
Barriers to providing rehabilitation services in LMICs are discussed in more detail 
in Tables 12.10 and 12.11. An audit of practice in China (considered an upper 
MIC) demonstrated reduced access to surgery and orthogeriatric services at a 
Beijing hospital in comparison to the United Kingdom [9]. Since that time a retro-
spective before–after study has demonstrated that improvements in both time to 
surgery and orthogeriatric management are possible with implementation of a co-
















Access at shopping centres 
Personal Factors
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Fig. 12.1 Interactions between the components of the World Health Organization (WHO) 
International Classification of Functioning, Disability and Health (ICF) framework. Source: WHO 
2001 [10]
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12.4  Factors Associated with Poor Outcomes  
After Hip Fracture
Some types of patients with hip fracture appear to be at particular risk of poor out-
comes – these include male patients, people living in supported accommodation, 
those with poorer mobility pre-fracture and those with depression or dementia [13, 
16, 17]. People with dementia are also less likely to receive rehabilitation [17, 18]. 
For people with dementia who receive rehabilitation, improvements comparable to 
other populations are achievable but this may take longer [19]. Although mortality 
following hip fracture has been found to be higher in men than women, recovery of 
mobility is unaffected by gender [17, 20].
Delirium is very common after hip fracture and although it is associated with 
poorer outcomes, routine assessment by rehabilitation staff remains uncommon 
[13]. In one prospective study, delirium remained in 39% of people with hip fracture 
at discharge from hospital and in 32% 1 month after fracture [21]. Even after con-
trolling for pre-fracture physical and cognitive frailty those people who had delir-
ium were twice as likely to have poor functional outcomes (in terms of mobility and 
recovery of activities of daily living) than those without [21].
Those who are older are more likely to have poorer mobility, need assistance at 
home, lose their ability to go outside on their own, cook their own dinner and be 
unable to prepare their own breakfast [17, 20]. Low food intake post-operatively, 
poor nutrition and malnourishment pre-operatively are associated with worse recov-
ery of mobility and function [22, 23]. A systematic review of nutritional interven-
tions found low-quality evidence to support the effectiveness of multi-nutrient 
supplements started before or soon after surgery in older people recovering from hip 
fracture to prevent complications [24]. Amongst nursing home residents, the factors 
most strongly associated with death or new total mobility dependence are being 
aged more than 90, having very severe cognitive impairment and receiving non-
operative management of the hip fracture [25]. Longer lengths of stay, re-hospitali-
sation, older age, chronic or acute cognitive deficits and depressive symptoms while 
in hospital are also predictive of poorer recovery of mobility and activities of daily 
living [13].
12.5  Key Elements of a Rehabilitation Pathway
After the immediate post-operative period, a rehabilitation pathway should be fol-
lowed that includes the elements addressed in Table 12.1. In particular, there is a 
need to assess frailty, establish goals to maximise mobility and other aspects of 
function, assess the requirement of aids (using occupational therapy services where 
available) and determine strategies to support and improve independence in activi-
ties of daily living [26]. Medication management should ensure all prescribed medi-
cations are necessary, minimise the use of antipsychotics and sedatives and ensure 
adequate pain management. Osteoporosis should be treated as appropriate and falls 
prevention strategies reinforced with both patients and families.
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Table 12.1 Key elements of a typical rehabilitation pathway, based on the Alberta Hip Fracture 
Restorative Care Pathway [26]
Category of care
Frailty Undertake frailty assessment, instigate interventions as appropriate, involve 
patient in establishing goals to maximise function and achieve safe discharge
Activities of 
daily living
Ensure progression in recovery of pre-fracture level of independence, aiming 
for further improvement depending on tolerance
Assess need for aids and develop strategies to improve independence
Demonstrate safe transfer using aids and equipment as appropriate
Ensure there is adequate support in the home environment in terms of 
assistance from a caregiver or service
Recommend the family consider a medical alert system if available and 
appropriate
Bathing and grooming: Encourage and support independence, bathing and 
grooming out of bed with assistance if necessary
Dressing: Support getting out of bed and dressed daily, using dressing aids 
as necessary
Toileting: Encourage regular toileting to promote continence, toileting 
should be in the bathroom, not using bedpans or urinals
Eating: A high protein/calorie diet should be continued and meals taken in a 
chair or dining room. An oral nutritional supplement should be considered
Support for activities of daily living should be provided after discharge. 
Appropriate home equipment should be provided (mobility aid, raised toilet 
seat and toilet surround and other items as required)
Mobility Consider conducting an assessment of mobility/activities of daily living to 
enable monitoring of recovery of mobility (e.g. the Timed Up and Go test, 
Barthel Index of Activities of Daily Living)
Exercise incorporating strengthening, balance and functional components 
should be continued after discharge
Walking with or without an aid for at least 50–100 m should be undertaken 
at least three times daily, or as appropriate depending on pre-fracture 
mobility
Capacity to walk the distance required to attend meals in the home setting 
should be demonstrated
Ensure ability to manage stairs if necessary and to mobilise safely outside 
the home in all weather conditions, uneven surfaces, curbs, etc.
Arrange further mobility training after hospital discharge
Medications A review of all medications should have been undertaken on admission, 
polypharmacy should be addressed
Use of sedatives and antipsychotics should be minimised or ceased and 
doses should be regularly reviewed
Medication should be adequate for pain control to enable optimal 
independence in activities of daily living
Cognitive and 
mental status
Strategies to prevent and treat delirium should be continued, including 
ensuring appropriate use of vision and hearing aids, fluid enhancement, 
orientation, optimising mobility and non-pharmacological sleep supporting 
strategies. Behaviour monitoring should be undertaken if necessary
Activity should be encouraged for those with dementia or depression, in 
terms of ambulation, exercise and social participation





Osteoporosis management should be considered if this hasn’t already 
occurred and continued post-discharge
Fall prevention strategies should be instigated and the use of hip protectors 
(if available) considered
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12.6  What Programmes Should We Recommend to Help 
with Recovery?
It is widely recognised that a vicious cycle can occur after a hip fracture where pain 
and hospitalisation result in disuse atrophy of muscles and general deconditioning 
which increases the risk of immobility and new falls and fractures [27]. While 
national clinical guidelines recommend providing balance and strengthening exer-
cise [28, 29], it is often unclear how much should be provided, what components of 
a rehabilitation programme are crucial and how long this programme should be 
provided for. Analysis of the components of interventions found to be effective in 
randomised trials can assist in addressing this uncertainty.
The characteristics of all randomised controlled trials of multidisciplinary reha-
bilitation approaches reporting impact on patient-centred outcomes or mortality 
(Table 12.2) and exercise and mobility training programmes (Table 12.3), within 
different settings as identified by systematic review to 2019, are presented below 
[30, 31]. The quality of the trials is represented with the Physiotherapy Evidence 
Database (PEDro) score (see https://www.pedro.org.au/), which scores ten items 
reflecting trial design including randomisation, blinding, balance in baseline char-
acteristics and follow-up. Details of the components of the programmes that have 
been demonstrated to be effective at improving mobility or function in randomised 
controlled trials are shown in Table 12.4 (multidisciplinary interventions in hospital 
or hospital and community setting), Table 12.5 (exercise programmes conducted in 
hospital settings), Table  12.6 (community-based multidisciplinary interventions) 
and Table 12.7 (community-based exercise programmes).
12.6.1  In-hospital Rehabilitation
Multidisciplinary programmes have been researched over a long period of time with 
significant changes to the components of treatment programs. Some trials provide a 
comparison to a usual care control group while others have a standard rehabilitation 
programme as the control group. Furthermore, some multidisciplinary programs 
begin soon after admission (e.g. Prestmo et al. [40]) and others include both in hos-
pital rehabilitation and community components (e.g. Cameron et al. [45]). A 1988 
trial demonstrated improvements in function on discharge for provision of multidis-
ciplinary care in comparison to standard orthopaedic care [37].
Table 12.4 shows the characteristics of hospital-based and hospital-plus commu-
nity-based multidisciplinary rehabilitation interventions in studies with demon-
strated effectiveness. Four trials of programmes delivered solely in a hospital setting 
have demonstrated effectiveness on patient-centred outcomes overall (Table 12.4). 
One effective in-hospital programme with comprehensive, multidisciplinary geriat-
ric care including early mobilisation, and daily training and a follow-up assessment 
at 4 months, demonstrated improvements in function at 1 year [42]. Another trial 
demonstrated improvements in mobility with orthogeriatric care for a subgroup 
who were living at home [44]. A third trial demonstrated reduced rates of delirium 
with daily geriatrician visits [38].
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Table 12.2 Characteristics of trials of multidisciplinary rehabilitation approaches reporting 
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members of a 





contacts pw with 
members of 
multi D rehab 
team
Note: as identified by systematic review to October 2019. aScored in duplicate by authors
ADLs activities of daily living, C community only, GP general practitioner, H hospital only, H&C 
hospital and community, HC health care, IADLs instrumental ADLs, multi D multidisciplinary, NA 
not available, NH nursing home, physio physiotherapist/physiotherapy, post-op post-operative, pw 
per week, rehab rehabilitation
NB Poor outcome = reviewer calculated composite outcome, defined as: bmortality at discharge or 
discharge to more dependent residence/NH, cmortality at 12 months or living in more dependent 
residence/NH, dmortality at discharge, discharge to more dependent residence and decline in 
mobility, emortality at discharge, not discharged to previous residence, not in same residence at 
12 months and reduced ADLs, fmortality at discharge or discharge to institutional care, mortality 
at 12 months or institutional care, g12-month mortality, admission to institutional care or decline in 
function
Table 12.2 (continued)
Table 12.3 Characteristics of trials of exercise and mobility training programmes reporting 
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C community only, H hospital only, H&C hospital and community, N no, PPT Physical Performance 
Test, POMA Performance Oriented Mobility Assessment, PPME Physical Performance Mobility 
Examination SPPB Short Physical Performance Battery, TENS transcutaneous electrical nerve 
stimulation, WES Walking Exercise Scale Y yes
aBased on systematic-review of MEDLINE, EMBASE, CINAHL, CENTRAL and PEDro database 
search records from inception to April 2019 for randomised controlled trials of exercise-based 
programmes aiming to improve mobility in older people post-hip fracture reporting data suitable 
for inclusion in meta-analysis, with a minim PEDro score of 5 or more
bOnly two out of three comparison groups examined exercise interventions
cScored in duplicate by current authors
Table 12.3 (continued)
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A more recent hospital-based trial has demonstrated effectiveness on a range of 
person-centred outcomes including mobility, function and quality of life at 1-year 
follow-up in comparison to standard orthopaedic care [40]. This programme pro-
vided comprehensive interdisciplinary care, early mobilisation and rehabilitation 
and also addressed psychosocial aspects of care through a focus on social situation 
and mental health.
Two exercise programmes that have demonstrated effectiveness in terms of 
improving mobility or function were delivered completely in an in-hospital (reha-
bilitation) setting (Table  12.5) [30, 31]. One study added progressive resistance 
training in the form of additional early post-operative, high-intensity bilateral quad-
riceps muscle strengthening to conventional physiotherapy. A significant improve-
ment in the Elderly Mobility Scale, leg extensor power of the fractured leg and 
functional reach was reported at 16 weeks, which was 10 weeks after the end of the 
intervention [30]. The other programme which delivered a high dose of in-patient 
rehabilitation including supervised balance exercises (five times weekly for 90 min, 
over 3 weeks), also demonstrated improvements in mobility and function compared 
to standard rehabilitation on discharge [31].
12.6.2  Rehabilitation in the Community
Six multidisciplinary interventions delivered across both hospital and community 
settings have demonstrated improvements in patient-centred outcomes in compari-
son to usual orthopaedic care (Table 12.4) [37, 50–53, 55]. Four of these trials were 
conducted in high income countries [37, 52, 53, 55] and two were conducted in 
Taiwan [51, 81]. In general, multidisciplinary programmes that emphasise early 
assessment through comprehensive geriatric assessment with appropriate early sur-
gery, early mobilisation, higher doses of mobility training and an emphasis on 
regaining functional independence are more effective. Multidisciplinary rehabilita-
tion programmes (including those with a focus on multidisciplinary factors where 
specialist teams are not available) should also begin soon after hospital admission 
and continue for a long period, including after hospital discharge.
It remains unclear what is the best link between orthogeriatric services and hip frac-
ture rehabilitation services to improve coordination for patients, but common gover-
nance structures, shared staff, shared information systems or formal arrangements for 
handovers are all options. These services should treat patients with dementia and delir-
ium and also include patients who are living in, or will live in, residential aged care 
facilities. High intensity and prolonged multidisciplinary rehabilitation programmes 
(e.g. Singh et al. [52]) are effective for a selected group of people with hip fracture.
There is an emerging view that hip fracture rehabilitation programmes should also 
be available to people with significant dementia who live in long-term care, or at 
home, with severe disabilities. A recent trial of a four-week multidisciplinary pro-
gramme delivered as a hospital outreach programme within long-term care demon-
strated improvements in mobility at the end of the programme, which was not 
maintained over 12 months, but a small improvement in quality of life was observed 
at 12  months (Table  12.6) [56]. Whilst the programme was found not to be 
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cost-effective, it demonstrates that improvements in patient-centred outcomes can be 
made after hospital discharge in a population living in long-term care.
As shown in Table 12.7, the exercise programmes that continued after discharge 
and were effective were programmes conducted over 12–24  weeks. At least for 
some individuals, there are benefits from exercise programmes delivered after dis-
charge from hospital. One of the most effective programmes identified in our review 
of trials of exercise and mobility training programmes was implemented as twice-
weekly sessions with a physiotherapist in an outpatient clinic for the first 3 months, 
then once weekly for a further 3 months (Table 12.7) [77, 78]. This was supple-
mented with exercises once a week at home. The exercise programme involved 
prolonged progressive resistance training, fitness warm-up and lower limb strength 
exercises, compared to a control group of the participant’s usual lifestyle, without 
any restrictions placed on the amount or type of exercise undertaken. This pro-
gramme significantly improved patient’s mobility after 3 months [77], but the mag-
nitude of the effect was even greater after 6 months [78]. While the strength of effect 
in this study may partly be due to a comparison against patients with no structured 
exercise programme, two other community-based programmes of progressive resis-
tance training in small groups also demonstrated large effects in comparison to 
alternative programmes [65, 66]. Another study has demonstrated that extra pro-
gressive resistance exercises in addition to a 12-week standard daily physiotherapy 
programme can provide additional benefits for mobility and function [76].
However, long-term provision of exercise programmes through outpatient clinics 
for whole populations may not be feasible, even in developed countries, as this 
would require an enormous expansion of rehabilitation services with associated 
costs. Greater provision of community exercise options in liaison with health pro-
fessionals may help to meet this gap, as has been recommended for people with 
neurological impairments [82].
12.6.3  Rehabilitation in Low Resource Settings
A trial conducted in Taiwan has demonstrated significant improvements in mobility 
and self-care extending to 2 years post-hip fracture from interdisciplinary rehabili-
tation programmes in comparison to usual care with no formal rehabilitation pro-
gramme [81]. A further trial demonstrated additional benefits of a comprehensive 
care programme addressing nutrition, depression management and falls prevention 
in addition to interdisciplinary care in the same setting [51]. Whilst the same inter-
disciplinary care may not be possible in low resource and LMIC settings, rehabilita-
tion programmes that address these principles using professionals with competencies 
in geriatrics, orthopaedics, physiotherapy, occupational therapy, nutrition, social 
work and psychology should be the aim.
Supervised exercise programmes may present access difficulties for people in 
remote locations or in low resource settings so home exercise, wider family involve-
ment or tele-rehabilitation options may be required.
A home-based exercise programme of simple, functionally oriented tasks with 
minimal supervision had a moderate effect on improving physical function [68]. In 
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this programme, a physical therapist taught the exercises and used cognitive and 
behavioural strategies to enhance attitudes and beliefs about the benefits of exercise 
and to overcome fear of falling during three home visits of 1 h (Table 12.7). Monthly 
telephone calls were also made by the therapists and an additional visit was provided 
if necessary. The participants were provided with a DVD of the programme to watch 
and a DVD player if necessary. Participants performed the exercises independently in 
their own home three times a week for 6 months, supported by a monthly telephone 
call from the physical therapist. The intervention also included a cognitive-behav-
ioural component in order to improve adherence. A secondary analysis of this trial 
indicates that self-efficacy may partially mediate the effects of this intervention on 
longer term functional outcomes [83]. Whilst physical therapists may not be available 
in all resource settings, this trial demonstrates the potential effectiveness of home-
based therapy. Alternative professionals with skills in physical therapy could provide 
training. Including caregivers in this training, where resources for watching a DVD 
and follow-up phone calls are not available, appears promising and warrants 
investigation.
12.7  Rehabilitation and Cognitive Impairment
Rehabilitation for people with dementia after hip fracture is complex. Approximately 
40% of patients who sustain a hip fracture have dementia [85, 86]. These patients 
have more complex care needs, with greater risks of complications, physical dis-
abilities and social care requirements compared to people without dementia [87]. 
This is due to a number of factors. Firstly, people with dementia are often more 
disorientated in hospital environments, being more prone to delirium. They often 
have difficulty expressing problems of pain, nausea and dizziness which impact on 
physical performance. Many people with dementia have movement limitations, 
which when combined with hip fracture, makes simple tasks like learning how to 
use walking aids and equipment very difficult. They often have a critical relation-
ship with informal caregivers (family/friends) which is strained after a hip fracture; 
greater considerations for supporting the patient–caregiver dyad may be required 
than for patients without dementia. Daily proactive geriatrician visits starting before 
or within 24 h of hip fracture surgery, with application of multiple types of treat-
ment, has been demonstrated to reduce delirium occurrence by 36%, and severe 
delirium by 60% [38]. Similar principles could be followed in LMIC settings with 
lesser intensity of inputs.
A number of research reports and guidelines recommend intervention with spe-
cific strategies including enhanced rehabilitation and care pathways to support recov-
ery from hip fracture for people living with dementia. However, the evidence base for 
these is sparse. Five trials have investigated enhanced rehabilitation models for this 
population; evaluating strategies designed specifically for people with dementia fol-
lowing hip fracture surgery. These are larger trials of patients following hip fracture 
surgery which have presented data specifically for the subgroup of patient with cog-
nitive impairment. These trials have tested two types of interventions: enhanced 
interdisciplinary inpatient rehabilitation and care models versus conventional 
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size PEDro Characteristics of intervention Comparator






283 4 Delirium-friendly care options 
including: Orientation 
strategies; night-time 
sedation, analgesia, and 
nausea; attention to catheter 









 64 6 MultiD team intervention: 
Individual care planning, 
monitoring for specific 
common complications (falls, 
delirium, bowel and bladder 
care, sleep, pain, pressure 
sores, physiological markers 
and nutrition), early inpatient 
rehabilitation with increased 
staffing ratio
Non-formalised and 
inconsistent provision of 
team working, 
individualised care 
planning, rehabilitation or 
complication monitoring. 
Prevention and treatment of 
decubitus ulcers, pain 
management and basic 





8 Early mobility and self-care 
(nurse delivered). Target of 
twice-daily physiotherapy 
with greater multiD team 










141 7 Enhanced multi D team 
rehabilitation including two 
times daily physiotherapy, 
multiD team meetings and 
improved communication 
across the team and with 
patients. Plus discharge 




participants encouraged to 
mobilise on the first 








160 6 Enhanced multiD team, two 
times daily physio, multiD 
team meetings, improved 
communication and 
individualise care. Plus 
individualised discharge 
planning, three home-based 




rehabilitation consisted of 
3 physiotherapy sessions, 
and no in-home 
rehabilitation. No further 
information provided
C community, H hospital, H&C hospital and community, MultiD multidisciplinary, physio 
physiotherapy
inpatient rehabilitation and care models [43, 88, 89] and secondly, enhanced interdis-
ciplinary inpatient and home-based rehabilitation and care models versus conven-
tional rehabilitation and care models [90, 91]. The characteristics of these trials and 
interventions are presented in Table 12.8. The enhanced models generally offer mul-
tidisciplinary programmes with greater intensity or length of programmes.
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12.7.1  Enhanced Interdisciplinary Inpatient Rehabilitation 
and Care
The clinical outcomes of enhanced inpatient rehabilitation care compared to con-
ventional care are summarised in Table  12.9. It appears there was no benefit of 
enhanced interdisciplinary inpatient rehabilitation over conventional care for out-
comes including personal ADL independence at four-month or 12-month follow-
up, walking independence without an aid or assistance at four-month or 12-month 





(months) Participants Study Outcome OR/MD (95% CI)
In-patient enhanced rehabilitation programmes
Personal activities 
of daily living 
independence
4 54 Stenvall 2012 [89] OR 4.14 (0.40–42.66)
12 47 Stenvall 2012 [89] OR 4.62 (0.18–119.63)
Walking 
independence 
without an aid or 
assistance
4 54 Stenvall 2012 [89] OR 7.63 (0.83–70.53)
12 47 Stenvall 2012 [89] OR 7.20 (0.74–70.42)
Mortality Discharge 151 Freter 2016; 
Stenvall 2012; Uy 
2008 [43, 88, 89]
OR 0.62 (0.22–1.74)
Hospital Length of 
Stay
Discharge 141 Freter 2016; 
Stenvall 2012  
[88, 89]
MD −3.24 (−8.75 to 2.26)
In-patient and community-based enhanced rehabilitation programmes
Mortality 3 184 Huusko 2000; 
Shyu 2012 [90, 91]
OR 1.20 (0.36–3.93)
12 177 Huusko 2000; 




3 184 Huusko 2000; 
Shyu 2012 [90, 91]
OR 0.46 (0.22–0.95)
12 177 Huusko 2000; 





3 43 Shyu 2012 [91] OR 5.10 (1.29–20.17)
12 36 Shyu 2012 [91] OR 58.33 (3.04–1118.19)
24 30 Shyu 2012 [91] OR 3.14 (0.68–14.50)
ADL performance 3 43 Shyu 2012 [91] MD 18.81 (9.40–28.22)
12 36 Shyu 2012 [91] MD 25.40 (10.89–39.91)
24 30 Shyu 2012 [91] MD 7.92 (−9.88 to 25.72)
12 36 Shyu 2012 [91] OR 0.20 (0.01–4.47)
24 30 Shyu 2012 [91] OR 0.77 (0.16–3.74)
CI confidence interval MD mean difference OR odds ratio
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follow-up or the number of drugs prescribed on discharge. Similarly, there were no 
differences in outcomes for mortality or hospital length of stay for enhanced inpa-
tient rehabilitation models over conventional care.
There was no benefit of an enhanced inpatient rehabilitation programme over con-
ventional rehabilitation for complications including pneumonia, pressure ulcers, post-
operative fracture or whether participants were living in care facilities at 4 months or 
12 months. However, there was a reduction in the enhanced interdisciplinary rehabili-
tation care model group for complications including urinary tract infection, nutritional 
problems, recurrent falls and post-operative delirium. Freter and colleagues also 
reported greater cognitive function for those who received the enhanced intervention 
5 days post-operatively compared to conventional rehabilitation [88].
12.7.2  Enhanced Interdisciplinary Inpatient 
and Home-Based Rehabilitation
The clinical outcomes of enhanced rehabilitation inpatient and home-based reha-
bilitation care compared to conventional care are summarised in Table 12.9. Findings 
suggest that enhanced inpatient and community-based interventions for people with 
cognitive impairment provide promising early outcomes, but do not differ to con-
ventional rehabilitation models longer term. Whilst people allocated enhanced 
interdisciplinary rehabilitation were less likely to be living in institutional care at 3 
months, this was less certain at 12 months. One trial conducted in Taiwan reported 
that patients who received enhanced rehabilitation strategies until 3 months post-
discharge had improvements in regaining pre-fracture walking levels and better 
ADL performance at 3 and 12 months, but did not differ from conventional rehabili-
tation at 24 months [91]. The evidence suggests no benefit of the enhanced inpatient 
and home-based intervention for outcomes including frequency of hospital admis-
sions, attendance at the emergency room/accident and emergency, incidence of falls 
or mortality at 4 or 12 months post-operatively.
Whilst the current evidence-base provides a basis, the data remain very low in 
quality due to the small number of participants and the serious risk of bias in trial 
designs. The evidence underpinning the rehabilitation of people with dementia fol-
lowing hip fracture is based on subgroup analyses of randomised controlled trials of 
people with and without cognitive impairment who have a hip fracture. Consequently, 
the evidence-base is underpowered. No data were provided on behaviour, quality of 
life, pain or complications. No trials have investigated interventions which have 
been specifically designed for people with cognitive impairment. It remains unclear 
whether rehabilitation models are more effective if they include dementia-focused 
interventions such as provision of cues, reminiscence therapy, the adoption of famil-
iarised routines or the use of assistive technologies. These are areas of research 
priority. Following this, it is hoped that health professionals will be able to be more 
evidence-based in addressing the complex care needs for this subgroup of the hip 
fracture population.
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Nevertheless, it is clear that patients with cognitive impairment also benefit from 
rehabilitation approaches and these patients should not be excluded from rehabilita-
tion following hip fracture.
12.8  Psychosocial Factors and Rehabilitation
Within the WHO ICF framework, psychosocial factors can be environmental or 
personal “contextual” factors (e.g. social support, self-efficacy, fear of falling) or 
psychological “body function” factors (e.g. mental health) that interact with health 
conditions to impact on a person’s functioning and recovery. Psychosocial factors 
are predictors of hip fracture recovery and their role in functional recovery after 
hip fracture has been acknowledged as important [92]. Depressive symptoms post 
hip fracture increase the likelihood of poorer mobility, function and psychological 
outcomes [92–94]. Fear of falling is common in people with hip fracture and is 
associated with poorer recovery, decreased mobility, anxiety and falls-related self-
efficacy [95–97]. Social support and caregiver responses also appear to play a 
dynamic role in recovery [98, 99]. However, the relationships between psychoso-
cial factors, rehabilitation programmes and outcomes are complex and inade-
quately understood.
Clinicians need to support patients’ adjustment to residual disability when pro-
viding rehabilitation to people with fragility fractures. Hip fractures are common 
and many older people in the community hold the fear that a hip fracture will pre-
cipitate a move into a residential aged care facility. In an Australian time–trade-off 
study, 80% of community-dwelling women at risk of hip fracture said they would 
rather die rather than suffer a hip fracture requiring relocation into a residential aged 
care facility [100]. The participants of this study commonly believed that they were 
living on “borrowed time” having survived beyond usual life expectancy. They per-
ceived any threat to their ability to live independently in the community as poten-
tially catastrophic.
When individuals experience changes in their health states, they often alter their 
internal standards, their values and concept of quality of life which is sometimes 
described as a “response shift” [101]. After a hip fracture, many people are left 
walking with an aid, with restrictions in the use of public transport, hobbies and 
roles, thus a significant loss of quality of life may occur. Maximising functional 
recovery is important but providing adequate support for older people to make 
“response shifts” and adjustments and to identify ways to compensate for changes 
is equally important e.g. by acknowledging losses in mobility but providing access 
to alternatives.
A randomised controlled trial of a home-based hip fracture rehabilitation inter-
vention which included psychological strategies improved mobility outcomes for 
patients [68, 83]. The study found that the intervention protected against the loss of 
self-efficacy. As self-efficacy appears to play a crucial role in maintaining exercise 
long-term, a focus on self-efficacy in hip fracture interventions may mean that 
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patients are more likely to continue activity independently [83]. Qualitative studies 
indicate that hip fracture patients recognise the importance of their own psychologi-
cal outlook and the need for social support in their recovery. Support from health 
professionals provides not only information and exercises but also emotional and 
motivational support and confidence boosting. Support from informal caregivers, 
family and friends is also seen as invaluable to help with ADLs, emotional support, 
encouragement and companionship [95, 102, 103]. Thus, inclusion of psychological 
and social interventions in hip fracture rehabilitation programmes is likely to be ben-
eficial. However, the specifics of how to best design such programmes to improve 
outcomes are yet unclear [92].
12.9  Delivery of Rehabilitation Following Hip Fracture 
in LMICs
The prevalence of hip fracture is expected to increase dramatically in middle-
income countries in Asia and Latin America, presenting a major challenge to reha-
bilitation care in coming years. By the year 2050, around 30% of the world’s hip 
fractures will occur in Asia, mostly in China and India. Although the rate of increase 
in incidence of hip fracture has been attenuated in Hong Kong and Taiwan, it has 
markedly increased for almost all age groups in both genders in mainland China 
[104]. India lacks a systematic data registry for fragility hip fractures, but a report 
in 2004 estimated an annual prevalence of 600,000 hip fractures, which will sub-
stantially increase, since the population over 60 years in 2026 will reach nearly 170 
million people [105].
Overall hip fractures in the Latin America region will increase by 700% in the 
population 65 and over with an estimated cost of $13 billion [106]. Based on popu-
lation ageing estimates in Brazil the increase of hip fracture prevalence is estimated 
to be nearly 250% between 2015 and 2040 [107]. In Mexico, another highly-popu-
lated country, hip fracture rate estimates are sparse, but one study showed similar 
rates to southern countries in Europe [108].
The impact of hip fractures is unfavourable for patients and their families in 
LMICs as many do not have health care systems which are able to deliver integrated 
services including rehabilitation. Barriers exist in terms of human resources capa-
bility, infrastructure, cultural and social influences and environmental context.
While research on barriers and facilitators for rehabilitation following hip frac-
ture is still scarce in most LMICs, Tables 12.10 and 12.11 describe known barriers 
to prompt in-hospital and community rehabilitation following hip fracture surgery 
in LMICs.
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Table 12.10 Barriers to prompt in-hospital rehabilitation following hip fracture surgery in LMICs





•  Long distances to find a proper 
trauma centre
•  Lack of ambulance service in rural 
areas
•  Overwhelmed public hospitals 
(scarcity of beds)
• Fixed operative days of surgeons
•  Multiple poorly controlled 
comorbidities
•  Bias against admitting frail 
patients with multiple 
co-morbidities, pressure sores and 
those who carry high risks for 
surgery
Delayed or insufficient mobilisation 
and functional independence 
training
•  Surgeon’s choice of a conservative 
approach e.g. restricting 
weight-bearing
•  Lack of human resources 
(physiotherapists, occupational 
therapists, nurses)
•  Surgery on Fridays with no 
physiotherapists on weekends
•  Lack of co-management by 
orthopaedic and geriatric medicine 
(geriatric wards or comprehensive 
geriatric care units or geriatric 
consulting services)
•  Lack of in-patient rehabilitation 
services
•  Lack of falls prevention 
programmes
Lack of coordinated discharge plan 
and referral
•  Fragmentation of services and 
poor transition home programmes.
•  Lack of caregiving training 
programmes prior to discharge
Presentation and surgery times:
India: Patients travelled a mean of 
86.4 km to trauma services; 86% 
patients presented to hospital ≥1 day 
after fracture (mean 18 days), 10% 
operated in ≤24 h [109]
Colombia: 52% patients operated in 
1–3 days, 40% 4–6 days, 8% ≥7 days 
[110]
Beijing: 8% operated in ≤48 h [9]
Brazil: Mean 3 days between fracture 
admission; waiting time for surgery 
5.8 days. Nearly 70% operation >48 h 
[111]
Chile: Time between admission and 
surgery 19.3 days, 7% surgery in 
≤5 days [112]
Assessment:
Colombia: 64% not evaluated by 
physiotherapists in hospital [110]
Beijing: 3.8% falls risk assessment, 
22% orthogeriatric assessment [9]
India: 10% fall-risk assessment, no 
orthogeriatric care [105]
Rehabilitation:
WHO: LMICs have scarcity of 
rehabilitation professionals, many have 
<10 skilled practitioners per one 
million population [113]
Post-discharge:
Colombia: Common complaint is lack 
of interventions to prepare families 
and patients for discharge to home 
[110]
China: Most difficult tasks for family 
caregivers were providing assistance 
for stair climbing, emotional problems, 
management, walking training, 





•  Lack of knowledge or information 
of family members about the 
urgency of a fall-injury event
•  Patients’ beliefs in traditional bone 
healers and aversion to surgical 
interventions
Burden of family caregivers
•  Low socioeconomic background 
and social vulnerability
India: Most patients and relatives had 
no knowledge of the consequences of 
hip fracture injury in older people 
[109]
Internationally: Family financial 
overload related to medical 
appointments, private rehabilitation 
and transport [115]
(continued)
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•  Untrained health care 
professionals in primary and 
secondary care services
Delayed mobilisation and functional 
independence training
•  Evidence-based recommendation 
of early mobilisation, pain and 
delirium management, and fall risk 
assessment is not in routine care 
yet
•  Lack of training for nurses, 
physiotherapists and occupation 
therapists
•  Lack of a coordinated 
multidisciplinary approach
•  Failure to assess frailty and 
patients’ previous and ongoing 
cognitive status with consequently 
limited access to appropriate and 
timely rehabilitation interventions
•  Poor attitude or bias against 
patients who are very old and/or 
with cognitive decline due to 
belief that outcomes will be 
disappointing and rehabilitation 
ineffective, thereby hopeless
India and China: Lack of falls 
assessment significant gap in care 
pathway for hip fracture in hospitals 
[105, 109]
Brazil: Falls are the main cause of 
death during the first 30 days after 
surgery, representing 43.5% of deaths 
[116]
Table 12.10 (continued)
12.9.1  Key Evidence-Based Recommendations  
and Their Implementation in LMICs
Implementation of evidence-based recommendations in LMICs is challenging but 
should not be interpreted as a wasted effort. Table 12.12 lists some key evidence-
based recommendations and suggestions for implementation of in-hospital rehabili-
tation and community rehabilitation following hip fracture surgery in LMICs, based 
on expert opinion. Suggestions with limited formal evidence but apparent face 
validity include involving families as partners early and explicitly including them in 
the care plan and ensuring that ward nurses and therapists jointly commit to deliver-
ing the mobility goals.
With limited infrastructure (rehabilitation units and trained therapists) and rap-
idly growing demand, disruptive approaches to rehabilitation are needed in LMICs. 
WHO’s Integrated Care for Older People (ICOPE) programme for older people is a 
community-based primary care health ageing approach which focuses on ways of 
optimising a community dwelling older person’s function. However, many of the 
tools and resources provided in this programme allow community workers to design 
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Table 12.11 Barriers to rehabilitation in the community in LMICs




Lack of comprehensive geriatric care services to 
conduct structured, systematic inter-disciplinary 
geriatric assessment (including physical and 
mental health, function and social support 
condition)
Ineffective and under-utilised referral pathways 
to rehabilitation after hospital discharge
No timely and affordable rehabilitation 
interventions (long waiting times)
Lack of adequate service network and 
rehabilitation facilities to meet different 
rehabilitation needs (inpatient, outpatient and 
homecare)
Lack of rehabilitation staff, particularly 
occupational therapists
Poor adherence due to lack of transportation, 
inability of caregiver to take time off work and 
long distances to rehabilitation facilities
Inadequate resources (assistive technologies and 
devices)
Lack of standardised protocols for post-acute care
Lack of accessibility and poor neighbourhoods 
preventing independence in walking outdoors
Taiwan: Community-
based home care services 
are designed for people 
with long-term care needs 
and are mainly skilled 
nursing care—doesn’t 
completely fit post-acute 
care needs [117]
Brazil: 70% patients had 
≤3 months rehabilitation 
after surgery, mostly one 
time weekly;a 17% had 
home care rehabilitation 
[118]
India and Brazil: 
Physiotherapy largely 
delivered in acute care, 
access difficult in public 
services. Most families 
don’t have resources to 
pay for private services
Brazil: Majority of 
rehabilitation 
programmes based on the 
model of traditional 
clinic- and hospital-based 
settings, failing to reach 
frail older adults at home
Cultural and 
social influences
Negative social representation of old age
Cultural attitudes and beliefs toward disability in 
old age, older adults have to be convinced that 
mobility related problems are treatable and falls 
can be prevented
Brazil: Negative 
connotations of age and a 
sense of passivity were 
experienced by older 
adults after hip fracture 
surgery, leading to 




Lack of training on systematic inter disciplinary 
geriatric assessment
Lack of training on fragility fractures, frailty, 
sarcopenia and bone health
Lack of training on evidence-based exercise 
approach (balance and resistance training and 
falls prevention)
Lack of fracture liaison services with a 
multidisciplinary care approach
aSecondary data from a clinical trial
individualised programmes for older people. Available as an app or on-line some of 
these practical approaches (e.g. on nutrition, polypharmacy, carer support) could be 
helpful for primary care workers once a patient with a hip fracture returns home 
(available from www.who.int/ageing/health-systems/icope/en/).
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Table 12.12 Implementation strategies in LMICs, based on expert opinion
In-hospital rehabilitation evidence-
based recommendations Suggested implementation strategies
1.  Comprehensive screening and 
assessment of older adults 
immediately after admission on 
trauma or orthopedic ward by a 
skilled trained nurse
•  Make available a short, feasible, reliable and valid tool 
kit for nurses to screen for frailty and delirium
•  Identify poor nutritional status and dysphagia as early 
as possible
• Take actions to overcome modifiable risk factors
•  Where orthogeriatric care is not routine, nurses should 
request a geriatric consultation for complex cases
•  Where rehabilitation team members are available 
(physiatrist, physiotherapist, occupational therapist 
and speech therapy) a multidisciplinary assessment 
should be conducted
2.  Physiotherapy approach 
immediately after admission
If surgery is delayed, immediate physiotherapy should 
begin to prevent muscle strength decline of the 
non-fractured leg, avoid respiratory problems (such as 
pneumonia), and pressure ulcers
3.  Include caregivers in the care 
planning from time of ward 
admission
Caregivers may request to stay with older adults in the 
ward and should be included in the care plan. Train 
caregivers to identify signs of complications (such as 
delirium, swallowing problems, falls, pain) and help 
with daily basic activities, this can build and strengthen 
their skills for hospital discharge. Empower caregivers 
as co-participants in care during hospital stay
4.  Surgical planning should target 
early weight-bearing
Weight-bearing restriction in the post-operative phase 
should be avoided since it limits what a patient can 
achieve in terms of mobility and functional 
independence. Effective surgery allows early weight 
bearing
5.  Early mobilisation after surgery 
(24 h after surgery)
Unless medically or surgically contraindicated, 
physiotherapists and/or nurses should sit patients out of 
bed, and walk as early as possible
Care plans delivered co-jointly by nurses and 
physiotherapists can promote patients’ mobility over the 
entire day
6.  Early post-operative goal-directed 
mobilisation practice with balance 
and functional exercises
Begin progressive resistance exercises, weight-bearing 
exercises (unless contra-indicated) and balance 
exercises during hospital stay, starting as early as 
possible
Some services in LMICs are based on early discharge 
from hospital to rehabilitation at home (“hospital at 
home”). Harness informal and formal caregiving 
training and use technology but be aware how to 
achieve the best results when relying on families as 
therapists in LMICs, particularly when education levels 
are low
7.  Fall risk assessment during 
hospital stay
Provide falls risk assessments to patients/caregivers 
with educational information and referral to community 
services after discharge
8. Discharge planning Nurses should prepare caregivers for the level of care at 
home. Educational materials and practical carer training 
should be provided where possible [119]
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Access to rehabilitation with the associated opportunity to maximise function 
and quality of life is increasingly recognised as a human right. Efforts to increase 
therapist numbers and optimise older patients’ access to evidence-based hospital 
rehabilitation programmes have been strengthened by WHO’s recent Rehabilitation 
2030: Call to Action [1]. But as the pressure increases for health systems to provide 
universal coverage with access to rehabilitation it is likely that community-based 
rehabilitation will become more important as a cost-effective way to deliver ser-
vices. Globally, community rehabilitation is also likely to become the focus for 
future research efforts to maximise recovery, partly because of the long trajectories 
of recovery (particularly of mobility) after hip fracture and partly because older 
people are increasingly vocal about prioritising returning home as quickly as 
possible.
12.10  Conclusion
• A rehabilitation pathway includes: (1) early and intensive mobility and self-care 
retraining with medical minimisation of complications and problems from 
comorbidities; (2) chronic care interventions (including dementia and frailty 
assessment and falls prevention) and (3) access to community services, including 
aged care support services and allied health therapies.
• Patients with cognitive impairment should not be excluded from rehabilitation 
following hip fracture.
• Recovery time for different functional domains varies from less than 6 months 
for many activities of daily living and cognitive function to over a year for walk-
ing 3 m without assistance.
• Rehabilitation programmes should be multidisciplinary with integration of 
orthogeriatric and rehabilitation services, or include professionals with multidis-
ciplinary competencies. They should include early comprehensive geriatric 
assessment, surgery and mobilisation, with higher doses of mobility training and 
an emphasis on regaining functional independence. Programmes should also 
begin soon after hospital admission and continue after hospital discharge.
• In-patient rehabilitation programmes should include goal-directed mobilisation 
practice with balance and functional exercises.
• Structured exercise programmes should continue beyond the hospital setting for 
at least 12 weeks and may include progressive resistance training.
• Exercise programmes should incorporate components targeting self-efficacy to 
support patients to build their confidence to undertake exercise programmes 
post-discharge.
• Where possible a chronic disease self-management approach should be used 
with patients and families to promote self-efficacy and adherence to falls preven-
tion strategies, osteoporosis treatment and exercise programmes.
• Self-efficacy, social support and caregiver responses play a role in recovery and 
can assist in rehabilitation in hospital and at home. Caregivers should be included 
in every phase of the recovery e.g. during care and discharge planning.
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• Whilst there are many barriers to providing rehabilitation services in lower to 
middle income countries, implementation of evidence-based recommendations 
should not be viewed as futile. Health care professionals at all levels should not 
accept cognitive and physical functioning limitations as a normal age-related 
pathway for older patients after hip fracture surgery.
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13.1  Why Is Psychological Status Important 
in the Management of Hip Fracture?
Hip fractures are associated with reduced health-related quality of life (QoL). 
Buckling and colleagues [1] have found a pre-existing need for care, limited func-
tion, cognitive impairment and depression to be independent factors associated with 
lower QoL during a patient’s post-surgical period. To assign a realistic value to 
osteoporosis and osteoporotic fracture treatment, it is important to understand the 
full impact that osteoporotic fractures have on QoL. In fact, QoL can predict mortal-
ity, as well as physical and psychological functioning [2].
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13.1.1  Why Is Psychological Status Important in the Outcome 
of Hip Fracture?
Depression, delirium, and cognitive-impairment rates, at the time of hip fracture, 
have been estimated at between 9% and 47% (mean 29%), between 43% and 61% 
(mean 49%), and between 31% and 88% (mean 47%), respectively [3]. Mental 
health status at the time of surgery has been reported as being an important determi-
nant of the outcome, with mental disorders associated with poorer functional recov-
ery and higher mortality rates [4]. For example, a functional decline can lead to 
disability and may lead to prolonged hospital stays, institutionalisation and even 
death [5].
It has also been suggested that pre-fracture dependence in ADL is a stronger 
predictor of further functional decline—resulting in institutionalisation or death—
than pre-fracture dementia [6]. Furthermore, delirium is associated with lower func-
tional outcome in both short and long term and recovery increased length of stay, 
high risk of dementia and persistent cognitive deficits [7]. Delirium is also associ-
ated with other hospital-acquired complications that translate into higher rates of 
institutionalisation, greater need for rehabilitation and home healthcare services 
after discharge, increased mortality and healthcare costs, as well as an additional 
burden on the patient, hospital staff and family caregivers [8].
13.1.2  Why Is Psychological Status Important in Rehabilitation 
from Hip Fracture?
A study [9] showed that delirium was independently associated with poor func-
tional outcome 1 month after fracture even after adjusting for pre-fracture frailty. 
Also at the 6-month follow-up, it constitutes an independent risk factor for insti-
tutionalisation among hip-fracture patients who live at home before the fracture. 
In the case of patients who are able to return to their homes, delirium is a strong 
predictor of functional decline at the 6-month follow-up [10]. Regarding depres-
sion, the literature showed that approximately one in five people who are not 
depressed at the time of their fracture become so after 8 weeks [11]. In a long-
term study [12], functional healing was evaluated after 2 years in elderly cases 
with hip fractures, and depression was reported to have affected healing. A nega-
tive effect of depression on daily living activities emerged also at the end of a 
6-month period. A patient’s active participation in the rehabilitation process has a 
positive effect on healing. However, the presence of depression disrupts this pro-
cess because of reluctance, negative cognition and symptoms similar to psycho-
motor retardation. Depression in elderly hip- fracture cases was found to have 
affected daily living activity negatively.
The psychological state of the individual who suffers from a hip fracture is highly 
relevant when determining how well that person may recover [13]. The affective 
responses to a hip fracture predict both psychological and physical functioning over 
time, providing a potential target for the enhancement of recovery from this 
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debilitating injury [14]. It is also suggested that the effect of rehabilitation after hip 
fracture can be less effective if functions are restricted due to fear of falling (FOF) 
[15]. For all the aspects mentioned earlier, it seems important to take care of the HF 
patient’s psychological status.
13.1.3  Why Is Caregivers’ Psychological Status also Important?
Hip-fracture (HF) patients are among the most vulnerable of hospitalised patients. 
The associated caregiving rehabilitation task often falls to a member of the family. 
Most caregivers (86%) are family members (predominantly women) also known as 
‘informal caregivers’ [16]. They fulfil their role for between 7 and 11 h per day on 
average and anything up to 10–15 h when clinical conditions worsen: the more serious 
the fracture, the more support is needed [17, 18]. Usually, they have no professional 
assistance-procedure skills. Informal caregivers must cope with physical, psychologi-
cal and social stressors that affect their health status and quality of life negatively.
The primary stressors experienced by informal caregivers are related to the 
severity of the patient’s disease and the amount of time devoted to assisting him/her. 
Informal caregivers are an important resource for elderly patients suffering from hip 
fractures because they play a key role during their recovery. One important task is 
that of motivating the patients to adhere to their therapy programme. Elderly patients 
with a hip fracture may present with a complexity of other problems, which may be 
challenging to both them and their carers.
13.1.4  Consequences of Caregiving
The level of family caregivers’ mental health has been shown to be an important 
predictor of care recipients’ institutionalisation [19], and a risk factor for care–
recipient mortality. Objective primary stressors can affect various dimensions of 
burden differently: functional health has been found to be associated with time- 
dependent, physical and developmental burdens; cognitive status has been found to 
be associated with a time-dependent burden. Patterns of change in family caregiv-
ers’ mental health over time have also been explored, as have the relationships 
between family caregivers’ mental health and recovery outcomes of elderly hip- 
fractured patients. The findings suggest that, during the first year following patient 
discharge, family caregivers’ mental health is associated with patients’ post-fracture 
recovery, including the recovery of physical functionality, reduced pain and better 
health-related outcomes.
These results also suggest that, when estimating recovery times and health- 
related outcomes of patients who have suffered from hip fractures, healthcare pro-
viders should also consider the mental well-being of family caregivers. An 
understanding of the relationships between caregiver-related predictors and the 
recovery of elderly persons after hip-fracture surgery might provide a more holistic 
view of that recovery [20]. The perspective that tends to dominate much of the 
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literature is that care by family members is provided solely to older adults living at 
home. When caregivers are monitored over considerably long periods of time, it 
becomes evident that family caregiving responsibilities do not end with institution-
alisation of the disabled relative. Instead, this key transition appears to affect the 
type and intensity of help provided.
Unlike earlier studies that treated institutionalisation as an ‘endpoint’ in family 
caregiving, recent research has emphasised the continued involvement of relatives 
in care and the effects of nursing-home admission upon the stress and mental health 
of family members. There is a lack of literature addressing family caregiving for 
frail elderly people and its consequence on the life quality of family caregivers. The 
subjective responses of individuals to the environments in which they live play an 
important role in maintaining the status of their care recipients. High levels of 
depressive symptoms and low levels of life satisfaction in caregivers may also be 
associated with the low quality of the care provided to their frail care recipients and 
even with maltreatment of the elderly [21].
Caregiver burden and its associated stress impact negatively upon the caregivers’ 
perceived general physical and mental health [22] and have been negatively corre-
lated with the functional status of elderly family members 1 month after discharge 
following hip-fracture surgery [23, 24].
13.1.5  The Relationship Between Caregivers’ and Patients’ 
Psychological Status
In a recent study, we found a correlation between the patient’s psychological 
well- being and the caregiver’s burden. At the 2-month follow-up, the outcome of 
ADL scores was negatively associated with caregiver burden (p  <  0.01). 
Follow-up functional ability was higher in patients whose caregivers reported 
lower burden during their hospitalisation (p = 0.03). Interesting results regard the 
correlation existing between a patient’s psychological well-being and his/her 
mood; greater psychological well-being corresponds, in fact, to lower likelihood 
of depression.
A mutual relationship seems, therefore, to exist between the patient’s psychologi-
cal well-being and the caregiver’s burden, so that improvements in the state of health 
of the one boost that of the other, and vice versa. This datum confirms the importance 
of using a bio-psycho-social approach when dealing with both patients and caregivers 
and evaluating the HF patient’s and caregiver’s psychological status [25, 26].
13.2  How Should the Psychological Status of Patients 
and Caregivers Be Assessed?
In Table 13.1, we illustrate the different areas we believe it is important to evaluate 
to obtain a complete assessment of HF patients and relative caregivers during the 
different stages of the illness and recovery.
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13.2.1  The Psychological Evaluation of the Patient
The recovery process that follows surgery varies based on the patients’ comorbidi-
ties, cognitive and functional status and their psychosocial state. Well-being in this 
sense means more than health as such. It is important to evaluate different negative 
and positive dimensions to assess patients’ psychological status when following a 
bio-psycho-social approach.
13.2.1.1  Quality of Life
Health-related Quality of Life (QoL) is recognised as an important measure of 
health status that may be used for evaluating disease and health care services [27]. 
It is a broad, multidimensional construct that includes domains such as physical, 
psychological and social functionality [28], which permits identification of specific 
aspects of QoL and targeting of interventions needed.
Some patients suffer from QoL [29] and well-being loss [30] while others move 
to nursing home facilities [31]. According to Rasmussen and colleagues [32], well- 
being and self-efficacy are resources for both health and illness to be considered 
when exploring ways of promoting possibilities of recovery. The importance of 
patients’ perception of the care they receive has been highlighted in the literature 
over the past few years [33]. Without QoL data, the burden of osteoporotic fractures 
is likely to be underestimated [34]. The EQ-5D has been recommended for the 
assessment of QoL in elderly patients [35]. Although this instrument shows good 
psychometric properties in elderly patients, assessing the QoL of cognitively 
impaired patients is difficult. In people with mild and moderate dementia, these 
tests yield good validity and good-to-average test–retest reliability for the descrip-
tive system, but not for the Visual Analogue Scale (VAS), which is a part of this 
questionnaire.
Table 13.1 Areas to be evaluated in an integrative assessment in HF patients and caregivers, at 




1 2 3 4 5
Patient
Quality of life X X X
Fear of falling X
Pain X X
Activities of daily living X X X
Delirium X X





Psychological well-being X X X
Caregiver’s burden X X X
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Proxy assessment is, in some cases, the only way to gather information regarding 
QoL, when patients are unable to respond. Family caregivers tend to overestimate 
health limitations concerning less visible items (pain and anxiety/depression). Very 
frequently, healthcare professionals rate patients at the same level for all five domains 
(some problems with everything). No consensus has been reached as to the most 
appropriate proxy to apply, but a proxy assessment of EQ-5D seems, in our opinion, 
to be the best option when assessing QoL in patients with severe dementia. QoL 
should be assessed using the EQ-5D method upon admission to determine pre- fracture 
QoL and in post-admission 90-day and 1-year follow-ups. In patients affected by 
severe dementia, EQ-5D should be completed by a proxy, if one is available [36].
13.2.1.2  Fear of Falling
Fear of falling is linked to self-efficacy—the belief people have about their capabil-
ity to perform certain tasks [37].
After a hip fracture, older people have reported that their lives have changed 
physically, personally and socially [38]. McMillan and colleagues [39] conducted 
interviews 3 months after discharge from the hospital and found that during hip 
fracture rehabilitation, older people struggled to take control of their future lives by 
trying to balance risk-taking and help-seeking. The interviewees were aware that, 
on the one hand, it might prove risky to move around and that they were afraid of 
falling but, on the other, they wanted to be active and were trying to do things. They 
were determined to regain independence. To make progress, some of the interview-
ees stressed the importance of giving information to patients and to include them in 
talks regarding their progress. In the patient follow-up, FOF should be assessed 
90 days after admission.
13.2.1.3  Pain
In the HF patients, pain should be assessed, initially, during the EQ-5D test; how-
ever, as we said before, the VAS used by EQ-5D is not reliable in cognitively 
impaired patients [35]. Therefore, VAS within EQ-5D rates overall body pain, 
while we are also interested in the pain at the site of the fracture. The Verbal 
Rating Scale (VRS) performs well in cases of patients with dementia, and it is 
more informative regarding fracture-site pain [40]. Liem and colleagues [36] 
agree that this test should be used on the second day after surgery—or, in cases of 
conservative treatment, the second day after admission—and at 90 days and 1 year 
after admission.
13.2.1.4  Activities of Daily Living
Activities of daily living (ADLs) are an important health outcome in the orthogeri-
atric population. Recovery of pre-fracture health and functional levels is one of the 
main goals in hip fracture management. Therefore, it is important to assess deterio-
ration in functional level over time. The literature provides a vast selection of ADL 
measurement tools, but the Katz Activities of Daily Living Scale [41], is the most 
widely used. In many cases, it may prove difficult to assess pre-injury ADLs accu-
rately at the time of admission. In such cases, we suggest consulting a proxy, who 
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will typically be a family member, friend or caregiver. ADLs should be assessed 
upon admission to evaluate pre-fracture status. During patient follow-up, ADLs 
should be assessed after 90 days and 1 year after admission.
13.2.1.5  Delirium
Delirium in hip-fracture patients usually occurs during the 2–5 days following sur-
gery. It is common in elderly hip fracture patients, occurring in 10–61% of cases 
[42]. It can represent a difficult clinical condition to assess, as a fluctuation of 
symptoms can lead to failure to recognise its onset [43]. Dementia and cognitive 
decline, measured by MMSE, were found to be independent risk factors for delir-
ium [44]. The Confusion Assessment Method (CAM) [45] is a reliable and valid 
measure of delirium in the general medical and surgical population. The CAM 
focuses on four features: (1) acute change in mental status with a fluctuating 
course, (2) inattention, (3) disorganised thinking and (4) altered level of conscious-
ness and is a valuable instrument with which to assess delirium. Delirium should 
be assessed upon admission to evaluate the pre-fracture status and on discharge 
after acute hospitalisation.
13.2.1.6  Depression
Depression is the most common hip-fracture-related psychological disorder, 
although it is frequently difficult to assess it [46]. An independent relationship was 
found to exist between low functional capacity and depression symptoms in the 
elderly [47]. In elderly people who cannot walk well enough to perform daily living 
activities, social isolation often occurs, and social isolation is in itself a risk factor 
for depression [48]. Therefore, we can say that a vicious circle of low ADL is cre-
ated between pre-existing depression and an increase in depression that feelings of 
inadequacy when performing daily activities can produce. The Geriatric Depression 
Scale (GDS) may be a valuable instrument by which to assess depression [49]. 
Depression was observed more often in females and those who had lost their spouses 
[11]. Depression should be assessed upon admission to evaluate its pre-fracture 
status. During patient follow-up, it should be assessed after 90 days, 1 and 2 years 
from the date of admission.
13.2.1.7  Cognitive Impairment
Some studies suggest that cognitive impairment, found in 31–88% of elderly 
patients experiencing hip fractures, was a predictor of poor functional recovery after 
hip-fracture surgery [13]. Furthermore, pre-fracture cognitive impairment is also 
associated [4] with higher mortality rates. The Mini-Mental State Examination 
(MMSE) [50] may prove to be a valuable instrument for the assessment of cognitive 
impairment. Cognitive impairment should be assessed upon admission to evaluate 
the pre-fracture status.
13.2.1.8  Stress
The importance of the overlapping mechanisms of osteoporosis and psychological 
stress were documented recently.
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These factors can be extended to fragility fractures [51]. The Perceived Stress 
Scale [52] can prove useful when assessing stress. Stress should be appraised at 
discharge and 90 days after admission.
13.2.1.9  Anxiety
This emerged as one of the most important aspects regarding patients, especially 
their evaluation upon admission [26]. The Short Anxiety Screening Test [53] has 
been shown to be an easy and valuable one for the assessment of anxiety in this type 
of patient. Anxiety should also be assessed upon discharge and 90  days after 
admission.
13.2.2  The Psychological Evaluation of Caregivers
The increased risk of burnout identified among informal caregivers is closely related 
to their perceived level of burden, defined as a multidimensional response to nega-
tive appraisals and perceived stress [54]. Joint assessment of the dimensions of bur-
den and well-being, that coexist in caregivers’ experience, allows for the 
identification of personal and relational resources that may be usefully included in 
interventions addressed to caregivers [16, 17, 54].
13.2.2.1  Psychological Well-Being
The concept of subjective well-being (SWB) is multi-component by nature. It is 
affected by positive (e.g. happiness), negative (e.g. depressive symptoms) and cog-
nitive components (e.g. life satisfaction). Its multiple components are affected by 
different sets of social determinants and develop differently at successive life 
stages [55]. High care-demand levels may affect multiple aspects of caregivers’ 
lives, including free time, social life, emotional and physical health as well as per-
sonal development. These subjectively defined stressors are also called caregiver 
burden. Perceived caregiver burden may adversely affect their self-esteem and 
their sense of competency as a caregiver [21]. These might cause caregivers to suf-
fer from higher levels of depressive symptoms and become less satisfied with 
their lives.
In other words, multidimensional caregiver burdens may play a mediatory role in 
the association between objective primary stressors and caregivers’ SWB.  The 
Psychological General Well-Being Index (PGWBI) [56] can prove to be a valuable 
test for the investigation of patients’ and caregivers’ psychological well-being. 
Psychological well-being should be assessed after admission and at 90 days and 
1 year after admission.
13.2.2.2  The Caregiver Burden
Informal caregivers have to cope with physical, psychological and social stressors 
that affect their health conditions and quality of life negatively [57]. Over the last 
30 years, researchers have paid special attention to the investigation and assessment 
of burden [58]. The Caregiver Burden Inventory (CBI) [59] provides information 
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regarding both the Objective Burden (OB)—the time and commitment caregivers 
devote to caring activities daily—and the Subjective Burden (SB)—perceived lack 
of everyday opportunities, fatigue, physical problems, issues related to socialisation 
and participation, and how they feel towards the care–recipient. Caregiver burden is 
an all-encompassing term used to describe the physical, emotional and financial 
responses of a caregiver to the changes and demands caused by providing help to 
another person with a physical or mental disability.
Increasing numbers of studies have examined the caregiver-burden phenomenon, 
the lack of support given to caregivers and interventions focused on relieving care-
giver burden; this increase is probably due in part to greater evidence of caregiver 
burden being a determining factor in the quality of life (QoL) of caregivers. Several 
studies have revealed an association between the characteristics of patients and 
caregivers and caregivers’ QoL, with caregiver burden serving as an important pre-
dictor of QoL. Caregiver burden has also been used as an outcome variable rather 
than a predictor [60], suggesting that caregiver burden and QoL are closely related. 
Thus, caregiver burden seems to be a potential moderator of the associations 
between patients’ and caregivers’ characteristics and caregivers’ QoL. Some studies 
have shown that caregivers of elderly people suffering from hip fractures experi-
enced a multidimensional burden, including tiredness, emotional distress and role 
conflicts [22, 23].
Many caregivers assume the caregiver role with little or no preparation and have 
to learn to deal with several aspects of care in a very short time. Often caregivers do 
not know what to expect during hip fracture recovery. They face situations where 
they have to address various care-related tasks, such as the arrangement of rehabili-
tation services and assistive devices. These situations become more stressful when 
caregivers must juggle their work and family lives. The care burden related to hip 
fracture, an acute injury, may decrease over time; however, it is often prolonged 
over 12 months or more [61]. Caregivers tend to experience the greatest stress dur-
ing the first 2 months after fracture, the stress being associated with increased care 
demands and costs. Family caregivers of hip-fractured patients were reported as 
experiencing moderate burden [23]. Furthermore, the caregiver’s burden was nega-
tively related to the physical function of older patients with hip fracture. On the 
other hand, social support has been associated with a diminution of the caregiver 
burden [24]. The caregiver’s burden should be assessed after admission as well as at 
90 days and 1 year after admission.
13.3  How Can Psychological Status Be Influenced Positively 
by the Orthogeriatric Team?
We have found that a mutual relationship seems to exist between the patient’s psy-
chological well-being and the caregiver’s burden, so that improvement in the state 
of health of the one boost that of the other, and vice versa. The correlation emerging 
between patients’ psychological well-being and their caregivers’ burden confirms 
the importance of using a bio-psycho-social approach towards patients and 
13 The Psychological Health of Patients and their Caregivers
232
caregivers [25, 26]. Unfortunately, no specific researches have nowadays studied 
how the psychological status of the patient and the caregiver can be positively influ-
enced by the orthogeriatric team. Further studies are therefore needed to better 
understand what can be done to improve psychological health.
In the previous paragraphs, we showed the different negative and positive dimen-
sions that are important to evaluate, the staging we suggest and instruments we 
believe to be the most appropriate. The orthogeriatric team should address these 
aspects following a bio-psycho-social approach. The inclusion of a psychologist in 
the team can help in the assessment of the patients’ and the caregivers’ psychologi-
cal well-being, using the tools we have detailed earlier, but also enables psychologi-
cal counselling. In the course of counselling, the psychologist can also obtain more 
qualitative data, to tailor the intervention based on the resources and needs emerg-
ing and give feedback to the patients and their caregivers on the problems and the 
strengths that emerged in the assessment. A pilot study suggested, for example, the 
positive influence that twice-a-week counselling, for about 45 min, had a positive 
influence on HF patients’ depressive and anxious symptoms. Although long-term 
follow-up studies are necessary to evaluate whether good early results are sustained 
over a longer period, these data suggest that counselling can be useful in these 
patients [61].
The literature shows that these patients risk much longer, and more frequent 
hospital stays than other adults. Comprehensive discharge-planning programmes, 
including early identification of those at risk, can alter these statistics. Upon admis-
sion to care facilities, early multidimensional assessment can provide significant 
indications of how to address the entire course of patient treatment more efficiently. 
In our experience, the organisation of formative courses for caregivers and the 
implementation of a ‘caregiver help desk’, with the collaboration of case manager 
nurses, can be additional tools that the orthogeriatric team can use to promote a 
comprehensive discharge-planning programme enhancing, in this way, the psycho-
logical health of HF patients and their caregivers.
Greater psycho-educational support can be provided to patients and caregivers 
during rehabilitation, given the longer length of stay, compared to admission in 
other post-surgical settings.
13.4  Cultural Influence and the Anthropology of Care
To support patients and caregivers better, it is important to include cultural and 
anthropological influence in the dynamics of care.
All over the world women are the predominant providers of informal care to fam-
ily members with chronic medical conditions or disabilities, including the elderly 
and adults with mental illnesses. It has been suggested that several societal and 
cultural demands are made on women obliging them to assume the role of family 
caregiver.
Stress-coping theories propose that women are more likely to be exposed to care-
giving stressors, and are likely to perceive, report and cope with these stressors 
differently from men [62, 63].
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Many studies, which have examined gender differences among family caregivers 
looking after people with mental illnesses, have concluded that women spend more 
time in providing care and carrying out personal care tasks than men. These studies 
have also found that women experience greater mental and physical strain, greater 
caregiving-burden, and higher levels of psychological distress while providing care 
[64, 65].
However, an almost equal number of studies have not found any differences 
between men and women as far as these aspects are concerned. This has led to the 
view that though there may be certain differences between male and female caregiv-
ers, most of these are small and of doubtful clinical significance. Accordingly, care-
giver–gender is thought to explain only a negligible proportion of the variance in 
negative caregiving outcomes [66, 67].
A similar inconsistency characterises the explanations provided for gender dif-
ferences in caregiving such as role expectations, differences in stress, coping and 
social support, and response biases involved in reporting distress. Apart from the 
equivocal and inconsistent evidence provided, there are other problems in the litera-
ture on gender differences regarding the issue of caregiving. Most of the evidence 
has been derived from studies on caregivers dealing with elderly people suffering 
either from dementia or a variety of physical conditions [68, 69].
With changing demographics and social norms men are increasingly assuming 
the role of caregiver. However, the experience of care-providing men has not been 
adequately explored. The impact of gender on the outcome of caregiving may be 
mediated by several other variables including patient-related factors, socio- 
demographic variables, and the effects of kinship, culture and ethnicity, but these 
have seldom been considered in research into gender differences [70, 71].
Beyond the gender aspect, each culture and nation have its own way of establish-
ing the care relationship between the patient and the caregiver. A study conducted in 
different European countries, for example, found that in countries where cross- 
generational support is more strongly established (Italy, Spain), the impact of fragil-
ity fractures on caregivers is generally higher than in the other countries (i.e. France) 
[72]. Contemporary literature reveals that global economic shifts, migration, and 
chronic disease are enlarging the demand for care of the elderly while, at the same 
time, altering intergenerational expectations; the critical roles older persons play in 
familial care systems as global care chains are becoming increasingly clear [73]. 
Migrant care workers frequently look after elderly people with significantly differ-
ent bodily and historical experiences, drawing creatively upon their models of care 
to define cultural and gender-based identities and make claims concerning their 
contribution to the nation [74].
These aspects need to be considered, for example, during training courses for 
caregivers.
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The fragility fracture epidemic is considerable, affecting one in three women and 
one in five men over the age of 50 years in the Western world [1–3]. This has signifi-
cant cost to the individual (in terms of morbidity and mortality) but also accrues 
significant financial costs to the global health economy. Indeed, the annual cost of 
fragility fractures exceeded €37 billion in Europe (in 2010) [4] and $20 billion in 
the United States (in 1992) [5]. With the substantial burden of osteoporosis set to 
rise, the magnitude of this problem can only get larger.
In order to countermand the incidence of fragility fractures two main approaches 
are required. The first is to ensure that those with osteoporosis are adequately 
treated, but the second, on which we focus in this chapter, is the timely and effective 
identification of those at risk of fragility fractures [6].
The index fragility fracture is a vital signal to indicate the need to assess and treat 
osteoporosis the commencement, or at least consideration, of treatment. Despite 
this a large proportion of patients presenting to healthcare professionals remain 
needlessly at risk and untreated [4, 7] in a so-called ‘Treatment Gap’ [8], with esti-
mates suggesting that a mere 20% of fractured patients are assessed and treated 
appropriately (though this figure varies according to country and fracture site [9]). 
As a result, national and international clinical guidelines [10–12] and systematic 
reviews from the academic community [13, 14] recommend the use of a Fracture 
Liaison Service (FLS) in order to effectively close this treatment gap. It is also vital 
to establish an individual’s risk of fracture and use this parameter to determine a 
suitable management plan.
14.2  Fracture Risk Prediction
In 1994, the World Health Organization produced an operational definition of osteo-
porosis as a bone mineral density (BMD) T-score of −2.5 or lower [15] and this has 
subsequently become the diagnostic criterion. Indeed, there is a 1.5–2.5 fold 
increase in fracture risk with each standard deviation decrease in BMD [16], how-
ever, the sensitivity of BMD alone to identify those at risk of fracture is less than 
50% [17, 18] and many patients sustain fractures with a T score higher than −2.5. 
For this reason, fracture prediction tools have been developed to aid in the identifi-
cation of ‘at risk’ individuals.
The Fracture Risk Assessment Tool (FRAX) was developed via systematic meta- 
analysis of primary data from 9 geographically spread cohort studies and validated 
in a further 11 cohorts and was published in 2008 [19]. Key principles were used to 
identify variables to be included in the FRAX algorithm including:
• The variable should be intuitively linked to fracture.
• The variable should be readily clinically available.
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• The variable should be (at least partly) independent of BMD.
• The variable should be associated with a risk which might be reversed by phar-
macological therapy.
The clinical parameters chosen were age, sex, weight, height, previous fracture, 
parental hip fracture, current smoking, glucocorticoid usage, rheumatoid arthritis, 
secondary causes of osteoporosis, alcohol consumption and BMD (though this can 
be excluded in resource settings which preclude the measurement of BMD). The 
output is a 10-year probability of a major osteoporotic fracture (clinical spine, prox-
imal humerus, distal forearm or hip fracture) and the 10-year probability of hip 
fracture. Fracture incidence varies geographically across the globe [20] and FRAX 
is calibrated to provide country-specific models [21].
These percentage risks can be used to inform therapeutic intervention thresh-
olds. FRAX has been incorporated in more than 80 guidelines worldwide [21]. 
Examples include the guidance published by the National Osteoporosis 
Guidelines Group in the United Kingdom [22, 23], the National Osteoporosis 
Foundation (NOF) guidelines in the United States [24], The American College of 
Rheumatology (ACR) [25] and Scottish Intercollegiate Guidelines Network 
(SIGN) [26].
The Screening of Older women for the Prevention of fracture (SCOOP) trial 
aimed to establish the efficacy and cost-effectiveness of a community-based screen-
ing programme in primary care. A total of 12,483 women aged 70–85 years were 
recruited from general practice surgeries across the United Kingdom and ran-
domised to either fracture screening using FRAX with dual X-ray absorptiometry as 
required or ‘standard care‘ (as a control). The primary outcome was the proportion 
of individuals sustaining fragility fractures in each group and secondary outcomes 
included; the proportions of all fractures, the hip fracture rate, cost-effectiveness, 
mortality and EQ-5D in each group and the qualitative evaluation of acceptability 
for the participants.
The findings of the study were published in 2018. Although there was no signifi-
cant difference in the primary outcome of all osteoporosis-related fractures between 
the two groups (p = 0.178, HR 0.94 (0.85–1.03) or the rate of all clinical fractures 
(p = 0.83, HR 0.94 (0.86–1.03)), the rate of hip fracture was significantly lower in 
the screening arm (p = 0.002, HR 0.72 (0.59–0.89)) [27]. As shown in Fig. 14.1, the 
reduction in hip fracture risk was greater than 50% for those at highest risk of frac-
ture [28]. Later health economic analyses demonstrated that screening in this way is 
cost-saving [29]. In conclusion the SCOOP study suggests that adopting this screen-
ing strategy in this population had the potential to cost-effectively prevent 8000 hip 
fractures per year.
The use of fracture prediction tools, together with BMD measures (if available) 
and a population screening strategy can all assist in identifying patients at risk of 
primary and secondary fracture. Of course, a further method to identify and treat ‘at 
risk’ individuals is via a Fracture Liaison Service (FLS).
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14.3  Fracture Liaison Service
14.3.1  The FLS Model
The FLS model is a coordinator-based, secondary fracture prevention service which 
is implemented by a healthcare system in order to ensure that those patients present-
ing with a fragility fracture are identified as osteoporotic and at risk of falls, and 
thus managed as such [11, 30, 31] (Fig. 14.2). They serve two main purposes; one, 
to address the aforementioned problem of ‘The Treatment Gap’ and two, to improve 
communication between healthcare providers by providing a clearly defined path-
way for patients with fragility fractures. It is composed of a team of healthcare 
professionals including an FLS champion (usually from internal medicine or ortho-
paedics) and a team of junior clinicians, nurses, allied health professionals and 
administrators.
Through the work of a dedicated ‘case-finder’ (usually a clinical nurse specialist) 
the service will aim to identify and assess fracture patients according to pre- 
determined protocols in the geographic locality of the FLS and can be based in 
either primary or secondary care.
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Fig. 14.1 Impact of the SCOOP screening strategy on hip fracture compared with usual care 
(control arm). The result is depicted as a hazard ratio, across range of FRAX 10-year hip fracture 
probabilities at baseline (calculated without BMD). There was an interaction of efficacy with base-
line probability (p = 0.021). The symbols indicate the range of baseline probabilities in the whole 
study population (black symbols) and in the high-risk group identified by screening (white sym-
bols) [28]
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14.3.2  Evidence for Effectiveness of FLS
In 2013, there were 57 FLS worldwide registered with the IOF Capture the Fracture® 
programme. In the same year, FLS coverage was assessed in 19 of 27 European 
countries. It was estimated that there was an FLS in less than 10% of their health-
care institutions [9]. The story was even more concerning in the Asia-Pacific region 
with 9 out of 16 countries reporting that none of their hospitals had an FLS [32] and 
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Fig. 14.3 An example of a Fracture Liaison Service model in the United Kingdom
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only Singapore reported an established FLS in over half their hospitals [33]. The 
International Osteoporosis Foundation (IOF) Capture the Fracture® (CTF) initiative 
has also allowed effective mapping of FLS across the globe (Fig. 14.4) and thus 
demonstrates an increase in uptake since the 2013 census. Indeed, in 2018 the total 
number of FLS had risen to 327 (identifying over 345,000 fracture patients/year) 
with 80 new FLS in that year alone, and three new countries registering their first 
FLS; The Philippines, Sri Lanka and Saudi Arabia.
Beyond coverage, it was previously considered difficult to compare ‘inter- 
service’ efficacy and performance due to the wide range of service models in use 
[14], however, the CTF programme (launched in 2012) has drawn up standards 
against which services can be assessed. This ‘Best Practice Framework’ is an 
immense aid in comparing approaches and assessing the potential patient benefit. It 
identifies 13 criteria and standards including patient identification, patient evalua-
tion, post-assessment timing, vertebral fracture identification, assessment guide-
lines, assessment of secondary causes of osteoporosis, falls prevention services, 
multifaceted nature of assessment, medication initiation, medication review, com-
munication strategy, long-term management and database curation. Each of these 
standards is graded as bronze, silver or gold depending on the quality of the particu-
lar facet of the service. The FLS is then scored according to five domains composed 
of four different fracture types (hip, inpatient, outpatient and vertebral fractures) 
and an organisational domain (including falls assessment and database curation).
To engage the global medical community, CTF offers the Best Practice 
Recognition programme where FLS can submit their service to IOF for evaluation 
against the BPF standards in order to receive a gold, silver or bronze star. The FLS 
is showcased and plotted on the CTF Map of Best Practice that displays participat-
ing FLS in the programme and their respective achievement level (Fig. 14.4). To 
influence change, the map can be used as a visual representation of services which 
are available worldwide, their achievements, as well as the areas for improvement 
in secondary fracture prevention [34]. The map also serves as a policy advocacy tool 
that can be leveraged by healthcare professionals and clinics to reach out to policy 
makers in order to influence changes at national levels.
Fig. 14.4 The map of best practice recognises 327 FLS that identify over 345,000 patients every 
year in 41 countries
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Beyond the work by CTF, further analyses of the clinical and cost-effectiveness 
of FLS have been performed in recent years, including modelling within hypotheti-
cal cohorts.
Indeed McLellan and colleagues used a cost-effectiveness and budget-impact 
model (developed using 8 years of FLS data in a UK population) to show that, by 
implementing an FLS, 18 fractures could be prevented per year (for a hypothetical 
cohort of 1000 fragility fracture patients) providing an overall saving of £21,000 
[35]. A similar study of a hypothetical cohort of 1000 patients in a Swedish popula-
tion used a Markov micro simulation model to demonstrate that FLS implementa-
tion prevented 22 fractures with an incremental cost per QALY for FLS versus usual 
care of €14,029 [36].
In 2016, Hawley and colleagues examined the impact of FLS introduction or expan-
sion on hip fracture outcomes in the United Kingdom using the Hospital Episode 
Statistics database. Their natural experiment included patients across 11 acute hospital 
trusts in England who had sustained a hip fracture between 2003 and 2013 and were 
aged more than 60. Using time-series analyses, 30-day and 1-year mortality and sec-
ond hip fracture were examined before and after the change in fracture prevention 
services. Of the 33,152 primary hip fractures included in the study, 1288 (4.2%) went 
on to sustain a second hip fracture within 2 years, 3033 (9.5%) patients died within 
30 days of their primary hip fracture and 9662 (29.8%) died within 1 year [37]. The 
introduction or expansion of a nurse-led fracture liaison service was protective for 
30 day mortality (Hazard Ratio (HR) 0.80, 95% CI 0.71–0.91) and 1 year mortality 
(HR 0.84, 95% CI 0.77–0.93) (Fig. 14.5) [37]. However, there was no effect on the 
occurrence of second hip fracture and no account of whether patients were actually 
seen by the FLS. A parallel qualitative study was undertaken for the sites and identified 
ensuring good adherence as key for service effectiveness [38]. The findings of this 
study provide substantial evidence that delegating monitoring and adherence to exist-
ing primary care services blunts the effectiveness of FLSs and supports the need to 
include monitoring, at least in the short to medium term, within the FLS specification.
The cost-effectiveness of FLS as an intervention for hip fracture was addressed in 
2017 by Leal and colleagues who used Markov models to estimate the lifetime impact 
of an orthogeriatrician-led FLS, nurse-led FLS and usual care. They estimated that, 
for a female aged 83 years, an orthogeriatrician-led service was effective at £22,709 
per QALY for all costs and £12,860 per QALY for healthcare costs. For males the 
cost-effectiveness of healthcare costs was £14,525 per QALY. These findings demon-
strate that there is a significant economic rationale for the introduction of FLS. A more 
recent systematic review that included any study of FLSs irrespective of study design 
has also demonstrated the potential benefits from introduction of an FLS [39, 40].
The workforce impact and issues surrounding the running of an FLS were 
assessed in a qualitative analysis of interviews with 43 health professionals in the 
United Kingdom, all of whom had been involved in FLS [41]. Significant themes 
included communication, resourcing and adherence. It was felt that fracture preven-
tion coordinators improved communication within the multi-disciplinary team, 
however, communication between secondary and primary care was sometimes a 
challenge. It was noted that the writing of a business case (a fundamental step en 
route to establishing an FLS in a hospital trust in the United Kingdom) was chal-
lenging and that there was under-resourcing of FLS in some sectors. Patient 
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adherence to treatment was observed to be a weakness of the current FLS model and 
led to calls to improved medication monitoring.
In conclusion, an increasingly substantial body of research data supports the use 
of FLS by demonstrating a 50% reduction in hip fracture mortality, a 20% reduc-
tion in secondary fracture and reduced drug therapy and cost in regions served 
by an FLS.
14.4  How to Implement an FLS (a Step-by-Step Guide)
The key stages in the development of an FLS are developing national prioritisation, 
the business case, implementation and sustainability. The first step is prioritisation 
for FLS at the policy level nationally or regionally. This involves a national coalition 
of professional societies, patient groups, existing FLS champions and relevant pol-
icy makers at the regional and national level. Central to the process of prioritisation 
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patient, family, health care and societal benefits and includes a formal health eco-
nomic evaluation.
A FLS business case is then developed that reflects the local benefits of FLS 
implementation as well as the local FLS costs and inter-dependencies. This may 
need to be informed by pilot studies to ascertain the optimal minimally disruptive 
pathway for patients through the different stages of identification, investigation, 
treatment recommendation and monitoring [42]. Effective patient engagement is 
key to ensure the pathway is patient centred.
Effective staged implementation of the FLS and scaling to become sustainable 
requires embedding quality improvement cycles into service provision. The 
improvement cycles should be supported by local, regional and national and peer- 
peer and peer-expert forums for discussion and sharing learning. Tools to deliver 
these programmes of work are being developed by the Capture the Fracture working 
group and include national prioritisation advocacy, FLS budget impact calculators 
and different methods for mentoring FLSs through implementation and sustainabil-
ity of their services.
A coherent multi-disciplinary team should be identified and recruited, including 
a lead champion for osteoporosis, orthopaedic surgeon, physicians (likely to come 
from specialties including geriatrics, rheumatology or endocrinology), DXA- 
specialist radiologists, specialist nurses, physiotherapists and an FLS coordinator. 
The project team should also include representation from relevant stakeholders 
including pharmacy, primary care physicians, health system administration, patient 
champions, charity sector and the health system management funders. This team 
will provide a holistic overview and ensure that the FLS is structured to perform the 
functions required by all stakeholders. An initial audit should be performed in order 
to provide a ‘pre-FLS’ baseline for future analyses of quality improvement. The 
data collected should include the number of individuals aged ≥50 years who attend 
with a hip fragility fracture, with a previous fragility fracture in the last 2 years, 
already receiving anti-osteoporosis medications and discharged on anti- osteoporosis 
medication. Additional information on length of stay, discharge destination, health-
care costs and extension to other fracture types will depend on the availability of 
contemporary national data.
14.4.1  Benchmarking Your Service
The processes of quality improvement described through ‘Plan-Do-Study-Act’ 
above only allow assessment of the service against itself; however, it has previously 
been identified that it would be helpful to compare the service to other FLS both 
nationally and internationally. The IOF has devised a Best Practice Framework for 
this purpose and FLS can register on the CTF website to be mapped and bench-
marked. The 13 benchmarking criteria are graded as Level 1, 2 or 3 (3 being the best 
example of practice), as seen in Table 14.1 and include the following:
 1. Patient identification—patients with fragility fractures may be identified (level 
1), tracked through the health system and may be independently reviewed by 
the FLS (level 2 and 3).
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 2. Patient evaluation—assesses the percentage of patients with a fragilty fracture 
who have been evaluated for the risk of future fracture via a clinical prediction 
tool (FRAX®) or assessment of bone mineral density.
 3. Post-fracture assessment timing—assesses how quickly patients with fragility 
fractures are assessed with a formal fracture risk assessment by the FLS in 
weeks since the fracture.
 4. Vertebral fracture identification—despite being the most common fragility 
fracture many vertebral fractures are identified by chance (e.g. as incidental 
findings in radiological investigations) due to variation in clinical presentation. 
To achieve the highest level of practice in this criterion it is necessary to liaise 
with radiology to ensure that they identify and report vertebral fractures and 
provide a coherent pathway for these patients to access the FLS.
 5. Assessment guidelines—evaluates whether the practice of the FLS is aligned to 
local, national or international guidance for the assessment of fragility fractures.
 6. Secondary causes of osteoporosis—assesses the percentage of patients with 
fragility fractures who are screened for secondary causes of osteoporosis.
 7. Falls prevention services—concerns the percentage of patients evaluated for 
referral to a falls service.
 8. Multifaceted assessment—addresses the assessment (and management) of life-
style factors which may underlie the fracture.
 9. Medication initiation—includes the percentage of patients who were eligible 
for treatment receiving anti-osteoporosis medication.
Table 14.1 The Capture the Fracture® Best Practice Framework for the international benchmark-
ing of fracture liaison services
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 10. Medication review—includes the percentage of patients who are on anti- 
osteoporosis medication who have their compliance assessed and in whom 
alternative medications are considered.
 11. Communication strategy—assesses the quality of communication between the 
FLS and doctors in primary and secondary care including whether the follow-
ing items are communicated; FRAX® scores, DXA outcomes, vertebral imag-
ing, primary and secondary risk factors for fracture, falls risk, current medication 
and compliance, follow-up plan, lifestyle risk-factors and time since last 
fracture.
 12. Long-term management—assesses whether medication compliance and toler-
ance are assessed at 6 months and 1 year after commencement.
 13. Database—refers to whether the FLS contributes to a database for fragility 
fractures at a local, regional or national level.
It should be noted that these criteria are similar to the data collected as part of 
national registries, including the Australian and New Zealand Hip Fracture 
Registry [43].
14.4.2  Potential Barriers and How to Overcome them
In some cases, the instigation of an FLS is hampered by barriers, both perceived and 
real, which can potentially be overcome.
Inadequate financial resources to afford an FLS nurse specialist is one such 
example with a potential solution being the employment (or re-deployment) of a 
member of secretarial staff to take on the administrative duties which form part of 
the FLS nurse specialist role. Language is a potential barrier to engaging with global 
resources (such as those available through CTF), however, the Best Practice 
Framework (BPF) document is currently available in 12 major languages: English, 
French, Spanish, German, Portuguese, Polish, Italian, Hebrew, Russian, Slovak, 
Chinese (both traditional and simplified forms) and Japanese. The BPF question-
naire (which is completed by all FLS joining the Capture the Fracture program) is 
now available in eight languages: English, Polish, Spanish, Portuguese, Japanese, 
Russian, German and Slovak. A Thai version is being developed in collaboration 
with local FLS experts and medical association in 2019.
Lack of prior experience in running an FLS can lead to a lack of confidence and 
halting of an FLS initiative. This can be addressed via educational tools and direct 
mentorship from experienced FLS providers.
As part of the CTF Educational Programme, webinars have been organised since 
2015 with the aim to engage with the FLS community of CTF and provide relevant 
knowledge on FLS and secondary fracture prevention. The ongoing series of webi-
nars provide an opportunity to learn from FLS experts who have established leading 
FLS across the globe and contributed to development of guidelines and policy on 
secondary fracture prevention. To this date, 27 webinars have been organised on 
topics ranging from how to get mapped on CTF; global success stories of FLS 
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champions; the role of the FLS coordinator; fracture cascade and secondary fracture 
prevention; among many others. The webinars on how to get mapped on CTF have 
been conducted internationally in ten major languages (https://capturethefracture.
org/webinars).
The CTF mentorship programme connects leading FLS experts with institutions 
willing to establish a new FLS.  The programme creates the platform on which 
essential knowledge and skills can be exchanged by FLS champions with FLS in 
early stage of development, locally and regionally.
Since its inception in 2016, the mentorship programme has been running 
globally, offering a combination of both on-site training and FLS workshops to 
provide guidance on FLS implementation. On-site training has been conducted 
in France, Canada, Russia, Brazil, Argentina and United Kingdom; and FLS 
workshops in Russia, Mexico, Brazil, Argentina, Saudi Arabia and Australia. 
Interest has been growing especially in the Latin American, Middle East and 
Asia-Pacific regions.
The onsite training involves an FLS champion (mentor) hosting an FLS candi-
date (mentee) and training the candidate over the course of a day on the key steps of 
implementing an FLS and how to apply to CTF by submitting the BPF question-
naire. As the training follows a one-to-one scheme, the content is tailored to meet 
the precise needs of the mentee. On the other hand, FLS workshops involve a larger 
audience, often more than 15–20 FLS candidates within the same country. The four 
key steps of FLS implementation: (1) developing the policy case; (2) developing a 
business case; (3) how to implement and (4) how to make it sustainable are covered 
in 1 day. The workshops are organised in collaboration with a local patient or medi-
cal society that is a member of IOF and includes local experts in the panel. As with 
onsite training, the FLS workshops are customised to the health system of the 
country.
14.4.3  Implementation in a Low-Resource Setting
Fracture Liaison Services should seek to address the issue of fragility fractures 
within their given locality, and, of course, there will be variation in demographics of 
the patient group [44] and the healthcare resources available. However, the resources 
required to implement a FLS are actually fairly limited. The only technological 
components are a DXA scanner and a computer, and if neither of these is available 
then paper copies of the FRAX® tool are available for use in low-resource settings 
and treatment decisions can be made without bone mineral density data. In some 
areas, initiation of a single dose of zoledronate is triggered by the orthopaedic team 
in patients with hip fracture and normal laboratory results with calcium and vitamin 
D supplementation, reserving FLS for those patients with less severe fractures or 
abnormal laboratory findings [45]. The CTF mentorship scheme, described above 
provides expert support and advice to those setting up and FLS in a transitioning 
economy (though it should also be noted that a paucity of resources is not only a 
problem to transitioning economies).
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14.5  Conclusions
In conclusion, there is substantial evidence to demonstrate the clinical efficacy and 
cost-effectiveness of setting up a Fracture Liaison Service. In this chapter we have 
outlined a step-by-step guide for how to set up an FLS and benchmark it against 
other services internationally.
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A fracture is a dramatic event for every patient because of pain, immobility and 
therefore the overall deterioration of their quality of life. Unfortunately, epidemio-
logical data tell us that those who have suffered a fragility fracture are more at risk 
of suffering another in the same or other sites within a short time [1]. The goal of 
those treating a patient with recent fragility fracture should therefore not only be to 
treat the patient in the acute phase but also to prevent further fractures [2].
Interventions to increase bone mass to preventing further fragility fractures can 
be classified as pharmacological and non-pharmacological.
15.2  Pharmacological Treatment for All Patients 
with Fragility Fractures
Who are the patients that need pharmacological treatment? All European and inter-
national guidelines [3–5] do not base the need for treatment on the diagnosis of 
osteoporosis (based on the T-score) but on the risk of fracture, which is strongly 
influenced by the presence of a fragility fracture, especially vertebral or femoral 
fractures. A fragility fracture occurs spontaneously or following low-energy trauma 
in individuals with a low bone mineral density (BMD) [6].
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We do not need to apply an algorithm to decide who to treat because if our 
patient is a postmenopausal woman has had a fragility fracture, automatically we 
should consider her at high risk of further fractures. In the same way, an elderly 
patient with a hip fragility fracture should automatically be classified as having 
severe osteoporosis independently of other risk factors.
15.2.1  Bedridden Fractured Patients
Immobilisation itself causes osteopenia, indeed bedridden patients can suffer pain-
ful spontaneous fractures [7]. Secondary prevention trials usually do not include 
bedridden fractured patients, possibly because most common oral osteoporosis 
treatments are associated with esophagitis as a side effect and may increase the risk 
of reflux esophagitis for these patients [8]. However, a few studies on non-oral 
administration have shown good efficacy in patients with severe motor and intel-
lectual disabilities [9]. Although further studies are needed, it seems to be important 
to treat this category of patients as well.
In conclusion, all orthogeriatric patients should start pharmacological treatment 
to strengthen their bone to prevent further fractures.
15.2.2  Make a Diagnosis Before Treatment
Before treatment it is important to make a differential diagnosis between primary 
and secondary osteoporosis because the anti-osteoporotic drug treatment would be 
useless if the main illness causing osteoporosis is not treated too.
In hospital, during the acute phase, it is important to investigate the osteoporosis 
to exclude secondary forms, by means of simple first-level blood tests (erythrocyte 
sedimentation rate, blood count, serum levels of protein, calcium, phosphorus, alka-
line phosphatase and creatinine, 24 h urinary calcium) and some second level tests 
(TSH, Parathormone, 25-OH-vitamin D, serum protein electrophoresis). These tests 
are sufficient to exclude 90% of the secondary causes of osteoporosis. Only the 
evaluation of these parameters will guarantee that we are giving to the patient appro-
priate treatment [10].
It is important to make at any age a diagnosis of secondary causes of osteoporo-
sis, such as hyperthyroidism and hyperparathyroidism, because these can now be 
treated with drugs and not only by surgery [11, 12].
15.2.3  Set Up an Appropriate and Personalised Treatment
Some studies show that anti-osteoporotic drugs are frequently interrupted within 
1 month of their prescription; this happens not so much due to the occurrence of 
adverse events but mostly because patients have not been sufficiently informed 
about the importance of taking the drug and because they not receive personalised 
treatment [13].
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The orthogeriatric patient with non-vertebral fracture has specific characteristics: 
they are normally very old (over 75  years) and present all the characteristics of 
frailty (reduced mobility, malnutrition, comorbidity, cognitive impairment, poly-
pharmacy, neurosensory deficits). To improve adherence, in addition to osteoporo-
sis severity, the degree of frailty and social family support should be considered in 
the choice of treatment. Osteoporosis treatment presents many choices [14], both in 
the route of administration and dosage frequency, so it is possible to define, together 
with the caregivers, a tailored treatment (Fig. 15.1). For example, subcutaneous or 
intramuscular administration may be easier or more complicated than oral intake 
depending on the patient’s overall clinical and social conditions.
Sometimes, a drug recommended on the basis of severity of osteoporosis is not 
the most suitable for the patient. The need to renew the treatment plan every year, 
for an institutionalised elderly patient with a low family support, can be problem-
atic. Depending on the complexity of the patient, a specialist management of osteo-
porosis therapy by a bone specialist may be necessary.
Another important point to improve adherence is that, on discharge from the 
orthopaedic department, the patient should be referred to a Fracture Liaison service 
that can also follow up the patient and change the medication in the light of the 
occurrence of new fractures under treatment, BMD measurement, change in clinical 
or social conditions and so on [15].
15.3  Non-pharmacological Treatment
15.3.1  Lifestyle and Exercise
Excessive use or abuse of alcohol should be avoided for a number of health-related 
risks, including bone loss. Moderate drinking during a meal (one glass of wine or beer), 








Fig. 15.1 Tailored treatment of osteoporosis in elderly people
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excessive amounts are ingested, although its calciuric effect should be compensated by 
increasing calcium intake. On the other hand, any form of nicotine use should be dis-
couraged, although substantial negative effects of cigarette smoking on bone health are 
seen only in individuals with smoking histories of 30 pack- years or above.
By and large, the most important lifestyle factor to be included in managing 
patients with osteoporosis is physical activity. The amount and intensity of weight- 
bearing physical activity in young healthy individuals is a determinant of peak bone 
mass. Likewise, a sedentary lifestyle and prolonged bed rest lead to increased bone 
loss in the involutional period. Therefore, attempts should be made to encourage 
physical activity and implement a moderate exercise programme to minimise bone 
loss in elderly people.
For the older individual with vertebral fractures and severe loss of bone mass, 
walking may be the only feasible exercise. Swimming, which is an excellent exer-
cise for older individuals to condition muscle tone and strength, does not appear to 
alter bone loss patterns appreciably because it is not a weight-bearing exercise. 
Bone mineral content in the spine may be increased somewhat by more vigorous 
programmes, individualised for target heart-rate ranges, which depend on age and 
the maximum predicted pulse.
Cessation of exercise results in a gradual but progressive loss of bone. When 
recommending exercise regimens for elderly women of unknown cardiovascular 
fitness with established vertebral osteoporosis, patients should be advised about the 
adverse effects of strenuous exercise. Extension or isometric exercises are more 
appropriate for these individuals because vertebral compression fractures are more 
apt to occur during flexion exercise. These aerobic conditioning exercise pro-
grammes should be implemented with physician advice and should also include 
warm-up and cool-down intervals.
15.4  Pharmacological Interventions
A wide variety of drugs have been proposed for either preventing bone loss in high- 
risk populations or preventing fracture and further bone loss in individuals with a 
previous fracture.
15.4.1  Ca and Vitamin D to All Patients in Association 
with Anti-osteoporotic Therapy
There have been controversies in the literature on the efficacy of calcium and vita-
min D for the prevention of osteoporosis and fractures without other drugs. However, 
in the oldest patients, including orthogeriatric patients, all data confirm that vitamin 
D deficiency is very common and calcium intake is often not adequate.
So, osteoporosis guidelines recommend:
• Older people should routinely receive vitamin D supplements [16].
• In postmenopausal women with low BMD and at high risk of fractures, calcium 
and vitamin D should be used as an adjunct to osteoporosis therapies, otherwise 
the latter will be ineffective [3].
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There is broad consensus that vitamin D levels should be maintained above 20 ng/
mL; this would already be a good result for orthogeriatric patients, who generally 
have values lower than 8 ng/mL [17]. Regarding the recommended dose of vitamin 
D, local guidelines should be followed; the most widespread programme for the cor-
rection of vitamin D deficiency (<10 ng/mL) consists of cholecalciferol in quite high 
doses of 50,000  IU per week for 1 or 2 months; then continued daily, weekly or 
monthly doses that guarantee 1200 IU daily. The most appropriate form of vitamin D 
to use (cholecalciferol, calcifediol, alfacalcidol, calcitriol) depends on the patient’s 
condition and compliance. However, hydroxylated vitamin D metabolites increase 
the risk of hypercalcaemia and hypercalciuria; they may therefore need to be ruled 
out or monitored with serial serum and urinary calcium measurement [18].
It is difficult for older patients to have an adequate calcium intake by diet alone, 
but it is better to improve the dietary intake before giving a calcium supplementa-
tion. Many calcium formulations are available and the most suitable one should be 
recommended for each patient; for example, calcium carbonate should not be pre-
scribed for patients with dyspepsia or who use protonic pump inhibitors (PPI)—for 
these patients, formulations of calcium citrate are more suitable [19].
15.4.2  Choose the Safe and Effective Drug 
for the Orthogeriatric Patient
We have many drugs for the treatment of patients at high risk of fracture (see 
Table 15.1) [14], but we should choose drugs based on efficacy and safety evidence 
provided by targeted studies or extrapolated data in old age subgroups.
For example, the use of oestrogen, tibolone and selective oestrogen receptor 
modulators (SERMs) is not recommended in orthogeriatric patients because they do 
not fit the patient characteristics appropriate for these drugs according to the latest 
guidelines. Specifically, they are not usually under 60 years of age or <10 years past 
menopause, with low risk of deep vein thrombosis and low cardiovascular risk. 
Moreover, in most countries these drugs are approved for the prevention but not the 
treatment of osteoporosis, nor for secondary prevention of fracture [3, 14].
We can divide osteoporosis therapies into two groups: antiresorptive and anabolic.
Table 15.1 Fracture risk reduction and route of administration of antiresorptive drugs
Antiresorptive 





Alendronate Oral once daily or weekly Yes Yes Yes Yes
Risedronate Oral once daily, weekly, or monthly Yes Yes Yes Yes
Ibandronate Oral once monthly or intravenous 
every 3 months
Yes NDa NDa Yes
Zoledronic acid Intravenous once yearly Yes Yes Yes Yes
Denosumab Subcutaneous injection every 
6 months
Yes Yes Yes Yes
aStudies not powered to observe effect on hip or non-vertebral fracture risk
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15.5  Antiresorptive Therapies
The fracture risk reduction and route of administration of antiresorptive drugs are 
shown in Table 15.1.
15.5.1  Bisphosphonates
Bisphosphonates are chemically related to inorganic pyrophosphate, which is a 
potent inhibitor of calcium phosphate crystallisation and dissolution. These com-
pounds act primarily by inhibiting osteoclast-mediated bone resorption via a variety 
of mechanisms. Small changes in the basic structure of the bisphosphonate can 
result in extensive alterations in its biological, toxicological and physiochemical 
characteristics in addition to its therapeutic potential for the treatment of osteoporo-
sis. Of the bisphosphonates that have been synthesised, etidronate, clodronate, iban-
dronate, zoledronate, alendronate and risedronate have been available commercially 
for varying periods of time for the treatment osteoporosis. Others, such as neridro-
nate, are currently being tested for use in osteoporosis.
The bisphosphonates are not all the same; their effectiveness, long-term action 
and safety depend on the strength of their bond with hydroxyapatite (Fig. 15.2); 
because of this link they have different dosages and ways of administration so it is 
possible to choose a personalised treatment based on the needs of the patient [20]. 
Another advantage is the low cost of oral therapy which makes it accessible even to 
patients with low economic resources.
Clodronate is currently commercially available in a variety of international loca-
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affinity of bisphosphonates
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Alendronate was the first bisphosphonate to be approved by the U.S. Food and 
Drug Administration for the prevention and treatment of postmenopausal and 
glucocorticoid- induced osteoporosis and osteoporosis in men. Alendronate, an ami-
nobisphosphonate with approximately 700 times more potency than etidronate in 
inhibiting bone resorption, has been shown in several controlled trials to increase 
bone density and reduce vertebral and hip fractures among postmenopausal women 
with low bone density. It also increases bone density in men and women taking 
glucocorticoids and in men with idiopathic osteoporosis. Data on the effectiveness 
of alendronate are the largest currently available for any drugs used in osteoporosis 
treatment.
The Fracture Intervention Trial (FIT) was the first randomised, controlled trial 
designed with fracture reduction as the primary outcome. In the vertebral fracture 
arm of FIT, 2027 women with low bone mass and at least one pre-existing vertebral 
fracture were randomly assigned to receive a placebo or alendronate 5 mg (raised to 
10 mg at month 24) daily for 3 years [21]. They were also given 500 mg of calcium 
and 250 IU of vitamin D. The proportion of women with new morphometrically 
(radiologically) defined vertebral fracture(s) was 55% lower in those taking alen-
dronate (8%) relative to those taking placebo (15%). Likewise, the proportion of 
women with clinically evident (reported during the study as adverse events) new 
vertebral fractures was 47% lower in the alendronate (2.3%) relative to the placebo 
group (5.0%). The relative risk for two or more morphometric vertebral fractures 
was reduced by ~90% by alendronate treatment, demonstrating that the best results 
are obtained in subjects at the highest risk. Importantly, the incidence of hip frac-
tures was also reduced to 51% in women taking alendronate, an extraordinary find-
ing considering the size of the study that was not designed to detect effects on hip 
fracture, a much less frequent event relative to vertebral fractures [21]. These results 
remain a milestone observation that has revolutionised the approach to treating 
osteoporosis and demonstrate the efficacy of this bisphosphonate for fracture 
prevention.
In the non-vertebral fracture arm of the FIT trial, 4432 postmenopausal women 
with femoral neck T score <−1.6, but without vertebral fractures at baseline were 
studied in the same fashion as for the vertebral fracture arm. At the end of the study, 
there was an overall statistically significant 44% reduction in new morphometrically 
defined vertebral fractures in the alendronate group. Although clinical vertebral 
fractures or hip fractures were not statistically decreased in this study population, in 
the subgroup of women with femoral neck T-score <−2.5 there was indeed a reduc-
tion in both clinical vertebral fractures (36%) and hip fractures (56%) in the alen-
dronate group. This result underscores the concept that, in primary prevention, 
therapeutic interventions are only effective in subjects at risk. When the risk is low 
or absent, expecting an effect may be unreasonable. Hence, a diagnosis of osteopo-
rosis or a full estimation of fracture risk should always be made before committing 
a patient to long-term therapies with a bone active drug.
Risedronate. In early postmenopausal women, 5  mg daily of risedronate for 
2  years produced 5.7% and 5.4% increments of vertebral and trochanter bone 
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density, respectively. Efficacy on vertebral fracture prevention was demonstrated in 
the VERT (Vertebral Efficacy with Risedronate Therapy) trial, which was conducted 
on 2458 postmenopausal osteoporotic (femoral neck T-score <−2.5) women with at 
least 1 vertebral fracture at baseline, as two separate trials in North America and in 
the rest of the world [22]. Relative to women receiving only vitamin D (500 IU) and 
calcium (1000 mg), 5 mg of risedronate daily resulted in significant increases in 
bone density at the lumbar spine and proximal femur, and reduced the incidence of 
new vertebral fractures by as much as 65% within the first year of the study and by 
41% at 3 years [22]. As a secondary outcome, a significant 39% reduction in non- 
vertebral fractures among treated women was detected, but no significant reduction 
in hip fractures was noted. While the VERT trial was not powered to detect such an 
effect, the HIP (Hip Intervention Program) found a 30% reduction in new hip frac-
ture in women taking risedronate (pooled data from 2.5 and 5 mg daily) [23]. In 
addition to the indication for prevention and therapy of postmenopausal osteoporo-
sis, risedronate is also approved for the treatment of steroid-induced osteoporosis.
Ibandronate is a third generation, potent bisphosphonate currently available at 
150 mg once a month. Bone markers of turnover were also suppressed, although 
with a fluctuating pattern.
Zoledronate is the most potent bisphosphonate among the ones currently avail-
able in clinical medicine. With intravenous administration, zoledronate at a yearly 
dose of 5 mg is currently approved for the treatment of osteoporosis, hypercalcemia 
of malignancy and bone metastases. The Horizon trial [24] demonstrated a 40% 
reduction in zoledronate-treated patients versus placebo for hip fractures, rising to 
more than 50% for vertebral fractures. Zoledronate treatment is also associated with 
30% reduction in mortality. Recent data [25] have shown also a strong efficacy of 
zoledronate used every 18  months for 5  years in osteopenic post-menopausal 
women. Importantly, secondary analysis also proved efficacy for reducing the risk 
of cardiovascular diseases and mortality.
Use of zoledronate is limited by hospital setting and acute reaction symptoms.
15.5.1.1  Adverse Events
The common ones are upper gastrointestinal adverse reactions with oral dosing, 
acute phase reaction with intravenous dosing. The uncommon are bone, joint and 
muscle pain.
The rare ones are eye inflammation, femoral shaft or subtrochanteric fractures 
with atypical radiographic features, osteonecrosis of the jaw.
In recent years, the fear of rare side effects of bisphosphonates has increased, in 
particular, osteonecrosis of the jaw, an opportunistic infection with actinomyces 
caused by the inhibition of osteoclast activity that mostly happens after dental sur-
gery. It is appropriate to recall the Joint Position of ASBMR which reiterates that the 
incidence of this event is only 1:100,000 in patients who are treated with bisphos-
phonates for osteoporosis while it is much higher in patients treated for bone metas-
tases or immunosuppressed. It is however recommended to perform a dental check 
before starting therapy and always maintaining good oral hygiene.
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Contraindications for all these drugs are hypersensitivity and hypocalcaemia. 
For oral drugs: oesophageal abnormalities that delay emptying, inability to remain 
upright; zoledronic acid should not be used in impaired renal function (creatinine 
clearance less than 35 mL/min).
There is a warning about the use of bisphosphonates in patients with severe renal 
impairment.
15.5.1.2  Technical Remark
Since their chemical structure is acidic, bisphosphonates are irritant for the oesoph-
ageal mucosa if contact is prolonged. This problem can be overcome by taking the 
drug with 100–200 mL of water while standing upright for 30–40 min.
An important technical remark about in patients who are taking bisphosphonates 
is that fracture risk be reassessed after 3–5 years:
 – If the risk is still high: the patient should continue therapy.
 – If the risk has become low-moderate: the patient should be considered for a tem-
porary discontinuation of bisphosphonates (bisphosphonate holiday).
A bisphosphonate holiday should involve a reassessment of fracture risk at 
2–4 year intervals and consideration of reinitiating osteoporosis therapy earlier than 
5 years if there is a significant decline in BMD, a new fracture or certain other fac-
tors [3].
15.5.2  Rank Ligand Inhibitor
Denosumab is a human monoclonal antibody that specifically targets RANK 
Ligand, an essential mediator of osteoclast formation, function and survival. The 
binding of this drug to RANK ligand prevents the activation of RANK on the sur-
face of osteoclasts and their precursors. Prevention of the RANKL/RANK interac-
tion inhibits osteoclast formation, function and survival, thereby decreasing bone 
resorption and increasing bone mass and strength in both cortical and trabecular 
bone [26]. This drug therefore has a completely different mechanism of action 
from that of bisphosphonates and does not bind to bone, which is why it was more 
effective than bisphosphonates in the prevention of non-vertebral fractures. The 
effects of Denosumab on bone remodelling, reflected in bone turnover markers, 
reverse after 6  months [27] so it can administered only twice per year (see 
Table 15.2).
The positive effects of Denosumab treatment on BMD persist for 10  years 
(Freedom) and there is no increase in adverse effects [28]. Denosumab advantages 
for hip fracture patients are that it can be administered during hospitalisation in 
bedridden patients and doesn’t have a toxicity risk in patients affected by hepatic or 
renal chronic failure (even with dialysis) [29]. In countries where its prescription 
needs a bone specialist management, family or social support is necessary.
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15.5.2.1  Adverse Events
Uncommon: skin rash; rare: cellulitis, femoral shaft or subtrochanteric fractures 
with atypical radiographic features, osteonecrosis of the jaw.
Contraindications for Denosumab use are hypocalcaemia, pregnancy, 
hypersensitivity;
Warning: multiple vertebral fractures have occurred when Denosumab has been 
discontinued.
15.5.2.2  Technical Remark
A drug holiday is not recommended with Denosumab, administration should be not 
delay or stopped without subsequent antiresorptive therapy to prevent a rebound in 
bone turnover [30].
15.6  Anabolic Drugs
Anabolic drugs are recommended in postmenopausal women at very high risk of 
fracture, such as those with severe or multiple fractures. Osteoanabolic therapy has 
the potential to restore skeletal microstructure and uniquely transform osteoporotic 
bone towards normal [31]. We have two class of anabolic drugs: parathyroid hor-
mone receptor agonist and sclerostin antibody (see Table 15.3). Teriparatide is a 
current therapy, whereas abaloparatide and romosozumab should be considered 
emerging therapies.
The fracture risk reduction and the route of administration of anabolic drugs are 
shown in Table 15.2.
15.6.1  Parathyroid Hormone Receptor (PTHr) Agonists: 
Teriparatide and Abaloparatide
The safety and efficacy of PTHr agonists have not been established beyond 2 years 
of treatment so the maximum duration of therapy over a patient’s lifetime is 
24 months.
Table 15.2 Fracture risk and route of administration of anabolic drugs





Teriparatide Subcutaneous injection 
daily for 2 years





Yes NDa Yes Yes
Romosozumab Subcutaneous injection 
monthly for 1 years
Yes Yesb Yes Yes
aStudies not powered to observe effect on hip or non-vertebral fracture risk
bData available only in sequential therapy with alendronate
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In the registration study the hip fracture reduction for both agents was not statis-
tically significant, probably because the numbers of hip fracture were small and the 
studies were inadequately powered for this endpoint; however, increased bone 
strength in the hip has been reported with longer term treatment [32].
These agents are much more expensive than other antiosteoporotic drugs, for this 
reason, they are used only in secondary treatment.
Teriparatide is a fragment of full-length PTH, it is recommended for postmeno-
pausal women with osteoporosis at very high risk of fracture (severe or multiple 
fractures) [33].
In comparator studies, teriparatide was significantly more effective in:
 – Protecting postmenopausal women with osteoporosis from vertebral fracture 
than was risedronate [34].
 – Preventing new vertebral fractures in glucocorticoid-induced osteoporosis than 
was alendronate [35].
Its use is limited to 24 months due to a significant increase in osteosarcoma in 
rats given the drug for longer than this period but, since the introduction of 
Table 15.3 Fundamental recommendation in secondary prevention in the elderly (modified by 
the American Society of Bone and Mineral Research Secondary prevention Guidelines 2019)
•  Offer pharmacologic therapy for osteoporosis to people aged 65 years or older with a hip or 
vertebral fracture, to reduce their risk of additional fractures
  − Do not delay initiation of therapy for bone mineral density (BMD) testing
  − Consider patients’ oral health before starting therapy with bisphosphonates or denosumab
  −  For patients who have had repair of a hip fracture or are hospitalized for a vertebral 
fracture:
  Oral pharmacologic therapy can begin in the hospital and be included in discharge orders
   Intravenous and subcutaneous pharmacologic agents may be therapeutic options after the 
first 2  weeks of the postoperative period. Concerns during this early recovery period 
include:
   Hypocalcemia because of factors including vitamin D deficiency or perioperative 
overhydration
   Acute phase reaction of flu-like symptoms following zoledronic acid infusion, particularly 
in patients who have not previously taken zoledronic acid or other bisphosphonates
    If pharmacologic therapy is not provided during hospitalization, then mechanisms should 
be in place to ensure timely follow-up.
•  Initiate a daily supplement of at least 800 IU vitamin D per day for people aged 65 years or 
older with a hip or vertebral fracture.
•  Initiate a daily calcium supplement for people aged 65 years or older with a hip or vertebral 
fracture who are unable to achieve an intake of 1200 mg/day of calcium from food sources.
•  Because osteoporosis is a life-long chronic condition, routinely follow and re-evaluate people 
aged 65 years or older with a hip or vertebral fracture who are being treated for osteoporosis. 
Purposes include:
  − Reinforcing key messages about osteoporosis and associated fractures
  − Identifying any barriers to treatment plan adherence that arise
  − Assessing the risk of falling
  − Monitoring for adverse treatment effects
  − Evaluating the effectiveness of the treatment plan; and
  −  Determining whether any changes in treatment should be made, including whether any 
antiosteoporosis pharmacotherapy should be changed or discontinued
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teriparatide in 2002, in more than 1 million patients the rate of osteosarcoma has not 
been greater than expected [36].
Abaloparatide is a PTH-related protein analogue (PTHrP). It has a mechanism of 
action similar to teriparatide, but it showed a little more efficacy in preventing ver-
tebral fractures compared with placebo, and milder adverse events than teripara-
tide [37].
Abaloparatide is not available in Europe because EMA refused its commerciali-
sation on grounds of doubts about its effectiveness in reducing non-vertebral frac-
tures and a tendency to tachycardia and palpitations.
15.6.1.1  Adverse Events
Common: nausea, dizziness, muscle cramps, increased serum or urine calcium or 
serum uric acid; uncommon: orthostatic hypotension. Abaloparatide causes less 
hypercalcemia but causes palpitations [38].
Contraindications: Hypercalcemia, hypersensitivity, nephrolithiasis.
Warnings: should not be used in children or adolescents with open epiphyses, or 
patients with Paget’s disease of bone, previous external beam or implant radiation 
involving the skeleton, bone metastases, history of skeletal malignancies, other 
metabolic bone diseases or hypercalcaemic disorders.
15.6.2  Anti-Sclerostin Antibody: Romosozumab
Romosozumab is a monoclonal antibody that binds and inhibits sclerostin. It exerts 
a dual effect on bone: increased bone formation and decreased bone resorption [39]. 
During 2019 it was approved by FDA and EMA and in Japan for the treatment of 
osteoporosis in postmenopausal women at high risk of fracture.
The sequence of Romosozumab followed by an antiresorptive therapy may pro-
vide significant benefits for the treatment of osteoporosis in women at high risk for 
fracture [40].
Another study demonstrated that 1 year of Romosozumab followed by 1 year of 
Denosumab treatment in the FRAME trial led to BMD changes similar to 7 years of 
Denosumab treatment [41]. An increased risk of cardiovascular events was observed 
compared with alendronate but not compared with placebo.
15.6.2.1  Adverse Events
Common: Injection-site reaction (pain (1.6% of patients), erythema (1.3%), pruritus 
(0.8%), haemorrhage (0.5%), rash (0.4%) and swelling (0.3%).
Contraindications: hypersensitivity.
15.6.2.2  Technical Remark for Anabolic Agents
In patients who have completed a course of anabolic agents, it is recommended 
to switch to treatment with antiresorptive therapies, to maintain bone density 
gains [3].
L. Tafaro and N. Napoli
269
15.7  Influence of Osteoporosis Medication 
on Fracture Healing
Pharmacologic agents that influence bone remodelling are an essential component 
of osteoporosis management. Because many patients are first diagnosed with osteo-
porosis when presenting with a fragility fracture, it is critical to understand how 
osteoporotic medications influence fracture healing. Vitamin D and its analogues 
are essential for the mineralisation of the callus and may also play a role in callus 
formation and remodelling that enhances biomechanical strength. In animal mod-
els, antiresorptive medications, including bisphosphonates, denosumab, calcitonin, 
oestrogen and raloxifene, do not impede endochondral fracture healing but may 
delay remodelling. Although bisphosphonates and denosumab delay callus remod-
elling, they increase callus volume and result in unaltered biomechanical properties. 
Parathyroid hormone, an anabolic agent, has demonstrated promise in animal mod-
els, resulting in accelerated healing with increased callus volume and density, more 
rapid remodelling to mature bone and improved biomechanical properties. Clinical 
data with parathyroid hormone have demonstrated enhanced healing in distal radius 
and pelvic fractures as well as postoperatively following spine surgery [42].
There is currently no evidence that osteoporosis treatments are detrimental for 
bone repair and some promising experimental evidence for positive effects on heal-
ing, notably for agents with a bone-forming mode of action, which may translate 
into therapeutic applications [43].
15.8  Conclusion
There is a range of good pharmacological options and indications for sequential 
therapy to reduce the risk of further fracture in orthogeriatric patients; despite this 
they are frequently undertreated. The literature shows that treatment can be started 
even in very old patients at high risk of fracture and may be continued for as long as 
the developing evidence shows efficacy and safety.
Undertreatment of patients following hip fracture is an important age-related health 
disparity that must be addressed by both health systems and individual clinicians. The 
challenge for the multidisciplinary approach to fracture patients is to abolish under-
treatment, thereby enabling a real improvement of quality of life for our patients.
New guidelines on secondary fracture prevention have been recently released by 
an international coalition led by the American Society of Bone and Mineral Research 
and should be followed by treating physicians and health care providers [44] (see 
Table 15.3).
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How Can We Prevent Falls?
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16.1  Epidemiology of Falls
Falls represent a major health problem in subjects aged 65 or older because of their 
high prevalence and the severity of their physical, functional, psychological and 
financial consequences. Indeed, approximately 30% of people living in the com-
munity aged over 65 years and 50% of those older than 80 experience at least one 
fall every year and one-third of fallers are repeated fallers. Falls result in injuries 
that require medical attention in 30%, fractures in 5%, a hip fracture (HF) in 1% or 
another major injury in 5–6%. Every year, around 50 million falls occur in Europe 
amongst community-dwelling older people, 2.3 million persons aged 65 years or 
older attend emergency departments for a fall-related injury, 1.4 million are admit-
ted to hospital and 36,000 die from falls. Falls induce psychological consequences 
in patients, including fear of falling and loss of confidence that can result in self- 
restricted activity levels, reduction in physical function and social interactions, and 
put a major strain on the family. With the ageing of the population, fall has become 
the third leading cause of years living with disability in older subjects and one of the 
main causes of admission to a nursing home [1].
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Falls represent also a major health problem in nursing homes, half of residents 
experiencing at least one fall every year. Fallers are most often women and repeated 
fallers in nursing homes. Indeed, falls prevalence is about 2 and 1.5 falls per person- 
year in institutionalised men and women, respectively [2, 3]. Falls are a major cause 
of hospital admission in nursing homes patients, 7.5–15% of residents being admit-
ted to hospital every year after a fall and hip fractures accounting for 10% of overall 
admissions [3]. Falls also account for up to 70% of accidents in hospitalised patients; 
approximately 30% of falls occurring in inpatients result in physical injury, with 
4–6% resulting in serious injury [4].
The health care expenditure for treating fall-related injuries in the European 
Union is estimated to be €25 billion each year, fractures accounting for about 
1–1.5% of health care expenditure. The ageing of the population could result in 
annual fall-related expenditures exceeding €45 billion by the year 2050 [1]. Persons 
aged 80 years or older account for almost 50% of all fall-related emergency depart-
ment visits and 66% of total costs [5]. The costs of long-term care at home and in 
nursing homes show the largest age-related increases and account together for 54% 
of the fall-related costs in older people [6]. Fractures, especially HF, that are most 
often caused by a fall from a standing position, account for up to 80% of the fall- 
related healthcare costs [1]. About 10% of patients are hospitalised for a second 
injury in the year after the HF [7], and the major concerns of people after a hip 
fracture are the fear of falling and of re-fracturing [8].
For all the above reasons, falls prevention is now widely recognised as one of the 
main priorities to promote active and healthy ageing in older subjects (http://pro-
found.eu.com/wp-content/uploads/2016/12/Silver-Paper-Executive-Summary-
Final.pdf).
Most guidelines for the prevention of falls in older people [AGS/BGS Clinical 
Practice Guideline Prevention of Falls in Older Person-2010  (https://sbgg.org.br/wp-
content/uploads/2014/10/2010-AGSBGS-Clinical.pdf); Stopping Elderly Accidents, 
Death, and Injury (STEADI) initiative, Center for Disease Control and Prevention (https://
www.cdc.gov/steadi/index.html); [9] recommend to assess regularly the older patients’ 
risk for a fall and to propose interventions adapted to the risk of falling, considering that 
patients with repeated or injurious falls, especially those who have experienced a hip 
fracture, are at the highest risk of new incident falls and fractures.
16.2  How to Assess Older Patients’ Risk of Falling
Subjects aged 65 or older at increased risk of falling can be screened:
 – By themselves or their caregivers using simple questions
For the experts of the STEADI programme, subjects with a history of fall in 
the previous year, who feel unsteady when standing or walking, or subjects who 
scored 4/12 points or more on the stay independent brochure (https://www.cdc.
gov/steadi/pdf/STEADI-Brochure-StayIndependent-508.pdf) should be consid-
ered at increased risk of falling and should require further assessment provided 
by a general practitioner [10, 11].
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 – By healthcare providers using simple questions and tests
Three simple questions:
The STEADI initiative recommends healthcare providers to include in the rou-
tine examination of patients 70 and older three questions: Have you fallen in the 
past year? Do you feel unsteady when standing or walking? Do you worry about 
falling? If the patient answers no to all these key screening questions, he/she can be 
considered at low risk of falling. If the patient answers “yes” to any of these key 
screening questions, further assessment is needed to distinguish subjects at moder-
ate or high risk of falling. The AGS/BGS 2010 and the 2013 NICE guide-
lines  (https://www.nice.org.uk/guidance/cg161) recommend accordingly that all 
older persons who are under the care of a health professional (or their caregivers) 
should be asked at least once a year about falls, frequency of falling and difficulties 
in gait, balance and muscle strength. This routine assessment is especially impor-
tant in patients with multimorbidities that may induce falls, such as Parkinson’s 
disease, kidney, vision and cognitive impairment, incontinence, depression or with 
polypharmacy [12–14] and in patients admitted to the emergency room or hospi-
talised. Indeed, nearly half of hip fracture patients have visited the emergency 
room (ER) or have been admitted to hospital in the year prior to fracture, a quarter 
of them for a previous fall [15]. Unfortunately, very few of the patients visiting the 
ER or hospital receive falls counselling [15], which is a major missed opportunity 
since patient-centred interventions can reduce incident falls and fracture in older 
people presenting to the ED after a fall [16] or a fracture [17].
 – Simple physical tests:
AGS/BGS-2010 and 2013 NICE guidelines recommend to assess balance and 
gait using simple tests such as the timed up and go test (TUG) and the ‘turn 180°’ 
test (TT). These tests are indeed easy to perform in any setting and their admin-
istration requires no special equipment. Cut-off values for abnormal results 
remain however discussed (the risk of falling is increased when the TUG is >15 s 
(threshold for sarcopenia) [18] and a TUG >20 s indicates a significant gait dis-
order). The one-leg stand test can also easily been used, with the same limits (the 
risk of falling is low when >10 s and high when <5 s) (https://www.nice.org.uk/
guidance/cg161; [19]). Other tests such as the Berg balance test, the Tinetti scale, 
the functional reach and the dynamic gait test need equipment or clinical exper-
tise. Dual-task testing can also be used since patients who reduce their walking 
speed when performing a second task are more prone to falls. People with a dif-
ference of 4.5 s or more between the TUG test (simple task) and the dual manual 
task TUG test (TUG test while carrying a glass of water in one hand) or who 
need 14.7  s or over to perform the cognitive TUG (TUG test while counting 
backward in threes from a random start point) are at risk of falling, especially in 
case of Parkinson’s disease [20].
A low muscle strength is a significant but less consistent risk of falls or injurious 
falls than gait and balance impairments. Muscle strength can be assessed using grip 
strength, which requires specific equipment [19] or more easily by measuring the 
chair rising performance [21]. Time to perform five chair-rising stands can be con-
sidered as normal when <12 s and may be a sign of sarcopenia when >15 s [18].
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The STEADI algorithm recommends to use the TUG, the 30-s chair stand and the 
four-stage balance test to identify people with gait/strength/balance disturbances, 
although cut-off values are not indicated (https://www.cdc.gov/steadi/index.html).
The Short Physical Performance Battery (SPPB), which includes sit-to-stand 
performance, walking speed and balance performance, can also be used since it 
demonstrates a significant association with fall history [21]. The Physiological 
Profile Assessment (PPA), which involves a series of simple tests of vision, periph-
eral sensation, muscle force, reaction time, postural sway and the Timed Up and Go 
test can also identify people at risk for falls [22].
The Downton Fall Risk Index (DFRI) that is a composite index of five groups of 
fall risk factors including previous falls, medications (tranquilisers, sedatives, diuret-
ics, antihypertensives, antiparkinsonian drugs, antidepressants), sensory disability 
(visual or hearing impairment, impaired motor skills (reduced muscle strength or 
loss of function in a limb), cognitive disability (orientation to time, place, and per-
son) and walking ability (unsafe gait) has been shown to predict hip fracture [23].
16.2.1  Definition of Older People at Low, Moderate or High Risk 
of Falling
In order to be pragmatic and based on the three above questions (history of falls and 
injurious falls, fear of falling or feeling of unsteadiness) and the three simples tests 
(TUG, one-leg stand and five chair-rising) that take less than 5 min to be asked and 
performed, it can be proposed that:
• People at low risk of falling are those without any history of fall in the 12 last 
months, fear of falling or feeling of unsteadiness and without balance (e.g. one- 
leg stand test >10 s), gait (e.g. timed up and go test <12 s) and muscle strength 
(e.g. five sit-to-stand test in <12 s) problem.
• People at high risk of falling are those 1. with a history of repeated or injurious 
falls in the six previous months or 2. with a fear of falling or a feeling of unsteadi-
ness or a history of one fall in the 12 last months associated with a significant 
balance (e.g. one-leg stand test <5 s)or gait (e.g. timed up and go test >20 s) or 
muscle strength problem (e.g. five sit-to-stand test in >15 s).
• People at moderate risk of falling are those who are nor at low or high risk of 
falling.  There is a continuum among patients at moderate risk of falling, 
approaching low risk when the number of risk factors is low and high risk when 
the number of risk factors is high.
16.3  Fall Prevention Intervention in Patients with Low Risk 
of Falling
Education and exercise should be offered in older subjects at low risk of falling 
since people with high activity and performance are, with those with the lowest 
activity/worst physical performances, the subjects at the highest risk of falls [24].
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Education: The STEADI initiative provides educational materials and brochures 
for family caregivers (https://www.cdc.gov/steadi/pdf/steadi-CaregiverBrochure.
pdf) including the following educational messages: (1) A healthcare provider should 
be told right away in case of fall, unsteadiness or fear of falling; (2) medications, 
including over-the-counter medications and supplements, should be regularly 
reviewed by a healthcare provider or a pharmacist, especially in case of dizziness or 
sleepiness; (3) the interest of taking vitamin D supplements to improve bone, muscle 
and nerve health should be regularly discussed with an healthcare provider; (4) phys-
ical activities that improve balance and lower limbs muscle strength (like Tai Chi) 
should be regularly performed to prevent falls and also to improve well-being and 
confidence; (5) eyes should be checked by a health provider at least once a year to 
optimise vision (e.g. to update eyeglasses, if needed, and to optimise the treatment of 
condition like glaucoma or cataracts); (6) feet should be checked by a health provider 
at least once a year to a allow a safe and comfortable walking (to provide well-fitting 
shoes discuss with good support inside and outside, and ask whether seeing a foot 
specialist is advised). Counselling is also (7) home safety should be optimised by 
keeping floors clutter-free, removing small throw rugs or using double- sided tape to 
keep the rugs from slipping, by adding grab bars in the bathroom next to and inside 
the tub, and next to the toilet, and having handrails and lights installed on all stair-
cases. A checklist is also available to find and fix hazards at home on the STEADI 
site (https://www.cdc.gov/steadi/pdf/steadi-Brochure-CheckForSafety-508.pdf).
Community exercise programmes to maintain or improve balance and strength: 
The programmes with the best evidence are the Otago Exercise Programme (OEP), 
Tai Chi, the Falls Management Exercise programme (FaME -sometimes called 
PSI), Lifestyle-integrated Functional Exercise (LiFE) and the Ossebo programme 
[25]. On the whole, physical activity in older people may reduce the risk of fall- 
related injuries by 32–40%, including severe falls requiring medical care or hospi-
talisation, and improves physical function in older people without or with frailty or 
Parkinson’s disease  (http://bachlab.pitt.edu/sites/default/files/DiPietro2019.pdf). 
The effect on the rate of falls of resistance exercise (without balance and functional 
exercises), dance or walking is uncertain [26]. The NICE guidelines recommend to 
promote the participation of older people at low risk of falls in exercise programmes, 
considering also the psychological and social values of such exercise programmes 
in addition to their physical benefits (https://www.nice.org.uk/guidance/cg161).
Systematic vitamin D ±  calcium supplements should not be recommended in 
subjects with low or moderate risk of falling since their effectiveness to prevent 
fractures or falls is not demonstrated [27, 28]. High-dose vitamin D may even have 
adverse effects on fall risk [29].
16.4  Multifactorial Interventions in Patients with Moderate 
Risk of Falling
A targeted intervention programme should be offered in patients at moderate risk of 
falling including.
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Education: Interventions that aim to increase knowledge/education about fall 
prevention alone seem not be able to reduce significantly the rate of falls. The NICE 
guidelines recommend however to implement measures to enhance “fall awareness” 
in older people at moderate or high risk of falling and healthcare professionals 
(https://www.nice.org.uk/guidance/cg161). The education material provided by the 
STEADI initiative described previously for people at low or moderate risk of falling 
can be used by patients at high risk of falling and their caregivers (https://www.cdc.
gov/steadi/materials.html). The Prevention of Falls Network for Dissemination 
(ProFouND) that is an European Commission funded initiative dedicated to the dis-
semination and implementation of best practice in falls prevention across Europe 
has also produced documents to influence policy and increase awareness of falls for 
health and social care authorities, the commercial sector, NGOs and the general 
public (http://profound.eu.com/).
Exercises supervised by a physiotherapist or in a community fall prevention pro-
gramme: Exercise when challenging, progressive, regular and conducted in the long 
term is indeed effective to prevent falls and falls requiring medical attention and 
fractures (no proof for HF specifically) in older persons living in the community 
(http://profound.eu.com/wp-content/uploads/2016/12/Falls-Intervention-
Factsheets-FinalV2.pdf; [26, 30]).
Exercises that allow to develop and mobilise sufficient attention resources to 
recover a stable posture following an external perturbation such as dual-task training, 
and exercises to improve floor-rise ability, should be included in clinical practice 
[31]. Tai Chi is effective to reduce falls in people at low or moderate risk of falling 
and there is no evidence that walking or brisk walking reduces the risk of falling [32].
Whole body vibration, through its ability of enhancing balance, improving leg 
and plantar flexor muscle strength, and reducing fall rate may also help reduce the 
risk of fracture [33, 34].
On the whole, dedicated falls prevention programmes conducted in people living 
in the community at low to moderate risk of falling decrease falls and fall-related 
injury rates by 20–40% and are cost-effective [32, 35, 36].
Modification/progressive withdrawal of fall risk-increasing drugs (FRIDs): 
Polypharmacy is a risk factor of falling. The most common FRIDs are—psychotro-
pic drugs, such as sedatives, hypnotics, antidepressants, antipsychotic medications, 
antiepileptics, opioids and other drugs which can cause sedation, delirium or 
impaired balance and coordination (including those that induce hyponatremia)—
cardiovascular drugs and other drugs which can cause or worsen orthostatic hypo-
tension (such as anticholinergic drugs) and induce cardiac arrhythmias (such as 
drugs at risk of GT prolongation) [37–39].
A meta-analysis of randomised-controlled interventions aiming to prevent falls 
in the elderly living in the community showed that slow withdrawal of psychotro-
pics and prescribing modification programmes for primary care physicians signifi-
cantly reduce the risk of falling [32, 40].
Vision optimisation: Visual control plays a role in the assessment of the risks in 
the environment and in the effectiveness of protective responses to avoid a fall 
explaining why poor vision is associated with a risk of fall-related injuries including 
HF [41, 42]. Cataract surgery on the first affected eye and replacement of multifocal 
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glasses by single lens glasses are effective in reducing the falling rate in older peo-
ple living in the community [32].
Treatment of foot problems: Physical examination should include feet and foot-
wear check and foot problems should be addressed. Indeed, one trial conducted in 
305 participants has shown that multifaceted podiatry, and foot and ankle exercises 
reduce significantly the rate of falls in people with disabling foot pains [32].
Vitamin D supplementation at patients at risk of vitamin D deficit: The STEADI 
guidelines recommend vitamin D and calcium supplementation in all patients, 
whatever their risk of falling. Taking vitamin D supplements, however, does not 
appear to reduce falls in most community-dwelling older people, but may do so in 
those who have low vitamin D blood levels [32, 43]. Vitamin D deficiency indeed, 
especially when sufficiently deep to induce elevated PTH, predisposes both to falls 
and HF [44]. Thus, people at moderate risk of falling who are at risk of vitamin D 
deficits (low outdoor activity, high fat mass) should be offered vitamin D supple-
ments without any vitamin D serum measurement during the winter season (https://
www.has-sante.fr/jcms/c_1525705/fr/avis-de-la-has-concernant-l-evaluation-du- 
risque-de-chutes-chez-le-sujet-age-autonome-et-sa-prevention). Calcium supple-
mentation is not recommended in patients at moderate risk of falls [45].
16.5  Multifactorial Falls Risk Assessment and Interventions 
in Patients with High Risk of Falling
The AGS/BGS 2010/ [46] and STEADI initiative recommend to offer a multifacto-
rial fall prevention programme in complex patients with an history of recurrent or 
injurious falls or with a fall with significant balance, gait, or muscle strength disor-
ders (https://www.nice.org.uk/guidance/cg161; https://www.cdc.gov/steadi/pdf/
steadi-Algorithm-508.pdf). Indeed, this kind of programme that identifies modifi-
able risk factors and propose a personalised fall prevention programme reduces the 
number of falls in randomised controlled trials (RCTs) (https://www.cochraneli-
brary.com/cdsr/doi/10.1002/14651858.CD012221.pub2/full) and in pre-post- 
intervention studies [47]. The NICE recommends that individualised multifactorial 
assessment and intervention should be performed by healthcare professionals with 
appropriate skills and experience, normally in the setting of a specialist falls service 
(most often called falls clinics) with clinic-level quality improvement strategies (eg, 
case management), multifactorial assessment and treatment (e.g. comprehensive 
geriatric assessment) (https://www.nice.org.uk/guidance/cg161).
According to the STEADI initiative and the NICE guidelines, the management 
of patients at risk of falling starts with the management of conditions that alter gait, 
balance and mobility such as postural dizziness and postural hypotension, cognitive 
impairment, metabolic abnormalities such as hypoglycaemia [48] or hyponatraemia 
[49], sleep disturbances [50], muscle weakness and urinary incontinence [47] and 
conditions that induce fainting. Insertion of a pacemaker should be considered for 
older people with frequent falls associated with cardioinhibitory carotid sinus 
hypersensitivity, or sinus node dysfunction, conditions which cause sudden changes 
in heart rate and blood pressure [32, 51]. Multifaceted podiatry and foot and ankle 
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exercises reduce significantly the rate of falls in people with disabling foot pains 
[32]. A falls and fracture successful multifactorial intervention programmes in older 
people at high risk of falling should also comprise, besides education (see above):
Modification/progressive withdrawal of fall risk-increasing drugs (FRIDs): As 
indicated previously, progressive withdrawal of fall risk-increasing drugs reduces 
the risk of falling [32, 40]. Polypharmacy and fall-risk increasing drugs remain 
however prevalent in patients discharged from orthogeriatric care after surgery for a 
hip fracture [52, 53]. FRIDs are present in two-thirds of patients visiting fracture 
liaison services [54], benzodiazepines and opioids being more specific risk factors 
of HF [55]. This suggests the interest to conduct interventions on drug use at dis-
charge of patients admitted to hospital for a falls-related injury [52, 53].
Vision optimisation: Any history of cataracts, macular degeneration, glaucoma or 
visual loss should be identified in people at high risk of falling and those people 
should be referred to an eye doctor when no eye examination has occurred during 
the past year. Vision assessment and referral are therefore a component of success-
ful multifactorial falls prevention programmes, especially when associated with 
home hazard intervention [32, 56].
Exercises: As indicated previously, programmes that combine balance and mod-
erate intensity strength training either alone or with other interventions, especially 
vision assessment and treatment and environmental assessment and modification, 
are effective to prevent falls, fall-related fractures and other types of injurious falls 
https://www.nice.org.uk/guidance/cg161; [26, 32, 36, 57–60]). Tai Chi is not rec-
ommended in patients at high risk of falling [32].
Exercises improving medial-lateral stability are especially recommended in 
patients at high risk of falling and fracture since sideways falls are associated with 
a sixfold increased risk for hip fracture [61, 62]. Exercises enhancing anterior–pos-
terior postural control are also warranted, given that forward falls can also result in 
hip impact [63]. Exercises to help reduce the hip impact during the descent stage of 
falling and therefore make landing safer may include exercises of forward or back-
ward axial rotation of the torso and pelvis during descent [64] and exercises to 
strengthen upper extremity muscles to make protective responses during falls more 
effective [65, 66].
The NICE and ProFouND initiative recommend that the exercise programme in 
patients at high risk of falling should be individually prescribed and monitored by 
professionals, such as physiotherapists, sport scientists and specialist exercise 
instructors, who are appropriately trained in delivering falls prevention exercise pro-
grammes (http://profound.eu.com/wp-content/uploads/2016/12/Falls-Intervention-
Factsheets-FinalV2.pdf; https://www.nice.org.uk/guidance/cg161).
Evidence from the 2018 PAGAC Scientific Report indicates that older people who 
have sustained hip fracture should benefit from weight-bearing, multicomponent 
activity [67]. The meta-analysis of RCT by Lee et al. reported that progressive resis-
tance exercise significantly improved overall physical function (mobility, balance, 
lower limb strength or power and performance tasks) after hip fracture surgery [68].
When associated with orthogeriatric co-management and physician consulta-
tions, group exercise and vibration-therapy over a 18-month period can reduce the 
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re-fracture rate, improve balance and mobility and reduce costs in fragility hip frac-
ture patients [69].
Home hazard intervention: The majority of fall-related injuries occur while older 
people move around home. Interventions to improve home safety, such as night-
lights or bathroom grab bars, appear to be effective to reduce falls, especially in 
people who fall at home or have received treatment in hospital following a fall 
(https://www.nice.org.uk/guidance/cg161), and especially when carried out by suit-
ably trained healthcare professionals, such as occupational therapists [32]. Indeed, 
home assessment visits by occupational therapists prior to hospital discharge for 
patients recovering from hip fracture can reduce the number of readmissions to 
hospital, increase functional independence at 6 months and may reduce the risk of 
falls in the first 30 days after discharge [70].
Assuming that home safety measures reduce fall-related hip fractures in accor-
dance with the reduction of the rate of falls, a home safety intervention to prevent 
falls could be cost-effective in impaired elderly people living in the community [71].
NICE and ProFouND guidelines recommend to seeking opportunities from 
the Information and Communication Technologies (ICT) sector to provide solu-
tions for fall-detection and prevention (http://profound.eu.com/wp-content/
uploads/2016/12/Falls-Intervention-Factsheets-FinalV2.pdf; https://www.nice.
org.uk/guidance/cg161).
Vitamin D and calcium: Screening of vitamin D deficiency by measuring serum 
total 25(OH)D is recommended in individuals with a history of falls or nontrau-
matic fracture and in patients at risk of vitamin D deficiency, such as patients with 
diseases affecting vitamin D metabolism and absorption, and osteoporosis [72]. 
Measuring blood 25OHVitamin D in recurrent fallers or after a fall-related fracture 
helps to guide the vitamin D deficits correction. Vitamin D and calcium supplemen-
tation may reduce falls in patients with increased risk for falls and a vitamin D 
deficiency [32, 43, 45].
Osteoporosis screening and treatment if needed: Bone health should be assessed in 
patients at high risk of falls, and especially in those with sarcopenia or with an history of 
fracture [73]. A low bone mineral density, a poor physical function and falls are indeed 
the strongest independent risk factors for a subsequent nonvertebral fracture [74].
The NICE and more recently the European guidelines recommend to perform a 
BMD and calculate the FRAX risk (calculation without BMD if DXA is not possible) 
in patients at high risk of falling in order to determine if an osteoporosis treatment is 
required (https://www.nice.org.uk/guidance/cg161; [75]). Nevertheless, life expectancy 
should be taken into account when assessing the appropriateness of DXA in fallers, as 
osteoporosis treatments require at least 12 months to decrease the fracture risk [75].
16.6  Fall Assessment and Prevention in Care Settings
The 2016 NICE guidelines do not recommend to use fall risk prediction tools to 
assess the risk of falling in inpatients, but rather to consider that all hospitalised 
patients aged 65 years or older are at high risk of falling as well as patients aged 50 
16 How Can We Prevent Falls?
282
and older with underlying conditions (https://www.nice.org.uk/guidance/cg161;). 
Some tools with good sensitivity and specificity can however been used to screen 
patients particularly at risk of falling at hospital, including the STRATIFY tool that 
assesses five factors (patients who present or not to hospital with a fall or who has 
fallen on the ward since admission; patients agitated, visually impaired, in need of 
especially frequent toileting, with poor transfer and mobility, living in a nursing 
home or not) [76] and the Hendrich II Fall Risk Model that consists of eight vari-
ables including (confusion/disorientation/impulsivity, symptomatic depression, 
altered elimination, dizziness/vertigo, gender, any administered anti-epileptics, ben-
zodiazepines and the “get up and go” test) [77].
Similarly, risk assessment tools do not add significant value to nurses’ judgment 
for identifying individuals at high risk of falls in daily practice [78]. Indeed, most of 
nursing home residents are at high risk of falling since a fall history, gait and bal-
ance instability, cognitive and functional impairment, sedating and psychoactive 
medications and multimorbidity are significant risk factors of falling in nursing 
home residents [3].
If the same guidance relating to community-dwelling older adults at high risk of 
falling presented above applies to acute and long-term care settings (http://pro-
found.eu.com/), the evidence for effective falls prevention interventions in acute 
and subacute wards and in nursing homes is more limited [3, 79, 80].
The NICE guidelines underline the fact that architects should take into account 
improvements to the inpatient environment to prevent falls when designing new set-
ting for older people (https://www.nice.org.uk/guidance/cg161). The clinical effec-
tiveness of compliant flooring at preventing serious fall-related injuries among 
long-term care residents remains discussed [81]. International evidence suggests 
that physical restraints may increase the risk of falling by limiting mobility in this 
group of frail elderly persons [82].
A key component for falls prevention in care settings and for physical restraint 
reduction in nursing homes is the implementation of a proactive organisational 
strategy that includes leadership, individualised patient education programmes 
combined with staff education and training, careful monitoring with audit, remind-
ers and feedback to staff, provision of equipment, supportive risk management and 
change agent [57, 79, 83].
16.7  Fall Assessment and Prevention in Patients 
with Cognitive Impairments
Almost two-thirds of people with dementia living in the community fall annually, 
i.e. a rate that is twice that of the population without cognitive impairment [84]. 
Falls are a major cause of injury to cognitively impaired older people [85]. The high 
prevalence and morbidity of falls in dementia are in part due to the relationship 
between low performance in attention and executive function and gait slowing, 
instability and future falls [86].
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This explains why some recent falls prevention programmes in cognitively 
impaired older people include, in addition to the above conventional measures, 
the prescription of walking aids and training programmes targeting identified gait 
abnormalities and appropriate to the individuals’ cognitive capacity, non- 
pharmaceutical and pharmaceutical strategies to increase attention, cognitive 
training and behavioural change/modulation to improve planning, judgment, 
inhibitory control and flexibility/problem-solving skills in order to improve safely 
mobilisation during challenging circumstances [87]. Thus, cognitive training, 
dual-task training and virtual reality modalities are promising strategies to 
improve mobility in older adults with cognitive impairment and dementia [86]. In 
the advanced stage of dementia, recurrent falls can be sentinel events indicating 
the need for a palliative approach to care with a focus on symptom management, 
comfort and dignity.
16.8  Falls Clinics and Fracture Liaison Services
Falls clinics are one approach by which older people with high levels of falls risk 
can be managed. Falls clinics, that are however too seldom in the world, offer 
detailed multidisciplinary assessment and make recommendations or implement a 
range of targeted falls and falls injury-prevention strategies based on the assessment 
findings. Several pre–post clinic intervention studies and randomised controlled- 
studies have indicated substantial reductions in falls and related injuries (between 
30 and 77%) in high falls–risk populations, and improvements in other outcomes 
such as balance and mobility, physical functioning, fear of falling and engagement 
with falls prevention interventions [47, 88, 89]. The number of patients to see in a 
fall clinic to prevent a fall or an injurious fall has been found to be 5 and 6, respec-
tively [89].
As indicated previously, a fragility fracture is one of the strongest risk factor for 
a subsequent nonvertebral fracture [74, 90]. Fracture liaison services (FLS) working 
together with geriatric units specialised with falls prevention are probably the most 
efficient way of addressing primary and secondary prevention of fracture including 
the assessment of both bone health and falls risk [75, 91, 92], especially in frail 
older patients [93].
16.9  Conclusion
Falls are a major public health problem in the elderly population. Some simple 
questions related to fall and fall-related injury in the previous months, feeling of 
unsteadiness and fear of falling, and some simple tests that aim to assess balance/
gait and muscle strength (e.g. timed up and go and sit-to-stand tests) may help dis-
tinguish people at low, moderate or high risk of falling. Balance and strength exer-
cises and education are recommended to reduce falls in people whatever the risk of 
16 How Can We Prevent Falls?
284
falls. A multifactorial falls and fracture risk assessment and prevention should be 
offered to older people at high risk of falls, i.e. those who present for medical atten-
tion because of a fall, especially after a fracture or who are recurrent fallers. This 
multifactorial falls risk assessment and prevention should be offered by a healthcare 
professional with appropriate skills and experience, normally in the setting of a falls 
clinic, in link with a fall liaison service in case of fall-related fracture. Individualised, 
targeted multifactorial interventions comprise the management of specific causes of 
gait/balance and muscle strength disturbances, prescription of vitamin D supple-
ments when blood level of vitamin D is low and of BMD and FRAX risk calculation 
in order to determine recommendations for osteoporosis treatment, measures to 
improve home safety (at best delivered by an occupational therapist), a review of 
medications, vision optimisation, insertion of a pacemaker in case of carotid sinus 
hypersensitivity and multifaceted podiatry. Because falls and fracture are most often 
preventable, it is now crucial to overcome limited awareness and usage of solutions 
to prevent and monitor falls and osteoporosis and make these available (Action 
Group A2 of the European Innovation Partnership on Active and Healthy Ageing 
(EIP on AHA)) (https://ec.europa.eu/eip/ageing/actiongroup/index/a2_en).
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17.1  Introduction
The aims of this chapter are to provide an overview of the role of nurses in the mul-
tidisciplinary orthogeriatric team and help medical, surgical practitioners and thera-
pists to understand the potential of the nursing team to foster collaboration in 
achieving best outcomes for patients. The call to action issued by the Fragility 
Fracture Network [1] describes four pillars of fragility fracture care, all of which 
involve expert nursing: (1) multidisciplinary co-management in the acute fracture 
episode; (2) post-acute rehabilitation; (3) secondary prevention after every fragility 
fracture and (4) the formation of multidisciplinary national alliances. These pillars 
support the need for nursing education, collaboration between nurses and their sup-
porting local, national and global associations and the development of education, 
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clinical guidance and resources that can be adapted and adopted in any part of the 
world so that best practice nursing care can be achieved. In some countries, regions 
and/or localities, the concept of orthogeriatric nursing has yet to be fully recog-
nised. Even so, the principles of orthogeriatric care and management can be applied 
in any setting with consideration of the context of local practice, culture and 
resources.
17.2  Nursing Care Quality
Orthogeriatric patients have complex health care needs, many of which can be met 
by skilled, compassionate nursing. Nursing involves autonomous and collaborative 
care that includes the promotion of health as well as prevention of illness and sup-
porting recovery during ill health and following injury and surgery. Nursing also 
embodies advocacy, promotion of safety, leadership and participation in shaping 
health policy [2]. Nurses make a unique contribution to orthogeriatric care because 
they spend the most time with patients and develop a therapeutic relationship with 
individuals and their families while acting as coordinators of care. They understand 
the patient experience of the fracture and its care through qualitative exploration of 
experiences. These experiences are often described as difficult and painful, leading 
to significant decrease in quality of life, and are fraught with restrictions and inse-
curity [3, 4], although patient experiences in resource-poor countries have yet to be 
studied or documented.
Hip fracture audit, where it takes place, has had a significant impact on the qual-
ity of medical and surgical care, but with a limited focus on nursing. It is essential 
that indicators of the value of nursing care are developed and measured [5]. The 
overall contribution of health care delivery is often measured in terms of health 
status, outcomes, readmissions rates, length of stay, complication rates and mortal-
ity [6], but these do not always help to capture the specific contribution of nurs-
ing care.
Nurse-sensitive quality indicators include patient comfort and quality of life, 
complication rates, safety, empowerment and satisfaction. More specific clinical 
indicators can include healthcare-associated infection, pressure ulcers, falls and 
drug administration errors [7]. Pain management, delirium, pressure ulcers, 
hydration and nutrition, constipation, prevention of secondary infections and 
venous thromboembolism (VTE), rehabilitation and remobilisation are all nursing 
care priorities [5] but evidence-based nurse management strategies need to co-
exist with medical and therapist models of care. This includes reducing the risk of 
complications and mortality, improving recovery, maintaining function and 
improving patient experiences. Preventing harm and patient safety, focused on 
avoiding adverse events, are multidisciplinary concerns that vary depending on 
the country and its resources. Nurses, through their extended contact with patients, 
remain central to recognising risk and alerting other team members. Nursing qual-
ity indicators should also take into consideration the local context and available 
resources.
J. Santy-Tomlinson et al.
295
17.3  Acute Care
The high prevalence, complexity of needs, length of stay and cost, often make hip 
fracture care the focus of practice development. The skills and knowledge needed to 
look after patients with hip fractures, however, also apply to the management of all 
older people with fractures and include fundamental aspects of nursing care for the 
adult as well as specialised interventions for older people [8, 9]. A hip fracture is a 
sudden traumatic event, threatening many aspects of patients’ lives and a forceful 
reminder of their mortality [10]. Care is dominated by restoring function, so physi-
cal care attracts the most attention and the primary goal of nursing is to maximise 
mobility and preserve optimal function whilst also prioritising psychosocial factors 
so that patients can participate in their rehabilitation [11].
Emergency care following hip fracture usually takes place in Emergency 
Departments that are noisy, busy and overstimulating, making them inappropriate 
care environments for vulnerable older people in a state of personal and physical 
crisis. Avoiding the impact of this situation requires consideration of three princi-
ples [12]:
• Timeliness—avoiding unnecessary and unwanted delay.
• Effectiveness—aiming for optimal outcomes using the best available evidence.
• Patient-centeredness—care that is respectful of and responsive to individ-
ual needs.
This is equally true of the hospital ward and perioperative environment which are 
rarely designed to meet the needs of frail older people.
17.3.1  Complexity and Frailty
Trauma care for older people must follow the same principles as for all age groups 
but the normal and abnormal changes of ageing, compounded by active comorbidi-
ties, mean that morbidity and mortality are increased concerns [13].
Trauma/orthopaedic services evolved to treat all adult patients, irrespective of 
age, following all types of musculoskeletal injury. However, there has been less 
focus on the complex needs of those who are older and frail but have also sustained 
a fracture. Highly skilled nursing is needed that is tailored to the needs of the older 
person. This must encompass expert care of both the older person and the individual 
with a musculoskeletal condition/injury.
These “complex patients” present with multiple problems including; comorbid-
ity, multimorbidity, poly-pathology, dual diagnosis and multiple chronic conditions 
[14] with multiple interlocking problems related to both breadth (range) and depth 
(severity) [15]. In the orthogeriatric patient there are three main facets of complex-
ity; the person, the fracture and the care environment—all of which have a signifi-
cant impact on patient care outcomes and are influenced by nursing care (see 
Fig. 17.1).
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Complexity and frailty are linked. As described in Chap. 4, frailty is a distinctive 
health state in which multiple body systems gradually lose their in-built reserves; 
incidence increases with age and is associated with negative outcomes such as falls, 
hospitalisation, poor functional outcomes and death [17]. Dramatic changes in their 
physical and mental well-being after any event which challenges a frail person’s 
health, such as an injury or surgery leads to increased vulnerability and diminished 
resistance to stressors [18]. Frailty can be physical or psychological or a combina-
tion of the two elements when physical frailty is coupled with cognitive impairment 
[19]. Frailty is known to be a dynamic state, varying in severity with capacity to be 
made better and worse. It is not an inevitable part of ageing; but is a long-term con-
dition that is linked with falls and fractures.
The identification of frailty is an interdisciplinary responsibility, but nurses need 
to recognise it in patient assessment so that care can be planned accordingly [20]. In 
collaboration with the orthogeriatric team, a validated assessment tool may identify 
frailty and its contributing factors as part of the multidisciplinary assessment pro-





























Fig. 17.1 The complexity of nursing care needs for hospitalised patients with hip fracture 
(adapted from Hertz & Santy-Tomlinson 2017 [16])
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Sarcopenia, reduced muscle mass and strength, is an additional driver for spe-
cialised nursing care for orthogeriatric patients, increasing fracture risk as it contrib-
utes to falls and is associated with lower bone mineral density, partly due to reduced 
forces of muscle on bone [17]. This combination of problems affects balance, gait 
and overall ability to perform tasks of daily living, highlighting the link between 
frailty, falls and fragility. Just as osteoporosis predicts the future risk of fracture, 
sarcopenia is a powerful predictor of future disability and need for specialised nurs-
ing care to reverse or manage decline.
17.3.2  Nursing Assessment and Management of Pain
Frequent, accurate pain assessment is essential. Pain in older people is often under- 
reported by patients and ignored by health care professionals. Unmanaged or under-
managed pain increases the risk of delirium, impaired mobility, chronic pain and 
poorer long-term function [21]. Cognitive impairment increases the risk of pain not 
being recognised. The individual and highly variable nature of pain and an individ-
ual’s response to it make accurate assessment central to nursing care that facilitates 
individualised pain management and monitoring. If pain is poorly controlled, 
mobilisation will be delayed, increasing the risk of complications of prolonged 
immobility, increased dependency and delirium.
Verbal reports of pain are valid and reliable in patients with mild to moderate 
dementia or delirium but the assessment of pain in a patient with more severe 
cognitive impairment may be more difficult. It has been shown that cognitively 
impaired and acutely confused patients receive less analgesia than their unim-
paired counterparts. Using specific assessment tools can help staff to understand 
the individual needs of a person with dementia and encourages families to share 
patient information, characteristics and behaviour that enable staff to better 
understand their pain experience and needs [22]. For pain assessment to be effec-
tive it must be carried out frequently and recorded accurately, just like vital signs 
or the administration of medication and other interventions. Pain management 
must provide sufficient relief to allow nursing care to be performed with least 
distress to the patient followed by reassessment and appropriate administration 
of analgesia.
As nurses become increasingly responsible for more advanced patient care inter-
ventions, non-medical prescribing will permit nurses to assess pain and to formulate 
a patient-centred plan for pain management. In some settings, advanced practitio-
ners with enhanced skills can prescribe a range of medications including opioid and 
non-opioid analgesics to enable a faster response to patient needs. Administration 
pre-operatively of nerve blocks for patients with hip fracture is becoming increas-
ingly common, minimising the need for opiates which have multiple risk factors in 
older and frail patients and have been shown to have a significant positive effect on 
the pain experience [23].
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17.3.3  Nursing Assessment and Management of Delirium
Delirium is a common and serious condition in older surgical patients, with an inci-
dence of up to 60% following hip fracture. It is identifiable by its sudden onset, 
fluctuating course and effect on consciousness and perception. The consequences of 
delirium can include [24]:
• Increased rates of complications.
• Increased length of hospital stay.
• Increased risk of dementia.
• More care and support needs following discharge.
• Increased risk of death.
Assessment of delirium has two focuses:
 1. Identification of those at highest risk.
 2. Identification of those developing symptoms of delirium.
Delirium is avoidable and the severity can be reduced through nursing interven-
tions as the nursing team are most likely to recognise the signs of delirium discussed 
in Chap. 11. Good communication with patients, family and carers can help practi-
tioners to recognise risk of delirium and subtle changes that suggest both delirium 
and its underlying causes, enabling them to co-ordinate multidisciplinary 
interventions.
Patients with or at risk of delirium and their carers need information about delir-
ium and what they might experience, encouraging them to report changes and 
inconsistencies in behaviour as there are several nursing interventions which may 
prevent delirium [25] as well as contribute to effective general nursing care of all 
older people:
• An environment that helps to re-orientate patients; large-face clocks and calen-
dars, well-lit areas with clear signage.
• Gentle re-orientation by introducing team members and with explanations of 
time and place; family/friends should be encouraged to visit and be supported in 
modifying their own communication.
• Dehydration, hypoxia and constipation prevention and management.
• Supported mobilisation to give more control.
• Recognition and management of infections.
• Assessment and management of pain.
• Ensure dentures are fitting correctly and encourage patients to eat.
• Resolve reversible causes of sensory impairment e.g. hearing and visual aids.
• Facilitating sleep and rest.
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17.3.4  Pressure Ulcer Prevention
Pressure ulcers (PUs) are serious complications of immobility, hospitalisation and 
surgery which increase the need for nursing care and extend hospital stay. Patients 
with hip fracture are at high risk, so prevention and management are central to 
patient safety. PU prevention is largely a nursing responsibility, but a multidisci-
plinary approach is needed to manage all risk factors.
Assessment of the skin on admission should be followed by frequent reassess-
ment. PUs can develop rapidly, so prompt and repeated assessment of risk using an 
appropriate and validated tool is essential in identifying the intrinsic and extrinsic 
factors that may lead to PUs. Identification of specific risk factors can then assist in 
planning and delivering appropriate interventions for prevention [26]. Examples of 
intrinsic and extrinsic factors are listed in Table 17.1.
Prevention strategies must be individualised to the patient’s skin condition and 
risk factors and based on evidence-based guidelines [27]. Interventions should 
include:
• Head to toe skin assessment at least once during each nursing shift.
• Pressure relieving/redistributing support surfaces on beds and chairs, including 
in the home.
• Off-loading of bony prominences, especially the sacrum and heels.
• Frequent re-positioning based on assessment of the individual’s tissue tolerance 
to pressure, including use of the 30-degree tilt to ensure off-loading of bony 
prominences.
• General skin care; careful washing and drying of the skin (especially following 
incontinence) and the use of emollient therapy to help promote the skin barrier 
function.
• Effective management of pain to promote movement and mobilisation.
• Nutrition and hydration.
Table 17.1 Common pressure ulcer risk factors for patients following hip fracture and surgery
Extrinsic
    •  Pressure—Bony prominences—Especially heels
    •  Shear
    •  Friction
    •  Skin moisture
Intrinsic
    •  Immobility
    •  Surgery
    •  Ageing, dry and damaged skin
    •  Concurrent medical conditions: e.g. diabetes, cardiovascular, respiratory, neurological
    •  Malnutrition
    •  Dehydration
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• Carefully selected support surfaces on beds and chairs;
 – Foam mattresses to redistribute pressure and reduce friction in patients at 
medium risk of PUs.
 – For patients at high to very high risk, dynamic pressure reducing equip-
ment such as alternating pressure mattresses for all patients until their 
mobility has improved enough for them to be able to change their own 
position.
 – Once remobilisation is in progress, these principles should also be applied to 
seating.
17.3.5  Nutrition, Hydration, Acute Kidney Injury 
and Constipation
Nutrition and hydration are fundamental to recovery and are the responsibility of 
the whole team, but the nursing team is central to adequate dietary and fluid intake 
because of their extended presence. Routine care must include assessment of nutri-
tional status on admission, nutritional intake following admission, nurse-based 
strategies to improve calorific intake and, where appropriate, referral for dietetic 
advice (see Chap. 18). Team communication should maximise nutrition and fluid 
intake in close collaboration with patients/families. Minimal duration of pre- 
operative fasting is a priority [8] so nurses need to be able to assess the likely time 
of commencement of surgery.
Fluid management in older people can be difficult; they may self-regulate 
fluid to try to control urinary incontinence/frequency and difficulties in access-
ing toilet facilities. Close monitoring of fluid balance is an essential aspect of 
nursing care to prevent or identify acute kidney injury. Patients’ acceptance of 
drinks is often poor and nursing interventions to promote adequate fluid intake 
should include:
• Accurate administration of prescribed IV and parenteral fluids.
• Avoidance of long periods of fasting, including interdisciplinary commitment to 
ensuring the timing of older patients’ surgery is managed and transparent.
• Assisting with oral fluid intake with regard for patient preferences and monitor-
ing fluid intake/output.
• Appropriate toilet signage, regular toileting and other measures to enable patients 
to maintain continence.
• Close observation of vital signs and other indicators of health deterioration.
Renal function is affected by the ageing process as well as ill health. Acute kid-
ney injury (AKI) is a significant cause of death in hospitalised older people: a sud-
den episode of kidney failure or damage that happens rapidly and is normally the 
consequence of acute illness, trauma or surgery and leads to reduced renal func-
tion [28].
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Nurses can identify those at risk of AKI:
• Age 65 years or over.
• History of acute kidney injury.
• Chronic kidney disease.
• Symptoms of urological conditions.
• Chronic conditions such as heart failure, liver disease and diabetes mellitus.




• Oliguria (urine output less than 0.5 mL/kg/h).
• Nephrotoxic drug use within the last week (especially if hypovolaemic) e.g. non-
steroidal anti-inflammatory drugs (NSAIDs), angiotensin-converting enzyme 
(ACE) inhibitors, angiotensin II receptor antagonists (ARBs) and diuretics.
• Exposure to iodinated contrast agents within the past week.
• Cancer and cancer therapy.
• Immunocompromise (e.g. HIV infection).
• Toxins (e.g. some herbal remedies, poisonous plants and animals).
Risk should be documented and discussed within the MDT and an enhanced plan 
of care initiated. In at-risk patients baseline assessment of blood creatinine should 
be conducted with daily monitoring in the peri-operative period and continued regu-
larly throughout admission. Medication review should be conducted pre- operatively 
and, in the peri-operative period, identification of nephrotoxic drugs and those that 
may significantly reduce BP during acute illness.
Management of AKI depends on the cause. Nursing interventions include:
 1. Identifying those at risk/presenting with AKI, reporting to senior clinicians.
 2. Accurate recording and documentation of fluid balance.
 3. Maintaining fluid intake.
 4. Acting as a conduit of information between the MDT and the patient and family. 
In the frailest patients, where the risk of AKI is highest, patient/carer involve-
ment is essential in ensuring adequate fluid intake.
Constipation can be acute or chronic and is a common complication following 
fracture and during periods of ill health/immobility. Prevention should be consid-
ered early in the care pathway. Prevention of constipation from a nursing perspec-
tive should involve:
• Regular assessment of bowel function including frequency and consistency of 
defaecation.
• Providing and encouraging a palatable fibre-rich diet and prevention of 
dehydration.
• Careful but early use of prescribed aperients.
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17.3.6  Healthcare Associated Infection
17.3.6.1  Pneumonia: Nursing Assessment, Prevention 
and Management
Nursing interventions to prevent pneumonia reflect general good nursing practice 
for the older people:
• Universal infection prevention precautions.
• Good pain relief to facilitate coughing, deep breathing and mobility.
• Early, regular mobilisation; encouraging activity out of bed.
• Prevention of aspiration risks.
• Encourage patients to sit in a chair for meals.
• Monitoring of dysphagia and swallow and cough reflexes.
• Thickener in drinks or modified diets as appropriate.
• Education of family/carers about the risk and preventive strategies in use.
• Reporting of signs and symptoms of respiratory problems to medical 
practitioners.
Patients with pneumonia need to be closely monitored by the nursing team for 
further deterioration. Adequate nutrition is central to supporting recovery and 
enteral feeding may be needed, although nasogastric feeding can increase the risk of 
aspiration. Hydration, early mobilisation, encouraging deep breathing and cough-
ing, regular changes of position, chest physiotherapy and nebulisers to moisten 
secretions can also assist in recovery.
17.3.6.2  Urinary Tract Infection: Nursing Assessment, Prevention 
and Management
Prevention, recognition and management of urinary tract infection (UTI) are the 
responsibility of the whole team, but are a fundamental nursing role. Strategies for 
prevention, risk reduction and recognition of UTI include:
• Avoiding indwelling urinary catheters as much as possible.
• Insertion and removal of urinary catheters under aseptic conditions.
• Using a closed drainage catheter bag system.
• Compliance with infection prevention precautions when inserting, handling and 
removing catheters.
• Meticulous perineal hygiene.
• Removal of indwelling urinary catheters as soon as possible.
• Reducing the risk of dehydration.
• Early mobilisation to reduce urinary stasis.
• Monitoring for signs of developing infection; particularly delirium, fever and 
tachycardia.
• Obtain a urine sample for microbiological analysis and referral to medical staff 
if symptoms of urinary tract infection are present.
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17.3.7  Venous Thromboembolism: Nursing Interventions 
for Prevention
Following hip fracture there is a high risk of venous thromboembolism (VTE). 
Although prevention and medical management of VTE are considered in Chap. 7, 
the nursing role in prevention includes assessment of risk on admission and when 
the patient’s condition changes using a risk assessment tool. Nursing specific mea-
sures that contribute to the prevention of VTE include:
• Restoration of mobility.
• Supporting early mobilisation and leg exercises to activate the calf muscle pump.
• Maintaining adequate hydration.
• Patient and carer information about the causes, prevention and the need to com-
ply with prophylaxis, especially on discharge/transfer.
• Observation of patients for signs and symptoms of deep vein thrombosis and 
pulmonary embolism.
Nursing interventions for prophylaxis focus on mechanical measures, particu-
larly graduated compression “anti-embolic” stockings. Stockings can, however, 
contribute to lower limb compartment syndrome, skin ulceration and common pero-
neal nerve palsy and should not be used in patients with cardiac or vascular disease, 
fragile skin or limb shape/deformity preventing correct fit. Safe use of compression 
stockings includes making sure that stockings are correctly fitted, checking to make 
sure the fit is not affected by changes in leg shape due to oedema and ensuring 
stocking are removed regularly for hygiene purposes, assessment of neurovascular 
status of the limb and checking for skin problems [29].
17.4  Rehabilitation, Discharge and Continuing Care
Independence in physical function and quality of life drive multidisciplinary reha-
bilitation. Effective rehabilitation is important as it promotes independence and sup-
ports patients in reaching their potential. Rehabilitation in the hospital setting and 
beyond tend to be largely a nursing role, alongside therapists, because of the need 
to support rehabilitation as part of 24 h and extended care in a collaborative, sup-
portive culture with patient motivation in mind. There is limited evidence, however, 
regarding the value of different care strategies in supporting rehabilitation and dis-
charge and which team members can best provide such care.
Early supported multidisciplinary rehabilitation can reduce hospital stay, improve 
early return to function and impact positively on both readmission rates and the 
level of public-funded home care required [30]. Community rehabilitation schemes 
facilitate early discharge of less frail patients to their own home. Ongoing rehabili-
tation allows them to continue to improve functionally and progress towards their 
goals after discharge, although in many settings this is not provided.
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From admission, patients should be offered a formal, acute, orthogeriatric or 
orthopaedic ward-based hip fracture programme that includes the following [31]:
• Comprehensive multidisciplinary geriatric/orthogeriatric assessment and con-
tinuous review.
• Rapid preoperative optimisation of fitness for surgery.
• Early identification of individual goals for rehabilitation; to recover mobility and 
independence and facilitate return to pre-fracture residence and long-term 
well-being.
• Liaison or integration with related services, particularly mental health, falls pre-
vention, bone health, primary care and social services.
• Clinical and service governance responsibility for all stages of the pathway of 
care and rehabilitation, including those aspects delivered in the community.
Patients with hip fracture have a lower perception of readiness for hospital dis-
charge than other medical–surgical groups [32]. Improvements are needed in nurs-
ing practice so that patients feel adequately prepared for discharge and achieve the 
best possible outcomes. Discharge planning in acute hospitals is multidisciplinary, 
but nurses take responsibility for much of this, particularly patient and family edu-
cation, coordination and liaising with follow-on care providers.
The responsibility for care after discharge is often delegated to the patient and 
their family along with the general practitioner and, sometimes, community care 
staff. The patient and their caregivers must be able to understand the discharge 
instructions so that they can recall aftercare instructions and remember to follow 
them. Providing patients with written discharge instructions has proven to be valu-
able, as has the provision of information in electronic formats via a smart phone or 
tablet applications and other devices [33]. Supporting oral information/education 
with written/electronic information on discharge helps older people with percep-
tion, visual, auditory and/or cognitive problems to manage the complex multiple 
messages.
In an ideal world, patients should have the option to receive rehabilitative care in 
a specialist rehabilitation setting. This is not an option in most resource-poor set-
tings and is rarely the case even in settings with better resources. The fundamental 
goal of orthogeriatric care is to discharge the patient to either independent or sup-
ported living in their own home or to alternative accommodation where post- 
discharge care can be provided either permanently or temporarily. Patients and 
families need intensive support when returning to a community setting or moving to 
residential care following discharge. Issues that need to be considered include the 
prevention of future falls, the continued management of bone fragility and second-
ary fracture prevention as well as the need for continued progress towards optimum 
achievement of rehabilitation. Post-discharge services vary significantly globally, 
and the availability of specialist community nursing resources is even more of a 
challenge than in the hospital setting.
Nurses must be aware of the possibility and effects of care giver burden espe-
cially since the majority of orthogeriatric patients require physical care after 
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discharge. Care giver burden is defined as “the physical, emotional and financial 
responses of a caregiver to the changes and demands caused by providing help to 
another person with a physical or mental disability” [34]. Continued support of 
care givers should be in place following hospital discharge. Ongoing communi-
cation and contact are vital in ensuring care giver burden is minimised. The abil-
ity of informal care to meet the care needs of patients is limited, so longer term 
plans may need to be in place if care needs are prolonged or carers are not able 
to cope [35].
17.5  Palliative and End of Life Care
Hip fractures can herald decline in function and independence and may indicate the 
beginning of the end of life. Such decline leads to a variety of experiences and 
symptoms that increase patient need for carefully planned sensitive nursing care. 
Palliative care is defined by the World Health Organization [36] as: “an approach 
that improves the quality of life of patients and their families facing the problems 
associated with life-threatening illness, through the prevention and relief of suffer-
ing by means of early identification and impeccable assessment and treatment of 
pain and other problems, physical, psychosocial and spiritual”. This approach 
should be available for people who are struggling to recover from a hip fracture 
whether they are likely to be at the end of their lives or require intensive support for 
management of symptoms and experiences when outcomes from the acute care epi-
sode are poor.
The fundamental aims of palliative care include [36]:
• Providing adequate pain relief and minimising discomfort by providing symp-
tom relief.
• Affirming life and regarding dying as a normal process.
• Intending neither to hasten nor postpone death.
• Integrating the psychological and spiritual aspects of patient care.
• Offering a support system to help patients live as actively as possible until death.
• Offering to provide a system of support to help the family cope during the 
patient’s illness and death and in their own bereavement.
• Working collaboratively as a team to address the needs of patients and their fami-
lies, including bereavement counselling, if indicated.
• Enhancing quality of life and positively influencing the course of illness.
• Applicable early in the course of illness, in conjunction with other therapies that 
are intended to prolong life, such as chemotherapy or radiation therapy, and 
includes those investigations needed to better understand and manage distressing 
clinical complications.
This philosophy allows for physical, psychological, social and emotional care 
for patients and their families when the patient does not have the physical resil-
ience to fully recover from/survive the trauma of the injury. Typically, palliative 
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care is provided by an MDT who focuses on the assessment and treatment of pain 
and other symptoms whilst ensuring that care is enhanced by patient-centred com-
munication and decision-making across the continuum of care settings, from hos-
pital to home.
Identifying patients for whom a palliative care approach is most appropriate is 
difficult and is influenced by cultural issues. Nurses play a key role in helping the 
patient throughout this process. Following hip fracture, patients may have multiple 
co-morbidities that can additionally limit life, but most recover well from surgery 
and have good functional outcomes and subsequent quality of life. Appropriate 
models of end of life care are currently a matter of considerable discussion and 
debate. Palliative care has not previously been a natural consideration in orthopae-
dic care, so this is a matter for continuing debate and discussion rather than some-
thing that is currently integrated into practice [13].
The patient and family must be included in making decisions that ensure on- 
going care and treatment is appropriate to the patient’s needs. Good nursing care for 
those at the end of their life should include physical, emotional and psychological 
aspects of care along with spiritual support [37]. The process of dying creates mul-
tiple emotions and feelings for all involved: the patient, family, carers and the care 
providers [36]. It is the responsibility of the MDT, through good communication 
with patients and families, to identify those who were frail pre-fracture and for 
whom the fall, fracture, surgery and hospitalisation experience may lead to the 
“winding down” of the body at the end of life.
17.6  Secondary Prevention, Health Improvement 
and Health Promotion
The nursing team are in an ideal position to recognise and act on the need for bone 
health assessment and identification of those whose fracture requires investigation 
for osteoporosis (see Chap. 14) as they have the most sustained contact with 
patients. This, however, is not a simple process since most patients will be unaware 
of the influence of bone health on their current fracture. Early in the care trajec-
tory it may be a shock to them that the cause of the fracture may be fragile bone 
due to osteoporosis. While there is, therefore, an opportunity for nurses in any 
care setting to instigate bone health assessment referral, this needs to be discussed 
in a sensitive manner with patients and carers. Nurses need to be able to discuss 
the reasons for referral for bone health assessment with patients as soon as pos-
sible after the fracture has occurred so that patients and their families can be pre-
pared for the next steps. Conversations that introduce the topic of bone health and 
osteoporosis can be conducted during normal nursing care activities in a manner 
which enables patients to gradually acknowledge the need for them to consider 
their bone health. To do this, nurses working in acute settings need to have enough 
understanding of the processes involved in bone health assessment and the treat-
ment of osteoporosis so that they can effectively educate and counsel patients and 
their families.
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17.7  Nursing Resources, Education and Leadership
There is a global shortage of nurses owing to changing demographics, political 
ideologies and financial austerity and recruitment and retention problems. The 
availability of appropriately educated and skilled nurses to provide both fundamen-
tal and specialist care is a major concern. A large international study [38] demon-
strated that an increase in a nurses’ workload by one patient, from eight to nine 
patients per qualified nurse, increased the likelihood of an inpatient dying within 
30 days of admission by 7%. Under-resourcing nursing teams leads to insufficient 
capacity for the team to undertake actions to prevent morbidity and mortality. 
Studies have indicated that this “missed care” is associated with one or more adverse 
patient outcomes including; medication errors, urinary-tract infections, falls, pres-
sure injuries, critical incidents, quality of care and patient readmissions. The quality 
of studies relating to missed care is, however, weak and the link between missed 
care and mortality is yet to be explored in more robust research [19]. Most of the 
research has, however, considered high resource settings, while in lower resource 
settings the impact of limited resources on patients and communities has yet to be 
explored. In many settings the number of qualified nurses is severely limited and 
skills development focuses on nursing assistants and other team members.
Unless the nursing resource is protected and grows, the added nursing value 
needed to continue to improve outcomes and the quality of care for patients with 
fragility fractures globally will not happen. Sahota and Currie [39] pointed out that: 
“…looking after hip fracture patients well is a lot cheaper than looking after them 
badly”, the nursing resource is significant in this, meaning that it is important for the 
multidisciplinary community, through organisations such as the Fragility Fracture 
Network (FFN), to lobby governments and health and social care providers of to 
ensure that nurses are able to do undertake their role effectively, aligning the profes-
sion to the fourth pillar in the FFN call to action [1].
Nurses work in a professional culture of constant skills and knowledge develop-
ment through learning and reflection. Many nurses working in orthogeriatric set-
tings, however, are more likely to have been educated solely in the care of adults 
with musculoskeletal problems rather than to meet the complex needs of older peo-
ple. Multiple “orthogeriatric” specialist skills that combine orthopaedic care exper-
tise with the care of older people are needed that are based on an in-depth knowledge 
of the theory underpinning care. Few nurses working with patients with fragility 
fractures have undertaken education beyond that of their initial nursing qualification 
and they rely on knowledge and skills developed through generic, rather than spe-
cialist, education. This education and skills gap can result in care which does not 
meet all needs. Specialist orthogeriatric nursing education could have a positive 
impact on patient outcomes [19]. Many nurses working in orthogeriatric settings are 
better prepared educationally for the care of adults with musculoskeletal problems 
than to meet the complex needs of older people. Multiple specialist “orthogeriatric” 
nursing skills are needed as well as fundamental adult nursing skills. Specialist 
nursing qualifications in orthogeriatric care do not currently exist, so nurses are 
obliged to be reflective self-led learners who are able to extend their own knowledge 
17 Nursing in the Orthogeriatric Setting
308
of both caring for patients following trauma and the complex care of older people 
together through reflection.
Multidisciplinary orthogeriatric care can be fragmented and less effective if it is 
not managed or coordinated effectively; nurses’ 24-h presence and detailed knowl-
edge of patient pathways make them ideal care co-ordinators. The complex nursing 
care requirements of orthogeriatric patients mean that they should have their care 
led by those who are experts in the field with an intuitive understanding of need. In 
some settings care and its coordination are led by a specialist nurse or coordinator 
such as a hip fracture nurse specialist, elderly/elder care nurse specialist, trauma 
nurse coordinator, nurse practitioner or advanced nurse practitioner. In some coun-
tries, multidisciplinary collaborative working has supported the development of 
advanced nursing roles often operationalised as clinical nurse specialists, nurse 
practitioners or physicians’ assistants who have a variety of skills that are comple-
mentary to the MDT and enhance patient care. Care should be supervised and man-
aged by those who have enhanced experience, skills and knowledge in working with 
older people following fracture so that they perceive care needs holistically and 
from individual perspectives.
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Increasing numbers of fragility fractures in ageing populations represent a substan-
tial and significant pressure on patients, carers, healthcare systems and societies 
around the world [1]. Frail older people with fragility fractures require comprehen-
sive, orthogeriatric care [2]. Co-existing chronic diseases confound acute interven-
tions and efforts to improve recovery in rehabilitation, and have a negative impact 
on patient outcomes, long-term survival and quality of life.
An interdisciplinary approach to the management of the presenting fracture and 
pre-existing co-morbidities will improve outcomes. Preventing future fractures and 
additional harmful diagnoses should also be a priority for treating teams in the 
acute, rehabilitation and secondary prevention settings [1]. Individualised care is a 
core component of orthogeriatric care. However, this must be underpinned by inter-
disciplinary actions and systems that support timely and appropriate delivery 
of care.
Nutrition-related diagnoses are key predictors of initial and secondary fragility 
fractures and are among the most harmful co-morbidities in older orthopaedic 
patients across acute, rehabilitation and community settings. Nutrition interventions 
are core components of primary and secondary fracture prevention and have been 
shown to improve outcomes in the acute and rehabilitation settings.
Many models of nutrition care focus on highly individualised assessments and 
interventions provided by dietitians or medical nutrition specialists [3]. The high 
prevalence of protein–energy malnutrition and other nutrition-related diagnoses is 
well described across many orthogeriatric settings, and there are strong associations 
between nutrition-related diagnoses and patient and healthcare outcomes. Despite 
this, in many orthopaedic settings timely access to specialist clinical nutrition care 
is limited or absent [4]. Increases in diagnosis and referral rates, patient complexity, 
healthcare costs and service demands, combined with reduced lengths of stay and 
unsustainable health expenditure growth, suggest that it will not be possible to pro-
vide all patients identified at risk of a nutrition-related diagnosis with individual 
access to specialist nutrition services [3]. This chapter therefore presents a call to 
action. Systematised, interdisciplinary nutrition care actions are urgently required 
across the pillars of acute care, rehabilitation and secondary fracture prevention [1].
18.2  SIMPLE or Specialised Nutrition Care?
Models in which interdisciplinary healthcare workers provide early, supportive 
nutrition care across the three pillars may be best placed to deliver high value nutri-
tion support. Such models include the Systematised, Interdisciplinary Malnutrition 
Program for impLementation and Evaluation (SIMPLE), the More-2-Eat program 
and a multidisciplinary, multimodal nutrition care model applied in hip fracture by 
Bell et al. [3, 5, 6]. These models suggest that patients are triaged into three groups: 
those not at risk and appropriate for standard care, those who are at risk or malnour-
ished but do not require specialised nutrition care and those who are likely to benefit 
from a nutrition care specialist.
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These models have focused on implementing nutrition care in the acute setting 
for patients with, or at risk of, protein–energy malnutrition. This has included the 
use of action reflection cycles to collect relevant data justifying change, then pro-
gressively developing, implementing, evaluating and iteratively improving chosen 
nutrition care activities [7, 8].
Figure 18.1 provides a SIMPLE illustration of how to support nutrition care of 
the older patient with fragility fracture. This is considerate of key nutrition care 
models internationally [3, 5, 9–11], and supports different members of orthogeriat-
ric teams to contribute to systematised, interdisciplinary nutrition care for patients 
with, or at risk of a nutrition-related diagnosis, globally.
Specific strategies have not been identified, so that local teams can tailor the 
approach across a variety of nutrition-related diagnoses, frameworks and contexts. 
Systematised and interdisciplinary care nutrition actions are encouraged, but local 
processes should still inform referral for specialist nutrition advice when this is 
likely to add value. Conversely, if referral is unlikely to add value, for example 
when ongoing specialist intervention is unlikely to add benefit or improve what 
matters to the patient, supportive nutrition care should be the priority [12, 13].
The underlying themes along the bottom of the model highlight that successful 
and sustained nutrition care requires the engagement of local patients and teams 
using a knowledge translation approach; a ‘cut and paste’ approach to process 
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Fig. 18.1 Nutritional care of the older patient with fragility fracture
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18.3  Screening for Nutrition Risk (SIMPLE)
Nutritional risk increases substantially with age, multimorbidity and fragility frac-
ture, and screening and/or assessment should be routine across orthopaedic settings. 
A two-step approach, with ‘first pass’ nutrition screening, followed by a detailed 
assessment by a qualified health professional, is often applied as an efficient 
approach to making a nutrition-related diagnosis [15]. In high-risk settings, such as 
acute hip fracture units (with a high proportion of patients at malnutrition risk), the 
poor sensitivity of common screening tools and the need for prompt nutrition care, 
support proceeding straight to detailed assessment and intervention [15]. Nutrition 
screening to identify patients at risk of a nutrition deficiency, excess or imbalance 
state should be quick and easy and designed to be administered by diverse people 
with limited or no training [16].
18.4  Interdisciplinary Assessment (SIMPLE)
Where patients are identified at nutrition risk, appropriately trained interdisciplinary 
team members should undertake further nutrition assessment. The lack of distinc-
tion between screening and assessment measures, the diversity of nutrition-related 
diagnoses and factors contributing to their development and the presence of con-
founding co-morbid conditions have resulted in the absence of any gold standards 
for nutrition screening or diagnosis [17–19]. Not surprisingly, a range of nutrition 
screening and assessment tools have been applied or recommended in orthogeriatric 
settings; Table 18.1 applies an ABCDEF anagram to highlight nutrition assessment 
measures, screening tools and malnutrition diagnostic criteria commonly reported, 
observed, applied or recommended for use in orthogeriatric settings [4, 10, 15–38] 
(Table 18.1). Local treating teams should select measures, tools and diagnostic cri-
teria that have proven concurrent and predictive validity in the population in which 
they are to be applied, and that are feasible for local implementation [19, 21, 39, 40].
The ease of retrospective access and cut-off measures have led to the continued 
practice of using single-point nutrition outcomes measures, such as BMI or albu-
min, in clinical and research settings [17, 22]. Single measures may be appropriate 
for some specific nutrition-related diagnoses, for example some vitamin deficiency 
states. However, applying single measures for the definition of protein–energy mal-
nutrition should probably be avoided. Protein–energy malnutrition has traditionally 
been assumed to apply to ‘stick thin’ patients with low BMIs. However, there is now 
a clear imperative to screen for malnutrition in overweight and obese as well as 
underweight older people [41]. Protein–energy malnutrition is evident across BMI 
ranges and the risks of increased morbidity and mortality associated with rapid loss 
of muscle mass are now becoming recognised across under-, overweight and obese 
BMI categories [42, 43]. Serum albumin and other markers of visceral protein status 
are also not reliable as a standalone malnutrition markers in acutely unwell orthoge-
riatric populations [18, 44]. Inflammation is today considered the major reason for 
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reduced serum levels of visceral proteins, and inflammation due to disease or ageing 
is well recognised as a contributor to the development of malnutrition [44]. 
Inflammation is also a predictor of sepsis, longer hospital stay and readmission and 
mortality, so it is not surprising that studies report associations between low visceral 
proteins and poor patient and healthcare outcomes.
Table 18.1 Nutrition assessment measures, screening tools and malnutrition diagnostic criteria 
commonly applied or recommended for use in orthogeriatric settings
Nutrition assessment measures







Bioelectrical impedance analysis 
(BIA)













Physiological contributors to 
wasting
Physiological contributors to 
cachexia
e.g. COPD, heart failure, some 
cancers




Diets and dietary restrictions e.g.: Special diet | Poor diet | 
Monotonous diet
E: Environmental and psycho-social assessment













Screening tools for protein-energy malnutrition
Mini Nutrition Assessment [23]
Malnutrition screening tool [24]




Mini Nutrition Assessment- Short Form [27]
Malnutrition Universal Screening Tool [10]
Prognostic nutrition index [28]
Simplified Nutrition Appetite Questionnaire [29]
Criteria for protein-energy malnutrition diagnosis
ASPEN/Academy Criteria (2012) 
[30]
ESPEN criteria (2015) [31]
Mini Nutrition Assessment [23]
Subjective Global Assessment 
[32]
GLIM criteria [33]
ICD 10 criteria [34]
Mini Nutrition Assessment- Short Form [27]
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Differences in study designs, populations, evidence-based outcomes, guidelines 
and consensus recommendations preclude making specific macro- or micronutrient 
recommendations. Consequently, local teams should consider latest evidence and 
relevant national or international recommendations for macro- and micronutrients. 
As a start point, ageing-related inefficiencies in absorption and utilisation suggest 
considering an energy intake target of 30 kcal/kg bodyweight daily in older patients, 
and at least 1 g/kg protein with individual adjustment for nutritional status, physical 
activity level, disease status and tolerance [45, 46].
Dehydration should also be closely monitored as this can be causative for frac-
ture incidence and a substantial and significant contributor to subsequent harm [47]. 
Unless a clinical comorbidity requires a different approach consensus daily recom-
mendations suggest 1.6 L for women and 2.0 L for men with normal physical activ-
ity in a moderate climate [46, 48].
In summary, in many settings, a positive nutrition risk screen simply informs a 
referral for a thorough assessment and diagnosis by an appropriately trained nutri-
tion care specialist, prior to commencing nutrition care interventions. A SIMPLE 
alternative is recommended; orthogeriatric teams need to action opportunities for 
systematised nutrition care from the point of risk identification. These may consider 
opportunities for timely nutrition diagnoses, goal setting, interventions and evalua-
tion processes.
18.5  Make the Diagnosis/(es) (SIMPLE)
A broad array of nutrition-related diagnoses are observed across orthogeriatric set-
tings and can result from deficiency, excess or imbalance states that lead to adverse 
effects on body form, function, clinical outcomes, healthcare systems and commu-
nity costs (Table 18.2) [34].
Cachexia, sarcopaenia, frailty and osteoporosis are of particular interest, given 
their prevalence trajectories and likely impact on outcomes globally. Concurrent 
diagnoses, for example of obesity and malnutrition, are also worthy of special atten-
tion. The most outstanding single diagnosis in terms of reported prevalence, inci-
dence and harm imposed on patient and healthcare systems is protein–energy 
malnutrition. In many settings globally, the skeleton continues to hide in the hospi-
tal closet; undervalued, under-recognised, and consequently, undertreated [49, 50].
Protein–energy malnutrition (malnutrition) is an ICD-coded condition that can 
be treated using medical nutrition therapy [34]. Its prevalence varies across orthoge-
riatric settings, reflecting differences in screening and diagnostic tools, as well as 
real differences in the populations observed. Estimates suggest that less than 1 in 3 
non-complex elective orthogeriatric inpatients are at risk of malnutrition, whilst up 
to two-thirds of hip fracture patients will have a diagnosis of protein–energy malnu-
trition by the time they are discharged from acute or rehabilitation care settings [36, 
50]. Although differences in design and tools again make comparisons difficult, the 
reported prevalence appears higher in studies from low- and middle-income coun-
ties than in high-income countries [51, 52].
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Protein–energy malnutrition is recognised as the most costly comorbidity in hip 
fracture, the one most likely to increase length of stay and a strong independent 
predictor of post discharge mortality [53, 54]. Table 18.3 highlights associations 
between protein–energy malnutrition and outcomes observed across orthopaedic 
specified studies and those including older, multimorbid populations including 
those with fragility fractures [18, 54–63].
Recent updates to key orthogeriatric evidence-based recommendations, guide-
lines and registry datasets suggest positive, albeit belated, recognition of the need 
for timely identification, treatment and monitoring of nutrition care across the acute, 
rehabilitation and secondary prevention orthogeriatric settings globally.
A thorough assessment will also identify the aetiology, or root cause, of the 
nutrition-related diagnosis or diagnoses being assessed [9]. A comprehensive list of 
all potential aetiologies observed in orthogeriatric settings is beyond the remit of 
this chapter, however, Table 18.4 provides some potential starting points for consid-
eration [17, 37, 50].
Efforts to identify a primary aetiology for a nutrition-related diagnosis in older, 
multimorbid inpatients are difficult, and perhaps over-simplistic [64]. For example, 
protein–energy malnutrition may be attributable to wasting, cachexia or a combination 
Table 18.2 Common nutrition-related diagnoses observed or reported within and across global 
orthogeriatric settings—with ICD-10 Diagnostic Code [34]
Undernutrition
• Protein–energy malnutrition—serve E43/moderate E44/unspecified E46
• Starvation related underweight—E43








• Vitamin D deficiency—E55
• Vitamin B12 deficiency—E53.8/intrinsic factor deficiency D51.0




• Fatty liver disease/non-alcoholic steatohepatitis—K76.0
• Excessive alcohol intake—F10.99
Nutrition imbalance states/metabolic disorders/autoimmune
• Osteopenia—M85.80
• Osteoporosis—M81.0/with fracture M80.0
• Diabetes mellitus—DM1 E10/DM2 E11
• Acute kidney injury—Unspecified N17.9
• Chronic kidney disease—Unspecified N18.9
• Irritable bowel syndrome—K58
•  Refeeding syndrome—Endocrine, nutritional and metabolic disease E00-E89/disorder of 
electrolyte and fluid balance E87. 8
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Table 18.3 Association between protein-energy malnutrition and outcomes in orthogeriatric 
settings
Affected Outcome
Patient Altered body composition /sarcopaenia
Reduced mobility/frailty/falls
Post-operative complications
  Increased infection risk
  Pressure injuries
  Wound complications
Functional impairment/apaty
Psychological effects/tendency to depression, anxiety, impaired social 
function
Delirium






  Infections/wound dehiscence
  Pressure injuries
  Harmful falls
  Delirium
Increased length of stay
Increased healthcare costs
Unfavourable discharge
  Unplanned hospital readmissions
  Increased requirements for rehabilitation
  Increased requirements for long term care
Society Increased caregiver burden
Increased societal healthcare costs
of these [30]. This is further confounded by the complex relationships and substantial 
overlap in variables applied for the purposes of screening and diagnosing protein–
energy malnutrition, wasting, cachexia, sarcopaenia, frailty, osteoporosis and other 
nutrition-related diagnoses [65]. It is therefore unsurprising that malnutrition is consid-
ered a ‘wicked’ problem [66, 67] (Table 18.5). A pragmatic approach would consider 
whether administration of nutritional intervention is likely to improve outcomes; if so 
then the aetiology is likely to include a nutritional component and locally tailored nutri-
tion interventions should be provided.
Once diagnoses and aetiologies have been articulated, these should be docu-
mented in the appropriate care record. Proper documentation is critical to providing 
quality standard care, communication with other professions and recording diagno-
sis that can have effects on other medical diagnosis or treatment [68]. Documentation 
also supports service planning and review processes, and in many settings also 
influences resource allocation.
Multidisciplinary clinicians should ensure that patients are aware of positive 
nutrition risk screens. Open and honest discussion about consequent nutrition- 
related diagnoses and a shared decision-making approach to treatment (and no treat-
ment) options should be considered within a sensitive approach that allows patients 
or carers to control the amount of information they receive [46, 69].
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A ‘truth-telling’ approach to informing patients of a diagnosis of malnutrition, 
for example may initially appear confronting. However, studies suggest that 
patients’ wish to understand a harmful diagnosis such as malnutrition far outweighs 
concerns over potential disbenefits of receiving this advice [69]. Recognition of a 
problem is a primary first step towards positive change, and awareness of nutrition 
status may positively influence treatment adherence or patient experiences.
18.6  Plan with the Patient (SIMPLE)
Wicked problems do not have magic bullets for care [70]. Multi-modal, interdisci-
plinary interventions should be considered to treat nutrition diagnoses, aetiologies 
or related conditions at both the individual and systems levels [9, 31, 38, 46, 71, 72]. 















Poor appetite/anorexia of old age
Poor or moderate self-reported health status
Sarcopaenia





Loss of interest in life/emotional well being
Social isolation
Food habits and preferences
Societal norms, trends and peer pressure
Workplace cultural
Competing interests/priorities






Institutional environments and 
processes
Food and fluid access
Transportation (dependent on)
Clinician capability and capacity
Perceptions, misinformation, and 
biases
Nutrition knowledge and 
misinformation
Restrictive diets






Table 18.5 Why malnutrition should be considered a wicked problem
• No gold standard screen or diagnosis
• Multiple aetiologies
• No single, clear intervention
• Socially complex
• Not the responsibility of single stakeholder/professional group
• Characterised by chronic policy failure
• Solutions require behaviour change
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Nutrition interventions planned at the individual level should consider a shared 
decision-making approach, including informed consent. This should be applied to 
establish nutrition treatment goals and intervention strategies and to establish moni-
toring and reassessment processes to identify whether interventions are effective 
and consistent with patient goals and healthcare system deliverables [3, 9, 46, 73, 
74]. Whilst these care processes are presented in linear fashion, this is not how care 
will or should be delivered in many real-world settings. Orthogeriatric teams should 
also engage patients in co-design approaches to improve systems, processes, 
resources, environmental and governance structures that facilitate delivery of nutri-
tion care across the three pillars of care [1, 75, 76].
To the best of our knowledge, no specific literature has focused its attention on 
the need for shared decision-making or co-design in orthogeriatics. Nevertheless, 
increasing evidence suggests the importance of these components in the nutritional 
care of frail and older patients. Patients should be encouraged to become more 
active in goal setting and developing strategies for ongoing care; these should ide-
ally be patient-driven and support patients and/or carers to make ‘informed choices’ 
about treatment options [77]. This is especially important in the absence of a ‘one 
strategy fits all’ approach to nutrition care. Building behaviour change through set-
ting small realistic goals, encouraging self-monitoring, providing positive feedback 
and health coaching are also potential opportunities that could implemented by 
interdisciplinary healthcare workers across orthopaedic settings [77]. Perhaps most 
importantly, goals and strategies should be individualised to consider the patients’ 
stage of change, health literacy, cognition and cultural needs [77]. Involving family 
and other significant support people, particularly those who are primary meal pro-
viders, in nutrition education strategies may positively influence behaviour 
change [77].
Who is best placed to facilitate appropriate goal-setting with patients varies 
across settings; how, when and where this takes occurs is also highly contextual. As 
an example, in a palliative situation, the patient should be offered whatever he or she 
likes to eat and drink orally, in the amount he or she likes to consume, regardless of 
nutrition status. This approach is mostly described by the term comfort feeding [78]. 
In this situation, meeting a patient’s nutritional requirements is obviously irrelevant, 
and nutrition treatment goals and strategies should focus on their comfort [79]. In 
contrast, the appropriateness of reinserting an enteral feeding tube, after its removal 
by a malnourished, acutely delirious hip fracture patient, is far more complex and 
would require attention to clinical judgement and shared decision-making [80, 81].
18.7  ImpLement Interventions (SIMPLE)
18.7.1  Interventions to Improve Nutrition Knowledge
The ESPEN guideline on clinical nutrition in geriatrics consequently recommends 
that patients and caregivers should be offered nutritional education in order to 
ensure awareness of, and basic knowledge on, nutritional problems and treatment 
options, to promote their appropriate nutrition care [46].
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Effective education of patients and healthcare workers should not just provide 
patients with basic information about nutrient sources and place posters in hospital 
ward treatment areas. As a first step in any patient education or counselling process, 
the information provider should ensure the patient is aware or the relevant nutrition 
diagnosis or diagnoses. The lack of recognition of the need to change is considered 
the fundamental barrier to commencement of change [82, 83].
A multicentre nutritional intervention study suggested additional factors that can 
enhance adherence in older patients after hip fracture [84]. Individualised dietary 
advice, frequent personal coaching by the health professional and continuity of care 
(monitoring, personnel and type of advice) are likely to contribute to greater adherence. 
Moreover, they seem to elicit high appreciation of the intervention by both participant 
and caregivers. A further study demonstrated that nutrition care is not a priority of hip 
fracture patients and their healthcare providers because people fail to pay enough atten-
tion to patient and healthcare worker perceptions, biases and beliefs [50].
Strategies to improve nutrition knowledge and awareness should also not be lim-
ited to patients, carers and direct healthcare providers. Health education theory, 
research and training processes should be used to modify social and political envi-
ronments to improve health [85]. Where available, ‘outer setting’ nutrition care 
drivers should be considered. Examples include care standards, accreditation 
requirements, hospital-acquired complication penalties, case-based reimbursement 
funding and benchmarked audit data sets. These should be leveraged to promote 
orthogeriatric nutrition care to healthcare executives, politicians, media, insurance 
and research-funding bodies [86]. Where such drivers are absent, orthogeriatric 
teams should advocate for their development and implementation.
18.7.2  Interventions to Influence Nutrient Intake
Numerous studies demonstrate that patients with hip fracture, and older adults in the 
acute and rehabilitation settings more generally, commonly fail to meet rudimentary 
recommendations for macronutrient, micronutrient and fluid intakes. In many cases, 
multiple nutrition-related diagnoses co-exist, for example in malnourished patients 
with co-diagnoses of obesity and pressure injuries; in such cases, clinical care pro-
cesses are best supported by dietitians or medical nutrition specialists, where avail-
able [42].
In most cases, the underlying treatment strategies for patients with undernutri-
tion revolve around the deficient nutrient or nutrients, whether protein and/or energy, 
fluids or micronutrients. Ensuring adequate provision and intake of fluids and 
micronutrients may not be an insurmountable challenge in acute, rehabilitation and 
secondary prevention settings with appropriate application of intravenous therapy 
and pharmaceutical support. Nonetheless, dehydration is still commonly observed, 
vitamin D and other micronutrient deficiencies often remain untreated and a high 
proportion of post-fracture patients fail to receive adequate bone protection medica-
tion. However, the most difficult challenge is the increased protein requirements of 
acutely unwell, older, multimorbid patients. Many intervention studies demonstrate 
persistent inadequate intakes with concomitant harm, even after intervention.
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There is no single intervention that will guarantee delivery of protein and energy 
intake adequacy across acute, rehabilitation, community or residential care home 
settings. Multimodal approaches that engage patients and treating teams in the iden-
tification of locally relevant, multimodal strategies seem more likely to yield 
improved intakes, patient and healthcare outcomes and patient-reported experiences.
Table 18.6 lists systematised and/or interdisciplinary strategies that are consid-
ered to positively influence macronutrient, micronutrient and/or fluid intake 
across orthogeriatric settings [6, 9, 17, 22, 38, 46, 71, 72, 89]. Specific strategies 
for nutrition care should be considered by local teams after considering relevant 
evidence- based recommendations and tailoring interventions to the local context 
and patient needs.




•  Assistance with access, preparation 
or storage
•  Assistive devices e.g. modified 
cutlery
•  Access to macro- and micronutrient 
supplements
• Allocation of funding and resources
•  Avoidance of prolonged Nil By 
Mouth, unnecessary post-surgical 
diets and/or restrictive diets
•  Clinical nutrition governance 
processes
•  Enjoyable eating experiences and 
mealtime settings
• Family/friends support
•  Food or fluid enrichment or 
functional changes
•  Food supply influence high-quality 
food and fluid choices/menus
• Mealtime preparedness activities
•  Menu standards, policies and 
procedures
•  Modified menus e.g. high protein; 
texture-modified menu assistance and 
dietary preference checks
•  Multidisciplinary assistance and 
encouragement with food, fluid or 
supplement intake
• Nutrition support teams
•  Provision for inclusion of nutrition 
supplements on medication 
administration records
•  Strategies to improve mobility/
functional status
•  Supportive nutrition care 
coordination roles (e.g. nutrition 
assistants)







•  Activities, therapies, or medications 
to:
  –  Optimise underlying conditions 
or comorbidities
  –  Manage nutrition impact 
symptoms
  – Influence appetite or intake
  – Improve mental health and 
wellbeing
•  High protein-energy oral nutrition 
supplements (e.g. Fluids, protein 
powders)
•  Individual or multi-nutrient 
micronutrient supplements
•  IV fluid therapy, enteral, or 
parenteral nutrition where 
appropriate and in line with patient 
goals/healthcare plans
Deprescription
•  Medication deprescription or dose 
adjustment
•  Mixed approaches 
(dietary ± supplements ± enteral or 
parenteral tube feeding)
•  Nutrition therapy where treatment 
goals or requirements no longer 
support medical nutrition therapy
•  Restrictive diets were unlikely to add 
benefit/negatively influencing 
nutrition status
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18.7.3  Interventions Leading to Coordinated Nutrition Care 
Across Disciplines and Settings
It is well recognised that dietitians, nutritionists and medical nutrition specialists are 
experts in nutrition care. However, in many settings, access to nutrition care experts 
is limited outside of acute care facilities or tertiary rehabilitation settings. In some 
healthcare settings, dietitians and medical nutrition specialists may be best placed to 
coordinate nutrition care across disciplines and settings, but this may not always be 
an option. Appropriately educated patients and their family, friends and social net-
works are also often ideally placed to provide supportive nutrition care.
Of focus though are the many interdisciplinary healthcare workers that orthoge-
riatric patients interface with across the three pillars of orthogeriatric care who may 
be able to provide supportive nutrition care processes. Where available, dietetic (or 
nutrition) assistants are particularly well best placed; but dietetic assistants are also 
not available in many settings even though they have been shown to reduce mortal-
ity in hip fracture [87].
As described in Chap. 17, the best-placed profession to oversee, lead and imple-
ment interventions to coordinate nutrition care is therefore nursing. Nurses are usu-
ally the main professional group providing care to patients and the best-placed 
Table 18.6 (continued)
Education • Dietary counselling
•  Inclusion of nutrition curriculum in 
interdisciplinary training and 
education
• Informed consent discussions
•  Mobile Health (mHealth) 
applications nutrition component in 
ward rounds, huddles, case 
conferences, interdisciplinary care 
planning meetings
•  Nutrition-related diagnosis and 
education provided to patients, 
caregivers and health professionals
•  Nutrition specialist representation in 
advocacy and governance roles
•  Quality improvement, research and 
development shared goal setting and 
treatment planning
• Standards, policies, guidelines
•  Traditional and social media 
marketing
Psychosocial • Group interventions
• Shared mealtimes/dining rooms
• Social support networks
•  Wellness/lifestyle/mindfulness/
cognitive behaviour therapy programs






• Food intake monitoring
• Nutrition re-screening
• Nutrition re-assessments
•  Patient-reported experience and 
outcomes measures (PROMS/
PREMS)





•  Discharge summaries/clinical 
handover documents
• mHealth apps
•  Nutrition specific fields in eHealth 
records and systems
• Referrals for ongoing care
• Self-management processes
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professional group to coordinate systematised or interdisciplinary nutrition care 
processes where specialist care is not available or is unlikely to add benefit. Nurses 
also have the most significant amounts of repeat-contact with patients and carers in 
different settings, whether over the full 24-h period in acute and rehabilitation set-
tings, or in other situations such as secondary prevention settings and home care.
Nurses also witness patients’ eating and drinking activities, have a strong under-
standing of barriers and enablers to nutrition intake, and are likely to be best placed 
to understand where the patient ‘fits’ within a social–ecological setting. This makes 
them ideal coordinators and champions of nutritional aspects of care. Nurses are 
often in the best position to conduct primary nutritional screening and assessment 
that identifies those in need of nutritional support to be provided solely by nurses or 
in collaboration with other members of the orthogeriatric team, or specialist care 
where accessible and likely to add benefit. In settings where dietitian, nutritionist or 
medical nutrition specialist resources are limited, nurses can provide excellent 
nutritional care to most patients whilst allowing nutrition specialists to focus on the 
most in need of their expertise.
Most, if not all of the strategies listed in Table 18.6 are considered to sit squarely 
in remit of nursing-led essential care [88]. Although it is difficult to identify an evi-
dence base for such fundamental aspects of nursing care, such nurse-led interven-
tions are likely to have a positive impact on nutritional status [89]. These fundamental 
aspects of nursing care are the responsibility of the whole nursing team, but require 
co-ordination and leadership so that they are a priority. In many settings, nursing 
professionals are well placed to guide allocation of resources, alterations to institu-
tional structures and organisational process reform.
A call to action is therefore made to global and local nursing leadership to engage 
patients, interdisciplinary teams and broad stakeholders to deliver high-value nutri-
tion care across the three pillars of orthogeriatrics.
18.8  Evaluating Ongoing Care Requirements (SIMPLE)
Patients with or at risk of a nutrition-related diagnosis will routinely require nutri-
tion monitoring or re-assessment strategies. Processes for re-screening should also 
be considered for those not currently at risk. What needs to be monitored, how 
often, and by whom will depend on many factors, perhaps most notably the nutri-
tion diagnosis in question, and resource constraints. This makes it challenging to 
provide definitive recommendations for clinical handover across the care pathway.
Local treating teams need to work with patients to identify the best opportunities 
for ongoing nutritional monitoring and evaluation. Discussions may consider the 
availability of access to specialist nutrition outpatient or community services and 
the potential benefits, costs and opportunity costs of these. Other alternatives for 
consideration could include general practitioners, nurse practitioners, mHealth pro-
grams, group programs or self-monitoring.
Finally, clinical audits of care delivery positively influence patient and healthcare 
outcomes. Table  18.7 provides a summative recap of potential opportunities for 
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systematised, interdisciplinary nutrition care approaches across acute care, rehabili-
tation and secondary prevention orthogeriatric settings, and how these may be eval-
uated [3].
18.9  Recommended Further Reading
• Bell JJ et al (2018) Rationale and developmental methodology for the SIMPLE 
approach: a Systematised, Interdisciplinary Malnutrition Pathway for impLe-
mentation and Evaluation in hospitals. Nutr Diet 75(2):226–234
• King PC et al (2019) “I wouldn’t ever want it”: a qualitative evaluation of patient 
and caregiver perceptions toward enteral tube feeding in hip fracture inpatients. 
J Parenter Enteral Nutr 43(4):526–533
• Volkert D et al (2019) ESPEN guideline on clinical nutrition and hydration in 
geriatrics. Clin Nutr 38(1):10–47
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Fragility Fracture Audit
Cristina Ojeda-Thies, Louise Brent, Colin T. Currie, 
and Matthew Costa
19.1  Introduction
Hip fracture is a common, serious and costly injury that presents acutely, requires 
surgery, carries both residual disability and a high mortality, and is much easier to 
identify and register than other osteoporotic fractures [1, 2]. It is therefore an ideal 
index condition for clinical audit and also a tracer condition for the broader fragility 
fracture pandemic now challenging healthcare systems worldwide. Even though 
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age-adjusted incidence of hip fractures is falling in some regions, population inci-
dence is increasing due to rising life expectancy worldwide, and is estimated to grow 
from 1.66 million in 1990 to 6.26 million in 2050, with steep increases throughout 
Asia and Latin America [3, 4], potentially placing the healthcare systems of these 
regions under considerable stress. Good management of hip fracture demands inte-
gration of excellent nursing, surgical, anaesthetic, medical and rehabilitative care. 
Furthermore, there is a relatively strong evidence base on key quality standards for 
aspects of care in all phases of management, many of which have been implemented 
by clinical teams working with hospital management authorities to improve cost-
effectiveness and quality of care [5]; some of these indicators have been used for 
international comparisons of care across different healthcare systems [6]. Quality 
care of this tracer condition benefits the care of other types of fragility fracture, via 
good orthogeriatric care, and access to rehabilitation units and fracture liaison ser-
vices [7]. Ideally, sustained audit with continuous feedback can deliver continuous 
quality improvement by allowing organisations first to ascertain the nature of the 
care they provide, including its deficits, then to use data to prompt clinical and ser-
vice structure improvements and then to assess the impact of these (Fig. 19.1) [8].
19.2  Hip Fracture Audit
Orthopaedic audit as we know it was born in Sweden in the 1970s and began with 
elective surgery in the form of the Swedish Knee Arthroplasty Register and Swedish 


















Fig. 19.1 Clinical audit 
cycle (adapted from: Limb 
C, Fowler A, Gundogan B, 
Koshy K, Agha R. How to 
conduct a clinical audit and 
quality improvement 
project. Int J Surg Oncol 
(N Y). 2017;2(6):e24(8))
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system—providing free care at the point of delivery in publicly funded hospitals, 
and patient traceability since every citizen has a national personal identification 
number—made implementation of a national registry relatively easy. More national 
registries developed in the following decades, among them the Swedish Hip Fracture 
Registry or Rikshöft, initiated in Lund in 1988 by Professor Karl-Göran Thorngren 
[11]. Rikshöft differed from previously existing orthopaedic registries in that, 
besides data regarding fracture type and treatment, it also collected data on patients’ 
functional level and residential status.
This was followed by the Scottish Hip Fracture Audit (SHFA) [12], based on 
Rikshöft and initiated in 1993, and the Standardised Audit of Hip Fracture in Europe 
(SAHFE) initiative (1994–1998) [13], with participation from 15 European nations, 
with the goals of (1) devising a standard data set for documentation of treatment and 
outcome for hip fractures; (2) piloting the use of such a dataset within Europe; (3) 
promoting Europe-wide comparisons of demographic features, surgical techniques 
and rehabilitation methods; (4) determining the practicalities of collecting and dis-
seminating this information on a Europe-wide basis; (5) evaluating the effectiveness 
and differences of hip fracture care throughout Europe and (6) facilitating the dis-
semination of the best practice of hip fracture surgery and rehabilitation through-
out Europe.
As a result of these initiatives, several other national audits emerged in Europe in 
the following decade, the most important of which was the National Hip Fracture 
Database (NHFD) which covered England, Wales and Northern Ireland, and is cur-
rently the registry with the highest number of cases collected [14]. National hip 
fracture audits were however mainly limited to Scandinavia, Great Britain and 
Ireland. The Fragility Fracture Network (FFN), a global not-for-profit organisation 
founded in 2011, sets out to promote the wider establishment of hip fracture audit—
as a way to assess the effectiveness of national fragility fracture networks—and 
latterly has directed its efforts towards creating regional and national alliances.
Its Hip Fracture Audit Special Interest Group proposed a Minimum Common 
Data set (Fig. 19.2)—a concise, practical and cost-effective data set for audit start- 
ups working within resource constraints—that also served to facilitate large-scale 
international comparisons of case-mix, care and mortality outcomes [15]. It should 
be considered a minimum recommended data set, to which other variables can be 
added at the discretion of each local, regional or national audit. The FFN Hip 
Fracture Audit Database Pilot Phase included hospitals from Lübeck and Stuttgart, 
Germany; Celje, Slovenia; Msida, Malta; and Barcelona, Spain; the latter two hos-
pitals discontinuing their participation due to organisational constraints, mainly the 
heavy reliance on the enthusiasm of individual clinicians. In spite of these issues, 
the Pilot Phase detected large differences in case-mix, care provided and process 
measures (Fig. 19.3) and usefully highlighted some of the problems encountered by 
nascent hip fracture audits.
Several new hip fracture audits have been initiated in the past decade, many in 
regions far from traditional Anglo-Saxon or Scandinavian influence. While not a 
national-level system, Kaiser Permanente is the largest managed health care organ-
isation of the United States with over 11 million insured and created a hip fracture 
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Fig. 19.2 Fragility Fracture Network’s Hip Fracture Audit Special Interest Group Minimum 
Common Dataset (FFN MCD)
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Fig. 19.3 Results of the FFN Hip Fracture Audit Database Pilot Phase (Data extracted from: 
Bunning T, Currie, CT. Final Report of the Hip Fracture Audit Database (HFAD) Pilot Phase. 
Crown Informatics Limited; 2017 [15]). (a) Fracture type; (b) operation performed; (c) time to 
surgery and (d) discharge destination
2.07 Fracture Type 2016
3.03 Operation Performed 2016
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registry in 2009 as part of its National Implant Registries to track implants in 
patients insured by the company. Its 2017 report includes over 44.000 patients. 
Other national audits have been created in Norway [16], Denmark [17], Ireland 
[18], Australia and New Zealand [19], Germany [20], the Netherlands [21, 22], Italy 
[23], Spain [24] and France (see Box 19.1). There are, however, marked differences 
across the health care economies in which they function and in how they are organ-
ised and financed. Such factors account for considerable differences in their growth 
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and continuity; their differing ascertainment and follow-up rates and the wide vari-
ability documented in Table 19.1. A large majority of the countries with established 
audits have publicly funded healthcare systems, which seem to offer a more favour-
able environment for clinical audit and comparison among hospitals.
Box 19.1List of National Hip Fracture Registries and Their Web Addresses, When 
Available. Audits Marked with Asterisk Are Currently in Their Pilot Phases
• Sweden (Rikshöft)—https://rikshoft.se/
• Scotland, Scottish Hip Fracture Registry (SHFA)—https://www.shfa.
scot.nhs.uk





• Norway, Nasjonalt Hoftebruddregister (NHR)—http://nrlweb.ihelse.net/
• England, Wales & Northern Ireland (National Hip Fracture Database, 
NHFD)—https://nhfd.co.uk/
• United States (Kaiser Permanente Hip Fracture Registry)—https://
national-implantregistries.kaiserpermanente.org/
• Ireland (Irish Hip Fracture Database, IHFD)—https://www.noca.ie/audits/
irish-hip-fracture-database
• Australia, New Zealand; Australian and New Zealand National Hip 
Fracture Registry (ANZHFR)—https://anzhfr.org/
• Germany, Alterstraumaregister (DGU-ATR)—http://www.alterstrau-
maregister-dgu.de
• Netherlands, Dutch Hip Fracture Audit (DHFA)—https://dica.nl/dhfa/home
• Italy, Gruppo Italiano di Ortogeriatria (GIOG)*—https://www.sigg.it/
gruppo-di-studio/gruppo-italiano-di-ortogeriatria-giog-sigg-aip-sigot/
• Spain, Registro Nacional de Fracturas de Cadera (RNFC)—http://rnfc.es/
• France, Groupe d’étude en traumatologie ostéo-articulaire (GETRAUM)*—
http://www.getraum.fr/
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Other start-ups have been reported in the last decade, most notably Hong Kong 
[32, 33], Malaysia [34] Lebanon [35] and Iran [36, 37], but detailed continuing 
information about their survival and impact is, to our knowledge, not in the public 
domain. Other countries such as France, Mexico [38] and Japan [15] are in the pilot 
phase of national hip fracture audit development. Two are of special interest on 
account of their size and demography. Japan has the highest life expectancy world-
wide [39], and Spain has the highest life expectancy in Europe [6] and is predicted 
to overtake Japan by 2040, with both countries forecast to exceed 85 years of life 
expectancy by 2040 [40].
Regional initiatives including those from British Columbia [41] and the Baltic 
Region [42] should also be mentioned. Several other countries are using large clini-
cal databases to analyse hip fracture management. In the United States, the 
Nationwide Inpatient Sample (NIS) collects retrospective data from patients admit-
ted using the ICD-9 codes. Other examples include the American College of 
Surgeons prospective National Surgical Quality Improvement Program (NSQIP) 
and the Trauma Quality Improvement Project (TQIP) using data obtained directly 
from the medical records by trained surgeons. Though not specific to hip fracture, 
they include much hip fracture data and are a source of research studies [43, 44] due 
to their large numbers of patients and available data. Other studies have, however, 
shown significant variation in data inclusion and completeness, which could jeop-
ardise the validity of conclusions reached in evaluating the care provided [45, 46].
Other countries with quality analyses based on general clinical or national data-
bases are Germany, with its impressive external quality assurance programme for 
orthogeriatric care [47, 48]; Canada with the Canadian Institute for Health 
Information [49, 50] and South Korea using data from the Health Insurance Review 
and Assessment Service [51, 52].
19.3  Obstacles to Hip Fracture Audit 
and International Comparison
Several authors have recently compared national hip fracture audits, showing impor-
tant differences in inclusion criteria, follow-up, variables included and coverage 
[22, 24, 53, 54]. For example, the minimum age at which hip fracture patients are 
included ranges from all adults in the Netherlands to patients 75 years old or older 
in Spain. Follow-up ranges from 30  days for many registries such as Scotland, 
Ireland and Spain to 120 days for Sweden, Norway, the UK, Germany and Australia 
and New Zealand. Others, such as Denmark and Italy, have several cut-off points for 
follow-up. Data collected on function also vary between registries: while some col-
lect the ability to walk assisted or unassisted indoors or outdoors, others use scores 
such as the cumulative ambulation score (e.g. Denmark) and a new mobility score 
(e.g. in Ireland) [18]. Functional and residential status data are more difficult to col-
lect than discrete hard data such as re-operation rates or mortality, but it can be 
argued that the former is just as, if not more, relevant for the patient than the latter 
[55]. Very few registries include data regarding quality of life, with Germany and 
the NHFD collecting EQ-5D data.
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However, collection of data after discharge can be more resource intensive—
and loss of follow-up can pose a threat to the integrity of an overly ambitious audit 
data set. Some registries, such as the Kaiser Permanente and Norwegian hip frac-
ture registry, are incorporated into larger administrative databases analysing joint 
implants, but largely lack clinical follow-up. For these reasons, we believe that an 
international consensus defining a limited but robust core data set—to be included 
by all interested audits, whatever other data they collect, and judiciously adapted 
in the light of emerging evidence—is paramount, and accordingly is proposed by 
the FFN. In terms of coverage, the UK NHFD and the Danish audit capture practi-
cally all occurring hip fractures. Other still nascent audits such as those in 
Australia, New Zealand, Spain and Holland include between one-quarter and one-
half of estimated yearly hip fracture numbers. Since hospitals already interested 
in improving hip fracture care and providing orthogeriatric care are more likely to 
be early adopters of a voluntary hip fracture audit, concerns arise for possible 
inclusion bias. Fracture care and outcomes in such settings are better than aver-
age, so the overall reported quality of care may deteriorate as later adopters join 
the audit.
Some audits require individual patient consent to inclusion, as is the case in 
Spain [24], Italy [23] and Norway [16, 56]. The need for informed individual patient 
consent to store routinely collected healthcare data is debatable. In the European 
Union, a new framework known as the General Data Protection Regulation (GDPR) 
[57] came into force across the EU on 25 May 2018. The GDPR requires that pro-
cessing of personal data is fair, lawful and transparent. Currently there is nothing in 
the legislation that prevents clinical audit being carried out locally or nationally. 
Health data are defined under the GDPR via a special category of personal data and 
can be processed in situations where it is necessary to do so for reasons of public 
health. Regarding the conditions for lawful processing of personal data (Article 6), 
clinical audit fulfils GDPR Articles 6(1)(c), “processing necessary for performance 
of contract” with the data subject, or Article 6(1)(e), “processing is necessary for the 
performance of a task carried out in the public interest or in the exercise of official 
authority vested in the controller”, and Article 6(1)(f), “processing is necessary for 
the purposes of legitimate interests”. With reference to conditions for processing 
special categories of personal data (Article 9), “processing is necessary for the pur-
pose of preventative… medicine… the provision of health or social care or treat-
ment or the management of health or social care systems and services…” (Article 
9(2)(h)) and “processing is necessary for reasons of public interest in the area of 
public health, such as… ensuring high standards of quality and safety of health 
care…” (Article 9(2)(h)). The Irish National Office for Clinical Audit has recently 
analysed the relevance of the GDPR and patient consent for national clinical audit 
[58], and has concluded that (1) for national clinical audit, all patients meeting the 
criteria of the audit should be included, so that a full national picture can be col-
lected; (2) consent would not be appropriate because the patient could decline to 
give their consent or subsequently withdraw their consent at any time. Both of these 
individual rights would prevent collection of a full national picture; (3) national 
clinical audit should not rely on consent as the lawful basis but should instead 
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justify such audit on the public health lawful basis as applicable e.g. Articles 6(1)
(e), 6(1)(f). Finally, (4) the collection of data, validation of data, review of outliers 
for national clinical audit does not require consent and (5) patients should, however, 
be informed that their data may be used as part of a national clinical audit e.g. 
through information leaflets.
Patients with cognitive impairment—occurring in up to 30% of patients with hip 
fracture—are excluded when consent is required, which greatly limits the practical 
utility of audit findings. Validity of consent from a patient’s family varies across 
jurisdictions, may be time-consuming and may thus increase preoperative delay. In 
some jurisdictions, a supplementary explanation about audit and its value may be 
provided during consent to surgery—with opt-out where feelings are strong. 
However, the evidential value of findings from an audit that includes all, or almost 
all, cases is such that all reasonable and sympathetic measures available should 
endeavour to achieve universal coverage.
19.4  Hip Fracture Audit and the Improvement of Care
Since improving care is the main purpose of audit, the acquisition, ownership, anal-
ysis and use of data are of vital importance. Audit data can be collected by individ-
ual units and used by clinicians and management for internal quality reporting and 
continuous improvement or for external monitoring by health authorities and 
national governments for purposes of accountability for sanction or reward [59]. 
Data can be collected in an automated fashion through hospital administrative data-
bases and coding by non-clinical staff, but the reliability of these data is relatively 
low, with median values for diagnostic accuracy around 80% [60, 61]. Electronic 
health records may be expected to improve the reliability of this data, again with the 
above proviso.
It should be noted that using outcome data for sanction or reward can lead to 
perverse incentives—such as targeting inclusion and treatment to the patients with 
the best prognosis or assigning patients to more serious risk categories. To avoid 
such “gaming”, responsible clinician involvement to defend data reliability is vital. 
Where possible, data linkage with centralised national statistics, using patient iden-
tifiers such as national personal identification numbers, is of great value in tracking 
both inclusion rates and survival. Data protection laws vary between jurisdictions, 
and may complicate achieving data linkage, but uploading to national level may be 
facilitated by a process of pseudo-anonymisation of bulked annual data.
Clinical outcomes such as mortality and residential status depend on many fac-
tors not related to quality of care. A systematic review showed that, though signifi-
cant, the correlation between the quality of clinical practice and hospital mortality 
was low [62]. Risk adjustment would account only for the variables that have been 
measured and these could have a different effect across groups. Other outcomes 
such as quality of life or change in residential status are also relevant, especially for 
patients and their families, while healthcare systems should also consider readmis-
sion and reoperation rates.
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Measures of clinical process are, however, easier to collect and compare. These 
should be quality- and evidence-based, and the effort required to improve the pro-
cesses analysed should be proportionate to the contingent gains; improvement 
should also not come at the expense of other variables not monitored. The combina-
tion of audit, guidelines and standards constitutes the basis of clinical governance 
for hip fracture care, and good hip fracture audit has been shown to improve process 
indicators such as reduction in surgical delay, as well as outcome indicators such as 
30-day mortality, with some reports estimating over a 1000 lives saved by the NHFD 
since its inception in 2007 [63, 64].
Most hip fracture registries and their governing agencies have implemented 
national standards which address similar quality goals, such as geriatrician involve-
ment, surgical delay, early mobilisation and prevention of new fractures [14, 19, 31, 
65–67]. Some of these quality standards are summarised in Table 19.2. The NHS’s 
National Institute for Health and Care Excellence (NICE) defined quality standards 
for hip fracture care in 2012 and updated them in 2016 [69]. Building upon these, 
the British Orthopaedic Association, together with the British Geriatrics Society, 
the NHFD and FFN-UK have recently updated the “BOA Standard of Care (BOAST) 
for the older or frail orthopaedic trauma patient”, adding detail for fragility fracture 
patients beyond hip fracture [70].
In addition, the Best Practice Tariff (BPT), an individual patient-level payment 
made to hospitals when they deliver care which meets all of the quality standards in 
the audit, was introduced in England in 2010 and relied heavily on NHFD data [14]. 
Criteria were updated in 2017 to include delirium, nutrition and early physiother-
apy. Achievement of BPT criteria has been shown to lead to improved survival fol-
lowing hip fracture, both in single-centre cohort studies [68] and when comparing 
results in England and Scotland, with over 1000 deaths avoided per year in England 
that could be attributed to these interventions [71]. The UK NHFD incorporates 
standards from all three criteria as benchmarks that are publicly available on their 
website, with BPT criteria achieved for 57.1% of all NHFD patients in 2017.
Quality standards are regularly updated and modified, and while initial standards 
focused mainly on acute care, they now incorporate achievement of rehabilitation 
and post-acute care goals and more. All registries studied include secondary fracture 
prevention among their quality standards [31, 65–67]. The Irish Hip Fracture 
Database has also implemented a BPT since 2018 and in the initial 12-month period 
there has been a significant improvement in data quality seen in the Irish Hip 
Fracture Care Standards and hospital governance arrangements [18]. The most 
notable improvement has been the development of an orthogeriatric service in 
almost every hospital.
Clinical audits must be sustained in order to maintain continuous improvement 
and benchmarking standards should be updated to close the quality improvement 
circle. Interruption of the Scottish Hip Fracture Audit showed a deterioration of 
process indicators such as time to theatre, which recovered when the audit was re- 
introduced 5 years later [72].
Finally, national registries have been the source for further research regarding 
hip fracture care both for comparison of local results with other international 
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registries [46, 47, 66] and for studies adding on national registry data to address 
specific questions. An excellent example is the UK Anaesthesia Sprint Audit of 
Practice (ASAP-2) [73], a large NHFD-based prospective study including 11,085 
cases. This highlighted the critical importance of maintaining intra-operative sys-
tolic normo- tension and identified the associated risks of higher dosages of sub-
arachnoid local anaesthetic. Together with its predecessor ASAP-1 [74], this has 
transformed the evidence base for hip fracture anaesthesia, which had previously 
consisted of a number of small trials from one or two hospitals, which often excluded 
patients with cognitive impairment (typically c. 30%) and were thus of limited 
impact in terms of the care of the typical hip fracture casemix. Another Anaesthesia 
Sprint Audit of Practice, ASAP-3, aimed at studying the anaesthetic management of 
periprosthetic fractures, is set to commence in 2020.
Many published single-hospital NHFD reports have documented care quality 
improvements such as improved pain control, reductions in peri-operative medical 
and surgical complications, and more rapid recovery, and reduced length of stay, 
sometimes with substantial reductions in bed days. More recently, the World Hip 
Trauma Evaluation (WHiTE) initiative has been set up to measure outcome in a 
cohort of hip fracture patients within the framework of the NHFD [75]. Under indi-
vidual patient consent or family agreement where appropriate, WHiTE has recruited 
over 20,000 patients with hip fracture and collected patient-reported outcome mea-
surement in more than 80% of participants. Studies such as WHiTE provide reliable 
observational outcome data, but also act as a platform for virtual clinical trials 
which can assess single interventions such as new forms of surgery and also serves 
as a framework to assess innovations throughout the hip fracture journey of care 
from pre-hospital pain relief to community rehabilitation [76].
Though good evidence can be obtained from both registries and clinical trials, 
registry studies are not equivalent to formal clinical trials. In orthopaedic surgery, 
knowledge usually advances from individual case series of a new operative tech-
nique or care process to case–control studies and then randomised trials. However, 
even these trials usually show results under optimal conditions in academic or spe-
cialised centres, with a high risk for publication bias. National guidelines are usu-
ally based on systematic reviews of randomised investigations, while these are 
excellent in compensating for confounding factors, they present problems in addi-
tion to selection and publication bias. Clinical trials are cost-intensive and often 
limited to a short observation period. Ethical issues arise when studying controver-
sies such as surgical delay or weight-bearing after hip fractures.
National registries, however, pose the advantage of covering all incident cases 
within a country, reflecting the breadth of experience and training across a whole 
healthcare system, rather than specialist academic centres. They therefore offer a 
truer picture of everyday practice and regional variability. Another advantage of 
national registries is their large case numbers, allowing for collection of data of 
uncommon patient features and adverse events, such as surgical delay of patients 
with double anticoagulation, or fat embolism syndrome. They also allow for analy-
sis of patient-centred outcome variables such as patient quality of life, social living 
situation and functional capacity from a representative group of patients, though 
trials are more likely to collect good quality outcome data especially during follow-
 up, largely as a result of better funding.
C. Ojeda-Thies et al.
349
Finally, continuous data collection allows for identification of time trends in hip 
fracture epidemiology and the effects of measures implemented by healthcare prac-
titioners or healthcare systems. Interestingly, the BMJ recently pointed out that 
“observational research using Big Data can explore the effect of disease and care on 
many patients… at a low cost per question. Big Data are more representative of the 
‘real world’ than Little Science trials that recruit a few patients from referral cen-
tres. Clinical trialists can often use Big Data to design more efficient and useful 
trials…” [77]. The implications of this for audit-based clinical research in hip frac-
ture care appear to be clear—with Big Data abundantly available now and for the 
foreseeable future.
19.5  Audit of Other Fragility Fractures and Fracture Liaison 
Services (FLS)
While hip fracture audit is relatively established in many regions worldwide, other 
fragility fractures are audited much less commonly. This is in large part due to the 
difficulty of identifying cases that frequently do not require hospital admission; as a 
matter of fact, many vertebral fractures go clinically undetected [78, 79]. As noted 
above, nearly all hip fractures are diagnosed acutely, hospitalised and managed sur-
gically, making them easier to identify and register. In the United Kingdom, the 
Royal College of Physicians (RCP) is leading a 2020 Sprint Audit to investigate 
vertebral fracture identification [80]. Sweden has developed a Fracture Registry 
including all types of fractures (fragility and non-fragility) starting in 2011, cover-
ing 80% of orthopaedic departments in 2018. It has to date collected more than 
400,000 fracture cases, including patient-reported outcome measures [81, 82]. 
Many hip fracture registries already include non-hip femoral fractures or plan to do 
so: while the German registry includes periprosthetic fractures and peri-implant 
fractures, the NHFD and ANZHFR are planning to add distal femoral fractures, and 
several arthroplasty registries are performing sub-analyses of periprosthetic frac-
tures. These, while they study intraoperative factors and issues related to prosthetic 
design, often lack data regarding patient outcomes [83–85].
Further audit research is now focussing on Fracture Liaison Services (FLS) data-
bases, for example that in England under the RCP, as part of the same Falls and 
Fragility Fracture Audit Programme (FFFAP) together with the NHFD [86], and in 
Canada, with 45 FLSs in 2018 [87]. Spain is currently piloting a fragility fracture 
and FLS audit, the REFRA-FLS-registry, with over a dozen hospitals participating 
[88]. The international development of FLS programs has previously been exten-
sively studied in the book by Seibel and Mitchell [89]. These FLS registries, how-
ever, are more centred on secondary prevention than on acute multidisciplinary care 
and post-acute care and rehabilitation, and do not report on individual fracture types 
apart from ad hoc research studies such as the proposed RCP Vertebral Fracture 
Sprint Audit mentioned above. Finally, FLS registries appear to work best where 
they are integrated with other fracture registries (e.g. hip fracture audit), rather than 
when they are standalone registries.
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19.6  Expansion of Hip Fracture Registries in Other Regions
Healthcare administrators have an interest in not only providing quality care but 
also cost-effective care. As the Blue Book published by the British Orthopaedic 
Association and British Geriatrics Society states, “Looking after hip fracture 
patients well is a lot cheaper than looking after them badly” [90]. In many countries, 
open comparisons between hospitals and regions have become commonplace; this 
however requires a certain cultural sensitivity. Press coverage of registry reports can 
be misleading, because journalists may not understand the importance of case-mix 
and random variation, since low-volume hospitals are more likely to show poorer 
figures due to statistically non-significant adverse events. Participation of healthcare 
professionals in the evaluation and communication of audit reports is important. 
Emphasis should be placed on overall changes in outcomes or process, rather than 
on outliers, and on targeting the particular strengths and weaknesses of organisa-
tions. Over time, small marginal gains of only 1% can amount to large improve-
ments [91–93]. Delaunay states “registries are a manifestation of the evaluation 
culture. Thus, their widespread development in some countries (such as 
Scandinavian, Australia, UK) and their virtual absence in others (such as southern 
European countries) highlights the impact of cultural differences on healthcare eval-
uation” [94]. Though newer registries such as those from Spain, Germany, the 
Netherlands and Italy do not yet offer publicly available data comparing hospitals, 
other established registries, such as the NHFD, the IHFD and the ANZHFR, do, 
though they did not do so in their early stages.
Public recognition of registry participation such as in Germany—in which par-
ticipation is a prerequisite of being recognised as a “Geriatric Trauma Centre”, or of 
achievement of standards or improvement, such as the SHFA’s “Golden Hip Award” 
can help raise awareness and raise the enthusiasm of healthcare professionals and 
administrators initially not aware of issues regarding the hip fracture care process. 
At a global level, the recent award in a world-wide WHO competition to the Spanish 
RNFC hip fracture audit as the best healthcare initiative to benefit elderly patients 
did much to raise the profile of hip fracture care internationally [95]. Though the 
reality of fragility fracture management can be very different in regions such as 
Southeast Asia and Latin America in comparison to Northern Europe, the same 
general principles apply for registry implementation. It is important, while main-
taining a minimum common dataset, to tailor audit data sets to each country’s par-
ticular social and healthcare characteristics, as small local gains can lead to 
significant improvements and healthcare savings over time, especially in regions 
with rapidly growing elderly populations.
Several nascent registries arose as collaborative initiatives by scientific societies, 
as in Australia and New Zealand, Spain, Italy, France and Germany. The number of 
disciplines actively participating in these registries is variable, with some depending 
almost exclusively on orthopaedic surgeons and/or geriatricians, and others more 
widely inclusive. It is important for the healthcare providers and governments to 
recognise the importance of these registries as instruments for assessment of vari-
ability, benchmarking and quality improvement. The cost of maintaining a national 
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registry is a small fraction of the overall expense of hip fractures on a healthcare 
system; the care of 3.5 million fragility fractures which occurred in the European 
Union in 2010 was estimated to have cost 37 billion euros [96]. Meanwhile, the UK 
NHFD has been estimated to cost approximately 0.5% per case of the total cost of 
hip fracture care [7]. Improvements in care processes and outcomes of good audits 
allow for cost savings many times higher than the cost of maintaining the audit 
itself. It is much more expensive to ignore current information when deciding policy 
than it is to invest in obtaining that information through audits. Audit provides infor-
mation with the potential to deliver care that is both better and cheaper, which trans-
lates into a brief but effective formulation: “If you think information’s expensive, 
try ignorance”.
19.7  New Developments in Fracture Audit
Electronic health records (EHR) may make manual entry of many of the variables 
such as time of admission or surgery superfluous. However, the large number and 
variability of providers of EHRs and operating systems make automated data diffi-
cult, and healthcare administrations should consider automated data extraction for 
registry analysis when choosing one EHR system over another.
Automation of data reporting allows for real-time data evaluation and communi-
cation: prompt recognition of changes in the care process or adverse effects allows 
for quick responses by healthcare professionals and a more direct sense of their 
participation in audit. This is in contrast to the often cumbersome and sterile annual 
reports in which it is difficult to establish connections between actions and their 
results.
The UK NHFD webpage is exemplary in that sense [97], with online charts 
updated every 2 months comparing individual hospital, regional and national over-
all performances and their evolution over time, as well as performance in relation to 
different standards, including the quartiles achieved for each indicator. With increas-
ing numbers of web-based registries, automation of these reports is feasible, with 
the Baltic Fracture Consortium using the R programming language to offer real- 
time statistical reports (including analyses such as Fisher’s test to assess for signifi-
cance of complication rates) to participants [42].
In line with the regionalisation strategy promoted by the FFN, establishment of 
new fragility fracture audits should be encouraged and supported, especially in 
regions likely to be most seriously affected by the fragility fracture pandemic, such 
as Asia and Latin America. Pilot studies have revealed the reality of surgical delay 
in countries such as India [98], Mexico [99], Peru [100]—with only 30, 10.5 and 
5.3% receiving surgery within 48  h of hospital admission, respectively—or the 
Mediterranean region, with Portugal, Italy and Spain among the four countries of 
the OECD with the lowest proportion of hip fractures operated on in less than 48 h 
[6]. This is far from what is considered standard in Western countries with longer 
established hip fracture audit, and the scope for improvement is large. But with 
clinically led, web-based hip fracture audit established as a mature technology 
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supporting the substantial international expansion of effective quality improvement 
in hip fracture care in recent years, there are now grounds for cautious optimism 
about facing up to the challenge of care for the impending global pandemic of fra-
gility fractures. With continuing international collaboration and the support of sci-
entific societies such as the FFN, there is promise too for large-scale clinical and 
epidemiological research to improve the evidence-base for hip fracture care, and 
thus to create a virtuous cycle of continuing improvement in care, outcomes and 
cost- effectiveness over the coming decades.
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